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1. Introduction 
1.1 Background to Luminescence 
1.1.1 History 
 
Luminescence, the spontaneous emission of radiation from an electronically excited species, is of 
great importance to many areas of science and technology. Various types of luminescence exist and 
are defined by their mode of excitation. Chemiluminescence, for example, is the emission of light 
following excitation via a chemical reaction. An early illustration of chemiluminescence comes from 
a Bolognian cobbler, Vincenzo Cascariolo, in 1602 who observed purple-blue light from a mineral 
which had been baked in a hot oven.1 This light was later recognised as luminescence from the 
formation of impure barium sulphide. Photoluminescence, which is the main focus of this 
introduction, is the emission of light following direct photoexcitation of the emitting species. In 1565, 
Nicolás Mondardes, a Spanish physician, observed a peculiar blue colour in the infusion of a Mexican 
wood, Lignum nephriticum, used to treat urinary diseases. The colour is now known to originate from 
the photoluminescence of matlaline (Figure 1.1).2 A final early example, which has relevance to the 
location in which this thesis is being written, is the sapphire blue photoluminescence of calcium 
fluoride crystals (Figure 1.1). Edward D. Clark, in 1819, commented that the crystals, found in 
Weardale, County Durham, surpassed in magnificence and beauty any other mineral he had ever 
seen.3     
 
 
Figure 1.1 From left to right: blue photoluminescence from an aqueous solution of matlaline found in Lignum 
nephriticum; calcium fluoride crystals appearing emerald under direct sunlight and sapphire photoluminescence 
of the same crystal after UV excitation. 
 
Photoluminescence was again responsible for observations made by Sir David Brewster in 1833, who 
described a red emission from a green alcoholic extract of leaves4 (now known to be fluorescence 
from chlorophyll) and Sir John Herschel in 1845, who reported a celestial blue colour from an acidic 
solution of quinine.5 In 1852, after experiments with a number of compounds, including quinine, 
George G. Stokes introduced the term fluorescence to describe the emission of light from a compound 
at a wavelength longer than that of the incident light.6 He also noted that the dispersion of light took 
place in all directions. Many other contributions were made over the following years and today the 
application of photoluminescence ranges from fluorescence microscopy and plasma screens to 
counterfeit banknote detection.7 
Introduction                                                                                                                             Chapter 1 
 
2 
 
1.1.2 Fluorescence and Phosphorescence 
 
Fluorescence and phosphorescence are both forms of photoluminescence and are best illustrated by a 
Jablonski diagram (Figure 1.2).8 Following absorption of light by a molecule in its ground singlet 
state (S0), fast relaxation occurs to its lowest lying singlet excited state (S1) by internal conversion. 
From here, radiative emission (fluorescence), non radiative decay and intersystem crossing to the 
triplet excited state (T1) can all take place. From the triplet state both radiative (phosphorescence) and 
non-radiative decay can occur to return the molecule to its ground state. Due to the dissipation of 
energy in the excited state, fluorescence always occurs at a longer wavelength than absorption. This is 
known as Stokes’ shift.6 The rate of internal conversion to the lowest lying vibrational level of S1 or 
T1 is typically much faster than the rate of radiative decay (1012 vs. 108 s-1). As a result, the emission 
spectrum is generally independent of the excitation wavelength. The ability of a compound to absorb 
light is quantified by the molar extinction coefficient.  
 
Figure 1.2 Jablonski diagram showing the important processes in photoluminescence. 
 
1.1.3 Lifetime, Quantum Yield and Quenching 
 
The lifetime of an excited state is defined by the average time a molecule spends in the excited state 
prior to returning to the ground state. Fluorescence lifetimes are of the order of 10 ns, whereas 
phosphorescence lifetimes are longer. The lifetime is often used to distinguish phosphorescence from 
fluorescence although, strictly, phosphorescence is defined by a change in spin multiplicity from the 
excited state to the ground state.   
 
The quantum yield is the ratio of photons emitted to photons absorbed. The ‘brightness’ of a 
compound can be thought of as the product of the molar extinction coefficient, which defines the 
efficiency of absorption, and the quantum yield. The quantum yield is governed by the rate of 
radiative decay relative to all other non-radiative decay pathways. Quenching processes are those 
which decrease the overall emission by increasing the rate of non-radiative decay or providing 
alternative non-radiative decay pathways. These processes lead to a reduction in the quantum yield. 
Quenching processes can be collisional or static and include energy transfer, electron transfer and 
vibrational quenching. Quenching processes are of great importance when designing emissive 
molecules and are the subject of Chapter 6. 
Introduction                                                                                                                             Chapter 1 
 
3 
 
1.2 Luminescence in Biological Systems 
1.2.1 Fluorescent Dyes 
 
Fluorescent dyes are highly emissive organic molecules possessing large molar extinction coefficients 
and high quantum yields. They can be used to label, analyse and clarify the roles of biomolecules in 
living systems (Figure 1.3).9 One of the most common dyes, fluorescein, and its derivatives, has 
found many applications in biological imaging as pH sensors,10 calcium indicators,11 and markers for 
the study of enzyme kinetics.12 The sodium salt of fluorescein is also used extensively as a diagnostic 
tool in the field of optometry. 
 
Figure 1.3 Examples of common commercially available fluorescent dyes.  
 
Less desirable properties of fluorescein derivatives include a relatively high rate of photobleaching 
and broad emission bands. To address these issues, dyes based upon BODIPY and Alexa Fluor were 
developed.13 These systems have increased resistance to photobleaching and have sharp emission 
bands. As with fluorescein, derivatives of the core structures lead to dyes with useful properties. 
 
Despite their versatility, fluorescent dyes have a number of drawbacks, limiting their use in biological 
systems. These include: short lived excited states, making differentiation from background 
autofluorescence difficult; small Stokes’ shifts, limiting their use in fluorescence microscopy and 
featureless, often broad emission spectra, which restrict their use as responsive probes.  
 
1.2.2 Metal Complexes 
 
A more in-depth discussion of lanthanide complexes as emissive compounds is given in Section 1.3. 
This section will focus only on the transition metal complexes, which make up a large class of optical 
probes. In general, these complexes combine a d6 (RuII, OsII, ReI and IrIII) or d8 (PtII) metal with highly 
conjugated ligands, giving rise to intense ligand to metal (LMCT) or metal to ligand (MLCT) charge 
transfer bands.14 
 
Low spin d6 ruthenium polypyridyl complexes have been used to study biological systems for many 
years. Stereoselective binding of tris(phenanthroline)ruthenium(II) to DNA was monitored by changes 
in the MLCT emission as early as 1984.15 A more recent example is shown in Figure 1.4, in which a 
ruthenium complex is able to permeate a myeloma cell, due to conjugation with a polypepide chain.16 
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The photophysical properties of this complex (λex = 470 nm, λem= 600 nm, τem = 480 ns, Φem = 6 %) 
allow its visualisation by fluorescence microscopy. The emission lies outside the range of background 
fluorescence from endogenous species and the relatively high quantum yield and high molar 
extinction coefficient at 470 nm result in a bright complex.  
 
   
Figure 1.4 A ruthenium bipyridine complex conjugated to an arginine polypeptide, aiding fast uptake of the 
complex into a myeloma cell, visualised by fluorescence microscopy.  
      
Many other metal complexes have been developed for use in cellular studies. As with the example 
above, these complexes typically have much larger Stokes’ shifts than the fluorescent dyes and longer 
excited state lifetimes, making them amenable to time-resolved microscopy and fluorescence lifetime 
imaging. They also show good photostability. One limitation of these systems is their lack of 
responsiveness to their surroundings. Whilst this may be advantageous for some applications, they 
primarily function as cellular stains and do not report changes in their local environment. 
 
1.2.3 Recombinant Fluorescent Proteins and Quantum Dots 
 
Two final systems worthy of mention are the fluorescent proteins17 and quantum dots.18 Fluorescent 
proteins (FPs) consist of imidazolinone dyes within a β-barrel tertiary structure. They allow 
monitoring of live cells by fluorescence microscopy, due to their high quantum yield, stability within 
cells and resistance to quenching, thanks to the tertiary structure of the protein. Mutations of the 
protein have led to several ‘colours’ of fluorescent protein (green, cyan, yellow), which vary in their 
excitation and emission wavelengths. The limitations of FPs, as with the fluorescent dyes, are their 
short excited state lifetimes and small Stokes’ shifts.  
 
Quantum dots (QDs) are fluorescent semiconducting nanocrystals (common QDs include CdSe and 
ZnS) and are used as fluorescent tags due to their tuneable emission, high extinction coefficients and 
good photostability. Their application in living systems, however, is limited by the invasive nature of 
the large nanoparticles, which are likely to affect the physiology of dosed cells. Despite this 
drawback, the first clinical trial of quantum-dot technology in humans was recently approved by the 
U.S. Food and Drug Administration.19 
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1.3 Emissive Lanthanide Complexes 
1.3.1 Introduction to Lanthanide Emission 
 
Lanthanides form trivalent cations with partially filled 4f orbitals. The electronic energy levels of 
these ions are described by the Russell-Saunders coupling scheme.20 The majority of the lanthanides 
have electronic excited states which radiatively decay to the ground state. Sm3+, Eu3+, Tb3+ and Dy3+ 
all emit in the visible region of the electromagnetic spectrum, while Nd3+, Ho3+, Er3+ and Yb3+ emit in 
the near-IR region. The most commonly studied lanthanides with respect to luminescence are Eu3+ 
and Tb3+, whose excited states are 5D0 (17,200 cm-1) and 5D4 (20,400 cm-1), respectively.21 Splitting of 
the ground state, due to spin-orbit coupling, leads to emission spectra with several bands, denoted by 
their ∆J value. The emission spectrum of Eu3+ (Figure 1.5) has five manifolds due to splitting of the 
7F ground state. Within each manifold, further splitting is also observed. The f orbitals are fairly well 
penetrating and therefore show little interaction with the ligand field. As a result, Ln3+ emission 
spectra are sharp and generally independent of the coordination environment. Having said this, the 
form and fine splitting of the Eu3+ spectrum is known to be dependent upon the symmetry about the 
Eu3+ centre and the nature of coordinating species. In general, the higher the degree of symmetry 
about the Eu3+ centre, the simpler the spectrum appears (i.e. less fine splitting). Further details on the 
factors affecting the Eu3+ emission spectrum are given in Section 3.1. 
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Figure 1.5  left) A typical europium emission spectrum, with five transitions denoted by their ∆J value. Further 
splitting within each transition is also observed and right) the 5D0 and 7FJ energy levels, giving rise to the 
europium emission.  
 
Transitions between f orbitals are very weak as they are formally Laporte forbidden. Unlike transition 
metal d-d transitions, this selection rule is not overcome by ligand field interactions, due to the 
contracted nature of the f orbitals. An advantage of the forbidden nature of these transitions is that the 
excited state lifetime is long (µs – ms), allowing time gated studies, which can distinguish the 
lanthanide emission from the background fluorescence present in most biological systems.  
 
A disadvantage to the forbidden f-f transitions is the resulting low molar extinction coefficients 
(0.5-3 mol-1 dm3 cm-1),22 leading to inefficient population of the excited states upon optical 
irradiation. Instead, sensitised emission is generally employed. This process utilises a proximal 
Introduction                                                                                                                             Chapter 1 
 
6 
 
chromophoric group, with a high molar extinction coefficient, which absorbs light energy and 
then transfers this energy to the lanthanide excited state. The processes involved are illustrated 
with a Jablonski diagram (Figure 1.6). 
 
 
Figure 1.6 Jablonski diagram showing the processes of sensitised emission. 
 
 
The energy transfer step is thought to proceed via either a Förster23 or Dexter24 mechanism. The 
former is a through-space, dipole-dipole interaction, which is strongly dependent upon the donor-
acceptor spectral overlap and has an r-6 dependence, whereas the latter involves a short range electron-
exchange energy transfer process. The reverse process, back energy transfer, can take place if the 
sensitiser triplet state is close enough in energy (within 1,500 cm-1) to the Ln3+ excited state and 
results in a decrease in the lifetime and quantum yield of a Ln3+ complex. To maximise the quantum 
yield of a complex, the sensitiser triplet state must be high enough in energy to minimise back energy 
transfer, whilst remaining close enough in energy to maximise spectral overlap, assuming a Förster 
mechanism for energy transfer. 
 
1.3.2 Quenching Processes 
 
An appreciation of quenching processes is important when using lanthanide complexes in any 
luminescence application, especially in biological systems, where many endogenous quenchers are 
present. Quenching processes are those which reduce the overall quantum yield of lanthanide 
emission. The key quenching processes which can take place during sensitised emission of a 
lanthanide complex are shown in Scheme 1.1.25 Quenching can occur at: the singlet excited state of 
the sensitiser, which can lose energy by fluorescence or be quenched by electron transfer; the 
sensitiser triplet state, which can lose energy by phosphorescence or be quenched by energy transfer 
to molecular oxygen and the lanthanide excited state, from where both energy (ET) and electron 
transfer (eT) can occur.  
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Scheme 1.1 
 
The presence of inner sphere water molecules bound to the lanthanide metal also reduces the overall 
quantum yield of Eu3+ and Tb3+ complexes. The excited state energy levels of Eu3+ and Tb3+ 
approximately correspond in energy to some of the higher vibrational energy levels of water. As a 
result, nearby water molecules effectively quench the Eu3+ and Tb3+ excited states by populating the 
O-H vibrational energy levels. Other X-H oscillators, such as N-H and C-H, can have a similar 
quenching effect, in which the energy transfer process follows an r-6 dependence on distance. The 
quenching effect is not as efficient with D2O, compared to H2O, due to the lower energy of the O-D 
oscillation. By measuring the difference in lifetime of Eu3+ and Tb3+ emission in H2O and D2O, the 
number of inner sphere water molecules, q, can be estimated, according to Equations 1.1 and 1.2.26   
 
 = 1.2		
 − 
 − 0.25 − 0.075                                       [1.1] 
 
 = 5.0		
 − 
 − 0.06 − 0.010                                       [1.2] 
 
where: qLn is the inner sphere hydration number; k is the inverse of the excited state lifetime, τ and n is 
the number of proximal NH oscillators, for the particular case of a secondary amide group, 
coordinated by the carbonyl oxygen.26  
 
1.3.3 Ligands for Lanthanide Ions 
 
As previously discussed, the f orbitals of the lanthanide ions are contracted and show little interaction 
with the ligand field. As a result, bonding between the ligand and metal is mostly electrostatic and 
non-directional, leading to the most common coordination numbers of 8 and 9. The ligand plays an 
important role in lanthanide complexes. Firstly, it provides a binding site for the central ion. A good 
ligand should minimise dissociation of the lanthanide, especially in biological media where some Ln3+ 
ions have moderately high toxicity levels.27 The ligand also imparts function on the complex. Water 
solubility, localisation within biological systems and toxicity of the overall complex are all modulated 
by the choice of ligand. In terms of luminescence behaviour, the ligand is integral in determining the 
photophysical properties of the overall complex. For Eu3+ complexes, the ligand also affects the form 
of the emission spectrum.  
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While this thesis concentrates mainly on the properties of Eu3+ complexes, it is necessary to introduce 
at this stage complexes of Gd3+, for which ligand design is a very important consideration. Gd3+ has 
an isotropic arrangement of 7 unpaired electrons in the 4f orbitals. As a result, it greatly enhances the 
rate of relaxation of proximal water protons in a magnetic field. This property is exploited in magnetic 
resonance imaging (MRI), which use Gd3+ complexes as contrast agents.28 Free Gd3+ has a high 
toxicity in humans so it is necessary to design ligands whose complexes have very high stability 
constants and kinetic inertness. These ligands are equally applicable to Eu3+ binding, as the ionic radii 
of Eu3+ and Gd3+ are similar (1.09 and 1.08 Å, respectively for the nine-coordinate complexes). 
 
For the purpose of this section, the ligand refers to the moieties directly bound to the Ln3+ centre. 
Sensitising groups are often directly bound to the Ln3+ to maximise energy transfer. An in-depth 
discussion on the choice of sensitising groups is given in Section 1.3.4 and will not be discussed in 
detail in this section. One example, however, in which the sensitising group is also the ligand is the 
Eu3+ tris bipyridine complex, [Eu·L1.1]3+.29 This macrocyclic complex, first reported by J.-M. Lehn in 
1987, exhibits high kinetic stability and allows sensitisation of Eu3+ at 303 nm. The quantum yield of 
this complex is only 2 % in aqueous solution. This is due to quenching of the Eu3+ excited state by 
two inner sphere water molecules, within the cryptate cavity.   
 
 
 
Chelated ligands, such as L1.1 form very stable complexes, as is expected by the unfavourable entropy 
changes required to displace such ligands. Two ligands commonly used for lanthanide complexation 
are DTPA (L1.2) and DOTA (L1.3). While both ligands make use of the chelate effect to form highly 
stable complexes, DOTA also benefits from the macrocyclic effect, in which the ligand is 
preorganised so that little change in conformation is required upon binding to Ln3+. This is reflected in 
a higher binding constant for DOTA ([Eu·DOTA]-, log K = 23.5)30 compared to DTPA ([Eu·DTPA]2-, 
log K = 22.4).31 Due to their high stability, Gd3+ complexes of DTPA and DOTA are used 
commercially as contrast agents, under the trading names Magnevist32 and Dotarem,33 respectively. 
 
DOTA is one of the most commonly used ligands for Ln3+ binding and, as a result, a good deal is 
known about its solution and solid state structures. The coordination geometry about the Ln3+ centre is 
approximately monocapped square-antiprismatic or twisted square-antiprismatic, where the four 
cyclen N atoms describe the basal plane and the four carboxyl O atoms form the apical place.34 The 
capping ligand is typically a solvent molecule, such as H2O. Complexes of DOTA exist as two 
enantiomeric pairs of diastereomers arising from two elements of chirality, associated with the sign of 
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the 12-N4 ring N-C-C-N and the N-C-C-O torsion angles. The terms ∆ (clockwise) and Λ 
(anticlockwise) are often used to represent the latter, whilst the terms δδδδ (positive torsion angle) and 
λλλλ (negative torsion angle), represent the former (Figure 1.7). The four possible solution state 
structures (Figure 1.8) may interconvert in aqueous solution but in the solid state [Eu·DOTA]- exists 
as a square antiprismatic Λ(δδδδ) / ∆(λλλλ) pair of enantiomers, with a capping H2O molecule.35 
 
 
Figure 1.7 Conformations of Ln(III) complexes of DOTA showing the limiting orientations of the cyclen ring, 
and the layout of the acetate arms. 
 
 
Figure 1.8 The four stereoisomers of [Ln·DOTA]- complexes. Interconversion between enantiomeric pairs 
is possible through successive arm rotation and ring inversion. 
 
Due to their high stability, there are many examples of emissive Eu3+ complexes based on DOTA, in 
which at least one of the carboxylate pendent arms is replaced by a sensitising group or some other 
moiety to alter the characteristics of the complex.36 Replacement of all four carboxylates for pyridyl 
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moieties gives the ligand L1.4.37 The complexes, [Ln·L1.4]3+ crystallise in different geometries, 
depending upon the size of Ln3+. The early lanthanides, including [Eu·L1.4]3+, form twisted square 
antiprismatic structures, with the stereochemistry, ∆(δδδδ). In the solid state, this complex has a 
capping triflate anion. In aqueous solution, a q value of 0.4 was calculated from lifetime 
measurements. Such a value suggests an equilibrium between the q = 0 and q = 1 complexes on the 
millisecond timescale of the measurement. The stereochemistry of [Eu·L1.4]3+ was investigated by 1H-
NMR and it was found that two diastereomers, ∆(δδδδ) and ∆(λλλλ), exist in solution in the ratio 85 : 
15. Relative to DOTA, one disadvantage of this neutral ligand is its lower kinetic stability. In a 
competition assay, it was found that one equivalent of DTPA caused dissociation of the Eu3+ ion. This 
was confirmed by 1H-NMR and a reduction in the europium luminescence lifetime upon dissociation. 
This result shows the need for charged donors, to increase thermodynamic stability and kinetic 
inertness. 
N
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Both ligand systems, L1.3 and L1.4 are based upon cyclen, a twelve member ring with four coordinating 
N atoms. This system can also be called 12-N4. The ring system 9-N3 makes up another class of 
ligands, which are less well studied for Ln3+ binding. Early work by Sherry and Geraldes investigated 
the NMR applications of [Gd·L1.5].38 The triacetate of 9-N3, L1.5, contains six donor atoms capable of 
binding a metal ion and has been used in binding studies of radioisotopes, 111In and 67/68Ga.39 In the 
solid state, these complexes are C3 symmetric with an octahedral metal ion centre (Figure 1.9). The 
111In complex was found to retain C3 symmetry in the solution state and was kinetically stable over the 
pH range -0.7 – 12.40    
 
 
Figure 1.9 Crystal structure of the C3 symmetric complex GaL1.5.40 
 
Introduction                                                                                                                             Chapter 1 
 
11 
 
As discussed above, Ln3+ ions favour a coordination number of 8 or 9. To allow the 9-N3 core 
structure to accommodate Ln3+ ions, the tris(picolinate) ligand, L1.6 was developed.41 The complex 
[Ln·L1.6] is 9 coordinate, C3 symmetric and, due to the electrostatic interaction between the positively 
charged Ln3+ ion and the three carboxylates, forms highly thermodynamically and kinetically stable 
complexes. The pyridyl group is a moiety which can be further functionalised to allow incorporation 
of a sensitising group. One example of this is the ligand L1.7, which exchanges carboxylate for the 
isosteric tetrazole moiety, which are deprotonated at pH 7 (pKa ≈ 4.9).42 The pyridyl-tetrazole unit is 
able to sensitise Eu3+ emission at a wavelength of 315 nm with a quantum yield of 20 % in the solid 
state. Solution state properties of [Eu·L1.7] were not reported due to low solubility. A water soluble 
derivative, [Eu·L1.7b], was found to bind Ln3+ ions and sensitise the emission of the near-IR emitters, 
Nd3+, Er3+ and Yb3+.43 
 
 
Towards the development of new ligands, exchange of the carboxylate ligating groups in L1.3 and L1.5 
for phosphinate groups gives the ligands L1.8 and L1.9.44, 45 The advantages of phosphinates over 
carboxylates are threefold. Firstly, the pKa of phosphinates are lower (1.38 for [Y·L1.9] (R = Me) vs. 
3.07 for [Y·L1.5])46, leading to complexes which are more kinetically stable towards acid dissociation. 
Secondly, upon phosphinate oxygen binding, the P centre becomes stereogenic. In octahedral 
complexes of the type [Ln·L1.9], two diastereoisomers may result from co-operative binding of all six 
donor atoms (i.e. RRR/SSS and RSR/SRS). This extra degree of stereochemistry gives rise to a number 
of possibilities, such as differential chiral interactions. Finally, the pentavalency of P provides a 
position for further functionalisation, leading to improved solubility properties or conjugation to other 
moieties. 
 
 
Examples of systems based on phosphinate ligands include the C3 symmetric octahedral complexes 
[Co·L1.9], [Ni·L1.9] and [Ga·L1.9] (R = Me in each case), which form enantiomers, and were found to 
be either RRR or SSS at P. For the [Ga·L1.9] complex, the resultant racemic mixture was separated by 
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chiral-HPLC.45 A second example of [Ga·L1.9] (R = CH2CH2CO2-) was found to have log K[GaL] = 
26.2, demonstrating its high thermodynamic stability.47 One 12-N4 example is the complex [Tb·L1.8]- 
(R = CH2Ph),44 which is q = 0 (coordination number = 8), due to the more bulky nature of the 
phosphinate groups relative to carboxylates. Sensitised Tb emission via the benzyl group leads to a 44 
% quantum yield for [Tb·L1.8]- in water.   
 
A brief mention of the related phosphonate complexes is also necessary. As with the phosphinate 
analogues, complexes of 12-N4 tetra(phosphonate) (L1.10), are 8 coordinate (q = 0) and have very high 
kinetic and thermodynamic stability. An example is [Gd·L1.10], which has been used as an outer 
sphere water relaxation agent for MRI.48 
 
From this brief summary of some of the ligands which are used for Ln3+ binding, several conclusions 
can be made. Firstly, ligands should be kinetically and thermodynamically stable towards metal 
dissociation by competing ligands or extremes of pH. Macrocyclic chelating ligands serve this 
purpose well. The inclusion of charged donors, such as carboxylate O atoms, increases the stability of 
complexes due to strong electrostatic interactions. Phosphinates are an attractive alternative to 
carboxylates due to their additional steric bulk, shielding of the Ln3+ centre and the pentavalency, 
allowing functionalisation of the binding moiety. Pyridine donors are also useful, in that they can be 
modified to form sensitising groups, as revealed in the next section.  
 
1.3.4 Chromophores for Lanthanide Sensitisation 
 
The processes involved in sensitisation of the luminescent lanthanides were illustrated by a Jablonski 
diagram in Figure 1.6. The important steps were: sensitiser excitation (S0 → S1) by absorption of 
incident light; intersystem crossing (S1 → T1); energy transfer to the lanthanide excited state (T1 → 
Ln*) and lanthanide emission (Ln* → Ln + hν). It follows that a good sensitiser should have the 
following properties: a high molar extinction coefficient with an excitation wavelength above 300 nm 
to avoid the excitation of endogenous biological fluorophores; a small singlet-triplet energy gap to 
maximise the rate of intersystem crossing; a triplet energy around 2000 cm-1 above that of the 
lanthanide excited state to allow efficient energy transfer but minimal thermally activated back energy 
transfer and a short distance between the sensitiser and the lanthanide ion to maximise the rate and 
efficiency of energy transfer. The term chromophore is often used in place of sensitiser as it describes 
the ability of the moiety to absorb light in the UV-visible wavelength range. 
 
One of the compounds currently used commercially for Eu3+ sensitisation is the tris(bipyridine) 
complex, [Eu·L1.1]3+, which was introduced in Section 1.3.3. The excitation wavelength for the 
trisbipyridine sensitiser (λabs = 303 nm) is low compared to some of the more recently developed 
chromophores. However, with a molar extinction coefficient of 18,000 M-1 cm-1 and an absorption 
spectrum with a shallow tail into the longer wavelength region of the spectrum, excitation at 337 nm 
is possible, avoiding the excitation of biomolecules. From the lifetime values of [Eu·L1.1]3+ in H2O 
and D2O, a q value of 2 was calculated.49 This leads to a low quantum yield due to quenching of the 
Eu3+ excited state by inner sphere water molecules. However, commercial assays which use this 
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complex are carried out in the presence of 0.4 M F- ions, which almost completely displace the two 
inner sphere H2O molecules, increasing the quantum yield to 10 %.50 The structurally related 
terpyridine ligand L1.11 forms complexes of the type [Ln·L3]3+, which result in a 9 coordinate Ln3+ 
centre. Whilst both L1.11a and L1.11b are able to sensitise Eu3+ emission, it was found that the addition 
of the tBu groups led to a 7 fold increase in quantum yield, due to an increase in the efficiency of the 
intersystem crossing process.51 
 
A disadvantage to the terpyridines shown is their low aqueous solubility. Whilst modifications to the 
core structure have led to greater solubility, an alternative sensitiser is tetraazatriphenylene.52 
Complexes based on DOTA with the tetraazatriphenylene sensitiser ([Ln·L1.12]) are water soluble and 
have found application in fluorescence microscopy.53 This sensitiser has a fast rate of intersystem 
crossing and a triplet energy suitable for sensitising both Eu3+ and Tb3+ emission. It is also electron-
poor and so is difficult to oxidise, a process which can lead to quenching of the singlet excited state. 
As with the bi- and terpyridines, tetraazatriphenylene directly binds to the Ln3+ centre via a five-
membered chelate. This leads to efficient energy transfer and a high quantum yield of 18 % for the 
complex [Eu·L1.12]. Table 1.1 summarises the properties of complexes incorporating selected 
pyridine-based and tetraazatriphenylene chromophores. 
 
 
 
Table 1.1 Summary of the photophysical properties of complexes incorporating bipyridine, terpyridine and 
tetraazatriphenylene chromophores. All values measured at 298 K in H2O unless stated.  aValues measured in 
CH3CN. 
          
Complex λmax /nm ε / M–1 cm–1 ms
Ln
OH /2τ  ms
Ln
OD /2τ  %/2
Ln
OHΦ  )77(/ 1 KcmEGdT −   
[Eu·L1.1] 303 18,000 0.34 1.54 2.0 29,200 
[Eu·(L1.11a)3] 305 9,300 2.31a - 1.3a 22,900 
[Eu·(L1.11b)3] 305 7,700 2.14a - 10a 22,750 
[Eu·L1.12] 340 3,500 1.06 1.15 18 24,000 
 
In contrast to the electron deficient tetraazatriphenylene choromphore, the 2-hydroxyisophthalamide 
based ligand (L1.13) is electron rich and contains several oxygen donors.54 One similarity to the pyridyl 
based sensitisers is that they both directly coordinate to the lanthanide centre in a multidentate 
manner. The ligand L1.13 forms 1 : 1 complexes with Ln3+, giving complexes which are q = 0 and, in 
the case of [Tb·L1.13]-, has an exceptionally high quantum yield of 59 %. The quantum yield of 
[Eu·L1.13]- was 6 %. The large difference in quantum yield originates from the difference in Ln3+ 
excited state energy (Eu3+ (5D0) at 17,200 cm-1 and Tb3+ (5D4) at 20,400 cm-1). The ligand has a triplet 
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energy of 23,350 cm-1 and therefore has better overlap with the Tb3+ excited state.55 A density 
functional theory (DFT) calculation was used to identify the pi-pi* character of the lowest lying singlet 
and triplet excited states of L1.13. With a view to enhancing the ability to sensitise Eu3+, a screening 
process led to the use of 1-hydroxypyridin-2-one (L1.14a).56 The triplet energy of this moiety lies lower 
in energy and the complex [Eu·(L1.14a)4]- (q = 0) has a quantum yield of 21 %. Interestingly, the 
complex [Eu·L1.14b]- has a much smaller quantum yield as a result of an inner sphere water molecule 
quenching the Eu3+ excited state. Sensitisation of Tb3+ by L1.14 has a very low efficiency due to back 
energy transfer to the sensitiser triplet state. Upon degassing a solution of [Tb·L1.14]-, the emission 
intensity increases, due to a reduction in quenching of the triplet state by molecular oxygen. The two 
sensitisers in L1.13 and L1.14 are excellent sensitisers for Tb3+ and Eu3+ emission, respectively (Table 
1.2). The presence of 4 sensitising groups per Ln3+ leads to high molar extinction coefficients. 
However, the ability to add further function to complexes based on these ligands is not 
straightforward. For example, introduction of a group which can conjugate to other biomolecules is 
non-trivial due to the highly symmetric nature of the ligands (i.e. can you functionalise one group 
only). Also, due to the electron rich nature of the chromophores, there may be biocompatibility issues 
involving oxidation processes within a biological environment.    
 
         
N
O NH
O
O
        
                                L1.13                                          L1.14a                                                                  L1.14b 
 
Table 1.2 Summary of the photophysical properties of lanthanide complexes with 2-hydroxyisophthalamide and 
1-hydroxypyridin-2-one chromophores. All values measured at 298 K in H2O unless stated.   
          
Complex λmax /nm ε / M–1 cm–1 ms
Ln
OH /2τ  ms
Ln
OD /2τ  %/2
Ln
OHΦ  )77(/ 1 KcmEGdT −  
[Tb·L1.13] 350 26,800 2.60 3.22 59 23,350 
[Eu·(L1.14a)4] 345 18,800 0.74 0.98 21 21,260 
[Eu·L1.14b] 345 18,200 0.48 1.22 3.6 21,260 
 
Another class of chromophores are the tricyclic heterocyclic aromatics. The properties of the Ln3+ 
complexes based on a DOTA ligand, with one carboxylate group exchanged for the sensitising 
moiety, are shown in Table 1.3. The phenanthridine complex [Eu·L1.15] is able to sensitise Eu3+ 
emission in the protonated form shown. Above pH 6, the Eu3+ emission is switched off, due to photo-
induced electron transfer at the phenanthridine N in the singlet excited state. The result is a probe 
which can report pH by a change in intensity of Eu3+ emission.57 The disadvantage to this type of 
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on/off switch is that, intracellularly, the probe concentration is unknown and the measurement cannot 
be calibrated. Other applications of complexes incorporating the phenanthridine chromophore are 
limited by the pH dependence on emission intensity. The acridone based complex [Eu·L1.16] appears 
to have favourable absorption properties (λabs = 410 nm, ε = 5,300 M-1 cm-1).58 However, the relative 
energies of the n-pi* and pi-pi* transitions in the acridone sensitiser are sensitive to solvent polarity. In 
non-polar media, the energy of the singlet excited state is around 25,000 cm-1 and the quantum yield 
for fluorescence (Φf) and intersystem crossing (Φisc) are 2 % and 96 %, respectively. Upon moving to 
a polar solvent, the lowest lying singlet energy state drops in energy to around 23,500 cm-1, due to the 
increasing contribution of the pi-pi* transition, and the values of Φf and Φisc become 98 % and 0.1 %, 
respectively. Consequently, the quantum yield for europium emission of [Eu·L1.16] in aqueous media 
is low, and cannot be considered for use in the aqueous cellular environment. 
 
Table 1.3 Summary of the photophysical properties of tricyclic heterocyclic chromophores. All values measured 
at 298 K in H2O unless stated.   
          
Complex λmax /nm ε / M–1 cm–1 ms
Ln
OH /2τ  ms
Ln
OD /2τ  %/2
Ln
OHΦ  )77(/ 1 KcmEGdT −  
[Eu·L1.15] 365 5,000 1.48 0.41 1.4 22,000 
[Eu·L1.16] 410 5,300 0.35 1.20 5.3 21,500 
[Eu·L1.17] 330 6,900 1.75 0.50 6.9 23,700 
[Eu·L1.18] 375 5,360 1.96 0.62 2.2 24,800 
[Tb·L1.19] 355 15,050 2.24 2.65 15 23,450 
 
More recently, lanthanide complexes containing the azaxanthone ([Ln·L1.17]) and azathiaxanthone 
([Ln·L1.18]) sensitisers have been exploited in a number of analytical experiments.59 In contrast to the 
acridone sensitiser, the quantum yield for intersystem crossing of azaxanthones remain high in polar 
media (Φisc = 82 %). A low fluorescence quantum yield (Φf = 1 %), along with an appropriate triplet 
energy (23,700 cm-1), make azaxanthones excellent candidates for Eu3+ and Tb3+ sensitisation. In a 
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similar manner to ligands L1.11 – L1.14, the azaxanthone sensitiser can bind directly to the europium 
centre via the nitrogen lone pair, maximising the rate of energy transfer. Upon exchange of oxygen for 
sulphur, the excitation wavelength of the azaxanthone is red-shifted from 335 nm to 375 nm, while 
maintaining a relatively high molar extinction coefficient (~6,000 M-1 cm-1). This benefit is offset by 
the increased fluorescence from the azathiaxanthone centred at 437 nm. Indeed, a related complex to 
[Eu·L1.18] reports a fluorescence quantum yield of 44 % in aqueous media.57 As with [Eu·L1.16], the 
polarity of the solvent has an effect on the fluorescence. As the polarity decreases, fluorescence also 
decreases, with the maximum emission wavelength shifting to the blue. Such behaviour illustrates the 
sensitivity of the excited states to solvent effects. 
 
While the azaxanthones and azathiaxanthones are effective sensitisers, their molar extinction 
coefficients are not as high as some of the previously reviewed chromophores, which make use of 
multiple chromophores per complex. To improve both the molar extinction coefficient and the 
excitation wavelength, the pyrazoyl-1-azaxanthone sensitiser (L1.19) was synthesised.60 Pyrazoyl 
groups are known to be effective donors in lanthanide complexes61 and the increase in conjugation 
length enhances the photophysical properties of the established azaxanthone sensitiser. The terbium 
complex, [Tb·L1.19], has a molar extinction coefficient of around 15,000 M-1 cm-1 in water, an 
excitation wavelength of 355 nm and a quantum yield of 15 %.62 An analogue of [Tb·L1.19], which 
varies only in the nature of the pendant arms, has a quantum yield of 61 % – an exceptionally high 
value for such complexes. The pyrazoyl-1-azaxanthone sensitiser clearly illustrates the benefit of 
increasing conjugation length on excitation wavelength and molar extinction coefficient. However, a 
balance must be maintained, as increasing conjugation length will naturally decrease the triplet energy 
of the sensitiser, thereby increasing the rate of thermally induced back energy transfer. 
 
 
 
The sensitisers discussed above predominantly have excited states which are believed to involve n-pi* 
or pi-pi* transitions. These sensitisers typically have molar extinction coefficients around 5,000 – 
10,000 M-1 cm-1 per chromophoric moiety. Another class of chromophores, whose lowest excited 
states involve an internal charge transfer (ICT) mechanism, are the pyridylalkynylaryl moieties, such 
as L1.21, in which the aryl group is electron rich.63 The ICT arises due to flow of charge from the 
alkoxy O donor to the pyridyl N acceptor,64 and is seen as a broad band in the absorption spectrum 
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centred at 332 nm. Chromophores of this type have large molar extinction coefficients around 25,000 
M-1 cm-1. [Eu·(L1.21)3]3-, which contains three bound sensitisers, exhibits an overall molar extinction 
coefficient of 78,700 M-1 cm-1, is q = 0 and has a quantum yield of 16 % in H2O. The chromophore 
without the alkoxy donating group, L1.20, has been known since 198865 and its use as a lanthanide 
sensitiser was reported shortly afterwards.66 The addition of the O-alkyl group raises the λabs to a value 
which is suitable for biological applications.  
 
One final class of sensitiser worthy of mention is the transition metal (TM) complexes.67 In these 
systems, energy transfer occurs from a transition metal excited state (commonly a Ru(bipyridine)3 
MLCT state)68 to the lanthanide excited state. This method is more relevant for the near-infrared 
emitting lanthanides such as Yb3+, Nd3+ and Er3+, as their emissive excited states lie fairly low in 
energy. A rare example of such a sensitisation pathway for Eu3+ emission utilises an Ir3+ complex as 
the sensitising moiety ([Eu·L1.22]-).69 The subsequent emission appears white, due to both Eu3+ red and 
Ir3+ blue emission. The system shown is likely to suffer from instability, as the Ir complexes are 
bound to the Eu3+ centre by a single conjugated carboxylate. This group will be easily displaced by 
competing ligands. In general, sensitisation of Eu3+ via transition metal complexes will always suffer 
from inefficient energy transfer, due to the large distances between the donor and acceptor complexes 
and competing processes, such as emission from the TM complex. 
 
 
[Eu·L1.22]- 
 
From this summary of sensitising moieties, several important properties are apparent. Firstly, the 
chromophore should have a high molar extinction coefficient at an absorption wavelength above 300 
nm. The rate of intersystem crossing must be fast and, importantly, the energy of the triplet state 
should be well matched in energy to the Ln3+ excited state (~2000 cm-1 above) to maximise the energy 
transfer step. The most common sensitisers are aromatic heterocycles with extended conjugation and 
typically include pyridyl donors, as they can bind directly to the lanthanide centre and are readily 
modified into useful chromophores. 
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1.4 Fluorescence Resonance Energy Transfer 
1.4.1 Principles of Fluorescence Resonance Energy Transfer 
 
Fluorescence resonance energy transfer (FRET) is a process commonly used to probe interactions 
between biomolecules. It can be used to signal the presence or absence of a certain molecule, to 
identify protein-protein interactions and may also be used to measure distances between molecules. 
FRET describes the transfer of energy between two fluorophores, a donor and an acceptor. The 
process begins with the absorption of light by the donor, promoting it to its excited state. Providing 
there is overlap between the donor emission spectrum and the acceptor absorption spectrum, and that 
the two species are close in space, energy transfer can occur. Note that the energy transfer is non-
radiative but, instead, requires an interaction between the transition dipoles of the donor and the 
acceptor. Once energy transfer has occurred, emission from the acceptor is observed. Figure 1.10a 
shows the basic FRET experiment.8 
 
Figure 1.10 a) Schematic showing FRET between a donor and an acceptor, b) the excitation (blue) and emission 
(red) spectra of two cyanine dyes. The spectral overlap integral is highlighted in green. The yellow and red 
highlighted areas illustrate suitable wavelengths to excite the donor and measure acceptor emission, respectively 
and c) FRET efficiency as a function of r / R0. 
 
The rate of energy transfer, kT, is given by the equation: 
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

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r
RkT τ
                                                           [1.3] 
 
where: τ0 is the radiative lifetime of the donor in the absence of the acceptor; R0 is the Förster radius – 
defined as the distance at which the extent of energy transfer is 50 % and r is the internuclear distance 
between the donor and acceptor. R0 is constant for a specific donor-acceptor pair and depends upon 
the donor emissive quantum yield, the acceptor molar extinction coefficient, the overlap integral of 
the donor emission spectrum with the acceptor absorption spectrum (Figure 1.10b) and the orientation 
of the two transition dipole moments. In solution, the orientation of the dipole moments is the average 
of all possible orientations but when the fluorophores are in fixed orientations, for example within a 
protein, they may have a significant effect upon R0. The FRET process is very sensitive to the distance 
between the donor and acceptor (r-6 dependence). By definition, when r is equal to R0 energy transfer 
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is 50 % efficient. When r is twice R0 the energy transfer drops to 1.5 % (Figure 1.10c). Due to this 
high sensitivity, the extent of energy transfer can be used as a ‘spectroscopic ruler’ to measure 
distances between sites on proteins.70 FRET is usually only observed for values of r up to 10 nm.71  
1.4.2 Examples of FRET in Biological Systems 
 
Many examples of the use of FRET to gain information on biological systems are available in the 
literature. One such example which makes use of the fluorescent dyes fluorescein and rhodamine is 
illustrated in Figure 1.11.72 Here, the activity of sortase, an enzyme essential for the colonisation and 
propagation of bacteria within a host, is monitored by FRET. When sortase is active, a 
transpeptidation reaction occurs and the emission of rhodamine, due to energy transfer from 
fluorescein, is observed. 
 
 
Figure 1.11 Analysis of the sortase-catalysed transpeptidase reaction with intramolecular FRET between 
fluorescein and rhodamine. 
 
It is also possible to monitor levels of biomolecules by the absence of FRET between a donor and an 
acceptor. In the given example (Figure 1.12), a quantum dot acts as the donor while a gold 
nanoparticle acts as the acceptor. In the absence of glucose, FRET occurs and no donor emission is 
observed. However, in the presence of glucose, the gold nanoparticle is displaced and emission from 
the QD is seen, due to the absence of FRET.73 
 
Figure 1.12 Schematic illustration of FRET between a QD and a gold nanoparticle which is inhibited by the 
presence of glucose. 
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Other examples of the use of FRET in biological imaging include the study of protein-protein 
interaction using different coloured fluorescent proteins as donors and acceptors.74 Multiple FRET 
sensors acting simultaneously have also been designed in which several signalling events are 
monitored at the same time, giving information on the precise timing of cellular events within a single 
cell.75 For this to be viable, several FRET donor-acceptor pairs must be used which are spatially and 
spectrally independent.  
1.4.3 Homogeneous Time Resolved Fluorescence 
 
Homogeneous Time Resolved Fluorescence (HTRF) is a technology which uses the properties of 
emissive Eu3+ and Tb3+ complexes to enhance the FRET experiment. The company CISbio Bioassays 
uses the Ln3+ complexes as donors in their commercial assays.76 The large Stokes’ shifts and sharp 
emission bands of these complexes aid the differentiation between donor and acceptor emission. The 
long luminescence lifetimes also allow time-gated detection methods to be employed, which avoid 
interference from background fluorescence. It is apparent that the observed lifetime of the acceptor is 
determined by the lifetime of the donor. Hence, a fluorescent dye acceptor (τ0 ~ 10 ns) can have a 
much longer observed lifetime (τobs ~ 1 ms), due to FRET from the long lived donor excited state. 
 
A schematic of the general antigen-antibody assay which makes use of HTRF technology is shown in 
Figure 1.13 .55 In the absence of the antigen under surveillance, the donor-labelled antigen binds to 
the acceptor-labelled antibody and FRET is detected by emission of the acceptor. In the presence of 
the target antigen, there is competition for the antibody binding site and the extent to which FRET 
occurs is reduced. By using time-resolved detection of the acceptor emission, the presence and 
activity of the target antigen can be measured. 
 
Figure 1.13 A schematic representing the general principle of the homogenous time resolved fluoro- (HTRF) 
immunoassay. In the presence of the competing antigen, the labeled antigen is displaced and FRET can no 
longer occur. 
 
As donors, currently the HTRF assay makes use of two compounds discussed in Section 1.3.4, 
[Eu·L1.1]3+ and [Tb·L1.13]-.29, 77 The acceptor pair for [Eu·L1.1]3+ is an allophycocyanin (APC) dye 
protein and for [Tb·L1.13]-, an enhanced green fluorescent protein (EGFP).78 Figure 1.14 illustrates the 
spectral overlap between the donors and their respective acceptors. A feature of each spectrum is that 
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the spectral overlap of donor emission with acceptor absorption is far from 100 %. In the [Eu·L1.1]3+ 
case, only around 25 % of the Eu3+ emission overlaps with the APC absorption spectrum. Improving 
spectral overlap is one of the areas for development, to increase assay efficiency and reduce cost. 
 
 
Figure 1.14 Schematics representing the spectral overlap between left) the donor emission of [Eu·L1.1]3+ and an 
allophycocyanin dye and right) the donor emission [Tb·L1.13]- (blue solid line) and the acceptor EGFP 
(absorption – red dashed line, emission – red solid line). 
 
1.5 Aims and Specification 
 
The aim of this project is to design, synthesise and characterise a highly emissive europium complex 
to act as a donor in the HTRF experiment, described above. The currently used donor, [Eu·L1.1]3+, was 
first synthesised in 1987 and, while it serves its purpose, improvements are always sought to increase 
efficiency and ultimately, reduce cost. Specific areas in which improvements are desired include 
increasing the spectral overlap integral illustrated in Figure 1.14 and increasing the overall emission 
quantum yield, which is 10 % in the presence of 0.4 M potassium fluoride. The specification for a 
donor complex is as follows: 
 
i) An emissive europium complex donor – Design and synthesise a europium complex 
which absorbs incident light and luminesces with the characteristic europium emission 
spectrum between 580 and 720 nm.  
 
ii) Optimise the form of the emission spectrum – With respect to the spectral overlap 
integral, maximise the europium emission in the spectral region at which the acceptor 
absorbs light: that is the 600 – 630 nm region. This is the ∆J = 2 part of the europium 
emission spectrum. It follows that the Eu emission should be minimised in the other parts 
of the spectrum. In particular, the emission should be minimised in the spectral region in 
which the acceptor emits light. 
 
iii) Select a chromophore with a suitable absorption wavelength – The absorption 
wavelength should be above 320 nm to avoid competition for the excitation light source 
by other fluorophores in the assay.  
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iv) Maximise the molar extinction coefficient – Choose a suitable chromophore which can 
sensitise Eu3+ emission and has a high molar extinction coefficient. From the discussion 
in Section 1.3.4, it is apparent that polyaromatic heterocycles are well suited to this task.  
 
v) Maximise the quantum yield – Combine a chromophore which efficiently populates the 
Eu3+ excited state (fast intersystem crossing and appropriate triplet energy level) with a 
complex whose quenching processes are minimised. To achieve this, the Eu3+ centre 
should be well shielded from external quenchers, including H2O (i.e. a q = 0 complex). 
 
vi) Design a stable complex in the assay medium – The Eu3+ complex should be kinetically 
and thermodynamically stable towards dissociation induced by competing ligands, metal 
ions and other species in the assay medium. From the discussion in Section 1.3.3, a 
multidentate chelating ligand, ideally with charged donor groups, would serve this 
purpose. 
 
vii) Water solubility – The final complex should be soluble in the assay medium, which is a 
buffered aqueous solution containing proteins, ions and other compounds. 
 
viii) A conjugation point – The final complex should have a single functional group, such as 
a primary amine or a carboxylic acid, which allows coupling to a vector, which is then 
tagged to the target species (e.g. an antigen, antibody or protein)  
 
The following chapters show the synthesis and characterisation of a number of Eu3+ complexes which 
aim to meet one or more of the specifications above. In Chapter 2 the number of integral 
chromophores is varied from one to four with a view to maximising the molar extinction coefficient. 
Chapter 3 focuses on increasing the spectral overlap integral and gives a discussion on the factors 
which affect the form of the Eu3+ emission spectrum. In Chapter 4, the use of triazacyclononane as the 
core ligand is introduced, before Chapter 5 gives information on the final donor complex, which 
meets the specification given above. Chapter 6 is devoted to a study into the quenching mechanisms 
of certain endogenous quenchers.   
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2.  The 3-Azaxanthone Series 
2.1 Introduction 
 
1-Azaxanthone is well established as an excellent sensitising group for europium emission.1 However, 
due to the orientation in which the chromophore binds to the metal centre in ligand systems based 
upon DOTA, a maximum of two azaxanthone moieties per complex is attainable. To increase this 
value to three, and even four, sensitising groups per complex, the synthesis of a constitutional isomer 
of 1-azaxanthone was undertaken. The ability of 3-azaxanthone to sensitise Eu3+ and its photophysical 
properties were assessed. This was followed by the incorporation of the sensitiser into a number of 
model complexes based upon Eu(DOTA)-, in which the number of chromophores was varied from 
one to four ([Eu·L1(H2O)] – [Eu·L4]3+). As expected, increasing the number of sensitising groups led 
to an increase in the molar extinction coefficient. Each of the four complexes was fully characterised 
and their properties are discussed. Comparison of the complex [Eu·L2(H2O)]+ with the 1-azaxanthone 
analogue, led to some interesting differences in the behaviour of the complexes with protein. Cell 
microscopy studies were also carried out with both complexes and showed binding to the DNA of 
cells undergoing mitosis. As a result of the interesting properties of [Eu·L2(H2O)]+, the 3-
azathiaxanthone analogue was synthesised and a comparative analysis of their behaviour is given.  
 
 
 
 
2.2 Synthetic Aspects 
2.2.1 3-Azaxanthone 
 
The synthesis of 1-azaxanthone begins with 2-chloronicotinic acid.1 To carry out an analogous 
synthesis to form 3-azaxanthone, 4-chloronicotinic acid is required. While this precursor is 
commercially available, 4-chloro-6-methylnicotinic acid (3) is not. The methyl group in the 6- 
position is required for subsequent reactions. The first two steps towards the synthesis of 3 had been 
previously published2 and the conversion of 2 to 3 was achieved by stirring in neat POCl3 overnight at 
100 ºC (Scheme 2.1). The removal of excess POCl3 by distillation left the acid chloride of 3, which 
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was converted to the carboxylic acid by addition of water. The product, 3, was isolated as a light 
purple solid.  
 
Scheme 2.1 
With compound 3 in hand, the synthesis of 3-azaxanthone was carried out according to Scheme 2.2. 
Sodium methoxide was produced in situ by dissolving Na metal in dry MeOH. 4-Chloro-6-
methylnicotinic acid (3) and phenol were dissolved in the NaOMe solution. Excess MeOH was 
removed under reduced pressure to leave a residue which was heated to 180 °C for 2 h. After work up, 
the product (4) was purified by column chromatography. Cyclisation of 4 using polyphosphoric acid 
(PPA) gave 3-azaxanthone (5) in a high yield.  
 
Scheme 2.2 
Bromination of the methyl group of 5 was attempted using a variety of conditions. Stirring in CCl4 
with N-bromosuccinimide (NBS) and dibenzoyl peroxide at 60 ºC was slow and several additions of 
NBS were required over a period of 72 hours. The reaction rate was increased upon irradiating the 
solution with a 100 W tungsten lamp. This is most likely due to the constant initiation of radicals 
when using the lamp. The heat generated by the lamp also helps the reaction to proceed. As 
dibromination is possible, the reaction was monitored by 1H-NMR and stopped when an optimal ratio 
of starting material to monobrominated product to dibrominated product was achieved. The products 
were separated by column chromatography and the overall yield was increased to 49 % by the 
conversion of the dibrominated product back to the monobrominated product using POH(OEt)2 and 
NH(iPr)2 in THF (Scheme 2.3).  
 
Scheme 2.3 
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2.2.2 Europium Complexes Containing the 3-Azaxanthone Chromophore 
 
Four europium complexes were synthesised, in which the number of chromophores varies from one to 
four. The sensitising groups are linked to a 1,4,7,10-tetraazacyclododecane (cyclen) ligand via an N–
CH2–chromophore linkage. The remaining pendant arms are carboxymethyl groups, as in the DOTA 
complex [Eu·L1.3]-. These were chosen as they are known to form kinetically inert lanthanide 
complexes with good aqueous solubility and europium complexes based on DOTA containing 
alternative sensitising groups have previously been synthesised,1 allowing direct comparison. 
 
The first complex synthesised was [Eu·L1(H2O)] (Scheme 2.4). The precursor trimester, 
DO3A(OtBu)3, was synthesised by a published procedure in reasonable yield.3 An SN2 nucleophilic 
substitution reaction between the primary bromide, 2-bromomethyl-3-azaxanthone (7) , and 
DO3A(OtBu)3 afforded 8 in excellent yield. The reaction was carried out in a small volume of dry 
CH3CN to maximise the rate and extent of reaction; K2CO3 was added in stoichiometric amounts to 
act as a base. Deprotection of the tert-butyl ester groups with CF3CO2H was followed by 
complexation in water with Eu(OAc)3. A slight excess of Eu(OAc)3 was used to ensure the 
complexation went to completion. Excess Eu3+ was removed at the end of the reaction by precipitation 
and syringe filtration of Eu(OH)3 from an aqueous solution at pH 10. High resolution mass 
spectrometry (HRMS) and reverse phase-high performance liquid chromatography (RP-HPLC) was 
used to confirm the formation and purity of [Eu·L1(H2O)].  
 
 
Scheme 2.4 
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The synthesis of [Eu·L2(H2O)]Cl was carried out using a similar reaction pathway to that of 
[Eu·L1(H2O)], starting from the commercially available, DO2A(OtBu)2 (Scheme 2.5). The resulting 
complex was isolated as an acetate salt. Small amounts of (CF3CO2)- salts may also have been present, 
so chloride anion exchange was undertaken, to ensure that each complex had the same counter-ion 
and that water solubility was maximised. Again, HRMS and RP-HPLC was used to confirm the 
structure and purity.  
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The synthesis of [Eu·L3(H2O)]Cl2 was achieved via a slightly longer route (Scheme 2.6) involving the 
protection of three of the cyclen nitrogens with tert-butoxycarbonyl (BOC) groups. By this method, 
mono-alkylation using ethyl bromoacetate was achieved in 77 % yield. Selective removal of the BOC 
groups was possible using CF3CO2H, obviating competitive ethyl ester hydrolysis. Alkylation with 
three equivalents of 2-bromomethyl-3-azaxanthone proceeded cleanly, provided that the intermediate 
11 had been thoroughly dried over K2CO3(s) in anhydrous CH2Cl2. The hygroscopic nature of ligand 
11 meant that without drying, hydrolysis of the brominated chromophore to form 2-hydroxymethyl-3-
azaxanthone competed with alkylation. Hydrolysis of 12 was initially attempted under basic aqueous 
conditions. However, due to low solubility, alternative conditions were necessary. Hydrolysis of 12 
was achieved in aqueous HCl (approximately 2 mM). Under reflux, the ligand fully dissolved, due to 
protonation of the chromophore and cyclen nitrogens. These conditions caused rapid hydrolysis of the 
ethyl ester, which was confirmed by 1H-NMR. The pH of the solution was adjusted to 5.8 by addition 
of aqueous NaOH before complexation with Eu(OAc)3. Complexation reactions are typically carried 
out at pH values above 5, as the carboxylate groups are deprotonated at this pH (pKa ~ 4.8). Upon 
complexation, the pH of the solution decreases, due to the expulsion of protons from the cyclen ring. 
As with [Eu·L2(H2O)]+, anion exchange was carried out on the final complex, whose synthesis was 
confirmed by HRMS and RP-HPLC. 
 
Scheme 2.6 
The synthesis of the final complex within the present series, [Eu·L4]3+, appeared straightforward but 
there were concerns about the steric demand of four chromophores and the chemical stability, with 
respect to metal ion dissociation, of a complex containing eight nitrogen donors. DFT Gaussian 
simulations of a structurally similar complex were carried outi which showed that complex formation 
should be feasible, as the bulk of the chromophore is directed away from the metal centre, thereby 
                                                          
i
 Calculation by Miss N. Hogg and Dr. I. Kuprov (Durham University) 
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reducing steric demand at the metal centre (Figure 2.1). This prediction was subsequently confirmed 
by the crystal structure of the tetrapyridyl complex, [Eu·L1.4]3+, discussed in Section 1.3.3.4 
      
Figure 2.1 left) Simulated 3D structure and 2D structure of a europium complex containing 4 pyridyl donating 
groups. Complexes contain carbon (grey), hydrogen (white), oxygen (red), nitrogen (blue), phosphorus (orange) 
and a central metal atom (light blue). Note the positions marked X, from which the 3-azaxanthone chromophore 
extends. 
The synthesis of [Eu·L4]3+ is shown in Scheme 2.7. 1,4,7,10-Tetraazacyclododecane was reacted with 
four equivalents of 2-bromomethyl-3azaxanthone in CH3CN, using K2CO3 as a base. Purification by 
column chromatography on alumina gave L4 in 60 % yield. As L4 is a neutral species, complexation 
was carried out in CH3CN with Eu(OTf)3. After two days, the solvent was removed under reduced 
pressure and the residue dissolved in 0.1 mL of MeCN. This solution was dropped into dry (Et)2O, 
resulting in precipitation of [Eu·L4]3+ as a triflate salt. Anion exchange to the chloride salt increased 
the water solubility and allowed the characterisation of the complex in aqueous solution by HRMS 
and RP-HPLC. 
N
N
N
N
N
N
N
N
O
N
O
O
N
O
O
N
O
O
N
O
Eu
O
N
O
Br
i) Eu(OTf)3
ii) Cl- anion exchange
3+
(Cl-)3
K2CO3
L
4
[Eu·L4]3+
60 %
15 %
N
N
N
N
O
N
O
O
N
O
O
N
O
O
N
O
H
HH
H
 
Scheme 2.7 
N
N
N
N
N
P
O
Eu
N
N
N
X
X
3+
X 
 The 3-Azaxanthone Series                                                                                                        Chapter 2 
 
 
33 
 
2.2.3 Terbium Complexes Containing the 3-Azaxanthone Chromophore 
 
Two Tb3+ complexes were synthesised in the azaxanthone series: [Tb·L1(H2O)] and [Tb·L2(H2O)]Cl. 
Each complex was synthesised from its respective ligand in an analogous manner to the Eu3+ 
counterparts, using Tb(OAc)3 in the place of Eu(OAc)3. The photophysical properties of each Tb3+ 
complex were analysed and are also investigated in the quenching experiments in Chapter 6.  
 
2.2.4 Bis(3-azathiaxanthone) Europium Complex 
 
The synthesis of the bis(3-azaxanthone) complex [Eu·L2b(H2O)]+ followed a similar pathway to that 
of the azaxanthone analogue, [Eu·L2(H2O)]+, with the exception of the first coupling step of the 
chromophore (Scheme 2.8). This reaction takes place in dimethylformamide at 150 °C with K2CO3 as 
the base. Cuprous bromide is also added in catalytic amounts. It is likely that the presence of Cu(I) 
increases the rate of thiolate addition at the 4-pyridyl position by the formation of a pyridyl cuprate 
intermediate. The remaining five steps towards the final complex [Eu·L2b(H2O)]+ were carried out in a 
similar manner to that of [Eu·L2(H2O)]+ and proceeded smoothly (Scheme 2.9).  
 
Scheme 2.8 
 
 
Scheme 2.9 
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2.3 1H-NMR Analysis 
 
Proton NMR analysis of each of the complexes [Eu·L1(H2O)] – [Eu·L4]Cl3 was undertaken in D2O at 
400 MHz and pD 5.8. 1H-NMR allows an assessment of the number of isomeric species in solution 
and gives information on the local symmetry on the NMR timescale. The neutral complex, 
[Eu·L1(H2O)], gave two sets of thirty paramagnetically shifted proton resonances in ratio 5:4 (Figure 
2.2). These correspond to the square-antiprismatic and twisted square-antiprismatic isomers that have 
been documented previously in NMR analyses of related derivatives of DO3A.5, 6 The mono-cationic 
complex, [Eu·L2(H2O)]+, gave rise to two sets of 18 proton resonances, in ratio 6:5 (Figure 2.3), 
consistent with the presence of two diastereoisomeric species with C2-symmetry.  The shifts of each 
set showed a strong correspondence with those observed for [Eu.L1(H2O)], in accord with this 
interpretation. For [Eu.L4]3+, only one set of twelve paramagnetically shifted resonances was observed 
(Figure 2.4), consistent with local C4-symmetry. Thus, the pyridyl H-6 proton resonated at +12.5 
ppm, with the ring ethylene protons observed as a single shifted AA’BB’ system, at +30.0, +14.2, -
10.9 and -29.1 ppm. 
 
Figure 2.2 1H-NMR analysis of [Eu·L1(H2O)] (400 MHz, D2O, pD 5.8).  
 
Figure 2.3 1H-NMR analysis of [Eu·L2(H2O)]Cl (400 MHz, D2O, pD 5.8). 
 
Figure 2.4 1H-NMR analysis of [Eu·L4]Cl3 (400 MHz, D2O, pD 5.8). 
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2.4 Photophysical Studies 
2.4.1 2-Methyl-3-Azaxanthone 
 
The absorption spectrum of 2-methyl-3-azaxanthone (5) was measured in methanol at 293 K (Figure 
2.5 left). The longest wavelength absorption maximum is at 324 nm and corresponds to a transition to 
the singlet excited state with predominantly n-pi* character with some degree of pi-pi* character, as 
previously observed for 1-azaxanthone.1 The absorption spectrum was run at a variety of 
concentrations. A plot of absorbance at 324 nm against concentration allows the determination of the 
molar extinction coefficient according to the equation, 
 
A = εcl                                                                    [2.1]                                          
 
where A is the absorbance, ε is the molar extinction coefficient, c is the concentration and l is the cell 
pathlength. The gradient of such a plot is equal to the molar extinction coefficient. From Figure 2.5 
right, a molar extinction coefficient of 5,600 M-1 cm-1 was calculated (MeOH, 295 K). This value is 
similar to the value recorded for 1-azaxanthone (6,900 M-1cm-1, λmax = 330 nm, MeOH, 295 K). The 
similarity between both λmax and ε suggest that the shift in position of N from the 1-position to the 3-
position does not greatly affect the photophysical properties of the azaxanthone and that 3-
azaxanthone should be as efficient at sensitising lanthanide emission as its parent chromophore.   
 
The fluorescence emission spectrum of 2-methyl-3-azaxanthone was recorded in methanol at 295 K. 
As with the 1-azaxanthone analogue, the intensity of the emission was exceptionally low, indicating 
that other processes (non-radiative decay and intersystem crossing) dominate the excited state 
properties of 2-methyl-3-azaxanthone. This was further indication that the chromophore would be 
well-suited to sensitisation of Eu3+ and Tb3+. 
 
 
Figure 2.5 left) Absorption of 2-methyl-3-azaxanthone at four concentrations (MeOH, 295 K) and right) 
absorbance at λmax as a function of concentration, allow calculation of the molar extinction coefficient. 
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2.4.2 Europium Complexes Based Upon 2-Methyl-3-Azaxanthone 
 
The photophysical characterisation of the complexes [Eu·L1(H2O)] – [Eu·L4]Cl3 was carried out in 
aqueous solution at pH 5.8 and 295 K (Table 2.1). The absorption spectrum of [Eu·L1(H2O)] in water 
is shown in Figure 2.6. Also shown is the absorption spectrum of 3-azaxanthone in methanol. It is 
worth noting that the absorption maximum has shifted by 4 nm to longer wavelength. This could be 
an effect of complexation but is more likely to be a consequence of the change in solvent. A similar 
red-shift was previously observed for 1-azaxanthone upon moving from a MeOH solution to a MeOH 
: H2O (2 : 1) mixture.1 The lowest energy transition for 1-azaxanthone in a less polar medium 
(MeOH) is n-pi* in character. Upon moving to a more polar medium, the contribution of the pi-pi* 
excited state, which is similar in energy to the n-pi* excited state, to the transition becomes greater and 
the wavelength maximum shifts slightly to the red. This same principle is likely to account for the 
shift observed in Figure 2.6.   
 
Figure 2.6 Absorption spectra of [Eu·L1(H2O)] in H2O (blue) and 2-methyl-3-azaxanthone in MeOH (red), 
showing a red shift of 4 nm in the maximum absorption wavelength. 
 
Molar extinction coefficients were calculated for each of the four Eu3+ complexes (Table 2.1). 
Comparison of the values for [Eu·L1(H2O)] and 3-azaxanthone, which both contain a single 
azaxanthone moiety per molecule, show a reduction in molar extinction coefficient upon moving to a 
more polar solvent. This is, again, consistent with observations noted for 1-azaxanthone in which a 
reduction in the oscillator strength of the transition due to a change in solvent polarity led to a 
reduction in molar extinction coefficient. As expected, the molar extinction coefficient approximately 
doubles upon doubling the number of sensitising groups.  
 
Table 2.1 Photophysical data for Eu3+ complexes of L1 – L4. (λex = 328 nm, pH 5.8) 
Complex ε / M-1 cm-1 
 	/	% 
 / (ms)-1 
 / (ms)-1 q 
[Eu.L1(H2O)] 2,500 6.9 1.67 0.51 1.1 
[Eu.L2(H2O)]+ 5,800 10 1.70 0.65 1.1 
[Eu.L3(H2O)]2+ 9,300 5.0 2.00 0.63 1.3 
[Eu.L4]3+ 15,600 5.4 1.41 0.83 0.4 
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By measuring the intensity of Eu3+ emission as a function of delay time after excitation, the 
luminescence lifetime of each complex was calculated in H2O and D2O (Table 2.1). The curves 
obtained (Figure 2.7) were fitted to Equation 2.2, to give the rate constant for decay of the lanthanide 
excited state, k. For [Eu·L1(H2O)], values of 1.67 and 0.51 (ms)-1 were found in H2O and D2O, 
respectively. The lifetime of Eu3+ emission, τ, is the reciprocal of k. For a given complex, the lifetime 
in D2O is always longer than in H2O, due to vibrational quenching by OH oscillators. As discussed in 
Section 1.3.2, values of kH2O and kD2O can be used to calculate the number of inner sphere bound water 
molecules, q. Knowledge of the q value is important, as it has consequences upon the emissive 
quantum yield and allows correlation between the photophysical properties of a complex with the 
structure and coordination sphere. 
 
 =  + 

                                                           [2.2] 
 
 
Figure 2.7 Emission decay curves of [Eu·L1(H2O)] in H2O and D2O, allowing calculation of k and τ. 
 
From the calculated q values, it is clear that for complexes [Eu·L1(H2O)], [Eu·L2(H2O)]+ and 
[Eu·L3(H2O)]2+, the average number of bound water molecules at any given time is 1. These values 
are not exact integers, due to variation in the metal to water bond distance, influence from other 
nearby X-H oscillators (such as C-H) and second sphere water molecules. A q value of 1 suggests that 
the steric bulk about the europium centre is not too great – there is space for a water molecule to enter 
the inner sphere. Upon moving to a fourth bound sensitising group ([Eu·L4]3+), the steric demand is 
starting to crowd the inner sphere and the q value decreases to 0.4. This value has still not reached 
zero which suggests that the stability of [Eu·L4]3+, from a steric point of view, should be relatively 
high. 
 
The quantum yield values of the four complexes are in the range 5 – 10 %.  These values are 
comparable to the quantum yields of complexes containing 1-azaxanthone, and indicate that the 3-
azaxanthone is able to efficiently populate the Eu3+ excited state. The non-zero q values for the four 
complexes are likely to limit the quantum yield. It may have been expected that [Eu·L4]3+ would have 
the highest quantum yield as it has the lowest q value. In fact, the quantum yield is much the same as 
the other complexes. This may well be due to an equilibrium between the q = 0 and q = 1 [Eu·L4]3+ 
complexes, as seen for the tetra pyridyl complex [Eu·L1.4]3+ (Section 1.3.3).4 The long lifetime of the 
Eu3+ excited state (0.70 ms) means that the exchange of H2O on and off the metal centre is not the 
determining step in the quenching process.      
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Figure 2.8 Emission spectra of the four europium complexes in water after excitation at 328 nm. Each spectrum 
was recorded with a complex concentration of 20 µM at pH 5.8 and 293 K. 
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The emission spectra of the four complexes were recorded after excitation at 328 nm (H2O, 295 K, 
Figure 2.8). Each spectrum shows the characteristic europium emission containing 5 bands and fine 
splitting in the ∆J = 1 to ∆J = 4 transitions. Ligand fluorescence can also be observed at 400 nm. The 
fluorescence is very low for each complex, confirming the hypothesis of a fast rate of intersystem 
crossing and energy transfer for the 3-azaxanthone sensitiser. The complex with three chromophores, 
[Eu·L3(H2O)]2+, shows the greatest fluorescence. This may be due to a slight excess of ligand in the 
sample or even a contaminant which fluoresces to give the unusually large peak at 450 nm. HPLC 
analysis (Appendix 1) shows that a small amount of impurity is present in the sample. Unfortunately, 
the amount of [Eu·L3(H2O)]2+ was too small to allow further purification. 
 
When analysing europium emission spectra, two features have been shown to determine spectral 
form. Firstly, the higher the degree of symmetry about the Eu3+ centre, the simpler the emission 
spectrum appears. Secondly, the donating group in the axial position of a square antiprismatic or 
twisted square antiprismatic complex affects the relative intensity of the ∆J = 2 transition. It is found 
that hard donors, such as H2O, lead to a decrease in the relative intensity whereas more polarisable 
donors lead to an increase. Further details of this aspect are given in Chapter 3 but, for now, these two 
empirical observations suffice. 
  
When comparing the emission spectra of [Eu·L1(H2O)] and [Eu·L2(H2O)]+, it is apparent that the 
increased symmetry of [Eu·L2(H2O)]+ leads to a less complex spectrum. There is more splitting in 
both the ∆J = 1 and ∆J = 2 bands for [Eu·L1(H2O)]. When looking at [Eu·L4]3+, the theory of high 
symmetry giving a simplified spectrum seems to fall down, as the complex has C4 symmetry and, yet, 
it has possibly the most complex spectral form of all. One explanation for this could be that the large 
size of the complex and the relatively soft donating ability of the nitrogen lone pairs, mean that at any 
one time many different conformations are adopted. Thermal fluctuations may cause the complex to 
move away from C4 symmetry and therefore result in a more complex spectrum.  
 
A correlation between the emission spectra and the q values of the four complexes is observed. A 
decrease in the number of hard H2O axial donors leads to an increase in the relative intensity of the ∆J 
= 2 band. Both [Eu·L1(H2O)] and [Eu·L2(H2O)]+ have q value of 1 and this is reflected in a ∆J = 2 
band of similar intensity to the less sensitive ∆J = 1 band. A q value of 0.4 was calculated for 
[Eu·L4]3+ and, as a result, the relative intensity of the ∆J = 2 band is greater than that of the other 
complexes.  
 
One of the aims of the project is to design a complex with a large ∆J = 2 band. Clearly, the absence of 
water in the capping position is an important factor when designing such a complex. It is likely that 
the relative intensity would increase even further if a more polarisable group were in the axial 
position. The absence of a capping H2O molecule is also likely to increase the overall quantum yield 
of the complex, as discussed above.  
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2.4.3 Photoluminescence Stability Assessment 
 
The presence of inner sphere water molecules can lead to a reduction in the Eu3+ emission intensity. 
There are many other processes which can also cause a decrease in emission intensity. A series of 
experiments was undertaken, with the assistance of workers from CISbioassays, to assess the relative 
photoluminescence stability of each complex in the presence of a million fold excess of Ca2+, Mg2+, 
Mn2+ or [EDTA]4-. Calcium and magnesium were chosen as common dications that can bind 
competitively to the macrocyclic ligand. Manganese is a dication of comparable size to magnesium, 
can act as a reductant and also has weak d – d absorption bands in the visible spectrum, giving it a 
light pink colour. The [EDTA]4- serves as a competitive ligand for the Eu3+ ion. In each case, the 
complex was present at 10 nM concentration in HEPES buffer at pH 7.4 and the additive (20 µM) was 
added. Following excitation at 337 nm, the Eu3+ emission intensity was measured at 15 min and 18h 
time-points (Figure 2.9). For each complex, the presence of added CaCl2 or MgCl2 did not 
significantly perturb the Eu3+ emission. The effect of added MnCl2 was more significant. 
[Eu.L1(H2O)] showed greater sensitivity to MnCl2 quenching than [Eu.L2(H2O)]+. The quenching 
mechanism must involve a short range encounter between the Eu3+ complex and the Mn2+ aqua ion. It 
may be that the cationic [Eu.L2(H2O)]+ complex, which is also more sterically bulky than 
[Eu.L1(H2O)], electrostatically and sterically inhibits a close encounter with the Mn2+ aqua ion, and 
therefore is quenched to a lesser extent. The quenching mechanism of Mn2+ is not known but is 
investigated in greater detail in Chapter 6.   
 
In terms of stability with respect to trans-complexation by excess [EDTA]4-, [Eu.L2(H2O)]+ and the 
sterically hindered complex, [Eu.L4]3+ were the most stable. This is intriguing, as the related 
tetrapyridyl complex [Eu.L1.4]3+ (Section 1.3.3) was found to dissociate in the presence of equimolar 
amounts of DTPA, another competitive multidentate ligand.4 For each complex examined, the 
diminution of Eu3+ emission after an overnight incubation suggested that no complex completely 
resisted the exchange process that involves dissociation of Eu3+ and competitive re-association with 
[EDTA]4-. 
 
 
Figure 2.9  Changes in Eu3+ emission intensity after 15 min (blue) or 18h (red) in the presence of the stated 
additives (10nM complex, 20mM additive,  λex = 335 nm, λex = 620 nm). 
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2.5 Comparative Studies 
2.5.1 Bis(3-Azaxanthone) and Bis(1-Azaxanthone) Europium Complexes 
 
Of the four complexes synthesised, [Eu·L2(H2O)]+ was found to have the most favourable properties: 
it has the highest quantum yield and shows the greatest resistance to quenching by MnCl2. As noted in 
Section 2.6, it also exhibits intriguing behaviour in the cellular environment. During the preparation of 
[Eu·L2(H2O)]+, an analogous complex [(1-AX)-Eu·L2]+ was synthesised. ii  This complex is the 
constitutional isomer of [Eu·L2(H2O)]+, incorporating two 1-azaxanthone groups. The behaviour of 
each complex in the presence of protein (HSA) and DNA was investigated. 
                       
Luminescence titrations were carried out for each complex with human serum albumin (HSA). This 
protein was added in increments from 0 – 700 µM (Figure 2.10), to an aqueous solution of the 
complex (20 µM). A study of the form of the two initial europium emission spectra, prior to HSA 
addition, shows clearly that the two species have different symmetry about the metal centre. The 
complexity of the splitting in the ∆J = 1 and ∆J = 4 bands seen in the spectrum of [(1-AX)-Eu·L2]+ 
implies a geometry about the europium centre of lower symmetry than that of [Eu·L2(H2O)]+. To 
allow binding to the Eu3+ centre of each azaxanthone nitrogen lone pair, [(1-AX)-Eu·L2]+ must adopt 
a conformation in which the two sensitising groups lean over the top of the complex – a large 
proportion of the chromophore lies along the principal axis. This increase in steric bulk about the z 
axis is reflected in a q value of 0. In contrast, [Eu·L2(H2O)]+ has a q value of 1. The bulk of the two 
chromophores now lie away from the principal axis, allowing a H2O molecule to coordinate in the 
axial position. It is apparent that access to three and four chromophores in this DOTA based system is 
only possible using the 3-azaxanthone chromophore. 
 
Upon addition of HSA to [Eu·L2(H2O)]+, the Eu3+ centred emission decreased but no change in the 
form of the spectrum was observed (Figure 2.10 upper). This is consistent with many other europium 
and terbium complexes, for which increasing amounts of protein reduce the emission intensity due to 
quenching. These mechanisms may include vibrational quenching of the lanthanide excited state by 
X-H oscillators (e.g. serine O-H, lysine N-H), or involve the sensitiser excited states. In contrast, the 
behaviour of [(1-AX)-Eu·L2]+ with serum albumin is quite different. Firstly, upon addition of HSA 
the form of the europium emission changes – the fine splitting of the ∆J = 1 band goes from three 
transitions to four, indicative of more than one emissive Eu3+ species in solution, and the ∆J = 2 band 
goes from two transitions to three, suggesting a change in symmetry about the Eu3+ centre upon 
                                                          
ii
 Synthesis of [(1-AX)-Eu·L2]Cl was carried out by Dr. G. –L. Law at Durham University 
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addition of protein. It seems plausible that increasing amounts of protein serve to displace one of the 
bound chromophores, which occupy a sterically demanding region in space, leading to a change in 
geometry about the metal centre and, therefore, a change in the form of the emission spectrum. 
Secondly, the ∆J = 2 to ∆J = 1 ratio increases in the presence of protein. This suggests that some 
polarisable group within the protein (perhaps a CO2- of a glutamate or aspartate residue) is binding to 
europium in the previously unoccupied axially position, leading to the observed change. Overall, this 
comparison shows the greater stability of [Eu·L2(H2O)]+, containing the 3-azaxanthone group, with 
respect to steric demand and displacement of the sensitising group by protein. 
 
 
 
Figure 2.10 Luminescence titrations of [Eu·L2(H2O)]+ (upper) and [(1-AX)-Eu·L2]+ (lower) with an increasing 
concentration of HSA (complex concentration 20 µM in H2O, λex = 328 nm, pH 7.4, 293 K) 
 
 
 
 The 3-Azaxanthone Series                                                                                                        Chapter 2 
 
 
43 
 
The luminescence lifetime was also measured as a function of added HSA. For [Eu·L2(H2O)]+, the 
lifetime was reduced by around 20 %, mirroring the reduction in emission intensity. The isomeric 
complex, [(1-AX)-Eu·L2]+, showed an increase in the luminescence lifetime of 50 % at 700 µM, 
implying that the protein may shield the Eu3+ centre, thereby increasing the excited state lifetime. 
Luminescence titrations with [Tb·L2(H2O)]+ and [(1-AX)-Tb·L2]+ gave similar results to the Eu3+ 
complexes. The [Tb·L2(H2O)]+ excited state was steadily quenched, reflected by a reduction in both 
lifetime and emission intensity. The lifetime of [(1-AX)-Tb·L2]+ increased by 65 % whilst the Tb3+ 
emission spectrum, which is less sensitive to its coordination environment, apparently remained 
unchanged. 
 
 
Figure 2.11 Luminescence titration of [Tb·L2(H2O)]+ with DNA (H2O, pH 7.4, 295K) and insert) Variation in 
the excited state lifetime as a function of added DNA. 
 
Luminescence titrations with calf thymus DNA (42% CG base pairs) were also carried out with each 
complex. DNA was added in increments up to a ratio of 4 base pairs per complex. Small decreases (~ 
10 %) in the luminescence lifetimes of [Eu·L2(H2O)]+ and [(1-AX)-Eu·L2]+ were observed. The forms 
of the emission spectra were unchanged and the intensities decreased slightly. Addition of DNA to the 
two Tb3+ complexes caused a 50 % reduction in the emission intensity and luminescence lifetime at 1 
base pair per complex (Figure 2.11). Previous studies examining the behaviour of various 
lanthanide(III) complexes in the presence of several nucleic acids have revealed charge transfer 
quenching of lanthanide emission,7 with Tb complexes much more sensitive to the quenching process. 
This process may involve exciplex formation between the chromophore and the electron rich C or G 
bases. Consistent with this idea, addition of poly(dAdT) (DNA without CG base pairs), to either 
[Tb·L2]+ or [(1-AX)-Tb·L2]+ led to a 20 % smaller reduction in the intensity of the lanthanide 
emission than with DNA. 
2.5.2 Bis(3-Azathiaxanthone) Europium Complex 
 
The azathiaxanthone complex [Eu·L2b(H2O)]+ was synthesised to investigate the effect of varying O 
for S upon the behaviour of the complex. It is known that the azathiaxanthones have longer 
wavelength absorption maxima, making them better suited for biological applications and also have 
potential use in two photon excitation studies.8 Despite the longer absorption wavelength, indicative 
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of a lower singlet excited state energy, the azathiaxanthones possess a smaller singlet-triplet energy 
gap than the azaxanthones.1 As a result, azathiaxanthones triplet energies (~24,000 cm-1) are in the 
range applicable for sensitisation of Eu3+, although Tb3+ sensitisation is less efficient.  
 
 
 
Table 2.2 Photophysical data for [Eu·L2(H2O)]+ and [Eu·L2b(H2O)]+ (H2O, 295 K unless otherwise stated). 
Complex λabs / nm ε / M-1 cm-1 
 	/	% 
 / (ms)-1 
 / (ms)-1 q 
[Eu.L2(H2O)]+ 328 5,800 10 1.70 0.65 1.1 
[Eu.L2b(H2O)]+ 368 6,200 8.3 1.76 0.63 1.1 
 
The photophysical properties of [Eu·L2b(H2O)]+ (Table 2.2) are very similar to those of 
[Eu·L2(H2O)]+, with the exception of the absorbance spectral profile. The absorption spectrum of 
[Eu·L2b]+ (Figure 2.12 insert) shows two maxima at 310 nm (ε = 12,000 M-1 cm-1) and 368 nm (ε = 
6,200 M-1 cm-1). As with the azaxanthones, these absorption bands are attributed to transitions with 
dominant n-pi* and pi-pi* character. The emission spectra of [Eu·L2b(H2O)]+ and [Eu·L2(H2O)]+ were 
measured following excitation at their respective absorption maxima (Figure 2.12). The form of the 
two emission spectra are very similar, indicating that the symmetry and coordination environment 
about Eu3+ is the same in each case. This is also confirmed by the measured q values of 1.1 for each 
complex. A second observation is the increased fluorescence centred at 440 nm for the 
azathiaxanthone analogue. The quantum yield for fluorescence is 37 % of the total emission. The 
significant amount of fluorescence suggests that the intersystem crossing process is less efficient for 
the azathiaxanthone chromophore than for the azaxanthone chromophore.  
 
 
Figure 2.12 Comparison of the absorption (insert) and emission spectra of [Eu·L2(H2O)]+ (λex = 328 nm) and 
[Eu·L2b(H2O)]+ (λex = 368 nm)  (H2O, pH 5.8, 295 K). 
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Both protein and DNA titrations were carried out with [Eu·L2b(H2O)]+ in an analogous manner to 
[Eu·L2(H2O)]+. The results were similar to those of [Eu·L2(H2O)]+. Upon addition of DNA, the Eu3+ 
excited state lifetime fell from 0.57 to 0.47 ms – an 18 % decrease. As with [Eu·L2(H2O)]+, there was 
no change in the form of the emission spectrum, suggesting no change in the Eu3+ coordination 
environment. It is supposed that quenching by DNA involves the chromophore excited state. The 
addition of HSA to [Eu·L2b(H2O)]+ led to a reduction in both the excited state lifetime and emission 
intensity, with no change in the form of the emission. 
 
The general conclusion from the comparison of [Eu·L2(H2O)]+ and [Eu·L2b(H2O)]+ is that varying the 
sensitising group from an azaxanthone to an azathiaxanthone does not significantly alter the structural 
or photophysical properties of the Eu3+ complex. The advantage of the sulphur containing complex is 
that the absorption spectrum shifts to a longer wavelength, making it more amenable to cellular 
studies, where endogenous fluorophores can absorb excitation light of shorter wavelengths.  
 
2.6 Cellular Studies 
 
One potential application of luminescent lanthanide complexes is to report information from within a 
cellular environment using fluorescence microscopy. The long lived excited state lifetimes and 
emission spectra in the visible region of the spectrum make them suitable for this purpose. As a result, 
newly synthesised complexes are often dosed in a number of cell lines to investigate their uptake, 
localisation and toxicity. Some complexes act as cellular stains while others are designed to report 
specific changes within the cell. For instance, Eu3+ based complexes have been designed which report 
changes in HCO3-,9 pH and pO210 by a change in the form or intensity of the emission spectrum. For 
the current series, [Eu·L1(H2O)] – [Eu·L4]3+, the uptake into cells, the localisation within the cell and 
the cytotoxicity were all assessed.  
2.6.1 Cytotoxicity 
 
An important property of an intracellular complex is its toxicity. The cytotoxicity of a given complex 
is quantified by its IC50 value, which is the concentration of compound required to inhibit cellular 
activity by 50 %. To calculate the IC50 value, NIH-3T3 cells were grown in 96-well plates. After 24 
hours, the cells were dosed with complex giving final concentrations over the range 0 – 200 µM. After 
a further 20 hours incubation, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
was added to each well. This is a compound which is metabolised by mitochondrial dehydrogenase of 
viable cells to give formazan, a bright purple, insoluble compound. The amount of formazan produced 
is a measure of the viability of cells after incubation with the complex. After 4 hours incubation with 
MTT, the amount of formazan was quantified spectrophotometrically upon dissolution in dimethyl 
sulphoxide. The IC50 value is determined as the concentration of complex required to reduce the 
absorbance to 50 % of that in the untreated, control wells. 
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Table 2.3 IC50 values (± 20 µM) for Eu and Tb 
complexes calculated using the MTT assay     
(NIH-3T3 cells). 
Complex IC50 / µM 
[Eu·L1(H2O)] > 200 
[Tb·L1(H2O)] > 200 
[Eu·L2(H2O)]+ > 200 
[Tb·L2(H2O)]+ > 200 
[Eu·L3(H2O)]2+ 80 
[Eu·L4]3+ 20 
[(1-AX)-Eu·L2]+ > 200 
[(1-AX)-Tb·L2]+ > 200 
[Eu·L2b(H2O)]+  > 200 
 
 
Figure 2.13 Transmission image of NIH-3T3 cells 
dosed with [Eu·L4]3+, showing membrane damage. 
 
The results of the cytotoxicity studies (Table 2.3) show that increasing the number of sensitising 
groups, increases the cytotoxicity. Complexes with one and two sensitising groups remain non-
cytotoxic up to 200 µM. Varying the Ln3+ ion from Eu3+ to Tb3+ does not appear to alter the toxicity of 
the complex. The complexes with three and four sensitising groups show higher toxicity. This is likely 
to be associated with the increase in hydrophobicity of these complexes, leading to rupturing of the 
phospholipid cell membrane. Figure 2.13 shows a transmission image of NIH-3T3 cells dosed with 
[Eu·L4]3+
 
(50 µM). The cells have no clear membrane and are leaking cytosol into the medium, 
consistent with necrotic cell death. 
2.6.2 Microscopy Studies 
 
Having established that complexes with one or two sensitising groups were non-cytotoxic up to 200 
µM, microscopy studies were undertaken with these complexes to investigate their cellular uptake and 
localisation profile. The complex [Eu·L1(H2O)] was dosed at 50 µM concentration with NIH-3T3 
cells and epifluorescence images were taken at 1, 4 and 24 hour time-points. Using excitation and 
emission filters, it is possible to selectively excite the Eu3+ complex and observe its emission. After a 
4 h incubation, Eu3+ emission is clearly seen from within the cell (Figure 2.14), confirming that the 
complex is able to permeate the phospholipid membrane and enter the cell.  
 
 
Figure 2.14 Localisation profile of [Eu·L1(H2O)] in NIH-3T3 cells at 4h incubation. From left to right: 
transmission image, Eu3+ emission, LysoTracker emission and a merged image.  
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The mechanism by which Ln3+ complexes containing azaxanthone sensitisers enter cells has been 
previously investigated.11 By dosing cells with inhibitors which selectively block certain uptake 
mechanisms, macropinocytosis was determined as the uptake mechanism, and can be assumed to be 
the mechanism by which [Eu·L1(H2O)] enters cells. To establish the localisation profile of 
[Eu·L1(H2O)] within the cells, co-localisation studies were performed using commercially available 
stains. LysoTracker is a dye which selectively stains the lysosomes of cells. By using different filter 
sets, it is possible to selectively observe [Eu·L1(H2O)] and LysoTracker emission. Figure 2.14 clearly 
shows the co-localisation of the two emissive species, indicating that [Eu·L1(H2O)] localises in the 
lysosomes of the cells. The lysosomes are vesicles formed from late endosomes and are responsible 
for trafficking within the cell, including the removal of waste material. Many Ln3+ complexes are 
visualised within the lysosomes as the cell attempts to remove the foreign material from within the 
cell.  
 
Lysosomal localisation was observed for [Eu·L1(H2O)], [Tb·L1(H2O)], [Eu·L2(H2O)]+, [Tb·L2(H2O)]+, 
[(1-AX)-Eu·L2]+ and [(1-AX)-Tb·L2]+ when dosed at 50 µM and visualised by epifluorescence 
microscopy. Rather different results were found for the complexes [Tb·L2(H2O)]+ and [(1-AX)-
Tb·L2]+ in HeLa cells, dosed at 0.5 µM and visualised by confocal microscopy. iii  Confocal 
microscopy makes use of laser excitation and is able to give images of much higher sensitivity and 
resolution than epifluorescence microscopy. Under these conditions, the two complexes under 
surveillance appeared to stain the cell nucleus. This was confirmed by co-localisation studies with 
Hoechst 33342, a nuclear stain. Furthermore, the staining was selective, with only those cells 
undergoing mitosis being stained. It is known that during the ‘M’ phase of mitosis, membrane 
permeability increases and this may account for this selective staining.12 For cells at each of the four 
stages of mitosis (prophase, metaphase, anaphase and telophase) chromosomal DNA could be 
visualised (Figure 2.15). In a separate experiment, a single cell was visualised at various time points 
as it underwent the early stages of mitosis (Figure 2.16). The cell cycle was prematurely stopped 
before anaphase, possibly due to phototoxicity caused by the excitation light source. These early 
results of complexes which selectively stain cells undergoing mitosis are unusual and further 
investigations are required into the mechanism of uptake, trafficking within the cells and the nature of 
the interaction with the chromatin. The DNA titrations with [Tb·L2(H2O)]+ and [(1-AX)-Tb·L2]+ 
(Section 2.5.1) showed that an interaction takes place, leading to a reduction in the Tb3+ emission, but 
suggested that DNA does not change the coordination environment of the Tb3+ centre. It is more 
likely, then, that the binding is via the sensitising group, which is flat and aromatic and may be able to 
intercalate into major or minor grooves of DNA. Another possibility is that the complexes bind to the 
protein within the chromatin, which is associated with the compacting of DNA. The protein titration 
with [(1-AX)-Eu·L2]+ showed that a specific interaction takes place between the complex and serum 
albumin, involving the protein directly binding to the Ln3+ centre. 
 
 
                                                          
iii
 Confocal images taken by Dr. Cornelia Man in Hong Kong University 
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Figure 2.15 Bright field (upper left and lower right) and fluorescence microscopy images of HeLa cells 
undergoing mitosis, with an illustrative schematic of the cell cycle (0.5 µM, [(1-AX)-Tb·L2]+, 3 h , λex 355 nm). 
 
 
Figure 2.16 Time course (5 min intervals) of fluorescence microscopy images staining chromatin in a cell 
undergoing division, showing the progression from interphase (top left for comparison) via prophase to 
prometaphase and metaphase (50 nM  [(1-AX)-Tb·L2]+, HeLa cell, λex 355 nm). 
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Confocal images were also taken of [Eu·L2b(H2O)]+ in PC3 (human prostate cancer) cells at 50 nM 
concentration (Figure 2.17).iv The ability of the azathiaxanthone sensitiser to absorb light at longer 
wavelengths than the azaxanthone analogue, allowed the use of a 405 nm laser excitation source. As 
with the complexes [Tb·L2(H2O)]+ and [(1-AX)-Tb·L2]+, [Eu·L2b(H2O)]+ could be visualised within 
the nucleus of the cell. However, rather than binding to DNA, localisation appears to be in the 
nucleoli, which contain ribosomes, responsible for protein production within the cell. This hypothesis 
of [Eu·L2b(H2O)]+ being protein bound is also supported by the non-specific localisation of the 
complex in the cytosol, which also contains many proteins. It is apparent from these microscopy 
studies that localisation within the cell is a complex process, which is dependent upon both the cell 
line and the exact structure of the lanthanide complex and is not easily rationalised. 
 
 
Figure 2.17 Confocal image of [Eu·L2b(H2O)]+ in a PC3 cell line (50 nM, 8 h). 
 
2.7 Conclusions 
 
The initial aim of this study was to investigate whether the 3-azaxanthone chromophore was able to 
sensitise Eu3+ emission and to compare this new chromophore with the 1-azaxanthone constitutional 
isomer. It was found that altering the position of the N in the chromophore did not significantly alter 
its photophysical properties. With an extinction coefficient of 2,500 M-1 cm-1 and a quantum yield of 
6.9 %, [Eu·L1(H2O)] is a moderately bright complex upon excitation at 328 nm with typical Eu3+ 
emission between 570 and 720 nm. The advantage of the 3-azaxanthone is the ability to incorporate 
up to four chromophores per complex, thereby increasing the molar extinction coefficient to 15,000 
M-1 cm-1 for the complex [Eu·L4]3+, which retains a quantum yield of around 5 %.   
 
The stability of the Eu3+ emission was investigated for each complex in the presence of a number of 
species which could reduce the emission intensity. It was found that the divalent cations Ca2+ and 
Mg2+, which could quench the emission by transmetallation, did not significantly perturb the Eu3+ 
emission. The competitive ligand EDTA showed some ability to extract the Eu3+ from its starting 
ligand, but only after an 18 h incubation time. The species that was able to quench Eu3+ emission to 
the greatest extent was Mn2+. The mechanism of this quenching process is further investigated in 
Chapter 6. The presence of protein and DNA resulted in a decrease in the emission of [Eu·L2(H2O)]+, 
                                                          
iv
 Confocal images taken by Dr. Robert Pal in Durham University 
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likely due to some non-specific binding. In contrast, the 1-azaxanthone complex [(1-AX)-Eu·L2]+ 
underwent a change in spectral form, indicative of protein binding directly to the Eu3+ centre.  
 
At this stage, a critical assessment of the complexes containing the 3-azaxanthone chromophore is 
necessary, with respect to their ability to act as donors in the HTRF experiment described in Section 
1.4 and the extent to which these systems meet the specification in Section 1.5. The excitation 
wavelength of this chromophore is suitable to the HTRF application. However, even the complex with 
the highest molar extinction coefficient ([Eu·L4]3+ at 15,000 M-1 cm-1) does not exceed that of the 
currently used tris(bipyridine) complex [Eu·L1.1]3+ (18,000 M-1 cm-1). The quantum yields are 
comparable with [Eu·L1.1]3+ but show no significant improvement. The stability of each of the 
complexes in the presence of Mn2+, an ion present in the HTRF assay medium, is also a concern. In 
terms of the form of the emission spectrum, [Eu·L4]3+ has a larger relative ∆J = 2 band, compared to 
the [Eu·L1.1]3+ complex, which would increase spectral overlap with the acceptor moiety in the FRET 
process. Unfortunately, [Eu·L4]3+ is also the complex of lowest aqueous solubility, due to the presence 
of four aromatic chromophoric groups. Overall, it is apparent that, although the 3-azaxanthone 
complexes would be applicable to HTRF application, they do not offer any significant advantage over 
the currently used complex.  Other sensitising groups must be investigated which can give large 
increases in both the molar extinction coefficient and emissive quantum yield, while remaining stable 
within the assay medium. The form of the emission spectrum must also be improved, which is the 
subject of the next chapter. 
 
Despite not being further pursued for HTRF applications, the curious behaviour of [Tb·L2(H2O)]+ and 
[(1-AX)-Tb·L2]+, which selectively stain the DNA of dividing cells, is worth further investigation. 
Experiments that reveal the nature of the mechanism of cellular uptake and trafficking within the 
cellular environment are worthy of attention. It is also interesting to find that the azathiaxanthone 
analogue, [Eu·L2b(H2O)]+, has a different localisation profile. Although a challenging exercise, it may 
be an area of future study to understand better the processes which determine intracellular localisation 
with these systems. 
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3. Evaluation of Structural Variation in 
Monosubstituted DO3A Systems 
3.1 Introduction 
 
The 3-azaxanthone series showed that the molar extinction coefficient of an emissive complex could 
be increased by incorporating multiple chromophores. Within this series however, the form of the 
Eu3+ emission did not meet the specification for a HTRF donor complex defined in Section 1.5, which 
calls for a large ∆J = 2 band, relative to the other emission bands. Enhancing the emission in the ∆J = 
2 region (600 – 630 nm) is required to maximise the spectral overlap integral with the designated 
acceptor moiety, an allophycocyanin dye protein, thereby increasing the FRET efficiency.  
 
Some of the factors which affect the various transitions in the Eu3+ spectrum are known. The form of 
the Eu3+ emission spectrum can be assessed as follows: the ∆J = 0 transition is formally forbidden but 
can gain intensity through J mixing and is sensitive to the symmetry of the complex; the magnetic 
dipole allowed ∆J = 1 transition is relatively insensitive to the coordination environment and typically 
consists of two (in Cn symmetry, where n ≠ 1) or three (lower symmetry complexes) bands; the 
hypersensitive ∆J = 2 and ∆J = 4 transitions are electric dipole allowed and their intensities are 
sensitive to the ligand field, particularly the polarisability of the axial donor in a square antiprismatic 
or twisted square antiprismatic geometry.1 The sensitivity of the ∆J = 2 band to the polarisability of 
the axial donor has recently been exploited to probe ratiometrically the concentration of
 
HCO3-. This 
involves displacement of a capping H2O molecule from a Eu3+ complex, causing a 5-fold increase in 
the relative ∆J = 2 intensity.2  
 
 
 
In this chapter, the axial ligand is varied in model [Eu·DO3A] systems, [Eu·L5], [Eu·L6]- and [Eu·L7]-, 
to investigate the effect upon the form of the emission spectrum. Having established the moiety that 
gives the largest ∆J = 2 band, the three carboxylate binding groups are exchanged for 
methylphosphinate groups ([Eu·L8]-), with a view to enhancing the stability of the emission, with 
respect to Mn2+ quenching. 
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3.2 Synthetic Aspects 
3.2.1 The DO3A Series 
 
The first complex that was synthesised, [Eu·L5], contains a polarisable phosphonyl group in the axial 
position of the Eu3+ coordination sphere. Synthesis of the phosphonyl moiety was achieved via a one 
pot, three step process in fairly high yield (Scheme 3.1). The commercially available starting material, 
2-bromo-6-methylpyridine (17) was lithiated with nBuLi and reacted with chloro-diethyl phosphine 
before being oxidised to the phosphine oxide by one equivalent of hydrogen peroxide. Purification by 
column chromatography on silica afforded 18 in 70 % overall yield. 
 
 
Scheme 3.1 
 
After bromination with N-bromosuccinimide (NBS) and dibenzoyl peroxide, mono-alkylation with 
the triester DO3A(OtBu)3 gave the intermediate 20. Deprotection of the three tert-butoxycarbonyl 
(BOC) groups of 20 with CF3CO2H and complexation with Eu(OAc)3 proceeded in high yield 
(Scheme 3.2). The purity of [Eu·L5] was confirmed by high resolution mass spectrometry (HRMS) 
and reversed phase-high performance liquid chromatography (RP-HPLC). 
 
 
Scheme 3.2 
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The next synthetic target, [Eu·L6]-, was selected due to the presence of a polarisable phosphinate 
group in the axial position of the Eu3+ coordination sphere. In contrast to [Eu·L5], the axial group is 
negatively charged, which was expected to increase the stability of the complex and cause a variation 
in the emissive spectral form. The synthesis of [Eu·L6]- (Scheme 3.3) involved the palladium catalysed 
cross coupling of 2-bromo-6-methyl pyridine (17) with ethyl phenylphosphinate, followed by 
bromination of the methyl group with NBS and dibenzoyl peroxide. Alkylation with DO3A(OtBu)3 
was followed by deprotection with 6M HCl at 100 °C and complexation with EuCl3, following 
adjustment of the pH to 5.8. Concentrated HCl was used for deprotection as it cleaves both the three 
BOC groups and the phosphinate esters. Purification at each step was achieved by column 
chromatography on silica and the purity of the final complex was confirmed by HRMS and RP-
HPLC. 
 
 
Scheme 3.3 
 
The final complex in the DO3A series is [Eu·L7]-, in which a carboxylate group caps the europium 
coordination sphere. The picolinate group has been used previously in C3 symmetric Eu3+ complexes 
(see [Eu·L1.6] in Section 1.3.3),3 giving a Eu3+ spectrum with a large relative ∆J = 2 band. 
Bromination of the commercially available material 24 using NBS was followed by reaction with 
DO3A(OtBu)3 (Scheme 3.4). Protecting group removal and complexation with EuCl3 led to the target 
complex in high yield. Deprotection was achieved in two steps: removal of the OtBu groups with 
CF3CO2H followed by base hydrolysis with aqueous NaOH (1 M). Both steps were carried out at 
room temperature. Single step deprotection with 6M HCl at 100 °C (deprotection conditions for 
[Eu·L6]-) was ruled out due to the possibility of decarboxylation of the acid group in the position 
alpha to the pyridyl N, as has previously been observed using acidic conditions and high 
temperatures.4 
 
 
Evaluation of Structural Variation in Monosubstituted DO3A Systems                                  Chapter 3 
 
55 
 
N
N
N
N
O O tBu
O
OtBu
O
tBuO
N
OEt
O
N
N
N
N
O OH
O
OH
OHO
N
OH
O
N
N
N
N
O O
O
O
OO
N
O
Eu
O
K2CO3
EuCl3
N
O
Br OEt
N
O
OEt
NBS
Dibenzoyl
Peroxide
DO3A(OtBu)3
93 %
57 %48 %
1) CF3CO2H
2) NaOH (1 M) 91 %
24 25 26
H4L
7[Eu·L7]-
 
Scheme 3.4 
 
During the course of these studies, Figueroa et. al. reported the synthesis and lanthanide coordination 
chemistry properties of L7.5 Their work included a DFT calculation for [Gd·L7]-, revealing a favoured 
mono-capped square antiprismatic structure with the carbonyl oxygen occupying the axial site (Figure 
3.1). In contrast, the related complex [Gd·L7b] exists as two diastereomers in solution in a 2 : 1 ratio.6 
In this complex, the axial donating ligand is a solvent molecule, due to the absence of the pyridyl 
carboxylate. The reduction in steric demand about the Ln3+ centre may be responsible for the presence 
of the two observed diastereomers.    
 
      
N
N
N
N
O O
O
O
OO
N
H2O
Eu
[Eu·L7b]
 
Figure 3.1 Calculated DFT structure of [Gd·L7], showing the carbonyl oxygen (O4) in the axial position of the 
square antiprismatic geometry.5 
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3.2.2 Methylphosphinate Complex 
 
It was determined that of the three complexes in the DO3A series, [Eu·L6]- gave the best Eu3+ spectral 
form. In an attempt to improve the stability of this complex, three methyl phosphinate groups were 
chosen to replace the three carboxylate groups of DO3A. The synthesis of [Eu·L8]- (Scheme 3.5) 
required mono-substitution of 1,4,7,10-tetraazacyclododecane (cyclen) with the 
pyridylphenylphosphinate moiety, 22. This was achieved using cyclen with three nitrogens protected 
with BOC groups. After alkylation in MeCN with K2CO3, the BOC groups were removed from 27 
with CF3CO2H. Following addition of the three methyl phosphinate groups using MeP(OEt)2 and 
paraformaldehyde in THF, each phosphinate esters group was hydrolysed in aqueous HCl (6 M). 
After pH adjustment, complexation was achieved with EuCl3 to give the target complex, [Eu·L8]-.  
 
 
Scheme 3.5 
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3.3 Photophysical Properties of [Eu·L5], [Eu·L6]- and [Eu·L7]- 
3.3.1 Emission Spectra and Excited State Lifetimes 
 
The absorption spectra of the complexes in the DO3A series each have a maximum absorption 
wavelengths around 275 nm (Figure 3.2 inserts), typical of a pyridyl pi-pi* transition. An absorption 
wavelength in this region does not meet the specification in Section 1.5. However, the pyridyl moiety 
can form the basis of a number of chromophores with longer wavelength absorption maxima and 
therefore serves as a good model at this stage. The pyridyl moiety is also useful, as it is able to 
populate the europium excited state after excitation at 275 nm, allowing the study of the emission 
spectra of the various complexes.  
 
 
     
 
Figure 3.2 Absorption (insert) and emission spectra for the three complexes, [Eu·L5], [Eu·L6]- and [Eu·L7]-. All 
spectra recorded in H2O (λex = 275 nm, 20 µM, pH 5.8, 295 K).  
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
400 450 500 550 600 650 700
R
e
la
tiv
e
 
In
te
n
s
ity
Wavelength / nm
 
0.00
0.05
0.10
0.15
0.20
200 250 300 350
Ab
so
rb
an
ce
Wavelength / nm
 
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
400 450 500 550 600 650 700
Re
la
tiv
e 
 
In
te
n
s
ity
Wavelength / nm
 
0.00
0.05
0.10
0.15
0.20
0.25
250 275 300 325
Ab
so
rb
an
ce
Wavelength / nm
 
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
400 450 500 550 600 650 700
Re
la
tiv
e 
In
te
n
s
ity
Wavelength / nm
 
0
0.04
0.08
0.12
250 275 300 325
Ab
so
rb
an
ce
Wavelength / nm
[Eu·L
7
]
-
 
[Eu·L
6
]
-
 
[Eu·L
5
] 
Evaluation of Structural Variation in Monosubstituted DO3A Systems                                  Chapter 3 
 
58 
 
The Eu3+ emission spectra of [Eu·L5], [Eu·L6]- and [Eu·L7]- were recorded in H2O (λex = 275 nm, 20 
µM, pH 5.8, 295 K) (Figure 3.2). No fluorescence is seen in the region 400 – 550 nm, demonstrating 
the efficiency of Eu3+ sensitisation by the pyridyl groups. In each case, it is clear that the ∆J = 2 band 
is the most intense transition. To allow visual comparison, the three spectra have been overlaid along 
with that of [Eu·L1.1]3+, which is the complex currently used as a donor in the HTRF experiment 
(Figure 3.3). The first striking feature is the difference in spectral form between [Eu·L1.1]3+ and the 
three new complexes. In particular, the ∆J = 2 band varies from the former, in which two distinct 
bands appear (605 and 620 nm), to the latter, which each have single emission bands centred at 615 
nm. This may be originating from the solvation conditions of the complexes. The [Eu·L1.1]3+ spectrum 
was recorded in 0.4 M KF, which is required to expel H2O from within the tris(bipyridine) cavity, 
thereby increasing the quantum yield. The new series of complexes are all 9 coordinate q = 0 systems 
and have an advantage over [Eu·L1.1]3+ in requiring no such additive.  
 
Table 3.1 Photophysical data for the three DO3A complexes and two reference compounds, [Eu·L1(H2O)] and 
the tris(bipyridine) complex [Eu·L1.1]3+. The data for complex [Eu·L8]- is also shown. All measurements in H2O 
(20 µM, pH 5.8, 295 K) aValues recorded in 0.4 M KF. 
Complex λex / nm τ (H2O) / ms q 
Intensity Ratios 
∆J = 2 / ∆J = 1 ∆J = 2 / ∆J = 4 
a[Eu·L1.1]3+ 303 0.34 0.0 1.40 1.30 
[Eu·L1(H2O)] 328 0.60 1.1 1.13 1.14 
[Eu·L5] 272 1.21 0.0 1.74 1.73 
[Eu·L6]- 272 1.27 0.0 2.14 2.40 
[Eu·L7]- 276 1.14 0.1 1.66 1.62 
[Eu·L8]- 272 0.95 0.0 3.02 5.10 
 
Comparing the emission spectra of the three new complexes (Figure 3.3), it is apparent that the 
species with the highest emission intensity in the ∆J = 2 manifold is [Eu·L6]-. To quantify this 
observation, integrated intensity ratios ∆J = 2 : ∆J = 1 and ∆J = 2 : ∆J = 4 were calculated (Table 3.1). 
The values for the 3-azaxanthone complex [Eu·L1(H2O)], which is based on the DO3A ligand, have 
also been included in Table 3.1. By comparing the intensity ratios for [Eu·L1(H2O)] (1.13 and 1.14) 
with those of [Eu·L5] (1.74 and 1.73) and [Eu·L7]- (1.66 and 1.62), it can be concluded that 
exchanging a H2O molecule in the capping axial position of a twisted square antiprismatic complex 
for a more polarisable group leads to an increase in the relative intensity of the ∆J = 2 transition. In 
comparison with [Eu·L1(H2O)] and [Eu·L1.1]3+, each of the synthesised complexes have improved 
intensity ratios, with [Eu·L6]- showing the highest values of 2.14 and 2.40. Data from Table 3.1 also 
show the correlation between the q value and the Eu3+ excited state lifetime in water, τ. Those 
complexes which are q = 0 have comparable lifetimes around 1.2 ms, whereas [Eu·L1(H2O)], which is 
q = 1, has a lifetime of around half this value, due to the vibrational quenching of inner sphere H2O 
molecules. 
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Figure 3.3 Comparison of the emission spectra of [Eu·L5] (purple), [Eu·L6]- (red) and [Eu·L7]- (green). The 
emission spectrum of the tris(bipyridine) complex [Eu·L1.1]3+ (grey) is also shown. All spectra recorded in H2O 
(20 µM complex, pH 5.8, 295 K) except [Eu·L1.1]3+ which also contains 0.4 M KF. Spectra have been scaled so 
that the total integrated intensity is equal for each spectrum. 
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3.3.2 Emission Stability 
 
Another important feature of the current series to consider and compare is the emissive stability of the 
complexes. This is assessed by measuring the emission intensity at a given wavelength in the presence 
of the same potential inhibitors used in the stability studies of the 3-azaxanthone complexes in Section 
2.4.3. Inhibitors include several cations, EDTA4- and two proteins (Figure 3.4). From the data, it is 
apparent that displacement of the Eu3+ ion by Ca2+ or Mg2+ does not occur. In contrast to the 3-
azaxanthone complexes, extraction of Eu3+ by the competitive ligand EDTA4- is negligible, even after 
18 h. This demonstrates the increased kinetic stability of the complexes with 9 coordinate charged 
ligands compared to, say, the 8 coordinate uncharged ligand in the complex, [Eu·L4]3+. As for the 3-
azaxanthone complexes, the inhibitor which caused the greatest reduction in emission intensity was 
Mn2+. In the cases of [Eu·L6]- and [Eu·L7]- the emission is completely absent. Displacement of the 
europium ion seems unlikely and a more rational explanation would be that the emission is quenched 
at some point along the sensitised emission pathway. Studies reported in Chapter 6 examine this 
quenching mechanism in more detail. The two proteins which were tested led to a reduction in the 
Eu3+ emission, and to the same extent with each complex. The most likely explanation is that amino 
acids containing aromatic moieties (Tyr, Trp, Phe), which have similar absorption spectra to the Eu3+ 
complexes, are absorbing some of the excitation light source, leading to an overall reduction in the 
number of complexes emitting light. Upon moving to Eu3+ complexes with chromophores which 
absorb light above 300 nm, this effect should no longer be observed.   
 
              
Figure 3.4 Stability data for [EuL5] (left), [EuL6]- (centre) and [EuL7]- (right) in HEPES buffer at two time 
points, 15 min and 18 h (10nM complex, λex = 335 nm, λex = 620 nm). 
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3.4 Comparative Analysis with the [Eu·L8]- 
3.4.1 Photophysical Properties 
   
From the study of the DO3A series, it was determined that the pyridylphenylphosphinate moiety (21) 
should be used in further complexes, as it leads to the most favourable Eu3+ emission spectrum. The 
complex [Eu·L6]-, however, suffers from severe quenching of emission by Mn2+ ions. In an attempt to 
improve the emissive stability of the complex, [Eu·L8]- was synthesised. In this system, the three 
carboxylate groups of the DO3A complex are exchanged for methylphosphinate groups. The 
advantages of phosphinate groups were discussed in Section 1.3.3 and include: the formation of 
complexes with greater stability, due to increased steric bulk about the Ln3+ centre; the introduction of 
stereogenic P centres, which may result in differential interaction with chiral species and the 
pentavalency of the P centre, leading to an R group (in this case Me) which can be varied to introduce 
function or variation in properties.  
 
 
 
The photophysical data for [Eu·L8]- were included in Table 3.1. As expected, the 9 coordinate 
complex has no coordinated H2O and has a luminescence lifetime around 1 ms. The absorption profile 
is unchanged from the [Eu·L6]- analogue, with a pyridyl absorption maximum at 272 nm. The main 
photophysical difference between the two complexes is in their emission spectra (Figure 3.5). Firstly, 
an increase in splitting of the ∆J = 2 band upon moving from the carboxylate to the 
methylphosphinate coordinating arms is observed. The intensity ratio of the ∆J = 2 : ∆J = 1 bands 
also shows a significant increase from 2.14 to 3.02. The ∆J = 2 : ∆J = 4 ratio has also increased from 
2.40 to 5.10. These large improvements in emission spectral form cannot be arising from the 
polarisability of the axial donor as it is the same in each case. Instead, the change in spectral form 
must arise from a change in the Eu3+ coordination geometry.  
 
DO3A complexes are known to adopt a mono-capped square antiprismatic or twisted square 
antiprismatic geometry and form two pairs of enantiomeric diastereomers.6, 7 The added complexity in 
the ∆J = 2 and ∆J = 4 region of the [Eu·L8]- spectrum suggest strongly that the symmetry about the 
Eu3+ centre is different. Whilst 9 coordinate systems based upon cyclen-tri(phosphinate) ligands (such 
as [Eu·L8]-) have not been well characterised, the related tetra(phosphinate) system have been 
investigated in detail.8, 9 The tetra(methylphosphinate) and tetra(benzylphosphinate) complexes give 
rise to a possible 24 isomers based upon being R or S at each P, the two ring conformations (δδδδ or 
λλλλ) and the helicity (∆ or Λ). In these systems, one major (> 90 %) diastereomer is present in 
solution – enantiomers of a twisted square antiprism. The tetra(phenylphosphinate) analogue exists as 
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a mixture of stereoisomers, as a result of being less sterically demanding. Upon exchanging one of the 
phosphinate arms in the tetra(methylphosphinate) complex for an alternative group (such as a 
carboxamide), the number of possible isomers increases to 32 – 16 enantiomeric pairs if the 
alternative group is achiral.10 If this group is also chiral, then each isomer becomes diastereomeric. In 
this situation, the number of isomers in solution increases to 64 – 32 pairs of enantiomers.11 Despite 
the many possible isomers, one major species is often observed for tri- and tetra(phosphinate) 
lanthanide complexes.10 In accord with this observation, the 31P-NMR spectrum of [Eu·L8]-, which 
contains three resonances, suggests that, despite the possible 64 isomeric structures due to the 
presence of three methyl phosphinate groups and one phenyl phosphinate group, a single major 
isomer exists in solution.  
 
 
Figure 3.5 Emission spectra of [Eu·L6]- (red) and [Eu·L8]- (blue) in H2O (20 µM complex, pH 5.8, 295 K). 
Spectra have been scaled so that the total integrated intensity is equal for each spectrum. 
 
3.4.2 Emissive Stability 
 
Stability assays were carried out comparing the behaviour of [Eu·L6]- and [Eu·L8]-, in the manner 
previously described. As expected, the presence of the methylphoshinate groups in place of the 
carboxylate groups reduces the quenching of emission by Mn2+, due to an increase in the steric bulk 
about the Eu3+ centre (Figure 3.6). The emission from [Eu·L6]- was entirely quenched by Mn2+, 
whereas the methylphosphinate analogue remained 50 % emissive, compared to a solution with no 
inhibitor. This result suggests that the Mn2+ quenching process involves some kind of encounter 
between the Mn2+ ion (or Mn(H2O)62+ as it is likely exist in solution) and the Eu3+ complex, and is 
dependent upon the proximity of the two species. It can therefore be tentatively proposed that the 
quenching mechanism involves the Eu3+ excited state, rather than an excited state of the sensitising 
group, which is equally accessible to Mn2+ in both the [Eu·L6]- and [Eu·L8]- complexes. Aside from 
Mn2+, all other inhibitors added to [Eu·L8]- caused the same response as in the assay with [Eu·L6]- - 
only protein led to a reduction in emission, mostly due to competitive absorption.  
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Figure 3.6 Stability data for [EuL6]- (left) and [EuL8]- (right) in HEPES buffer or at two time points, 15 min and 
18 h (10nM complex, λex = 335 nm, λex = 620 nm). 
 
3.5 Conclusions 
 
This brief study of three Eu3+ complexes based upon the DO3A core structure was designed to 
investigate the effect upon the emission spectrum of varying the axial donating group in the 
monocapped twisted square antiprismatic geometry. The specification set out in Section 1.5 calls for a 
large ∆J = 2 band to maximise the spectral overlap integral with the absorption spectrum of the 
designated accepted moiety in the HTRF experiment. The theory that preceded this study was that an 
increase in the polarisability of the axial donor leads to an increase in the relative intensity of the 
electric-dipole allowed ∆J = 2 transition. This was indeed found to be the case, with each of the three 
complexes displaying a larger ∆J = 2 band than [Eu·L1(H2O)], which has a water molecule in the 
axial position. 
 
Of the three new complexes, [Eu·L6]- gave the ∆J = 2 emission band with the highest relative 
intensity. This complex contains a pyridylphenylphosphinate moiety, with the phosphinate O 
occupying the axial position in the Eu3+ coordination sphere. One of the other benefits of [Eu·L6]- is 
that the phosphinate group is negatively charged and therefore forms a highly kinetically stable 
complex, which was found to be resistant to dissociation by Ca2+, Mg2+ and EDTA4-. The presence of 
protein was found to reduce the observed emission. This is thought to be due to the presence of 
aromatic chromophores (Phe, Tyr, Trp), which absorb at a similar wavelength to the pyridyl group in 
[Eu·L6]-. This pyridyl group could be extended in future complexes to form a sensitising group with a 
higher absorption wavelength maximum. In the stability assays, as with the 3-azaxanthone complexes 
in Chapter 2, Mn2+ was found to be the species leading to the greatest reduction in emission. In the 
case of [Eu·L6]-, the emission is completely quenched. Overall, however, the pyridyl 
phenylphosphinate moiety has led to favourable emissive properties and is worthy of consideration for 
further development. 
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With the desire to increase the stability of [Eu·L6]- towards quenching by Mn2+, the 
tri(methylphosphinate) complex, [Eu·L8]- was synthesised. This complex had an increased stability 
towards Mn2+ quenching and also gave an emission spectrum with an even larger ∆J = 2 emission 
band than [Eu·L6]-. Notwithstanding the improved stability, addition of Mn2+ was only found to 
reduce the emission of [Eu·L8]- to around 50 % of the value in the absence of Mn2+. To improve the 
stability further, variation of the alkyl group would be a next logical step. Lanthanide complexes 
containing benzylphosphinates and phenylphosphinates are known, and may lead to greater resistance 
to quenching. These complexes were not considered, however, as it was at this stage in the project 
that the C3 symmetric complexes based on triazacyclononane were synthesised. These complexes 
showed a much higher stability towards quenching by Mn2+, and are the subject of the next chapter.   
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4. An Isostructural Series of C3-Symmetric 
Lanthanide Complexes 
4.1 Introduction 
 
The theme of the previous chapter was to investigate the effect of the donor groups in the Eu3+ 
coordination sphere upon the form of the emission spectrum. In accordance with previous reports,1 it 
was found that an increase in the polarisability of the axial donor in a capped square antiprismatic 
geometry led to an increase in the relative intensity of the electric-dipole allowed ∆J = 2 transition. 
The group which gave the largest relative ∆J = 2 transition was the pyridyl phenylphosphinate group 
(21). Another factor which is believed to influence the form of the europium emission spectrum is the 
symmetry about the metal ion centre. In general, a high degree of symmetry leads to an emission 
spectrum with less complexity in the splitting of each manifold. For example, in pure C2 and C3 
symmetry, the ∆J = 1 manifold has two allowed transitions.2 In systems with a lower degree of 
symmetry, this manifold can have up to three transitions. It is also found that complexes in the same 
symmetry point group have, to a first approximation, the same number of transitions within each 
manifold.  
 
 
Figure 4.1 Emission spectra of aqueous solutions of left) [Eu·(L1.21)3]3- (λex = 340 nm),3 and right) a) Eu(H2O)9, 
b) [Eu(DPA)3]3- and c) [Eu(ODA)3]3- (λex = 395 nm in each case).4 
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The dependence of the Eu3+ emission spectrum upon the symmetry about the central metal ion is 
demonstrated by comparison of the emission spectra of [Eu·(L1.21)3]3- (Figure 4.1 left) and 
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[Eu·(DPA)3]3- (Figure 4.1 right, b). Both complexes are in the D3 point group. In each case, the 
charged oxygen donors form a slightly distorted trigonal prism about the Eu3+ centre, with the pyridyl 
N donor lying in the D3 horizontal plane, capping each rectangular face.5 The emission spectra of the 
structurally related complexes are very similar, with a large relative ∆J = 2 band and very similar 
emission in the ∆J = 1 region. 
 
The emission spectrum of [Eu·(ODA)3]3- (Figure 4.1 right c) shows that symmetry about the Eu3+ 
centre is not the only factor affecting the form of the emission spectrum. This complex is also in the 
D3 point groups but the form of the emission spectrum is quite different. The ∆J = 2 : ∆J = 1 
integrated intensity ratio is far less than that of [Eu(DPA)3]3- (1.3 vs. 4.2) and additional splitting is 
observed in the ∆J = 2 manifold. In this instance, it is the variation in the polarisability of the donor 
groups which causes the observed difference in spectral form.  
 
A further example is the complex [Eu·L1.6], structurally defined by Mazzanti,6 which was introduced 
in Section1.3.3. This is a C3 symmetric complex with a 1,4,7-triazacyclononane macrocycle and three 
picolinate groups. As with the complexes shown in Figure 4.1, the structure is a distorted tricapped 
trigonal prism and the resulting emission spectrum has a large relative ∆J = 2 transition (Figure 4.2). 
 
 
 
Figure 4.2 Emission spectrum of [Eu·L1.6] (H2O, 295 K, λex = 275 nm).6 
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From the examples given above, it is apparent that complexes of D3 or C3 symmetry, with pyridyl 
donating groups lead to emission spectra with large relative ∆J = 2 bands. This is one of the 
specifications set out in Section 1.5 and, as a result, the complex [Eu·L9] was a logical next target in 
the course of this project. In contrast to complexes [Eu·L1] to [Eu·L8]-, the core macrocycle is 1,4,7-
triazacyclononane. By incorporating three of the pyridyl phenylphosphinate groups, the overall ligand 
provides 9 donating groups and forms a structure which should be C3 symmetric and was anticipated 
to give a favourable emission spectrum. Having synthesised [Eu·L9], which was found to have some 
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interesting properties, it was decided that the full lanthanide series from Ce3+ to Yb3+ should be made. 
With twelve complexes in hand, any trends which may exist across the series could be investigated. 
The yttrium complex, [Y·L9], was also synthesised. The Y ion is triply charged and is of similar size 
to Ho3+ in nine-coordinate systems (104 pm).7 In contrast to the lanthanides, Y3+ is diamagnetic and 
[Y·L9] provides a useful complex for comparative NMR studies.  
 
4.2 Synthetic Aspects 
 
The synthesis of each complex in the [Ln·L9] series was achieved in five steps with an average overall 
yield of 14 % (Scheme 4.1). The first two steps had previously been carried out for the synthesis of 
[Eu·L6]-. Three equivalents of the brominated precursor 22 were reacted with the free base of 1,4,7-
triazacyclononane, which had been liberated from its hydrochloride salt by extraction into CH2Cl2, 
after the salt had been dissolved in aqueous NaOH (1M). The alkylation reaction was carried out in 
CH3CN at 50 °C and was monitored by LCMS, which revealed the formation of mono-, di- and tri- 
substituted products. After 3 hours, the trisubstituted product 30 was the major product and was 
isolated in 62 % yield. If the reaction temperature was increased to 80 °C, the tetra-substituted 
cationic product was formed. This made separation of 22 more challenging, as each compound has a 
similar Rf value (silica, CH2Cl2 : 10 % CH3OH). Following purification of the ligand 30, hydrolysis of 
the ethyl phosphinate esters with aqueous HCl (6 M) and complexation with LnCl3 were carried out in 
high yield. Use of LCMS confirmed the consumption of all starting ligand, H3L9.  
 
Scheme 4.1 
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Each complex in the [Ln·L9] series was purified by short-path column chromatography on silica. 
Hydrophilic, charged Eu3+ complexes are usually too polar to allow purification on silica. The neutral 
[Ln·L9] complexes incorporate three hydrophobic phenyl groups, and were mobile on the silica solid 
phase, using a solution phase comprising CH2Cl2, CH3OH and aqueous ammonia solution (35 % by 
weight) in a 80 : 20 : 1 ratio. The purity of each complex was confirmed by HRMS and RP-HPLC (a 
representative trace is shown in Figure 4.3). 
 
 
Figure 4.3 A representative RP-HPLC trace of [Ln·L9], using a gradient elution method (see Appendix 1). 
 
4.3 Structure Elucidation  
4.3.1 Solid State Structure 
 
The [Ln·L9] complexes were found to be soluble in CH3OH but only sparingly soluble in H2O. As a 
result, single crystals of each complex were grown by dissolving around 10 mg of complex in CH3OH 
(1 mL) and adding H2O (0.5 mL). Crystals grew within 16 h upon standing at room temperature. The 
ability to grow single crystals allowed the determination of the solid state structure of [Ln·L9] by X-
ray diffraction methods. Crystals were grown of all thirteen complexes ([Ce·L9] – [Yb·L9] and 
[Y·L9]). Seven of the structures were solved, including the Ce3+ and Yb3+ complexes, which have the 
largest and smallest ionic radii, respectively. 
 
           
Figure 4.4 Crystal structure of [Eu·L9] viewed left) down the z axis, showing the C3 symmetry and right) from 
the side, showing the three phenyl groups below the plane of the complex. The atoms shown are C (grey), N 
(blue), O (red), P (purple) and Eu (green). 
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The first structure solved was [Eu·L9]. The complex was found to crystallise in the space group P21/n, 
with 4 complexes in each monoclinic unit cell. In the solid state, the complex has pseudo-C3 
symmetry, which can be seen by looking down the z axis (Figure 4.4 left). The ligand has nine atoms 
bound to the Eu3+ centre in a slightly distorted tricapped trigonal prismatic geometry. The three ring N 
atoms and the three phosphinate O atoms make up the trigonal prism, with the three pyridyl N atoms 
capping each rectangular face. The Eu3+ ion lies in a plane with the pyridyl nitrogens (Figure 4.4 
right). All six Eu – N bond distances are similar (average bond distances: Eu – Nring 2.68 Å, Eu – Npy 
2.66 Å) and the three Eu – O distances are shorter (2.33 Å), reflecting the greater electrostatic 
attraction between Eu3+ and the charged O donors. 
 
The complex exists as a racemic mixture of two enantiomers. The three stereogenic phosphorus 
centres are either RRR or SSS (Figure 4.4 left). Due to the steric demand of the phosphinate phenyl 
groups, once the first phosphinate O has bound to the Eu3+ centre, rendering the chirality at 
phosphorus R or S, the other two must also become R or S, respectively. In the solid state, there is no 
evidence for any other diastereomers (RSR or SRS). For an R configuration at P, the average ring N-C-
C-N and substituent N-C-C-Npy torsion angles are + 47° and - 33°, consistent with a δδδ ring 
conformation and Λ configuration. Hence, the unit cell contains two (RRR)-Λ(δδδ) complexes and 
two of the enantiomeric (SSS)-∆(λλλ) complexes.  
 
Table 4.1 Selected distances (Å) for isostructural [Ln·L9]. 
Complex Ce Nd Sm Eu Ho Tm Yb 
Ln - O 2.41 2.38 2.34 2.33 2.29 2.26 2.25 
Ln - N(py) 2.73 2.69 2.67 2.66 2.64 2.62 2.62 
Ln - N(ring) 2.75 2.71 2.69 2.68 2.65 2.63 2.63 
Ln - P 3.62 3.58 3.55 3.54 3.51 3.49 3.48 
 
 
Figure 4.5 Bond distances and ionic radii of the seven isostructural [Ln·L9] complexes. 
The solid state structure of six other complexes in the [Ln·L9] series were solved. For each structure, 
the same space group, geometry and stereochemistry was observed to that of [Eu·L9]. The only 
variation across the series is the steady decrease in bond lengths between the central lanthanide and 
the nine coordinating donors (Figure 4.5 and Table 4.1). These decreases follow the lanthanide 
1.0
1.5
2.0
2.5
3.0
3.5
Ce Nd Sm Eu Ho Tm Yb
Di
st
an
ce
 
/ Å
Lanthanide
Ln - P
Ln - N(ring)
Ln - N(py)
Ln - O
Ionic Radius
 An Isostructural Series of C3 Symmetric Lanthanide Complexes                                            Chapter 4 
 
 
71 
 
contraction, in which the ionic radii of the Ln3+ ions decrease,7 due to an increase in effective nuclear 
charge felt by the outer f electrons. Typically, for series of Ln3+ complexes, the change in size of the 
lanthanide ion across the series enforces a change in geometry or coordination number upon the 
complex. An example is the series [Ln·L1.8]- (see Section 1.3.3).8 In this series, the tetraphosphinate 
ligand is 8 coordinate. The lanthanides with larger ionic radii accommodate a solvent H2O molecule, 
giving an overall 9 coordinate structure. Complexes beyond [Eu·L1.8]- can no longer accommodate 
this solvent molecule and are 8 coordinate. The advantage of an isostructural series, such as [Ln·L9], 
is the ability to observe changes across the series which are dependent solely upon the Ln3+ ion, as all 
other parameters are constant.    
 
4.3.2 Solution State Structure 
 
Determining the solid state structure is informative, but the majority of experiments are carried out in 
the solution state, and so an appreciation of the solution state structure is very important. The 
representative RP-HPLC trace (Figure 4.3) of [Ln·L9] shows a single peak, which is indicative of a 
single diastereoisomer in solution. RP-HPLC alone does not provide conclusive evidence for the 
stereochemistry. NMR is able to provide more information on the species present in solution. The 1H- 
and 31P-NMR of each complex was measured at 400 MHz (CD3OD, 295 K). For each complex, the 
31P-NMR spectrum shows a single resonance (Figure 4.6 upper shows the 31P-NMR spectrum of 
[Nd·L9]). This is consistent with the retention of the RRR or SSS stereochemistry at phosphorus in 
solution. Diastereoisomers, such as complexes with RSR at phosphorus, would be expected to show 
more than one resonance in the 31P-NMR spectrum. The 1H-NMR of [Nd·L9] shows a single species 
with 11 resonance – 8 of these resonances integrate to 3H and 3 resonances integrate to 6H, giving a 
total of 42H) – and no evidence for any minor species in solution (Figure 4.6). The observed 
resonances indicate that the C3 symmetry, observed in the solid state, is retained in solution. The four 
protons in the 1,4,7-triazacyclononane ring are likely those with the largest linewidths (0.73, 2.85, 
5.45 and 6.79 ppm), due to their close proximity to the paramagnetic Ln3+ ion. The same pattern of 
resonances integrating to 3H or 6H is observed across the series, with no evidence for the presence of 
minor species. The conclusion from NMR analysis is that in solution, the complexes [Ln·L9] remain 
isostructural, and exist as enantiomers of a single stereoisomer, as observed in the solid state. 
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Figure 4.6 1H-(lower) and 31P-(upper) NMR spectra for [Nd·L9] (CD3OD, 400 MHz, 295 K, pD 5.8). Residual 
solvent peaks are labelled S.  
 
A variable temperature NMR experiment was carried out to investigate whether any change in 
stereochemistry would take place at higher temperatures. The complexes, [Yb·L9] and [Pr·L9] were 
chosen to investigate, as the central ions lie at either end of the lanthanide series, and result in 
complexes with relatively sharp proton resonances, compared to some of the intermediate lanthanides, 
such as Ho3+ and Er3+. The [Yb·L9] proton resonances also occur over a large spectral range, 
enhancing any changes in shift which may take place.  
 
 
Figure 4.7 Variable temperature 1H-NMR spectrum of [Yb·L9] (CD3OD, 500 MHz, pD 5.8).   
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Upon increasing the temperature, the 1H-NMR spectrum of [Y·L9] was found to contract, with the 
spectral range decreasing from 39 ppm to 27 ppm (Figure 4.7). No addition peaks arose, which would 
indicate the appearance of a minor species. This suggests that the barrier for isomerisation to some 
other diastereomers is greater than the energy available at 45 °C. Over the chosen temperature range, 
the 31P-NMR spectrum contained a single peak, which shifted to a slightly higher frequency with 
increasing temperature. The variations of both the 31P and 1H resonances with T-1 and T-2 were plotted. 
It was found that both sets of resonances varied linearly with respect to T-2. This behaviour is 
normally ascribed to a dominant pseudo-contact (dipolar) contribution to the paramagnetic shift.9 The 
P atom is 3.56 Å from the Yb3+ centre and so could also be subject to a contact contribution to the 
observed paramagnetic shift, which would show a T-1 dependence.10 The small changes in 31P shift 
make the distinction between T-1 and T-2 dependence difficult to define. 
 
Figure 4.8 1H-COSY spectrum of [Y·L9] (CD3OD, 500 MHz, pD 5.8). 
 
4.4 1H-NMR Assignment 
 
For each complex in the [Ln·L9] series, the 1H-NMR spectrum shows 12 resonances, relating to the 12 
distinct proton environments in the C3 symmetric complexes. The ortho and meta phenyl protons are 
equivalent and integrate to 6H, while the remaining 10 resonances integrate to 3H, giving a total of 
42H. The spectrum of [Y·L9] shows no line broadening due to the presence of unpaired f electrons 
and is therefore a good point to begin assigning the spectra of [Ln·L9]. In the absence of line 
broadening, coupling between protons in [Y·L9] can be observed and a 1H-COSY spectrum was 
measured, to aid assignment (Figure 4.8). In the aromatic region of the spectrum there are 6 
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resonances, which can be fully assigned, using the COSY spectrum and by comparing the splitting 
patterns to those of the uncomplexed ligand, H3L9. The six remaining resonances from the CH2 
groups in the ring and linking the pyridyl moiety to the ring N become diastereotopic upon 
complexation, due to the rigidity of the complex. Diastereotopic protons couple to one another (2J ≈ -
16 Hz) and are clearly identified in the COSY spectrum. The linker CH2 group can be identified as it 
also shows weak 4J coupling to the pyridyl H3. Of the four magnetically inequivalent ring protons, 
absolute assignment is made difficult by the overlapping resonances at 2.66 ppm. It is postulated that 
the proton at 2.87 ppm is an equatorial proton (Figure 4.9). Equatorial protons should show 2J 
coupling to the axial proton on the same carbon and weaker 3J coupling to adjacent Hs. Axial Hs will 
show stronger 3J coupling to the axial H on the adjacent carbon, according to the Karplus equation.11 
The proton at 2.87 ppm is a doublet with weak coupling to adjacent protons, indicating that it is 
equatorial. In contrast, the proton at 3.66 ppm has a more complex splitting pattern and is likely to be 
an axial proton. 
Ha
Hb N
Hb' N
Ha'
Ln
 
Figure 4.9 Illustration of the ring proton orientations in the [Ln·L9] series, showing two axial (Ha) and two 
equatorial (Hb) protons. 
 
Figure 4.10 1H-NMR spectrum of [Eu·L9] (CD3OD, 400 MHz, pD 5.8); protons denoted a and b are axial and 
equatorial ring protons; c refers to the diastereotopic CH2 py protons.   
 
Having assigned the [Y·L9] spectrum, the 1H-NMR and COSY spectra were measured for the 
complex [Eu·L9] (Figure 4.10). The europium ion has 6 unpaired f electrons, which induce both a 
paramagnetic shift and line broadening in the 1H-NMR spectrum. The 1,4,7-triazacyclononane ring 
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protons are closest to the Eu3+ centre and show the greatest paramagnetic shift and are also the most 
line-broadened. These protons are also diastereotopic and show the strongest coupling in the COSY 
spectrum, allowing their assignment (-4.79, -0.93, -0.64 and 4.52 ppm). The remaining diastereotopic 
protons (CH2 linker) are also broadened and show coupling to the pyridyl H3 proton. Using the COSY 
spectrum and by comparison with [Y·L9], the [Eu·L9] spectrum was partially assigned. The [Eu·L9] 
1H-NMR spectrum was also compared to the assigned spectrum of the tri(picolinate)-
triazacyclononane complex, [Eu·L1.6], which incorporates three carboxylate groups, in place of the 
phenyl phosphinate groups of [Eu·L9].6 The two spectra are similar, indicating that the two complexes 
have similar solution state stereochemistry. The presence of only one series of mutually coupled sets 
of diastereotopic protons is consistent with a single isomeric structure wherein arm rotation (exchange 
pyridyl methylene groups) or ring inversion (exchanging axial/equatorial protons) is slow on the 
NMR timescale.  
 
To further investigate the solution structure of [Ln·L9], the 13C-NMR spectrum for [Yb·L9] was 
measured (Figure 4.11 lower). Nine C resonances can be seen between 120 – 170 ppm, relating to the 
aromatic C environments, and three further resonances at 36, 47 and 71 ppm, relating to CH2 groups. 
One of these groups is the methylene pyridyl linker, and the remaining two resonances arise from the 
ring CH2 groups. The total of twelve resonances confirms the C3 solution state structure and the 
presence of two distinct ring CH2 resonances indicate that the ring is rigid and that δδδ – λλλ 
interconversion does not take place on the NMR timescale. To investigate the energy barrier to 
interconversion, the 13C-NMR spectrum of [Yb·L9] was run at 50 °C (Figure 4.11 upper). 
Coalescence of the ring CH2 resonances was not observed upon heating, showing that the barrier to 
interconversion is high. 
 
 
Figure 4.1113C-NMR spectrum of [Yb·L9] at 22 °C (lower) and 50 °C (upper, CD3OD, 400 MHz, pD 5.8) 
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4.5 Photophysical Properties 
4.5.1 Absorption, Emission and Excited State Lifetimes 
 
The motivation behind the synthesis of [Eu·L9] was to investigate the effect upon the emission 
spectrum of a change in symmetry about the Eu3+ centre, relative to the earlier complexes, [Eu·L6]- 
and [Eu·L8]-. Within the new [Ln·L9] series, four of the complexes are emissive in the visible region 
of the electromagnetic spectrum. The photophysical properties of these complexes were assessed 
(Table 4.2). Each complex has a maximum absorption wavelength at 274 nm with a molar extinction 
coefficient of around 14,000 M-1 cm-1. As previously discussed, a maximum absorption wavelength of 
274 nm is too low for biological application but the pyridyl unit can be modified at a later stage into a 
chromophore that absorbs at longer wavelength. The extinction coefficient is reasonably high, due to 
the presence of three pyridyl groups. This highlights an advantage of the C3 symmetric [Ln·L9] 
system. Whichever sensitising group is eventually selected, the overall molar extinction coefficient of 
the complex will be around three times that of a single chromophore. Another property which affects 
the overall brightness of a complex is the quantum yield. The value for [Eu·L9] is 9.0 %, which is 
reasonably high. The [Tb·L9] has an exceptionally high quantum yield of 50 %. The large difference 
in these values arises from the overlap between the pyridyl triplet energy and the Ln3+ excited states. 
The pyridyl triplet state lies at around 32,000 cm-1,12 which is close in energy to some of the high 
lying Tb3+ excited states, which can decay to the emissive 5D4 state. Eu3+ does not have energy levels 
in this energy range, and so transfer of energy from the pyridyl group is less efficient. Despite this, the 
relatively high quantum yields for both complexes suggest the rate of Ln3+ excited state quenching is 
low. This is also reflected in the high emissive lifetimes of both Eu3+ and Tb3+ emission.  
 
Table 4.2 Photophysical data of the four complexes in the [Ln·L9] series that emit in the visible region of the 
spectrum. All data was recorded in H2O, unless otherwise stated. 
Complex λmax /nm ε / M–1 cm–1 msLnOH /2τ  ms
Ln
OD /2τ  q
 
%/
2
Ln
OHΦ  
[Sm·L9] 274 14,600 0.03 0.04 0.0 0.7 
[Eu·L9] 274 14,000 1.36 1.54 0.0 9.0 
[Tb·L9] 274 13,800 2.16 2.51 0.0 50 
[Dy·L9] 274 14,400 0.04 0.04 0.0 2.9 
 
 
The excited state lifetime and emissive quantum yields of [Sm·L9] and [Dy·L9] are significantly lower 
than the more emissive Eu3+ and Tb3+ complexes. Having said this, the quantum yield of [Dy·L9] is 
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more than twice that of R-(+)[Dy·BnMeH22IAM]+, (Φ = 1.3 % in H2O),13 one of only a few emissive 
Dy3+ complexes reported. 
 
Figure 4.12 Emission spectra of the four emissive complexes in the [Ln·L9] series (H2O, λex = 274 nm, pH 5.8). 
Spectra have been scaled so that the maximum intensity is equal in each case.  
 
After excitation at 275 nm, the emission spectra of [Sm·L9], [Eu·L9], [Tb·L9] and [Dy·L9] were 
recorded (Figure 4.12). Each spectrum contains several bands, due to splitting of the Ln3+ ground 
state energy levels, spanning the entire visible spectrum from 480 nm (Tb3+ and Dy3+) to 700 nm 
(Sm3+ and Eu3+). As is typical of emissive lanthanide complexes, emission bands are sharp and show 
fine splitting. The Eu3+ emission spectrum shows some very favourable properties. The C3 symmetric 
nature of the complex results in a spectrum with little fine splitting. Within the ∆J = 1 manifold, there 
is only one narrow transition. The ∆J = 2 band has a high relative intensity and is split into two 
transitions, while emission in the ∆J = 4 region is weak. The specification outlined in Section 1.5 calls 
for a large ∆J = 2 band relative to the ∆J = 1 and ∆J = 4 bands. The spectrum of [Eu·L9] fits this 
description very closely. 
 
Table 4.3 Comparison of the integrated intensity ratios of some of the complexes synthesised. All spectra 
recorded in H2O (pH 5.8). 
Complex 
Intensity Ratios 
∆J = 2 / ∆J = 1 ∆J = 2 / ∆J = 4 
a[Eu·L1.1]3+ 1.40 1.30 
[Eu·L1] 1.13 1.14 
[Eu·L6]- 2.14 2.40 
[Eu·L8]- 3.02 5.10 
[Eu·L9] 4.09 5.09 
 
Comparison of the emission spectrum of [Eu·L9] with [Eu·L6]- illustrates the improvement in the form 
of the spectrum, with respect to meeting the specification (Figure 4.13). The increase in intensity of 
the ∆J = 2 region is apparent, along with the reduction in emission in the ∆J = 1 and ∆J = 4 region. 
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The improvement can be quantified by measuring the integrated intensity of the various bands (Table 
4.3). The results show a 2.9 and 3.9 fold increase for [Eu·L9] in the ∆J = 2 : ∆J = 1 and ∆J = 2 : ∆J = 
4 ratios, respectively, relative to the [Eu·L1.1]3+ complex, currently used in the HTRF experiment. The 
origin of the favourable [Eu·L9] spectrum is the combination of polarisable phosphinate donors and 
the C3 symmetric geometry about the Eu3+ centre.  
 
Figure 4.13 Comparison of the emission spectra of [Eu·L9] and [Eu·L6]- (H2O, λex = 274 nm, pH 5.8). Spectra 
have been scaled so that the total intensity integral is equal in each case. 
 
4.5.2 Emissive Stability Assay 
 
As with the previously synthesised complexes, emissive stability assays were carried out for [Eu·L9] 
(Figure 4.14 left). As with the earlier complexes, the presence of a million fold excess of Ca2+, Mg2+ 
and EDTA4- did not perturb the Eu3+ emission. Encouragingly, Mn2+ also caused no reduction in the 
emission intensity after 15 min and only around 5 % reduction after 18 h. All complexes previously 
tested had shown some susceptibility to Mn2+ quenching, whereas [Eu·L9] appears to be almost 
unaffected by Mn2+. One possible explanation for this stability is the shielding of the Eu3+ centre by 
the three phenyl groups below the plane of the complex (Figure 4.14 right), reducing the probability 
of an encounter between an aqua Mn2+ species and the Eu3+ complex. Further investigations into this 
effect are reported in Chapter 6.  
 
 
Figure 4.14 left) Stability data for [Eu·L9] in HEPES buffer at two time points, 15 min and 18 h (10nM 
complex, λex = 335 nm, λex = 620 nm) and right) a side view of the crystal structure of [Eu·L9], showing the 
three shielding Ph groups. 
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4.6 Chiral Analysis 
4.6.1 Chiral Resolution 
 
The X-ray crystal structure of [Eu·L9] revealed the presence of two enantiomers in the solid state. The 
retention of this stereochemistry in the solution state was confirmed by 31P- and 1H-NMR. The two 
enantiomers have Λ(δδδ) (RRR at P) and ∆(λλλ) (SSS at P) stereochemistry. Separation of the 
enantiomers was achieved by chiral-HPLC, using a CHIRALPAK-IC column. The optimal conditions 
were found to be an isocratic elution of EtOH : MeOH : HNEt2 (50 : 50 : 0.1) at a flow rate of 1 mL 
min-1 at 15 °C. Under these conditions, the two enantiomers had a ∆tR of 1.6 min (Figure 4.15), and 
could be isolated as pure species. The overall structure of the complex is fairly rigid and the Λ and ∆ 
enantiomers have differential interaction with the chiral stationary phase, leading to the observed 
difference in retention times. In total, around 1 mg of each enantiomer was isolated from the racemic 
mixtures of both [Eu·L9] and [Tb·L9]. As expected, the choice of lanthanide does not affect the 
behaviour of the complex on the column. The separated enantiomers were dissolved in refluxing 
methanol overnight. Under these conditions, no racemisation took place, consistent with the rigidity 
of the structure, and a high kinetic barrier to racemisation.   
 
 
Figure 4.15 Chiral-HPLC traces of upper) the racemic mixture and middle) and lower) the two resolved 
enantiomers of [Eu·L9]. Each sample was run on a CHIRALPAK-IC column (ethanol : methanol : diethylamine, 
50 : 50 : 0.1 solution phase,  isocratic elution, 1 mL min-1, 15 °C). 
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4.6.2 Chiroptical Properties 
 
Initially the two enantiomers were identified by their retention time upon the chiral column. 
Enantiomer 1 eluted at 6.2 min, while enantiomer 2 eluted at 8.0 min. With the two enantiomers 
resolved, chiroptical analysis was carried out. The first measurement undertaken involved 
measurement of the circular dichroism (CD) spectra. The CD technique measures the differential 
absorption of left- and right-handed light as a function of wavelength. Enantiomers always have 
mirror image spectra and the spectra for the two [Tb·L9] species are consistent with this definition 
(Figure 4.16 left). The CD spectrum can be used to determine the absolute stereochemistry of the 
enantiomers. The CD spectrum of enantiomer 2 was compared with a calculated CD spectrum of ∆-
[Tb·L9] (Figure 4.16 right). The calculated spectrum is based upon the application of coupled 
oscillator model techniques.14 They make use of the atomic coordinates from the X-ray diffraction 
crystal structure and NMR data to compute a predicted spectrum. This work was undertaken by Prof. 
L. DiBari at the University of Pisa. The similarity between the two spectra indicates that enantiomers 
2 is the ∆(λλλ) (SSS at P) enantiomer. Hence, enantiomer 1 is the Λ(δδδ) (RRR at P) enantiomer. A 
crystal structure of either enantiomer would confirm this finding. At present, the amount of pure 
enantiomeric sample required to grow a suitable crystal is not available.  
 
 
Figure 4.16 left) CD spectra for enantiomer 1 (blue) and enantiomer 2 (red) of [Tb·L9] (298 K, CH3OH, 2.4 
mM, 0.02 cm cells) and right) comparison of the experimental (solid line) and calculated (dashed line) CD 
spectra for ∆-[Tb·L9]. 
 
Figure 4.17 Circularly polarised emission spectra for ∆ (red) and Λ (blue) enantiomers of [Tb·L9] (1 : 1 aq. 
CH3OH, 295 K). 
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The emission analogue of CD is circularly polarised luminescence (CPL), which measures the 
differential emission of right- and left-handed circularly polarised light. As with CD, mirror image 
spectra were measured for the enantiomers of [Tb·L9] (Figure 4.17) and [Eu·L9] (Figure 4.18). The 
dissymmetry factor, gem, quantifies the CPL, and has a maximum value of 2, according to Equation 
4.1. Lanthanides are pure spherical emitters, and both [Tb·L9] and [Eu·L9] have high gem values, up to 
0.4 (Table 4.4). The CPL spectra for SSS-∆-[Eu.L3] exhibited a sign sequence for the transitions in the 
∆J = 1 and ∆J = 2 manifolds that was similar to that observed with an enantiopure C4-symmetric ∆ Eu 
tetra-amide cyclen complex with an N4O4 donor set.15 This is consistent with the absolute 
configuration assignment made using the CD spectrum.  
 
[4.1] 
 
 Table 4.4 Emission dissymmetry factors, gem, for [Tb·L9] and [Eu·L9] (1 : 1 aq. CH3OH, 295 K). 
  
gem(Tb) gem(Eu) 
λ / nm 539 548 620 595 600 708 
∆ -0.16 -0.32 -0.28 +0.18 +0.33 +0.31 
Λ +0.15 +0.31 +0.28 -0.18 -0.33 -0.31 
 
 
Figure 4.18 Circularly polarised emission spectra for ∆ (red) and Λ (blue) enantiomers of [Eu·L9] (1 : 1 aq. 
CH3OH, 295 K). 
 
The chiroptical properties of [Tb·L9] and [Eu·L9] render these complexes highly suitable as the core 
structures for emissive probes for use in CPL and time-resolved spectroscopic application. For 
example, it may be possible to observe changes in the CPL from intracellular probes, in response to 
changes in the chiral cellular environment. To allow intracellular application, the core structure must 
be modified to allow excitation at wavelengths above 300 nm. This is most easily achieved by further 
functionalisation of the pyridyl moiety. 
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4.7 Methylphosphinate Analogue of [Ln·L9] 
 
The C3 symmetric complex, [Eu·L9], has many favourable properties for the HTRF application. The 
form of the emission spectrum meets the specification, the excited state lifetime is long, allowing 
time-gated detection of emission and the presence of three pyridyl units will triple the molar 
extinction coefficient of whichever chromophore is selected to take its place. One disadvantage of the 
complex is its low water solubility. An aqueous concentration of up to 100 µM is attainable, based 
upon absorbance values. However, increasing the aqueous concentration into the mM range is 
desirable. Within the core structure of [Ln·L9], three positions can be modified to increase the water 
solubility (Figure 4.19). Position 1 is the pyridyl ring, which will be modified at a later stage, to 
incorporate a Eu3+ sensitising group. Position 2 is within the core 1,4,7-triazacyclononane ring. 
Synthetic modifications in this position are known,16 and would allow addition of a water solubilising 
group, such as –(CH2)n-CO2-. The disadvantage of modifying this position is that the C3 symmetry 
about the Eu3+ centre is perturbed, which may cause a change in the form of the emission spectrum. 
The final choice is to alter the R group of the phosphinate donor moiety. Exchange of Ph for Me gives 
[Ln·L10] and should increase the aqueous solubility by reducing the hydrophobicity created by the 
three Ph groups. The methylphosphinate complex, [Ln·L10], was defined as the next synthetic target. 
 
 
Figure 4.19 [Ln·L9] positions available for functionalisation  
 
4.7.1 Synthesis of the P-Methylphosphinate Complex 
 
The synthesis of [Eu·L10] would be expected to follow a similar pathway to [Eu·L9] (Scheme 4.1), 
with the exchange of ethyl phenylphosphinate for ethyl methylphosphinate (31). Unfortunately, the 
starting material, 31, is not commercially available. The synthesis of 31, was achieved by stirring 
MeP(OEt)2 with one equivalent of H2O at room temperature under an atmosphere of argon (Scheme 
4.2). Under these conditions, 31 was generated, along with one equivalent of ethanol. This was 
confirmed by 1H-NMR.  
 
 
Scheme 4.2 
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The ethyl methylphosphinate (31) / ethanol mixture was used directly in the palladium coupling 
reaction with 2-bromo-6-methylpyridine. Dry, degassed (freeze-thaw cycle) toluene was added to the 
solution, which was bubbled with argon for 2 h, prior to the addition of the 2-bromo-6-
methylpyridine, NEt3 and Pd(PPh3)4. Bubbling of argon through the solution was continuous while the 
reagents were added, to ensure no atmospheric oxygen, that can poison the Pd(0) catalyst, entered the 
reaction mixture. After 16 h at 125 °C, the starting materials had been consumed and the product (32) 
was purified by column chromatography on silica.  
 
The remaining steps towards the synthesis of [Eu·L10] are shown in Scheme 4.3. The synthesis 
followed a similar pathway to that of [Eu·L9], with the exception of the functionalisation of the 
pyridyl methyl group prior to alkylation. Rather than bromination with NBS and dibenzoyl peroxide, 
an alternative route was attempted, which was designed to increase the yield and ease of the reaction. 
The alternative route involves formation of the pyridyl N-oxide 33, followed by rearrangement to the 
pyridyl-CH2OC(O)CF3, which is hydrolysed in situ to the alcohol 34 upon addition of anhydrous 
EtOH. After purification by column chromatography on silica, the alcohol was mesylated with mesyl 
chloride and NEt3 in THF. The mesylate 35 was then used in the alkylation step with 1,4,7-
triazacyclononane. Whilst the overall yield of the pyridyl methyl activation step was reduced (23 % 
for mesylation vs. 41 % for bromination), the advantage of the mesylation route is the ease of 
purification at each step, compared to the more challenging separation of the mono-brominated 
material from the di- and un-brominated products, formed in the NBS reaction. Another advantage is 
that in the subsequent alkylation step, no evidence for the tetra-substituted product was observed, 
even at 80 °C in CH3CN. This is in contrast to the more reactive brominated starting material, which 
required more stringent control over the reaction conditions to avoid over-alkylation. With the tri-
alkylated ligand in hand, hydrolysis and complexation gave [Eu·L10] in high yield. As with the 
phenylphosphinate analogue, [Eu·L10] was purified by short path column chromatography on silica. 
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4.7.2 Aqueous Solubility 
 
The methyl phosphinate analogue of [Eu·L9] was synthesised in order to increase the aqueous 
solubility of the resultant complex. Solubility of [Eu·L9] was assessed by measuring the absorbance of 
a saturated aqueous solution. A limiting concentration of around 100 µM was found. The more 
hydrophilic complex, [Eu·L10], was found to have a greater aqueous solubility than could be measured 
by absorbance. Using the extinction coefficient of 8,400 M-1 cm-1 and a maximum absorbance 
detection of 3, the complex concentration is > 350 µM, according to the Beer-Lambert equation. An 
empirical measurement found that 5 mg of [Eu·L10] was soluble in 1 mL of H2O, giving a 
concentration of around 6 mM. It can be concluded that, as expected, the methylphosphinate complex 
has far greater water solubility than the phenylphosphinate analogue. 
4.7.3 Structural Analysis 
 
Due to the increased solubility of [Eu·L10] in water, crystals could not be readily grown in the same 
aqueous methanolic solution used to grow crystals of [Ln·L9]. Despite this fact, NMR studies could be 
used to investigate the solution state structure of [Eu·L10]. The 31P-NMR spectrum shows a single 
resonance consistent with a single major diastereomer in solution. Comparison of the 1H-NMR of 
[Eu·L9] and [Eu·L10] reveals that the two complexes have the same structure in solution (Figure 4.20). 
The 1H-NMR spectrum for [Eu·L10] was measured in d-methanol to allow comparison with [Eu·L9]. 
The spectrum in D2O has the same form, with small shifts in the ppm values of some of the 
resonances. In solution, both [Eu·L9] and [Eu·L10] exist as a single diastereomer, with no evidence for 
any minor species. The chemical shift values of the ring and pyridyl protons are very similar in each 
case. Additional Me peaks are seen in the spectrum of [Eu·L10], along with the absence of the phenyl 
resonances. Overall, it can be reasoned that the two complexes have the same solution state structure, 
previously determined to be a 9-coordinate, slightly distorted, tricapped trigonal prism, with pseudo-
C3 symmetry.    
 
Figure 4.20 1H-NMR spectra of [Eu·L10] (upper) and [Eu·L9] (lower) (CD3OD, 400 MHz). 
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4.7.4 Photophysical Properties 
 
Having established that the solution state structure of [Eu·L10] is the same as that of [Eu·L9], the 
photophysical properties are expected to be somewhat similar. Analysis of [Eu·L10] was carried out 
under the same conditions as [Eu·L9] (Table 4.5). The maximum absorption wavelength and molar 
extinction coefficient both decrease by a small amount. The emission quantum yield has also dropped 
slightly. This may be due to a reduction in steric bulk, upon exchanging phenyl groups for methyl 
groups, allowing quenchers, such as H2O, greater access to the Eu3+ centre. This idea does not hold 
when looking at the excited state lifetime of [Eu·L10] in H2O, which is 15 % greater than the value for 
[Eu·L9]. Overall, the photophysical data are very similar. One of the favourable properties of [Eu·L9] 
was the form of the emission spectrum. To allow comparison with the spectrum of [Eu·L10], samples 
were made up with equal absorbance (0.10) and emission spectra were measured (Figure 4.21). The 
lower quantum yield of [Eu·L10] is apparent, by the overall lower emission intensity in each band. The 
encouraging feature from this comparison is that the two spectra have nearly identical spectral form. 
This result is entirely predictable, as it is known that [Eu·L10] has the same symmetry and donor set 
about the Eu3+ centre as [Eu·L9]. It can also be concluded from the two spectra that exchanging the 
phenyl groups for methyl groups does not affect the polarisability of the phosphinate donor, as the 
integrated intensity ratios of the ∆J = n bands remain similar. 
 
Table 4.5 Photophysical data for [Eu·L9] and [Eu·L10] measured in H2O, unless otherwise stated (295 K, pH 
5.8/pD 5.4). 
Complex 
λmax  
(nm) 
ε  
(M–1 cm–1) ms
Ln
OH /2τ  ms
Ln
OD /2τ  q
 
%/
2
Ln
OHΦ  
Intensity Ratios
 
∆J = 2 / ∆J = 1
 
∆J = 2 / ∆J = 4
 [Eu·L9] 274 14,000 1.36 1.54 0.0 9.0 4.09 5.09 
[Eu·L10] 272 8,400 1.56 1.60 0.0 7.2 4.11 5.40 
  
 
Figure 4.21 Comparison of the emission spectra of [Eu·L9] and [Eu·L10] (H2O, pH 5.8, λex = 274 nm, A = 0.10). 
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4.7.5 The Terbium Complex 
 
To allow comparison of the photophysical data of [Tb·L9], the methylphosphinate [Tb·L10] was 
synthesised in an analogous manner to the synthesis of [Eu·L10], with exchange of Eu(OAc)3 for 
Tb(OAc)3. Data for the two complexes is reported in Table 4.6. The change in molar extinction 
coefficient approximately mirrors the observed changes between [Eu·L9] and [Eu·L10]. The excited 
state lifetime and emissive quantum yield both increase slightly upon moving to the 
methylphosphinate complex. The increase in quantum yield suggests a better overlap between the 
pyridyl triplet excited state and the Tb3+ excited state. The long-lived excited state for each Tb3+ 
complex, reflects the shielded nature of the Ln3+ centre, rendering it resistant to quenching processes. 
 
Table 4.6 Photophysical data for [Tb·L9] and [Tb·L10] measured in H2O, unless otherwise stated (295 K, pH 
5.8/pD 5.4). 
Complex 
λmax  
(nm) 
ε  
(M–1 cm–1) ms
Ln
OH /2τ  ms
Ln
OD /2τ  q
 
%/
2
Ln
OHΦ  
[Tb·L9] 274 14,000 2.16 2.51 0.0 50 
[Tb·L10] 272 7,400 2.59 2.98 0.0 60 
 
 
4.8 NMRD Analysis of [Gd·L9] and [Gd·L10] 
 
Kinetically inert and thermodynamically stable lanthanide complexes are extensively studied for use 
as contrast agents in magnetic resonance imaging.17 A potential contrast agent must have a high 
efficiency in catalysing the water proton relaxation rate.18, 19 This property is quantified by the 
relaxivity, which is the increment of the water proton relaxation rate per unit concentration of the 
contrast agent. The relaxivity depends upon the structural, electronic and dynamic properties of the 
complex. Complexes of Gd3+ are most often studied, as the combination of a high magnetic moment 
with a long electronic spin relaxation time, leads to high relaxation rates.20 
 
The overall relaxivity is determined by the contribution of inner- and outer sphere relaxation 
mechanisms. The coordinatively saturated complexes, [Gd·L9] and [Gd·L10], have no inner sphere 
water molecules and can be described as purely outer sphere contrast agents. The outer sphere 
mechanism involves the electron – nuclear magnetic dipole coupling, which occurs when the solvent 
molecules approach the metal complex during their translational diffusion motion.21 It depends upon 
the translational diffusion coefficient, D, the electronic relaxation time, τS and the distance of closest 
approach of the water protons to the Gd3+ centre, a. The rate of outer sphere relaxivity is also 
dependent upon the magnetic field.21 Nuclear magnetic relaxation dispersion (NMRD) profiles show 
the relaxivity as a function of magnetic field strength and are measured by a fast field-cycling 
technique developed by Koenig and Brown.22 
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NMRD profiles were measured for [Gd·L9] and [Gd·L10] by Prof. Botta at the University of 
Alessandria (Figure 4.22). Some of the measured parameters are also shown in Table 4.7. The most 
noticeable difference between the two profiles is the low rate of relaxivity for [Gd·L9]. At 20 MHz 
field strength this value is 0.58 mM-1 s-1. A likely explanation for this low value is the nature of the 
solvation of the complex. To solubilise the complex, a solvent system of H2O : CH3OH (9 : 1) was 
used. The estimated value of a, the distance between the Gd3+ centre and the nearest water molecule, 
is 9.9 ± 3.2 Å, suggesting that the complex is surrounded by a shell of methanol molecules, shielding 
the complex from the approach of water. For the water soluble [Gd·L10], a more typical a value for 
outer sphere water of 4.3 ± 0.1 Å was estimated, leading to the higher observed relaxivity. The 
temperature dependence of the relaxivity was measured for [Gd·L10] (Figure 4.22 right), and revealed 
an increase in relaxivity at lower temperatures. As the a value should not be affected by temperature, 
the increase is associated with a change in τν and the diffusion coefficient, D. 
 
 
Figure 4.22 NMRD profiles for [Gd·L9] (90 : 10, H2O/CH3OH, left) and [Gd·L10] (H2O) with varying 
temperature (right). 
.  
Table 4.7 Outer sphere parameters for [Gd·L9] and [Gd·L10] where r1p20 is the relaxivity at 20 MHz, ∆2 and τV 
are terms which contribute to the electronic relaxation time, q is the number of inner sphere water molecules, a 
is the distance between the Gd3+ centre and the nearest water molecule and D is the diffusion coefficient. 
“outer sphere” parameters (25 °C) 
 
[Gd·L10] [Gd·L9] 
r1p
20
 (mM-1 s-1) 1.93 0.58 
∆2(s-2; ×1019) 2.75±0.07 3.16±0.94 
τV  (ps) 10±1 28±4 
q 0 0 
a (Å)* 4.3±0.1 9.9±3.2 
D (cm2s-1;×105)* 2.24 2.24 
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Comparison of the NMRD of [Gd·L10] with the tetra(methylphosphinate) complex (Figure 4.23) 
reveals a similar variation in relaxivity with magnetic field for each complex. The calculated 
parameters are shown in Table 4.8, where the tetra(methylphosphinate) complex is termed 
[Gd·L1.8(Me)]-. Each complex is q = 0 but the a value for [Gd·L1.8(Me)]- is slightly shorter, due to the 
different local hydrophobicity about the Gd3+ centre. This parameter, along with the larger ∆2 value, 
give [Gd·L1.8(Me)]- an overall higher relaxivity at 20 MHz. Similar analysis with the 
tetra(benzylphosphinate), [Gd·L1.8(Bn)]-, show that although the a value is the same as [Gd·L10], a 
lower overall relaxivity is measured, that can be tentatively ascribed to the difference in electronic 
relaxation time (Figure 4.23 right).  
             
L1.8(Me)                                      L1.8(Bn) 
 
Figure 4.23 Comparison of the NMRD profile of [Gd·L10] (●) with that of [Gd·L1.8(Me)]- (∆, left) and 
[Gd·L1.8(Bn)]- (◊, right). 
Table 4.8 Outer sphere parameters for [Gd·L10], [Gd·L1.8(Me)]- and [Gd·L1.8(Bn)]- where r1p20 is the relaxivity 
at 20 MHz, ∆2 and τV are terms which contribute to the electronic relaxation time, q is the number of inner 
sphere water molecules, a is the distance between the Gd3+ centre and the nearest water molecule and D is the 
diffusion coefficient.  
“outer sphere” parameters (25 °C) 
 
[Gd·L10] () [Gd·L1.8(Me)]- (∆) [Gd·L1.8(Bn)]- (◊) 
r1p
20
 (mM-1 s-1) 1.93 2.44 1.85 
∆2(s-2; ×1019) 2.75±0.07 7.1±0.1 7.1±0.1 
τV  (ps) 10±1 10±1 12±1 
q* 0 0 0 
a (Å) 4.3±0.1 3.6±0.1 4.3 
D (cm2s-1;×105)* 2.24 2.24 2.24 
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4.9 Conclusions 
 
The C3 symmetric complex, [Eu·L9], was synthesised to investigate the influence of the symmetry 
about the Eu3+ centre on the form of the emission spectrum. It had been established that incorporation 
of the pyridyl phenylphosphinate moiety (21) resulted in a favourable emission spectrum for the 
DO3A complex, [Eu·L6]-. By combining three such donor groups in the 1,4,7-triazacyclononane core 
structure, a ligand with 9 donor groups was synthesised. After complexation with Eu3+, X-ray 
crystallographic analysis and NMR data confirmed the pseudo-C3 symmetric nature of the complex. 
The emission spectrum of [Eu·L9] was found to meet the specification, outlined in the introduction, 
exceptionally well. With a large ∆J = 2 band, relative to the ∆J = 1 and ∆J = 4 bands, the form of the 
emission spectrum is very well suited to maximising the spectral overlap with the allophycocyanin 
acceptor in the HTRF experiment. The favourable emission spectrum comes from the combination of 
polarisable donors groups and a high degree of symmetry about the Eu3+ centre. 
 
Other favourable photophysical properties of [Eu·L9] are the long lived Eu3+ excited state and the 
reasonably high quantum yield. These two properties are, in part, due to the shielding of the Eu3+ 
centre by the three phenyl groups, which create steric bulk beneath the plane of the complex. This 
shielding effect is also thought to be partly responsible for the apparent emission stability of the 
complex in the presence of Mn2+, a species that has led to a reduction in the emission from each of the 
earlier complexes examined in this work and by researchers at CISbioassays, over the past decade. 
 
Taking into account all of the encouraging features of [Eu·L9], it was concluded that the core structure 
- 1,4,7-triazacyclononane with three pyridyl phosphinate groups – is ideally suited for the HTRF 
application and meets the specification, regarding emission spectral form and stability. By retaining 
the core structure and modifying the pyridyl ring, subsequent complexes can be designed which will 
allow sensitisation of Eu3+ emission at a wavelength > 330 nm, without affecting the spectral form or 
stability. These complexes are the subject of the next chapter.  
 
After the pleasing results from [Eu·L9], it was decided that the series [Ln·L9] should be synthesised to 
investigate any variations across the series. Crystal structures revealed that [Ln·L9] defined an 
isostructural series, with a slightly distorted tricapped trigonal prismatic geometry about the Ln3+ 
centre. NMR data showed that this geometry was retained in solution. Isostructural series of 
lanthanide complexes are rare, and the [Ln·L9] series will be used in future fundamental NMR studies.  
 
The complexes exist as enantiomers, arising from the chirality at P (SSS or RRR). The enantiomers 
have a ∆ or Λ configuration, respectively, and were found to interact strongly with the stationary 
phase of a chiral HPLC column, allowing resolution. With the two enantiomers isolated, CD and CPL 
analyses were undertaken. Circular dichroism aided the assignment of the two enantiomers, whilst the 
CPL from the Eu3+ and Tb3+ complexes was found to have gem values up to 0.4. There is potential for 
complexes based upon the core structure of [Ln·L9] to act as chiroptical probes, that can report 
changes in the chiral cellular environment by a change in CPL.     
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5. Emissive Europium Complexes Incorporating 
Arylalkynylpyridyl Chromophores 
5.1 Introduction 
 
As the previous chapters reported, a considerable amount of work was devoted to developing a Eu3+ 
complex with an optimised emission spectral form. The C3 symmetric complex [Eu·L9] comprises a 
1,4,7-triazacyclononane macrocycle with three pyridyl phenylphosphinate groups. The emission 
spectrum of [Eu·L9] has a large relative ∆J = 2 band and is very well suited to the desired FRET 
application. The emission is also stable in the presence of a number of common quenchers and 
competitors, including Mn2+. At this stage in the project, attention was focussed upon the remaining 
specification points, outlined in Chapter 1. The final target complex must include a chromophore that 
is able to sensitise Eu3+ emission at a wavelength above 300 nm. The complex should have a large 
molar extinction coefficient and emission quantum yield. Aqueous solubility and a position from 
which a vector can be conjugated are the final two specification points. 
 
  
 
The work in this chapter aims to meet these final points. The core structure of the target complex is 
the same as that of [Eu·L9], so as to retain the favourable emission spectral form and emissive 
stability. The three pyridyl groups will be modified to form chromophores, whose properties must 
meet the remaining targets regarding the molar extinction coefficient and quantum yield. One possible 
chromophore that could be incorporated is the 3-azaxanthone introduced in Chapter 2. However, it 
was concluded that incorporation of this moiety into Eu3+ complexes did not show large enough 
improvements upon the currently used complex, [Eu·L1.1]3+. A second option is the pyridylalkynylaryl 
chromophores, which were discussed in Section 1.3.4. Electron rich aryl groups result in internal 
charge transfer absorption bands with large molar extinction coefficients. The di-carboxylate ligand 
L1.21 was developed during the course of this project by Maury.1 It is able to sensitise Eu3+ emission 
with excellent photopyhsical properties (λex = 332 nm, ε = 25,000 M-1 cm-1). Incorporation of 
alkynylaryl moieties into the 4- position of the pyridyl phenylphosphinate groups of [Eu·L9] gives the 
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complexes [Eu·L11] and [Eu·L12]. The former is a model complex designed to investigate the 
photophysical properties of this new chromophore and the latter includes two polyethylene glycol 
chains to increase aqueous solubility and a primary amine as a point for conjugation. This chapter 
details the synthesis and characterisation of these complexes. A third complex was also synthesised, 
[Eu·L13]+, in which only two of the 1,4,7-triazacyclononane nitogens are alkylated with chromophoric 
moieties. The resultant ligand is 7-coordinate and [Eu·L13]+ has a single bound H2O molecule in 
aqueous solution. Addition of various anions and protein cause a change in the form and intensity of 
the Eu3+ emission, as a result of displacement of the labile solvent molecule. This complex is highly 
emissive and responsive to its environment, and may have potential as an intracellular probe. 
 
5.2 A New Chromophore 
5.2.1 Synthetic Aspects 
 
To allow formation of a longer wavelength absorbing chromophore from the pyridyl moiety in 
[Eu·L9], functionalisation in the pyridyl para position is required. A halide leaving group (Cl-, Br- or 
I-) opens up the possibility of transition metal catalysed cross coupling reactions with the alkynylaryl 
moiety. The first attempt to introduce such functionality was with the phenylphosphinate 21. N-oxide 
formation with MCPBA was followed by nitration with concentrated H2SO4 and HNO3. The intention 
was to then convert the NO2 group into a Br group. Two problems arose during the nitration step 
which made this route unfeasible (Scheme 5.1). Firstly, the ethyl phosphinate ester hydrolysed under 
the reaction conditions and secondly, nitration also took place at the para position in the phenyl group. 
While the resultant OH group can be re-esterified, using triethyl orthoformate, selective removal of 
the phenyl NO2 is less straightforward. As a result, an alternative reaction pathway was sought. 
 
 
Scheme 5.1 
An alternative route was undertaken to functionalise the starting material 2-bromo-6-methylpyridine 
(17). Again, N-oxide formation with MCPBA was followed by nitration (H2SO4 / HNO3, Scheme 5.2). 
The resulting para-nitro N-oxide 38 was isolated by dropping the reaction mixture into ice, causing a 
pale yellow precipitate to form. Formation of 38 was achieved on a 30 g scale.   
 
 
Scheme 5.2 
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Prior to conversion of the para-NO2 group to Br, the coupling reaction with ethyl phenylphosphinate 
was undertaken to ensure selective substitution in the pyridyl ortho position. Several routes were 
attempted (Scheme 5.3). Firstly, coupling was attempted between the N-oxide intermediate 38 and 
ethyl phenylphosphinate, using Pd(PPh3)4 as a catalyst. The reaction did not proceed, most likely due 
to oxidation of the catalyst to Pd(II) by the pyridyl N-oxide. Alternative routes were tried with greater 
success. Treatment of 38 with Fe(s) in AcOH led to the removal of the N-oxide and reduction of NO2 
to NH2, giving 2-bromo-4-amino-6-methylpyridine. In the absence of the N-oxide, coupling was 
achieved in a 42 % yield. A second route was also attempted in which the nitro group was left intact 
and the pyridyl N-oxide was removed using PBr3 to give 2-bromo-4-nitro-6-methylpyridine (39). The 
coupling reaction was, again, successful affording the para-nitro pyridine phosphinate 40. The yield 
of the coupling reaction was comparable for the para-NO2 and para-NH2 reactants. 
 
 
Scheme 5.3 
 
The para-NO2 compound (40) was deemed to be the intermediate which could be brominated with 
greater ease. Conversion of the nitro group to a bromo group was accomplished by stirring 40 in neat 
acetyl bromide (70 °C, 16 h). The resultant reaction mixture was dropped cautiously into ice cold 
CH3OH, which converts acetyl bromide to methyl acetate and HBr, which can be removed under 
reduced pressure. Hydrolysis of the ethyl phosphinate ester is unavoidable under the reaction 
conditions. Re-esterification was achieved by stirring the phosphinic acid in refluxing 
triethylorthoformate for 72 hours. The full synthesis is shown in Scheme 5.4. Purification of 42 was 
achieved by column chromatography on silica. Upon the initial scale-up of the palladium cross 
coupling step (39 → 40) from 100 mg to 2 g scale, the yield was found to be reduced to less than 10 
%. The majority of the starting material 39 was recovered and it was concluded that degradation of 
the catalyst was responsible for low yield. It was found that the yield could be increased using a 
number of simple procedures, prior to reaction. Firstly, starting materials of high purity were used (> 
98 %, determined by 1H-NMR). Each starting material was free from solvents such as CHCl3, which 
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can poison the catalyst. Before carrying out the reaction, the 2-bromo-6-methyl-4-nitropyridine was 
dissolved in toluene and dried thoroughly under reduced pressure and high vacuum to ensure removal 
of all such solvents. The catalyst used was fresh Pd(PPh3)4, stored under an atmosphere of argon. As 
with all air sensitive cross coupling reactions, the solvent was degassed (freeze-thaw cycle) three 
times to remove dissolved oxygen, which inactivates the catalyst. After addition of each starting 
material the solution was degassed once and after addition of all the starting materials the solution 
was degassed a further three times. Using these procedures, the reaction was successful on a 3 g scale, 
with a yield, after purification, of 45 %. 
 
 
Scheme 5.4 
With the para-Br group in place, Sonogashira cross coupling was achieved with the commercially 
available 4-ethynylanisole (Scheme 5.5). The general reaction mechanism is believed to involve the 
oxidative addition of the pyridyl bromide to Pd(0), after dissociation of at least one PPh3 ligand. The 
alkyne is activated by coupling to Cu(I) before being transferred to the Pd centre. Reductive 
elimination of the coupled compound converts Pd(II) back to Pd(0), which goes on to initiate further 
reactions. The reaction proceeded in high yield, although purification of 43 by column 
chromatography on silica was made slightly more difficult by the presence of POPh3, formed from 
dissociated PPh3, as both compounds have similar Rf values (silica, CH2Cl2 : 5 % CH3OH). 
 
 
Scheme 5.5 
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5.2.2 Photophysical Properties 
 
The absorption properties of 43 were measured in methanol at 295 K (Figure 5.1 and Table 5.1). The 
absorption spectrum shows a broad transition centred at 320 nm, assigned as an internal charge 
transfer (ICT) band from the electron-rich aryl O to the electron deficient pyridyl group. A similar 
absorption profile is observed for the related compound L1.21, which has the same arylalkynylpyridyl 
core structure.2 The 3-azaxanthone chromophore, 5, has a similar absorption maximum but has a 
narrower absorption band (Figure 5.1), previously ascribed as a pi-pi* transition with significant n-pi* 
character.3 The extinction coefficient of 43 was found to be 26,500 M-1 cm-1 at 320 nm. This is around 
a five-fold increase, relative to the 3-azaxanthone chromophore, and is very encouraging, considering 
that the final target Eu3+ complex will have three chromophores.  
 
Figure 5.1 Absorption spectra of the chromophore 43 (red) and 3-azaxanthone 5 (purple) (MeOH, 295 K). 
 
To assess whether the chromophore 43 has the potential to sensitise Eu3+ emission, measurement of 
the triplet energy was undertaken. A suitable sensitiser will have a triplet energy around 2,000 cm-1 
above the Eu3+ excited state (17,200 cm-1), to maximise energy transfer, while minimising back 
energy transfer. To measure the triplet energy, 43 was dissolved in EPA (ether : isopentane : ethanol, 
5:5:2; A = 0.1). The solution was cooled to 77 K, using an optical cryostat. The emission spectrum of 
the resultant glass was measured following excitation at 320 nm (Figure 5.2). The highest energy 
phosphorescence band, centred at 469 nm, was attributed to the 0 – 0 transition from the triplet 
excited state to the ground state, giving a triplet energy estimation of 21,300 cm-1. Further emission 
bands can be seen in the spectrum at longer wavelengths which can be assigned to emission from the 
triplet excited state to higher vibrational energy levels of the ground state. A triplet energy of 21,300 
cm-1 indicates that the chromophore 43 should be capable of sensitising Eu3+ emission (5D0 energy 
level lies at 17,200 cm-1), providing that the triplet energy does not decrease upon complexation or 
moving to aqueous conditions. 
 
Table 5.1 Comparative photophysical data for three chromophores: the arylalkynylphenylphosphinate 43; the 
arylalkynyl di-carboxylate L1.21 and the 3-azaxanthone 5. All values measured in MeOH at 295 K, except ET 
values, which are measured in an EPA glass at 77 K.   
Chromophore λmax / nm ε / M-1 cm-1 ET / cm-1 
Alkynyl Phosphinate, 43 320 26,500 21,300 
3-Azaxanthone, 5 324 5,600 23,700 
Alkynyl Carboxylate, L1.21 332 26,200 - 
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Figure 5.2 Emission spectrum of alkynyl chromophore 43 at 77 K (EPA glass, λex = 320 nm). 
 
5.3 The Model Complex 
5.3.1 Synthetic Aspects 
 
Having established that the chromophore 43 has potential as a sensitising group for Eu3+ emission, 
incorporation into a model complex was the next challenge. To allow alkylation with the 1,4,7-
triazacyclononane, activation of the methyl group was required. A first attempt at bromination was 
made using N-bromosuccinimide (NBS) and dibenzoyl peroxide via a radical reaction (Scheme 5.6 a). 
No bromination of the methyl group was observed, even when employing irradiation from a 100 W 
tungsten lamp, 2 equivalents of NBS and heating at 80 °C. Changes in the 1H-NMR spectrum and 
TLC showed that the starting material had been consumed. Side reactions, such as radical addition to 
the alkyne, are likely to account for the unsuccessful reaction. A second attempt involving oxidation 
of the methyl group to an aldehyde, followed by reduction to an alcohol and subsequent bromination 
was undertaken using selenium dioxide as the oxidising agent (Scheme 5.6 b). This attempt showed no 
CHO formation. After refluxing in dioxane for 14 h, the starting material was recovered, unchanged.  
 
N P
OEt
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Ph
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ii) NaBH4
iii) PBr3
 
Scheme 5.6 
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Having found difficultly in activating the methyl group in the presence of the alkyne, an alternative 
route was devised (Scheme 5.7), in which the methyl group is activated prior to the palladium cross 
coupling reaction. For example, an acetyl group can be converted into a leaving group, using reaction 
conditions which do not interfere with the C – C triple bond. Acetylation of the methyl group was 
achieved by stirring the N-oxide 44 in acetic anhydride at 120 °C. The reaction mechanism is believed 
to proceed via the formation of an N-acetate, before rearrangement to the acetate 45.4 With the acetate 
group in place, the cross coupling reaction proceeded in high yield, in part due to the ease of 
purification of 46 by column chromatography, as its Rf value is less close to that of POPh3 than the 
previously synthesised alkyne 43 (see Section 5.2.1). Hydrolysis of the acetate group was achieved in 
an anhydrous ethanolic solution of NaOEt. Under these conditions, the acetate group is cleaved but 
the phosphinate ethyl ester is retained. Conversion of the resultant alcohol to a bromide with one 
equivalent of PBr3 took place over 1 h at 20 °C. 
 
 
Scheme 5.7 
 
Initially, the hydrolysis step 46 → 47 was attempted in anhydrous methanolic NaOMe. Under these 
conditions, the alcohol was formed and the ethyl phosphinate ester was converted to a methyl 
phosphinate ester. Subsequent reaction to transform the alcohol into a leaving group with PBr3, PCl3 
and NBS/PPh3 were all unsuccessful, due to de-methylation of the methyl phosphinate ester. No de-
ethylation was observed for the ethyl phosphinate ester 47.   
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Alkylation of 1,4,7-triazacyclononane, with three equivalents of the brominated intermediate 48, was 
followed by hydrolysis of the ethyl phosphinate esters and complexation with Eu(OAc)3 (Scheme 5.8). 
The alkylation step was monitored by LCMS and stopped prior to formation of any tetra-substituted 
product. Some mono- and di-substituted products were present in the crude reaction mixture, leading 
to the low observed yield. Purification of 49 was achieved by column chromatography on silica. The 
hydrolysis of 49 was carried out on a 10 mg scale with NaOD in deuterated solvents (1 mL), which 
allowed the reaction to be monitored by 1H-NMR. Once hydrolysis was completed, the pD of the 
solution was adjusted to 6.2 and complexation with Eu(OAc)3 was carried out. As with the [Ln·L9] 
series, purification of [Eu·L11] was possible by short-path column chromatography on silica, using a 
mobile phase comprising CH2Cl2 and CH3OH (95 : 5, isocratic elution). The product was visualised 
by TLC as a bright pink/red spot, under irradiation at 365 nm. Identification of [Eu·L11] and 
assessment of purity were carried out by HRMS and RP-HPLC. 
 
Scheme 5.8 
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5.3.2 Structural Assignment 
 
Comparison of the 1H-NMR spectrum of [Eu·L11] with the parent complex [Eu·L9] reveals that the 
solution state stereochemistry of the two complexes is very similar (Figure 5.3). The total number of 
resonances (20 inequivalent Hs) indicates C3 symmetry. The 6 inequivalent shifted ring proton 
resonances (4 ring and 2 methylene linker group protons), which are similar in both spectra (7.5 ppm, 
4.5 ppm and 4 resonances between 0 and -5 ppm), show that the core structure about the Eu3+ centre is 
unaffected by the additional arylalkynyl groups. Additional aromatic peaks and the resonance due the 
three equivalent OMe groups (3.8 ppm) are present in the [Eu·L11] spectrum. The conclusion from the 
1H-NMR analysis is that the stereochemistry about the Eu3+ centre of [Eu·L11] is the same as that of 
[Eu·L9]: a slightly distorted tricapped trigonal prism, existing as enantiomers of a single diastereomer 
((RRR)-Λ(δδδ) and (SSS)-∆(λλλ)). The 31P-NMR, which shows a single resonance, confirms the 
presence of a single diastereomer. 
 
 
 
Figure 5.3 1H-NMR spectra of [Eu·L11] (upper) and [EuL9] (lower) (d-MeOD, 400 MHz, pD 6.2, 295 K).  
 
Upon standing in a MeOH : H2O solution (0.5 mL, 2 : 1 v/v), several single crystals of [Eu·L11] 
formed, allowing the solid state structure to be investigated by X-ray diffraction. As in the solution 
state, the pseudo C3 symmetry about the Eu3+ centre is apparent, with the three arylalkynyl groups 
extending away from the core of the complex (Figure 5.4). The angle between the three alkynyl rods 
shows deviation from 120°, in part due to the presence of disordered solvent molecules in the unit 
cell. As with the solid state structure of the parent complex [Eu·L9], the new complex [Eu·L11] is a 
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distorted tricapped trigonal prism, which exists as a single diastereoisomer. The unit cell contains four 
complexes as two pairs of enantiomers. As was expected, the presence of the three arylalkynyl groups 
does not alter the core structure of [Eu·L11], relative to the parent complex. Bond lengths for Eu – O, 
Eu – Npy and Eu – Nring and very similar for [Eu·L9] (2.33, 2.66 and 2.68 Å, respectively) and [Eu·L11] 
(2.32, 2.66 and 2.68 Å, respectively). As the core structure is unchanged, it is anticipated that the 
favourable photophysical properties of [Eu·L9] will also be retained in the model complex, [Eu·L11]. 
 
Figure 5.4 Solid state structure of [Eu·L11], assigned by X-ray diffraction studies. 
 
5.3.3 Photophysical Characterisation 
 
The aqueous solubility of [Eu·L11] is very low, due to the combination of three hydrophobic phenyl 
groups and the arylalkynyl rods. As a result, all photophysical measurements were carried out in 
methanol. The final target complex must be soluble in water and it is worth noting that, in general, the 
photophysical properties of emissive complexes are dependent upon the solvent. Despite this, the 
values of [Eu·L11] in methanol will give some indication of the properties of subsequent water soluble 
analogues.  
 
The absorption spectrum of [Eu·L11] shows a broad absorption band centred at 332 nm, with a slight 
shoulder at around 305 nm (Figure 5.5). Comparison with the spectrum for the parent methyl-
chromophore, 43 shows a red shift of 12 nm. As the solvent in the same in each case, this effect must 
be due to complexation with Eu3+. The absorption is believed to involve an ICT transition with charge 
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flowing from the aryl oxygen to the pyridyl nitrogen. A possible explanation for the increase in 
maximum absorption wavelength is that upon complexation, the nitrogen is bound to the positively 
charged Eu3+ centre, stabilising the LUMO, resulting in a decrease in energy of the charge transfer 
transition. The extinction coefficient of [Eu·L11] at 332 nm was found to be 58,000 M-1 cm-1. Whilst, 
this value is not quite three times that of the parent chromophore 43 (ε = 26,500 M-1 cm-1), it is 
impressively high and is very encouraging.     
 
Figure 5.5 Absorption spectra for the alkynyl chromophore 43 (red) and [Eu·L11] (blue), which incorporates the 
same chromophore (MeOH, 295 K). 
 
The emission spectrum for [Eu·L11] was measured in methanol, following excitation at 332 nm 
(Figure 5.6). No fluorescence is observed below 500 nm, indicating that the arylalkynylpyridyl 
chromophore is efficiently populating the Eu3+ excited state. The form of the emission spectrum is 
relatively simple, showing no splitting in the ∆J = 1 band and two predominant bands in the ∆J = 2 
manifold. This is indicative of the solution state C3 symmetry revealed by 1H-NMR analysis. 
Comparison of [Eu·L11] and [Eu·L9] shows that the two emission spectra are very similar (Figure 
5.7). This reinforces the understanding that the symmetry and coordination environment about Eu3+ 
determine the form of the emission spectrum and relative intensity of the various transitions. Upon 
closer inspection of the two spectra, it is apparent that the presence of the conjugated chromophore 
leads to a further increase in the relative intensity of the hypersensitive ∆J = 2 transition. The ∆J = 2 : 
∆J = 1 ratio, which quantifies this effect, has increased from 4.09 for the parent complex to 7.10.     
 
Figure 5.6 Emission spectrum for [Eu·L11] (MeOH, λex = 332 nm, 295 K).  
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Figure 5.7 Comparison of the emission spectra of [Eu·L11] (red, λex = 332 nm, MeOH, 295 K) and [Eu·L9] 
(blue, λex = 274 nm, MeOH, 295 K). Spectra have been scaled so that the total integrated emission is the same in 
each case. 
 
The excellent ability of the arylalkynylpyridyl chromophore to sensitise the Eu3+ excited state is clear 
from the intense emission. The mechanism by which sensitisation occurs has been proposed for the 
dicarboxylate analogous complex (Figure 5.8 right).2 The proposed mechanism involves transfer of 
energy from a relaxed charge transfer state to the Eu3+ excited state (Figure 5.8 left). A similar 
mechanism is likely to account for the sensitisation by the arylalkynylpyridyl chromophore. 
 
 
Figure 5.8 Jablonski diagram for the proposed sensitisation mechanism by which Eu3+ sensitisation occurs in 
the complex shown.2 
  
Two methods were employed to measure the emission quantum yield of the new complex. Firstly, the 
quantum yield was measured against standards, including [Eu·L1], [Eu·L2]+ and the tris(bipyridine) 
complex, [Eu·L1.1]3+. The second method utilises an integrating sphere and is a direct measurement of 
the photons absorbed and photons emitted.5 In each case a quantum yield of 52 ± 10 % was found. 
This is an exceptionally high quantum yield for a Eu3+ complex in solution and, when combined with 
the molar extinction coefficient of 58,000 M-1 cm-1, the overall brightness (defined as ε × Φ) of 
[Eu·L11] is extraordinarily high.  
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5.3.4 Emissive Stability 
 
Despite the low aqueous solubility of [Eu·L11], it was possible to carry out stability assays, in which 
the complex concentration is 10 nM in aqueous buffered solution (0.1 M HEPES). For the first time 
throughout the project the Eu3+ emission is not greatly perturbed by any of the additives (Figure 5.9). 
As with the parent complex, Mg2+, Ca2+ and EDTA4- did not cause any significant amount of 
dissociation of [Eu·L11] and Mn2+ did not quench the Eu3+ emission. In contrast to the parent system, 
the ability of [Eu·L11] to absorb incident light at 332 nm means that the competitive absorption of 
light from the two proteins is no longer problematic and more than 80 % of the Eu3+ emission is 
retained in the presence of either protein after 15 min. After 18 h incubation, small decreases in Eu3+ 
emission were observed. Despite this, [Eu·L11] remains the complex with the highest emissive 
stability synthesised up to this point in the project, and is comparable with the currently used 
[Eu·L1.1]3+ tris(bipyridine) complex.  
 
 
Figure 5.9 Stability data for [Eu·L11] in HEPES buffer (0.1 M) at two time points, 15 min and 18 h (10nM 
complex, λex = 335 nm, λex = 620 nm). 
 
 
5.3.5 The Terbium Analogue 
 
To investigate whether the pyridylalkynylaryl chromophore is able to sensitise Tb3+ emission, 
[Tb·L11] was synthesised by an analogous pathway to [Eu·L11], exchanging Eu(OAc)3 for Tb(OAc)3. 
Following excitation at 332 nm, the emission spectrum of [Tb·L11] was measured (Figure 5.10). An 
exceptionally weak emission spectrum was found, indicating that the chromophore is not able to 
efficiently populate the Tb3+ excited state. Deoxygenating the sample led to an enhancement in the 
Tb3+ emission, suggesting that back energy is taking place from the Tb3+ excited state to the sensitiser 
excited state, which is susceptible to quenching by molecular oxygen. Comparison of the Tb3+ 5D4 
excited state (20,400 cm-1) with the sensitiser triplet state (21,300 cm-1), shows that the two states are 
within the 2,000 cm-1 limit, required to avoid back energy transfer. Consequently, this chromophore is 
not suitable for sensitisation of Tb3+ emission. Modifications of the pyridylalkynylaryl chromophore, 
which lead to an increase in the excited state energy levels, are required to achieve Tb3+ sensitisation, 
and are beyond the scope of this project. 
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Figure 5.10 Emission spectrum for [Tb·L11] prior to (blue) and after (green) bubbling argon through the 
solution for 30 s (MeOH, λex = 332 nm, 295 K). 
 
The inability of the arylalkynylpyridyl chromophore to sensitise Tb3+ gives some indication of which 
energy levels are involved in the sensitised emission pathway. It is proposed that in the Ln3+ 
complexes, the ICT band, which is broad, has some overlap with the triplet state (Figure 5.11 left). 
The energy of the sensitiser excited states are close to the Tb3+ emissive state, allowing back energy 
transfer, whereas the Eu3+ emissive state is lower in energy and back energy transfer does not occur. 
The 77 K emission spectrum of the arylalkynylpyridyl chromophore, 43, and the complex [Gd·L11], 
show the appearance of the broad ICT band (centred at 362 nm) upon complexation, which overlaps 
with the triplet state at around 469 nm (Figure 5.11 right). 
 
      
Figure 5.11 left) Jablonski diagram showing the proposed sensitised emission pathway and right) the 77 K 
emission spectra of [Gd·L11] (blue) and the arylalkynylpyridyl chromophore 43 in (EPA glass, λex = 320 nm). 
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5.4 The Final Complex 
 
The model complex, [Eu·L11], has excellent photophysical properties, albeit in methanol. It was 
decided that an analogous complex with greater aqueous solubility would be an ideal candidate to test 
in the HTRF experiment. One final specification point was to incorporate a group which allows 
conjugation between the complex and a vector, which can be tagged onto an antigen or antibody. To 
fulfil these final two criteria, the model complex was modified by the addition of two short 
polyethylene glycol chains and a primary amine. The design of the final complex positioned these 
additional groups in the place of the three aryl OMe groups, with the intention of minimally 
perturbing the photophysical properties of the model complex.  
 
5.4.1 Synthetic Aspects   
 
The synthesis of [Eu·L12] (Scheme 5.9) followed a similar reaction pathway to that of [Eu·L11]. 
Exchanging ethynyl anisole for either the polyethylene glycol (PEG) or (CH2)3NHBOC containing 
alkynyl moiety, led to the two brominated intermediates, 54 and 55. The two trimethylsilyl protected 
alkynyl moieties were provided by CISbioassays.6 The cross coupling reaction was carried out in the 
same manner as for the synthesis of [Eu·L11], with the addition of tetrabutylammonium fluoride 
(TBAF), which cleaves the Si-C bond, leaving the free alkyne. The synthesis of the PEG containing 
brominated intermediate 54 proceeded smoothly. One step towards the synthesis of the 
(CH2)3NHBOC containing analogue, however, was more problematic. The primary amine was 
protected with a butoxy carbonyl (BOC) group. Under the bromination reaction conditions (53 → 55), 
small amounts of HBr were generated. This led to the partial deprotection of the BOC group, resulting 
in a mixture of the desired product 55 and its NH4Br analogue. Fortunately, the deprotected 
compound precipitated from solution and it was possible to decant the desired product from the 
reaction mixture. The NH3Br salt was then reacted with (BOC)2O in an attempt to regenerate more of 
compound 55. In total, 13 mg of 55 were produced, which was enough to proceed to the final steps.  
 
The final target complex, [Eu·L12], has two PEG containing chromophores and one (CH2)3NHBOC 
containing chromophore. To achieve this selectivity, 1,4,7-triazacyclononane (9-N3) with one nitrogen 
protected with a BOC group was used (provided by CISbioassays). Alkylation with two equivalents of 
the PEG containing intermediate 54, was followed by removal of the BOC group with CF3CO2H and 
alkylation with intermediate 55. Both 9-N3 containing intermediates were purified by column 
chromatography on silica. Deprotection of the final ligand 58 was carried out over two steps. Firstly, 
the BOC group was removed to liberate the primary amine as the protonated TFA salt. This was 
followed by hydrolysis of the three ethyl phosphinate esters. Each deprotection step was monitored by 
LCMS and, once completed, complexation was carried out using Eu(OAc)3. The final complex, 
[Eu·L12] was purified by column chromatography on silica with a gradient mobile phase comprising 
CH2Cl2 : CH3OH : aq. NH3 solution (90 : 10 : 0→1). The formation and purity of [Eu·L12] was 
confirmed by HRMS and RP-HPLC. 
Emissive Europium Complexes Incorporating Arylalkynylpyridyl Chromophores                 Chapter 5  
 
106 
 
 
 
N
N N
N
P
OEtO
Ph
N
P
EtO
O
Ph
R2
R1
i) CF3CO2H / CH2Cl2
ii) NaOH / MeOH / H2O
iii) Eu(OAc)3 / MeOH / H2O
N
NH HN
OO
OO
R1 = R2 = O
N
N N
N
P
OO
Ph
N P
O
O
Ph
N
P
O
O
Ph
R2
R1
R3'
Eu
R3 = O
O
O
NHBOC
O
59 %
N
N N
N
P
OEtO
Ph
N P
OEt
O
Ph
N
P
EtO
O
Ph
R2
R1
R3
i) CF3CO2H / CH2Cl2 96 %
ii) 55 / K2CO3 / MeCN 50 %
R3' = O NH3 CO2CF3
34 %
K2CO3 / MeCN
56
54
57
58
[Eu·L12]
 
Scheme 5.9 
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The low yields of the bromination of intermediate 53 with PBr3 and the N-oxide rearrangement (44 → 
45) led to an optimised route being devised (Scheme 5.10).i The rearrangement was carried out using 
(CF3CO2)O in place of (CH3CO2)O. The resultant CH2OC(O)CF3 intermediate hydrolysed upon 
addition of H2O : THF mixture (1 : 1), leaving an alcohol, which was stable under the cross coupling 
reaction conditions. Rather than using PBr3, activation of the alcohol was achieved using mesyl 
chloride, which does not interfere with the BOC protected amine. This alternative route increases the 
overall yield of the reaction scheme and is recommended for future syntheses.   
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Scheme 5.10 
 
5.4.2 Solubility Assessment 
 
The addition of two PEG groups to the model complex was undertaken to improve the water 
solubility of the final complex. The linking primary amine was also expected to give [Eu·L12] 
increased solubility. The presence of these additional groups certainly improved the aqueous 
solubility, relative to the model complex, [Eu·L11], although not as much as had been hoped. It was 
found that µM concentrations of [Eu·L12] were achievable but that mM concentrations were not. As a 
result, assessment of the photophysical properties of [Eu·L12] was carried out in a H2O : CH3OH (3 : 
1) solvent system. The HTRF experiment is carried out with a concentration of donor complex in the 
range 10 – 100 nM. The presence of water soluble vector (e.g. antibody, antigen) will also increase 
the solubility of the final donor moiety. It was concluded that the aqueous solubility of [Eu·L12] was 
sufficient for the initial testing in the HTRF application, but that increasing solubility will be an area 
of future research.  
                                                          
i
 Optimisation carried out with the help of CISbioassays 
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5.4.3 Photophysical Properties 
 
To allow direct comparison, the photophysical properties of the more water soluble complex, 
[Eu·L12], were carried out in an analogous manner to those of [Eu·L11] (Table 5.2). Although 
expected, the results were very pleasing. Despite the change in solvent system and the additional PEG 
and (CH2)3NH3 groups, the properties of the two complexes are very similar. The molar extinction 
coefficients and emissive quantum yields are very high, leading to exceptionally bright complexes. 
The excited state lifetimes are within 0.05 ms and each complex has a q value of 0, suggesting that no 
change in the Eu3+ coordination sphere occurs upon addition of the PEG and primary amine 
appendages. This is confirmed by inspection of two emission spectra, which reveal no distinguishable 
differences (Figure 5.12). It is clear that despite the loss of C3 symmetry of the complex as a whole, 
only the groups in close proximity to the Eu3+ centre, which retain the C3 symmetry, influence the 
form of the emission spectrum.        
 
Table 5.2 Photophysical data for the complexes [Eu·L11], [Eu·L12] and [Eu·L1.1]3+ (295 K). The solvent systems 
employed were a) CH3OH, b) H2O, CH3OH (3 : 1) and c) H2O + 0.4 M KF. Quantum yields ± 10 %.   
Complex λmax / nm ε / M-1 cm-1 Φ  (%) ∆J = 2 : ∆J = 1 Ratio q τ / ms 
[Eu·L11] a 332 58,000 52 7.1 0.0 1.30 
[Eu·L12] b 332 60,000 54 7.1 0.0 1.25 
[Eu·L1.1]3+ c 303 18,000 10 1.4 0.0 1.15 
 
 
 
Figure 5.12 Comparison of the emission spectra of [Eu·L11] (CH3OH, λex = 332 nm, 295 K), [Eu·L12] (H2O : 
CH3OH, 1 : 3, λex = 332 nm, 295 K) and [Eu·L1.1]3+ (H2O, 0.4 M KF, λex = 303 nm, 295 K) and insert) 
absorption spectrum for [Eu·L12] (H2O : CH3OH, 3 : 1, 295 K). 
 
Having established that [Eu·L12] has the photophysical properties required for the HTRF experiment, 
it is necessary to compare its properties with the currently used complex, [Eu·L1.1]3+ (Table 5.2). The 
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combination of a large extinction coefficients, due to three chromophores and a high emissive 
quantum yield, resulting from an appropriate sensitiser excited state energy and a well shielded Eu3+ 
centre, result in an 18 fold increase in the overall brightness (ε × Φ) for [Eu·L12], relative to the 
tris(bipyridine) complex. This is accompanied by a higher maximum absorption wavelength (Figure 
5.12 insert) and a 5 fold increase in the integrated intensity ∆J = 2 : ∆J = 1 ratio (Figure 5.12). 
Overall, [Eu·L12] is superior to the currently used complex, [Eu·L1.1]3+, and will be taken forward for 
testing in the HTRF experiment. 
 
5.5 A Responsive System 
 
One of the design specifications of the FRET donor complex, [Eu·L12], was that it should be 
unresponsive to its environment. This was achieved by shielding the Eu3+ centre, so that the presence 
of added anions, cations or proteins led to no change in the intensity or form of the emission 
spectrum. Another class of emissive Eu3+ complexes exists, in which changes in the emission 
spectrum report variations in the concentration of specific analytes.7 Of particular interest is the ability 
to measure fluctuations in the concentration of intracellular species.8, 9 A responsive system of this 
type must meet several important criteria. Firstly, the emission from the probe must show some 
variation which can be measured in response to the specific analyte. This can include an increase, 
decrease or change in form of the emission spectrum. The change must be calibrated, so that the 
analyte concentration can be measured directly from the emission spectrum. One way to achieve 
calibration is to use ratiometric analysis, which relies upon two or more emissive bands varying at 
different rates in response to the analyte. The ratio of the two peaks can then be used to measure the 
concentration of analyte. Using this method, the measurement is independent of the probe 
concentration, which is usually unknown in cellular applications. The second criterion is that the 
probe is selective to the specific analyte and unresponsive to other species. Finally, intracellular 
probes must be non-invasive and may also be required to localise in a specific region or organelle of 
the cell.10     
 
The emission from Eu3+ has several transitions, whose form and intensity are dependent upon the 
symmetry and speciation of the coordination sphere. As a result, Eu3+ complexes, whose coordination 
sphere is unsaturated, have been found to make excellent ratiometric probes. In these systems, 
exchange of a bound inner sphere solvent molecule by an analyte results in a change in the emission 
spectrum, which can be used to measure the analyte concentration. As these complexes are typically 
positively charged, anions, such as citrate, bicarbonate and lactate,8, 11, 12 are the most commonly 
probed analytes.  
 
For intracellular applications, it is necessary for an emissive probe to be bright (i.e. a high molar 
extinction coefficient and emissive quantum yield), to allow detection by fluorescence microscopy. 
After finding [Eu·L12] to have excellent photophysical properties, a responsive analogue was sought. 
The complex that was devised, [Eu·L13(H2O)]+, incorporates two sensitising groups, resulting in an 
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unsaturated Eu3+ coordination sphere. Luminescence titrations were carried out with a number of 
anions and protein to investigate the ability of [Eu·L13(H2O)]+ to act as a responsive probe. 
5.5.1 Synthetic Aspects 
 
The synthesis of a coordinatively unsaturated analogue of [Eu·L12] was straightforward, starting from 
the previously synthesised intermediate 57, which contains a 1,4,7-triazacyclononane ring, 
incorporating two chromophores with PEG appendages and a BOC group protecting the third ring 
nitrogen. Removal of the BOC group, by stirring in CF3CO2H / CH2Cl2 (1 : 1 v/v), was followed by 
hydrolysis of the two ethyl phosphinate esters and complexation with Eu(OAc)3 (Scheme 5.11). The 
charged complex was purified by preparative RP-HPLC, as an acetate salt, and HRMS was used to 
confirm the identity of the complex. 
 
 
Scheme 5.11 
 
5.5.2 Structural Analysis 
 
To analyse the solution state structure of [Eu·L13(H2O)]+, 1H- and 31P-NMR were employed. Two 
broad peaks in a 1 : 1 ratio were observed in the 31P-NMR spectrum. These peaks are likely to arise 
from two diastereoisomers: one being RR or SS at phosphorus and the other being RS or SR. In 
contrast to the sterically congested coordination sphere of [Eu·L12], which forces the stereochemistry 
at P to be RRR or SSS, the environment around the Eu3+ centre of [Eu·L13(H2O)]+ is less crowded, 
leading to the formation of multiple stereoisomers. A second possible explanation for the two 
observed shifts in the 31P-NMR spectrum is the presence of the Λ-SS and ∆-SS (or Λ-RR and ∆-RR) 
diastereomers. If this is the case, the two diastereomers must have similar energy as the observed ratio 
of the two peaks is 1 : 1. The 1H-NMR spectrum is more complex than that of [Eu·L12], indicative of 
multiple species in solution. 
 
From excited state lifetime measurements in D2O (τ = 0.49 ms) and H2O (τ = 0.33 ms), an estimated q 
value of 0.9 was found.13 This is consistent with the less congested Eu3+ centre, and implies that 
[Eu·L13(H2O)]+ will be able to act as a responsive probe. Overall, the Eu3+ centre is 8 coordinate, with 
7 ligand donors and a single bound H2O molecule.        
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5.5.3 Photophysical Properties 
 
Despite the variation in the structure of [Eu·L13(H2O)]+ from the coordinatively saturated [Eu·L12], it 
remains a highly emissive complex (Table 5.3). The molar extinction coefficient is around two thirds 
that of [Eu·L12], as a result of having one less chromophore. The quantum yield of 23 ± 10 % is 
exceptionally high for a q = 1 Eu3+ complex and illustrates how efficiently the pyridylalkynylaryl 
sensitiser is able to populate the emissive state. As expected, the excited state lifetime shows a 
decrease relative to [Eu·L12], due to the presence of an inner sphere water molecule.  
 
Following excitation at 332 nm, the emission spectrum of [Eu·L13(H2O)]+ was measured (Figure 
5.13). The complexity in the ∆J = 4 region of the spectrum, suggests the presence of more than one 
emissive species in solution, likely to be associated with the two diastereoisomers, indicated by the 
31P-NMR analysis. As with [Eu·L12], the ∆J = 2 band is the most intense transition, although its 
relative intensity is less, due to the hard H2O donor ligand in place of the polarisable phosphinate 
oxygen.  
 
Table 5.3 Photophysical properties for [Eu·L12] and [Eu·L13(H2O)]+ (H2O : CH3OH, 3 : 1, 295 K), a) quantum 
yields ± 10 %.  
Complex λmax / nm ε / M-1 cm-1 Φ  (%)a τ(H2O : CH3OH) / ms τ(D2O : d-MeOD) / ms q 
[Eu·L12] 332 60,000 54 1.25 1.76 0.0 
[Eu·L13]+ 332 44,000 23 0.33 0.49 0.9 
 
 
Figure 5.13 Emission and absorption (insert) spectra for [Eu·L13(H2O)]+ (H2O : CH3OH, 3 : 1, 295 K). 
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5.5.4 Luminescence Titrations 
 
Prior to commencing luminescence titrations, emission spectra of [Eu·L13(H2O)]+ were recorded in the 
presence of a 10,000 fold excess of a number of anions and the protein, HSA. The chosen additives 
were selected on the basis of either being biologically relevant (HSA, bicarbonate, citrate, lactate and 
phosphate) or being able to give some information on the binding mode of each species. Each limiting 
spectrum was overlaid with the initial spectrum in the absence of additive (Figure 5.14). The first 
striking feature is that each species causes a change in the form of the emission spectrum, indicative 
of a change in the Eu3+ coordination environment. Upon addition of each anion, an increase in the 
total intensity of the emission was found. This was accompanied by a change in luminescence 
lifetime, which was calculated in deuterated and non-deuterated solvents, allowing the determination 
of q values, which, in each case, were found to be 0.0. Together, these two factors indicate that the 
added anion displaces the bound H2O, changing the Eu3+ coordination environment and increasing the 
total emission, due to a reduction in vibrational quenching by H2O. Only addition of HSA caused a 
reduction in the observed emission intensity. As with each anion, a change in the Eu3+ spectral form 
was also observed upon addition of HSA. Again, a q value of 0.0 was estimated, suggesting that side 
chain Glu or Asp residues in the HSA displace the H2O molecule but also quenches the emission by 
some other mechanism, perhaps involving the charge transfer quenching of the sensitiser excited 
states. 
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Figure 5.14 Limiting emission spectra for [Eu·L13(H2O)]+ in the presence of an excess of anions or HSA (red). 
The emission spectrum in the absence of additive is also shown (blue). Each spectrum was recorded in H2O : 
CH3OH (3 : 1, λex = 332 nm, pH 7.4, 295 K). The selected anions are a) acetate, b) benzoate, c) citrate, e) 
bicarbonate, f) picolinate, g) lactate and h) hydrogen phosphate as their Na+ salts. 
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Upon closer inspection of the form of the limiting spectra, it is apparent that four of the spectra are 
very similar (Figure 5.15). Having previously established that the form and intensity of the Eu3+ 
emission spectrum are determined by the symmetry and coordination environment of the central ion, 
it can be concluded that these four additives must be binding in a consistent manner. Bicarbonate, 
which is not amongst the four anions in question, has previously been shown to bind in a bidentate 
manner to unsaturated Ln3+ complexes.7 Acetate, which is a similar size, is also known to bind in this 
way.14 The three remaining anions must also be binding via a carboxylate group (Figure 5.15 insert), 
as the similarity in the emission spectra indicates. While this binding mode is expected for benzoate, 
citrate is usually thought to bind via a 5-membered chelate involving the alcoholic OH and one of the 
acetate oxygens.7, 14 It appears that the steric demand about the Eu3+ centre may be too great to allow 
formation of 5-membered chelates. High steric demand about Eu3+ is also inferred by the coordination 
number of 8 in the absence of additive. It is rather intriguing that the [Eu·L13]+ emission spectrum in 
the presence of lactate does not resemble the spectra shown in Figure 5.15. Lactate is less sterically 
bulky than citrate, which may allow the formation of a 5-membered chelate and, therefore, a variation 
in the emission spectral form. As addition of HSA to [Eu·L13(H2O)]+ results in the same emission 
spectral form as acetate, it is reasonable to conclude that the protein is binding to Eu3+ via a 
carboxylate, perhaps a glutamate or aspartate residue, as previously observed for Ln3+ complexes.15 
 
 
Figure 5.15 Comparison of the limiting emission spectrum for [Eu·L13(H2O)]+ in the presence of excess 
benzoate, acetate, citrate and HSA (H2O : CH3OH, 3 : 1, λex = 332 nm, pH 7.4, 295 K). Insert) Possible binding 
mode for the four selected anions (R1 = R2 = sensitising groups, R3 = functional group dependent upon the 
specific anion). 
 
The limiting emission spectrum of [Eu·L13(H2O)]+ in the presence of the four biologically relevant 
anions indicated that each species binds to the Eu3+ coordination sphere, displacing H2O. To allow the 
calculation of binding constants, luminescence titrations were carried out with each anion, starting 
with bicarbonate. To a sample of [Eu·L13(H2O)]+ in H2O : CH3OH  (3 : 1, pH 7.4, 10 µM) aqueous 
NaHCO3- (2 mM) was added, initially in 1 µL aliquots. By minimising the volume of anion solution 
added, the change in [Eu·L13(H2O)]+ concentration was kept to a minimum. Emission spectra were 
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measured after each addition (Figure 5.16). The addition of aq. HCO3- led to an increase in the ∆J = 2 
: ∆J = 1 intensity ratio, which was plotted as a function of the total HCO3- concentration (Figure 5.16 
insert). The resultant curve was fitted to Equation 8.6 (see Experimental section), which assumes a 1 : 
1 binding mode, generating a binding constant, log K, for bicarbonate of 3.47. In the same way 
binding constants for citrate, lactate and phosphate were calculated (Table 5.4).  
 
 
Figure 5.16 Luminescence titration for [Eu·L13(H2O)]+ with added aq. NaHCO3 (2 mM) and insert) the 
integrated intensity ratio of ∆J = 2 : ∆J = 1 as a function of [HCO3-], allowing the calculation of a binding 
constant (10 µM complex, H2O : CH3OH, 3 : 1, λex = 332 nm, pH 7.4, 295 K). 
 
The three carboxy anions all have similar binding constants. The triply charged anion, citrate, is often 
found to have larger binding constants with Ln3+ complexes than the singly charged bicarbonate and 
lactate, due to greater electrostatic attraction to the Ln3+ centre.7 Citrate is also the largest anion and it 
appears that in the case of binding to [Eu·L13(H2O)]+, a balance is struck between electrostatic 
interactions and steric demand, resulting in the similarity in log K for the three carboxy anions. The 
anion with the largest binding constant is hydrogen phosphate, perhaps due the combination of its low 
steric bulk and being doubly charged, and despite its higher hydration energy in solution. 
     
Table 5.4 Binding constants (± 0.03) for the 1 : 1 binding between [Eu·L13(H2O)]+ and selected anions  constant 
(H2O : CH3OH, 3 : 1, pH 7.4, 295 K). 
 
Anion Log K 
Bicarbonate 3.47 
Citrate 3.54 
Lactate 3.51 
Hydrogen Phosphate 3.78 
 
 
A luminescence titration was also carried out with HSA. The protein was added as a solid over the 
concentration range 0 – 2 mM. The variation in the ∆J = 2 : ∆J = 1 intensity ratio, with added HSA 
revealed two processes taking place (Figure 5.17). Initially, the intensity ratio increases and is 
accompanied by a change in the form of the emission spectrum. This is followed by a decrease in the 
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intensity ratio but no further change in the form of the spectrum. This result suggests that HSA 
displaces H2O from the Eu3+ coordination sphere, leading to the change in spectral form, but also 
quenches the emission, leading to the reduction in both the overall intensity and the intensity ratio at 
higher HSA concentrations. 
 
 
Figure 5.17 Integrated intensity ratio of ∆J = 2 : ∆J = 1 as a function of [HSA] (10 µM complex, H2O : CH3OH, 
3 : 1, pH 7.4, 295 K). 
 
To investigate the selectivity of [Eu·L13(H2O)]+ to binding a particular anion, the emission spectrum 
was measured in the presence of a mixture of the four biologically relevant anions, at their estimated 
extracellular concentrations (Figure 5.18). The similarity in the form of the resultant emission spectra 
and the spectrum in the presence of excess bicarbonate, indicates that in the mixed anion system 
bicarbonate is bound to the Eu3+ centre. This is also suggested by the excited state lifetime, which is 
0.45 ms in both the mixed anion and bicarbonate systems. The singly charged bicarbonate anion is the 
smallest of the four tested anions and the observed selectivity of [Eu·L13(H2O)]+ for bicarbonate is 
likely to be associated with the steric demand at the Eu3+ centre, as previously elucidated.  
 
 
Figure 5.18 Comparison of the [Eu·L13(H2O)]+ emission spectrum in the presence of bicarbonate (red) and a 
mixed anion system (blue), comprising sodium salts of bicarbonate (30 mM), citrate (0.13 mM), lactate 
(2.3mM) and hydrogen phosphate (1.3 mM) (0.1 M NaCl, pH 7.4, 295 K).  
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5.6 Conclusions 
 
An initial investigation was undertaken to assess the photophysical properties of the 
pyridylalkynylaryl chromophore. The new chromophore was found to have a maximum absorption 
wavelength at 320 nm in methanol with a molar extinction coefficient of 26,500 M-1 cm-1. By 
measuring the phosphorescence spectrum at 77 K, a triplet energy of 21,300 cm-1 was estimated. It 
was, therefore, expected that the chromophore would be suitable for sensitisation of Eu3+ emission. 
 
Incorporation of the chromophore into a model complex, [Eu·L11], confirmed that population of the 
Eu3+ excited state was readily achieved by the pyridylalkynylaryl moiety. With a quantum yield of 52 
% and an overall molar extinction coefficient of 58,000 M-1 cm-1, the model complex is exceptionally 
bright. The coordination sphere about Eu3+ is the same for both [Eu·L11] and the parent complex, 
[Eu·L9], resulting in retention of the favourable emission spectral form. 
 
To increase the aqueous solubility of the model complex, [Eu·L12] was devised, which incorporates 
two PEG chains along with a primary amine, to allow vector conjugation. The favourable 
photophysical properties were not changed by these appendages and aqueous solubility was 
significantly increased. Each of the specification points outlined in the introduction (Section 1.5) is 
met by [Eu·L12] and the properties of this highly emissive complex make it very well suited to act as a 
FRET donor in the HTRF experiment. In comparison with the currently used donor complex, 
[Eu·L1.1]+, the new system, [Eu·L12], shows an 18 fold increase in brightness and a 5 fold increase in 
relative emission intensity in the ∆J = 2 manifold, resulting in better spectral overlap with the 
allophycocyanin acceptor moiety. The emissive stability of [Eu·L12] is high in the assay medium, 
without the need for 0.4 M KF, which is required to enhance the properties of [Eu·L1.1]+. One area for 
future development is to increase the aqueous solubility of [Eu·L12], which is low and at the workable 
limit for the HTRF experiment.   
 
Having accomplished the main goal of designing a bright, non-responsive Eu3+ complex, attention 
turned to the synthesis of a responsive system, which would be able to report changes in its local 
environment through a variation in the intensity and spectral form of the emission. The responsive 
complex, [Eu·L13(H2O)]+, contains one fewer sensitising group than [Eu·L12] and has a single inner 
sphere H2O donor. Upon addition of several biologically relevant anions, the H2O molecule is 
displaced, causing an increase in the intensity and a change in the spectral form of the emission. The 
spectral form is unique for each anion, although those which bind via a carboxylate group result in 
similar emission spectra. Binding of bicarbonate, a product of the Krebs cycle in mitochondrial 
respiration, to [Eu·L13(H2O)]+ was found to have a log K of 3.47 and was selective over the other 
anions that were examined, possibly due to the steric demand about the Eu3+ centre, leading to 
preferential binding of the smaller anion. This initial study into the properties of [Eu·L13(H2O)]+, 
suggest that it may find application as an intracellular responsive probe. Further experiments that are 
required to validate the use of this probe include analysis of the selectivity towards bicarbonate in a 
competitive medium, containing proteins, nucleotides and other biological anions. 
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The Tb3+ analogue of the model complex, [Eu·L11], was synthesised to assess the ability of the 
pyridylalkynylaryl chromophore to sensitise Tb3+ emission. After excitation of the complex at 332 
nm, very little Tb3+ emission was observed. This is due to thermally induced back energy transfer 
from the Tb3+ excited state to the sensitiser triplet or ICT state, which is quenched by molecular 
oxygen. By deoxygenating the sample, the emission increased, due to a reduction in this quenching 
mechanism. While the sensitiser excited state energy is too low to avoid back energy transfer from the 
Tb3+ excited state, it is very well placed to maximise transfer of energy to Eu3+, contributing to the 
high quantum yields observed for [Eu·L11] and [Eu·L12]. To allow efficient Tb3+ sensitisation, the 
chromophore requires modification, perhaps in the aryl O-R position, to increase to the triplet energy.     
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6. Investigation into the Quenching of 
Lanthanide Complexes 
 
6.1 Introduction 
6.1.1 Static and Dynamic Quenching  
 
Quenching refers to any process that reduces the overall emissive intensity of a sample, and is divided 
into two classes. Static quenching involves formation of a non-fluorescent complex between the 
quencher and the ground state emissive species. Dynamic, or collisional, quenching requires a 
diffusive encounter between the quencher and the emissive species, during its excited state lifetime. 
Both quenching processes require molecular contact between the quencher and the emissive species, 
leading to one application of quenching studies in the determination of the localisation of 
fluorophores within proteins.1 If the fluorophores is buried in the interior of a protein, the rate of 
quenching will be less than if the fluorophore is at the exterior of the protein, where it is more 
accessible to quenchers. 
 
Static quenching requires the formation of a complex between the quencher and the emissive species. 
One example is the quenching of the coumarin 120 by uridine.2 A stacking interaction takes place 
between the two flat aromatics, leading to a non-fluorescent complex. At higher uridine 
concentrations, the reduction in coumarin emission is attributed to a combination of static and 
dynamic quenching. 
 
Dynamic quenching involves an encounter between the quenchers and the excited state emissive 
species during the lifetime of the excited state, resulting in non-radiative decay to the ground state. 
Examples of dynamic quenching include electron or charge transfer, energy transfer and triplet state 
quenching by molecular oxygen. Amines, such as diethylaniline quench the fluorescence from 
aromatic hydrocarbons, such as anthracene, by formation of an excited state charge transfer complex, 
while electron rich fluorophores, such as indole, can be quenched by oxidation in the singlet excited 
state by electron scavengers (e.g. H+, histidine and Cu2+).3 
 
6.1.2 The Stern-Volmer Equation 
 
Dynamic quenching is described by the Stern-Volmer equation,1 
 

 = 1 + 	
 = 1 + 
                                                [6.1] 
 
where F0 is fluorescence intensity in the absence of quencher, F is the fluorescence in the presence of 
the quencher, kq is the rate constant for the bimolecular quenching process, τ0 is the excited state 
lifetime in the absence of quencher and [Q] is the concentration of quencher. The product of kq and τ0 
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is referred to as the Stern-Volmer constant, KSV. Conventionally, the reciprocal constant, KSV-1, is 
reported. This is the concentration of quencher required to reduce the emissive intensity to 50 % of its 
original value. For a quenching process between two species occurring via a single mechanism, a plot 
of F0 / F versus [Q] gives a straight line with a gradient KSV. For dynamic quenching, τ0 / τ versus [Q] 
will also give a straight line with a gradient KSV, hence, 
 

 =

 = 1 + 
                                                           [6.2] 
  
In contrast, for static quenching τ0 / τ is 1 for all [Q]. This is because static quenching is a purely 
ground state phenomenon, and does not affect the excited state properties of the emissive species. In 
the case of static quenching, the Stern-Volmer equation becomes, 
 

 = 1 + 
                                                                 [6.3] 
 
where KS is the association constant for complex formation between the quencher and emissive 
species. 
 
The difference in behaviour of τ0 / τ with [Q] is one way to differential between static and dynamic 
quenching. Another method is to measure the temperature dependence upon quenching. For dynamic 
quenching, increasing the temperature increases the rate of diffusion and therefore, the rate of 
quenching, whereas the rate of static quenching can be reduced at higher temperatures, due to the 
dissociation of weak quencher-fluorophore complexes.  
 
Deviation from linearity in the Stern-Volmer plots at higher [Q] occurs for both dynamic and static 
quenching, due to factors such as inner filter effects and interference from background fluorescence. 
When carrying out quenching experiments, pH, ionic strength and temperature are kept constant, as 
they may affect the rate of quenching. 
 
6.1.3 Quenching of Emissive Lanthanide Complexes 
 
Any process that reduces the emissive quantum yield of a lanthanide complex can be thought of as a 
quenching mechanism. Each of the excited states in the sensitised emission pathway is susceptible to 
quenching (Scheme 6.1). The quenching processes which deactivate the various excited states are an 
important consideration when designing and analysing emissive lanthanide complexes, particularly 
those meant for intracellular use, where many endogenous quenchers are present. 
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Scheme 6.1 
 
The sensitiser singlet excited state is sensitive to dynamic quenching by electron transfer. This process 
can be inter- or intramolecular and can be predicted by the Weller equation,4 
 
Δ =  
 −  −  − 

 ! "	$%&
'(
                                 [6.4] 
 
where Eox is the oxidation potential of the donor (e.g. an amine lone pair or an electron rich aromatic 
group), Ered is the reduction potential of the acceptor (e.g. an aryl group or a Ln3+ centre), Es is the 
singlet excited state energy in eV and e2 / εr is the attractive energy term related to formation of a 
radical ion pair (usually less than ca. 0.2 eV). An example of photo-induced electron transfer is the 
quenching of the phenanthridine sensitiser singlet state (Ered = –2.12 V in MeCN, ES = 3.54 eV, e2/εr = 
0.15)5 by triethylamine (Eox = +1.15 V). According to the Weller equation, ∆GET = – 30.9 kJ mol-1, 
and the photo-induced electron transfer is energetically favourable and quenching occurs.6 Upon 
protonation of triethylamine, its Eox value increases and quenching is no longer energetically 
favourable. Europium complexes, incorporating the phenanthridine chromophore have been devised, 
which act as pH sensors, based upon the turn-on of Eu3+ emission at low pH, due to a protonation of 
phenanthridine and reduction in photo-induced electron transfer quenching.7 
 
The sensitiser triplet state is susceptible to dynamic quenching by molecular oxygen.6 This process is 
particularly important if the triplet energy level (3sens) is close in energy (within 2,000 cm-1) to the 
Ln3+ excited state (Ln*). In this situation, back energy transfer from Ln* to 3sens results in a long 
lived observed triplet state, increasing the probability of quenching by dissolved oxygen. An example 
of this quenching process was seen for [Tb·L11] (Chapter 5), in which the pyridylalkynylaryl triplet 
state was too close in energy to the Tb 5D4 state, resulting in very weak emission. The intensity of 
emission was increased upon deoxygenating the sample, consistent with the hypothesised quenching 
mechanism. There are several examples of lanthanide complexes which can report pO2 by a change in 
either the intensity of emission of a single emissive complex8-10 or by the ratiometric analysis of Tb3+ 
and Eu3+ emission from complexes based on a common ligand.11 In the latter case, only the Tb3+ 
complex, whose excited state is higher in energy, is quenched by molecular oxygen, leading to 
internal calibration of the measurement.  
 
Another mechanism by which the sensitiser triplet state is quenched by intracellular reductants urate, 
ascorbate and catechol, has recently been elucidated, using transient absorption measurements.12 In 
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this study, it was found that the electron-rich quenchers formed excited state complexes (exciplexes) 
with the electron deficient 3sens state of heteroaromatic chromophores. The resulting charge transfer 
bands were found to be lower in energy than the 3sens state. As a result, the rate of back energy 
transfer from Ln* increased, leading to an overall reduction in emission intensity and luminescence 
lifetime.  
 
The final state along the sensitised emission pathway that is susceptible to quenching is the lanthanide 
excited state. We have seen examples of back energy transfer from Ln* to 3sens, leading to a 
reduction in emission. Other quenching processes include electron and energy transfer. Electron 
transfer to Tb3+ is energetically unfavourable (Ered = –3.5 V) but formation of Eu2+ is feasible, with a 
strong enough reducing agent (Ered = –0.8 to –1.2 V were reported for Eu3+ complexes with certain 
polar octadentate ligands).6 Energy transfer from Ln* is a more commonly encountered deactivation 
pathway. Differential transfer of energy to H2O and D2O vibrational energy levels is routinely used to 
determine the q value of Eu3+ and Tb3+ complex. As the name suggests, energy transfer is also 
responsible for the FRET process, exploited in the HTRF experiment, for which [Eu·L12] is 
anticipated to be an excellent donor moiety. As with each of the quenching mechanisms discussed 
above, energy transfer is highly dependent upon the distance between the quencher and emissive 
complex. Vibrational quenching (e.g. by H2O), to a first approximation, has an r-6 dependence, as 
does Förster energy transfer. Dexter energy transfer and electron transfer quenching have an e-βr 
dependence.13 Other factors, such as dipole orientations and spectral overlap, also affect the efficiency 
of energy transfer quenching.    
 
6.2 Quenching by Metal Ions 
6.2.1 Mn2+ Quenching 
 
Throughout this project, emissive stability assays were carried out with each new Eu3+ complex, to 
assess their ability to resist quenching by a number of cations, proteins and the competitive 
multidentate ligand EDTA4-. For the early complexes ([Eu·L1(H2O)] – [Eu·L8]), the quencher which 
perturbed the Eu3+ emission to the greatest extent was Mn2+. In the case of [Eu·L6] and [Eu·L7], the 
emission was completely quenched in the presence of a million fold excess of MnCl2. Upon moving 
to the C3 symmetric systems [Eu·L9] – [Eu·L12], quenching by Mn2+ was no longer observed. In an 
attempt to rationalise these findings, a number of initial quenching experiments were designed to shed 
light upon the nature of quenching (static or dynamic). Once dynamic quenching had been 
determined, further experiments were undertaken to assess which excited state along the sensitised 
emission pathway was being deactivated by Mn2+ and the mechanism of quenching.  
 
One process by which Mn2+ could potentially quench emission from the Eu3+ complexes is 
transmetallation. This process involves dissociation of Eu3+ from its ligand and subsequent 
complexation with Mn2+, and is dependent upon the thermodynamic stability of the Eu3+ and Mn2+ 
complexes and the kinetic stability of the starting Eu3+ complex. The ability of each of the synthesised 
Eu3+ complexes to withstand quenching by Mg2+ and Ca2+ suggests that this process does not take 
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place, as these ions have the same charge and, in the case of Mg2+, a similar ionic radius to Mn2+. It is 
also well established that the Ln3+ ions form kinetically and thermodynamically stable complexes with 
octa- and nonadentate ligands, whereas Mn2+ favours 6-coordinate octahedral ligands. 
 
To investigate alternative quenching mechanisms, MnCl2 was added to a solution of [Eu·L1(H2O)] 
(H2O, 100 µM complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 K) to give final Mn2+ concentrations 
of 0.1 and 10 mM. Upon addition of Mn2+, both the emission and excited state lifetime of [Eu·L1] 
decreased. The ratios F0 / F and τ0 / τ were similar, suggesting that dynamic quenching takes place. To 
better understand which excited state is quenched, the emission spectrum of [Eu·L1(H2O)] was 
recorded at each Mn2+ concentration, following excitation of the sensitising group (λex = 328 nm, 
Figure 6.1 left) or direct excitation of the Eu3+ ion (λex = 398 nm, Figure 6.1 right). Despite the low 
signal to noise ratio following direct excitation, it is apparent that the extent of quenching is 
approximately the same, independent of the mode of excitation. This is indicative of quenching of the 
lanthanide excited state, rather than one of the sensitiser excited states.  
 
 
Figure 6.1 Emission spectra for [Eu·L1(H2O)] in the presence of 0 mM (blue), 0.1 mM (purple) and 10 mM 
(orange) MnCl2, following excitation at left) 328 nm and right) 398 nm (H2O, 100 µM complex, 0.1 M HEPES, 
0.1 M NaCl, pH 7.4, 295 K). 
 
Several empirical observations also support the hypothesis that the Ln* state is quenched by Mn2+. 
The Eu3+ emission intensities of selected complexes were measured in the presence of a million fold 
excess of MnCl2. The percentage of emission, relative to the intensity of emission prior to Mn2+ 
addition, was recorded for each complex (Table 6.1). Comparison of the values for [Eu·L2(H2O)]+ and 
the constitutional isomer [(1-AX)-Eu·L2]+, show that Mn2+ quenching is more efficient for 
[Eu·L2(H2O)]+. Both complexes incorporate azaxanthone chromophores with similar singlet and 
triplet energies, implying that the quenching mechanism does not involve the sensitiser group. 
Instead, the quenching mechanism is likely to involve the Ln* state which is more accessible to Mn2+ 
in the case of q = 1 [Eu·L2(H2O)]+ than q = 0 [(1-AX)-Eu·L2]. A second observation that supports this 
hypothesis is the higher quenching of [Eu·L6]- (2 % retention of emission), compared to [Eu·L9] (96 
% retention of emission). Each complex incorporates the same pyridyl phenylphosphinate sensitising 
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group, suggesting that the greater retention of emission by [Eu·L9] arises from the shielding of the 
Eu3+ centre by the three phenyl groups below the plane of the C3 symmetric complex (Figure 6.2). 
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Table 6.1 Comparison of the rate of quenching by Mn2+ upon selected Eu3+ complexes. The retention of 
emission is the percentage of emission intensity observed after addition of a million fold excess of MnCl2, 
relative to the emission intensity in the absence of quencher, and are average values of three independent 
measurements (± 2 %). All Eu3+ complexes 10 nM, except [Eu·L1], which is 100 µM (H2O, 0.1 M HEPES, 0.1 
M NaCl, pH 7.4, 295 K).   
Complex λex / nm Retention of Emission 
[Eu·L1(H2O)]  328 5 % 
[Eu·L1(H2O)]  398 10 % 
[Eu·L2(H2O)]+ 328 59 % 
[(1-AX)-Eu·L2]+ 328 88 % 
[Eu·L6]- 275 2 % 
[Eu·L9] 275 96 % 
 
 
 
Figure 6.2 Side view of the crystal structure of [Eu·L9], showing the three shielded nature of the Eu3+ centre, 
reducing its accessibility to quenchers, such as Mn2+. 
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In a previous study discussed above, it was found that apparent quenching of the Ln* state by urate 
and ascorbate was, in fact, due to exciplex formation between the electron deficient sensitisers 
(azaxanthone and tetraazatriphenylene) and the electron-rich quenchers.12 This led to a lowering in 
energy of the sensitiser triplet state and an increase in back energy transfer from Ln*. Rather than 
direct quenching of Ln* itself, quenching was occurring at the sensitiser triplet state. In the case of 
Mn2+, the quenching must be taking place at the Ln* state, as the difference in quenching between 
[Eu·L6]- and [Eu·L9] indicates. Each complex incorporates a pyridyl-based sensitiser, whose triplet 
energy lies at around 30,000 cm-1. This is more than 12,000 cm-1 above the Eu3+ excited state, making 
back energy transfer unrealistic.    
 
 
Figure 6.3 Luminescence titrations for [Eu·L1(H2O)] (upper) and [Tb·L1(H2O)] (lower) with increasing 
concentration of MnCl2 (H2O, 20 µM complex, 0 – 3 mM MnCl2, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 K). 
 
Having established that Mn2+ quenching occurs with the Ln* state, an investigation into the 
mechanism of quenching was undertaken. Luminescence titration were carried out with [Eu·L1(H2O)] 
and [Tb·L1(H2O)] by measuring the emission spectra in the presence of increasing concentrations of 
Mn2+ (Figure 6.3). As expected, the intensity of emission decreases with increasing [Mn2+]. To 
quantify the rate of quenching, Stern-Volmer plots were carried out (Figure 6.4). Plotting either F0 / F 
or τ0 / τ against [Mn2+] gave similar slopes, consistent with a dynamic quenching mechanism. From 
the gradients of the slopes, Stern-Volmer quenching constants, KSV-1, of 1.22 and 0.16 mM were 
calculated for [Eu·L1(H2O)] and [Tb·L1(H2O)], respectively. The plots show no deviation from 
linearity, consistent with the presence of a single bimolecular quenching process. Stern-Volmer 
0.0
1.0
2.0
3.0
4.0
570 590 610 630 650 670 690 710
R
e
la
ti
v
e
 I
n
te
n
si
ty
Wavelength / nm
0
2
4
6
8
10
12
450 500 550 600 650
R
e
la
ti
v
e
 I
n
te
n
si
ty
Wavelength / nm
Investigation into the Quenching of Lanthanide Complexes                                                   Chapter 6 
 
127 
 
quenching constants were calculated for three other complexes: the tri(phenylphosphinate) C3 
symmetric complexes, [Eu·L9] and [Tb·L9], and the methylphosphinate analogue, [Eu·L10] (Table 
6.2). For both the [Ln·L1(H2O)] and [Ln·L9] complexes, the Tb3+ species was found to be more 
susceptible to quenching. This is inconsistent with a quenching mechanism involving electron transfer 
to the Ln* state, as reduction of Tb3+ is highly energetically unfavourable. According to the Weller 
equation (Equation 6.4), even the photo-induced electron transfer from Mn2+ to Eu3+ is energetically 
unfavourable, with a ∆GET = +41.5 kJ mol-1 (assuming, Eox(Mn2+) = +1.51 V, Ered(Eu3+) = –1.2 V, ELn* 
= +2.13 eV and e2/εr = 0.15). An alternative mechanism is energy transfer, which is highly dependent 
upon the distance between the donor and acceptor. This would explain the lower KSV-1 for [Eu·L10], 
compared to [Eu·L9], as the Eu3+ centre is less shielded in the methylphosphinate complex, allowing 
Mn2+ greater access to the central Eu3+ ion.        
 
 
Figure 6.4 Stern-Volmer plots for the quenching of [Eu·L1(H2O)] and [Tb·L1(H2O)] by MnCl2 (H2O, 20 µM 
complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 K). 
 
 
Table 6.2 Stern-Volmer quenching constants for Mn2+ quenching of selected Eu3+ and Tb3+ complexes (H2O, 20 
µM complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 K). 
 
Complex KSV-1 / mM 
[Eu·L1(H2O)]  1.22 
[Tb·L1(H2O)]  0.16 
[Eu·L9] 12.3 
[Tb·L9] 4.00 
[Eu·L10] 7.69 
 
 
 
For energy transfer to occur between Ln* and Mn2+, spectral overlap is required between the donor 
emission and acceptor absorption spectra. The absorption spectrum of MnCl2 was recorded in water 
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and was found to have an absorption maximum at 520 nm (Figure 6.5). This band arises from a d – d 
transition, which is spin forbidden in the high-spin d5 Mn2+ aqua ion, resulting in a very low molar 
extinction coefficient (ε = 0.018 M-1 cm-1). The emission spectra of [Eu·L9] and [Tb·L9] are also 
shown in Figure 6.5, and indicate that spectral overlap exists between both Ln3+ emission spectra and 
the Mn2+ absorption spectrum. It is also apparent that the spectral overlap is greatest for Tb3+, which 
explains the observed lower values of KSV-1 for Tb3+ complexes of a common ligand. The low molar 
extinction coefficient of Mn2+ may disfavour the hypothesis that energy transfer quenching leads to 
the observed Mn2+ emission. However, as the excited state lifetimes of Ln3+ are long-lived 
(millisecond range), many diffusive encounters can take place between Mn2+ ions and Ln*, increasing 
the probability of energy transfer.  
 
 
Figure 6.5 Molar extinction coefficient for MnCl2 (blue) as a function of wavelength (H2O, pH 7.4, 295 K). The 
emission spectra for [Tb·L9] (green) and [Eu·L9] (red) are shown to allow analysis of the spectral overlap 
integral.   
 
From this brief study of the mechanism of quenching by Mn2+ ions, it can be hypothesised that 
deactivation occurs from the Ln* state, via a mechanism involving energy transfer, during the excited 
state lifetime of Ln*.  
 
6.2.2 Cu2+ Quenching 
 
Parallel quenching studies were carried out with aqueous CuCl2 to investigate any differences in the 
ability of the two first row transition metals to deactivate the Ln* excited state. Under the same 
conditions as the Mn2+ quenching experiments, Cu2+ was found to reduce both the emission intensity 
and excited state lifetime of [Eu·L1(H2O)], [Tb·L1(H2O)] and [Eu·L9]. Stern-Volmer quenching 
constants were determined and compared with the values measured for Mn2+ quenching (Table 6.3). 
In the presence of Cu2+, [Eu·L1(H2O)] is quenched to a greater extent than [Tb·L1(H2O)]. This is in 
contrast to the quenching by Mn2+, which showed around 10 fold greater quenching for the Tb3+ 
analogue. A second observation is that the two Eu3+ complexes are quenched more efficiently by Cu2+ 
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than Mn2+. There is around a 3 fold increase in quenching for [Eu·L9] and a 15 fold increase for the 
less shielded [Eu·L1(H2O)].   
 
Table 6.3 Stern-Volmer quenching constants for Cu2+ and Mn2+ quenching of selected Eu3+ and Tb3+ complexes 
(H2O, 20 µM complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 K).  
 
Complex KSV-1 (Cu2+) / mM KSV-1 (Mn2+) / mM 
[Eu·L1(H2O)]  0.08 1.22 
[Tb·L1(H2O)]  0.18 0.16 
[Eu·L9] 3.78 12.3 
 
To investigate whether these finding are consistent with the proposed energy transfer quenching 
mechanism, the absorption spectrum of CuCl2 was measured (Figure 6.6). A broad d – d transition, 
centred at 810 nm is observed. In contrast to the absorption of Mn2+, the d9 Cu2+ transition is spin 
allowed, resulting in a higher molar extinction coefficient (11 M-1 cm-1).14 The Cu2+ absorption band 
tails into the spectral region of Eu3+ emission and, to a lesser extent, Tb3+ emission. This would 
explain to the higher rate of quenching of [Eu·L1(H2O)], and supports an energy transfer quenching 
mechanism. Compared to Mn2+, the greater molar extinction coefficient of Cu2+ and the better spectral 
overlap with Eu3+ emission, explains the higher rate of quenching by Cu2+ of both [Eu·L1(H2O)] and 
[Eu·L9].    
 
 
Figure 6.6 Absorption spectrum of CuCl2 (blue) as a function of wavelength (H2O, pH 7.4, 295 K). The 
emission spectra for [Tb·L9] (green) and [Eu·L9] (red) are shown to allow analysis of the spectral overlap 
integral.   
 
From the preliminary results of the quenching experiments involving several Ln3+ complexes and two 
transition metal ions, the proposed mechanism of quenching is energy transfer from the lanthanide 
excited state to the transition metal ions, whose d – d absorption bands show spectral overlap with the 
Ln3+ emission. Consistent with an energy transfer mechanism, which has an r-6 dependence, where r is 
the distance between the donor and acceptor, the complex in which the central Eu3+ ion is most 
shielded from the approach of a metal ion, [Eu·L9], shows the lowest rate of quenching.  
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6.3 Quenching by Ascorbate and Urate 
 
Ascorbate and urate are two abundant intracellular antioxidants.15 Previous reports have commented 
upon the ability of the two reductants to quench Eu3+ and Tb3+ emission in complexes that incorporate 
the electron deficient azaxanthone and tetraazatriphenylene sensitising groups.16 The mechanism of 
quenching was shown to involve the formation of an exciplex between the sensitiser triplet excited 
state and the quencher. To investigate the effect of these quenchers upon [Eu·L12] and [Eu·L13(H2O)]+, 
which incorporate the pyridylalkynylaryl sensitising group, luminescence titrations were carried out. 
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An aqueous solution of ascorbate (50 mM) was added in increments to solutions of [Eu·L12] and 
[Eu·L13(H2O)]+ (H2O : CH3OH, 3 : 1, 8 µM complex, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 K), to 
give final ascorbate concentrations over the range 0 – 10 mM. The emission spectrum and excited 
state lifetime were measured after each ascorbate addition. Emission spectra and the ascorbate 
concentrations were corrected for changes in volume upon addition of the ascorbate solution. The two 
Eu3+ complexes were found to have different behaviour in the presence of ascorbate. The 
coordinatively saturated complex, [Eu·L12], showed very little interaction with the intracellular 
reductant. The form of the emission spectrum remained unchanged throughout the titration, indicating 
that the Eu3+ coordination sphere was not altered by the ascorbate addition (Figure 6.7 left). Slight 
decreases in intensity were due to the change in volume of the sample and, once corrected, no 
variation in I0 / I with ascorbate concentration was observed (Figure 6.8 left). The excited state 
lifetime, which is independent of sample concentration, was also unperturbed by ascorbate, with τ0 / τ 
remaining around unity throughout the titration (Figure 6.8 right). 
Investigation into the Quenching of Lanthanide Complexes                                                   Chapter 6 
 
131 
 
 
Figure 6.7 Luminescence titrations for [Eu·L12] (left) and [Eu·L13(H2O)]+ (right) with increasing ascorbate 
concentrations (H2O : CH3OH, 3 : 1, 8 µM complex, 0 – 10 mM ascorbate, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 
295 K). For [Eu·L13(H2O)]+, only the emission spectra at 0 (blue), 60 (purple) and 940 µM (red) are shown. 
 
 
Figure 6.8 Variations in the total integrated emission, I0 / I (left) and excited state lifetime τ0 / τ (right) for 
[Eu·L12] (blue) and [Eu·L13(H2O)]+ (red) as a function of added ascorbate.  
 
The coordinatively unsaturated complex, [Eu·L13(H2O)]+, showed different behaviour in the presence 
of ascorbate. The overall intensity fell throughout the titration (Figure 6.7 right) and a plot of I0 / I as 
a function of ascorbate concentration gave an approximately straight line, whose gradient reports an 
observed Stern-Volmer quenching constant, KSV-1, of 0.14 mM (Figure 6.8 left). The excited state 
lifetime shows unusual behaviour (Figure 6.8 right). Initially, the addition of ascorbate led to a 
decrease in τ, giving a maximum τ0 / τ of 1.34 at 60 µM. As further additions were made, the excited 
state lifetime increased and τ0 / τ fell to a value of 0.83, at the point at which the titration was stopped. 
To allow interpretation of the change in excited state lifetime with added ascorbate, the emission 
spectrum of [Eu·L13(H2O)]+ is shown at three points in the titration: before the ascorbate addition 
([ascorbate] = 0 µM) , at the point with the lowest excited state lifetime ([ascorbate] = 60 µm) and 
after the final ascorbate addition ([ascorbate] = 940 µM). Between 0 – 60 µM, the emission spectrum 
is unchanged, but between 60 – 940 µM, the spectral form alters slightly, particularly in the 
hypersensitive ∆J = 2 band, indicating a change in either the symmetry or the nature of the Eu3+ 
coordination sphere. The relatively small changes in spectral form suggest a change in coordination 
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environment rather than symmetry, which typically leads to much larger changes in the emission 
spectrum. 
 
The results of the ascorbate titrations are not easily rationalised. The coordinatively saturated [Eu·L12] 
appears to show little interaction with ascorbate and no quenching is observed. In contrast, 
[Eu·L13(H2O)]+ shows two processes taking place depending upon the concentration of ascorbate. The 
interaction with [Eu·L13(H2O)]+ may be related to the positive charge, resulting in a greater 
Coulombic attraction and a higher probability of encounter with the ascorbate anion. At low 
concentrations of [Eu·L13(H2O)]+, a quenching mechanism takes place, leading to the reduction in 
both emission intensity and lifetime. As the concentration of ascorbate increases beyond 60 µM (7.5 
equivalents), the lifetime increases and there is a subtle change in the spectral form of the emission, 
although the emission intensity continues to fall throughout. The change in emission spectrum 
suggests that the ascorbate may show a weak binding interaction with the Eu3+ centre, which is only 
apparent at higher concentrations. This is supported by the q value which is initially 1.0, but falls to 
0.3 at the end of the titration, suggesting displacement of the bound H2O by ascorbate. The quenching 
mechanism, responsible for the initial decrease in τ, must involve either the Eu3+ centre or the electron 
deficient pyridyl moiety, both of which are more accessible to ascorbate in the q = 1 [Eu·L13(H2O)]+ 
complex, compared to [Eu·L12].  
 
A hypothesis for the quenching of [Eu·L13(H2O)]+ by ascorbate involves the initial encounter of the 
two species, with no displacement of the inner sphere H2O. Instead, a weak exciplex forms between 
the electron rich reductant and the electron deficient pyridyl moiety, leading to a lowering and 
broadening of the sensitiser excited state, causing back energy transfer from the Eu3+ excited state. 
This lowers both the excited state lifetime and emission intensity. This type of exciplex formation was 
observed between ascorbate and the electron deficient azaxanthone and tetraazatriphenylene 
sensitisers in previous studies.12 As the concentration of ascorbate increases, the weak binding 
interaction with [Eu·L13(H2O)]+ leads to displacement of the bound H2O molecule and an increase in 
excited state lifetime, due to the reduction in vibrational energy transfer quenching. Binding of 
ascorbate to Eu3+ does not alter the symmetry about the metal ion centre, resulting in only small 
changes in the emission spectrum. For the coordinatively saturated [Eu·L12], the access of ascorbate to 
both the Eu3+ centre and the electron deficient pyridyl group is greatly reduced, leading to no observed 
quenching of the emission or excited state lifetime. 
 
Luminescence titrations were also carried out with added urate under identical conditions. The 
addition of urate to samples of [Eu·L12] and [Eu·L13(H2O)]+ led to similar changes in the observed 
emission intensity and lifetime, as found with ascorbate. The integrated emission intensity, spectral 
form and excited state lifetime of [Eu·L12] did not change upon urate addition (Figure 6.9 left and 
Figure 6.10). In contrast, a decrease in intensity was observed upon urate addition to [Eu·L13(H2O)]+ 
(Figure 6.9 right and Figure 6.10 left), with an apparent Stern-Volmer quenching constant, KSV-1, of 
0.07 mM. Initial decreases in τ were found up to 15 µM urate, before an increase in τ was observed, 
with τ0 / τ reaching a maximum value of 0.90 at 280 µM urate (Figure 6.10 right). As with the 
addition of ascorbate, at the end point of the titration a q value of 0.3 was estimated. 
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Figure 6.9 Luminescence titrations for [Eu·L12] (left) and [Eu·L13(H2O)]+ (right) with increasing urate 
concentrations (H2O : CH3OH, 3 : 1, 8 µM complex, 0 – 300 µM urate, 0.1 M HEPES, 0.1 M NaCl, pH 7.4, 295 
K). For [Eu·L13(H2O)]+, only the emission spectra at 0 (blue), 15 (purple) and 300 µM (red) are shown. 
 
 
Figure 6.10 Variations in the total integrated emission, I0 / I (left) and excited state lifetime τ0 / τ (right) for 
[Eu·L12] (blue) and [Eu·L12] (red) as a function of added urate. 
 
The similarity in the results suggest that both ascorbate and urate quench [Eu·L13(H2O)]+ via the same 
mechanism. The smaller value of KSV-1 for urate was also found in the previous report, which first 
elucidated the mechanism of quenching,12 and is further support towards the exciplex formation 
hypothesis. The similarity in the [Eu·L13(H2O)]+ spectra at the end point of each titration, suggest that 
the binding mode of the quenchers is similar in each case. Some potential bidentate binding modes of 
the anions with [Eu·L13(H2O)]+ have been tentatively put forward (Figure 6.11), although these are by 
no means known to be the true structures. 
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Figure 6.11 Potential binding modes of urate and ascorbate to the Eu3+ centre of [Eu·L13]+. 
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6.4 Conclusions 
 
The quenching of Eu3+ and Tb3+ emission by Mn2+ was shown to be significant for a number of 
complexes. However, the complexes [Eu·L9], [Eu·L11] and [Eu·L12], which are based upon the 1,4,7-
triazacyclononane ligand, with three phenylphosphinate groups, were found to resist Mn2+ quenching, 
in screening assays. To understand the mechanism of quenching, a number of experiments were 
carried out. Comparison of Mn2+ quenching of complexes incorporating the same sensitising group, 
led to the conclusion that the quenching occurred via the Ln3+ excited state. This was supported by the 
fact that the quenching of Eu3+ emission was independent of whether direct excitation or a sensitised 
emission pathway was employed. Having established that quenching takes place at the Ln3+ excited 
state, the mechanism of quenching was further investigated. An electron transfer process was 
dismissed, due to the unfavourable free energy changes. Instead, an energy transfer mechanism was 
proposed in which Mn2+ accepts energy from the Ln* state, during the long excited state lifetime. The 
ability of Mn2+ to quench Tb3+ emission to a greater extent than Eu3+ emission was attributed to the 
better spectral overlap between the Mn2+ absorption and Tb3+ emission spectra. 
 
To provide further evidence for the hypothesised quenching mechanism, quenching experiments with 
aqua Cu2+ ions were also carried out. For complexes of a common ligand, it was found that Eu3+ 
emission was quenched to a greater extent than Tb3+ emission. This is consistent with an energy 
transfer mechanism, as the spectral overlap with the Cu2+ aqua ion absorption spectrum is greater for 
Eu3+ emission.   
 
An alternative quenching mechanism is hypothesised for the quenching of [Eu·L13(H2O)]+ by 
ascorbate and urate. At low quencher concentrations, the quencher forms a weak exciplex with the 
electron deficient pyridyl moiety, leading to quenching of the Eu3+ excited state by back energy 
transfer to the sensitiser excited state. As the quencher concentration increases, a binding process 
occurs, which displaces the inner sphere H2O molecule, leading to an increase in the observed excited 
state lifetime. This hypothesis is supported by a change in the q value and the form of the 
[Eu·L13(H2O)]+ emission spectrum. 
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7. Conclusions and Future Work 
7.1 General Conclusions 
 
At the outset of the project, the target was to synthesise a Eu3+ complex to act as a FRET donor in the 
HTRF experiment, using changes in fluorescence to analyse interactions between biological species. 
The currently used donor, [Eu·L1.1]3+, serves its purpose well, but improvements are sought, to 
increase the efficiency of the HTRF assay. To assess the progress made over the past three years, it is 
worth recapping the original specification, set out at the beginning of the project. The specification 
was as follows, 
 
i) Design and synthesise an emissive europium complex donor for HTRF application 
ii) Optimise the form of the emission spectrum 
iii) Select a chromophore with a suitable absorption wavelength 
iv) Maximise the molar extinction coefficient and emission quantum yield 
v) Design a stable complex in the assay medium 
vi) Ensure water solubility 
vii) Incorporate a conjugation point 
 
Development went through several stages before a final donor complex was synthesised. Initially, the 
3-azaxanthone group was used to sensitise the Eu3+ emission, but complexes incorporating this 
chromophore were found to possess molar extinction coefficients and emission quantum yields that 
were no higher than [Eu·L1.1]3+. The change in the form of the Eu3+ emission spectrum resulting from 
variation of the coordinating groups was investigated, and the core ligand structure was varied from 
1,4,7,10-tetraazacyclododecane to 1,4,7-triazacyclononane. At each stage of development, 
improvements were found in the Eu3+ emission spectral form and stability in the assay medium. 
 
Using the results from the early stages of the project, a final target complex was designed and 
synthesised, which met the specification. The emissive complex, [Eu·L12], comprises a 1,4,7-
triazacyclononane ring with three pyridyl phenylphosphinate groups, providing a 9-coordinate ligand, 
which saturates the Eu3+ coordination sphere. Each of the three pyridyl groups is functionalised in the 
4-position with alkynylphenoxy sensitising groups. Extending from two of the sensitising groups are 
short polyethylene glycol (PEG) chains and from the third, a primary propyl amine.  
 
The properties of the final donor complex fulfil each of the initial specifications set out (Table 7.1). 
The pyridylalkynylphenoxy chromophores are excellent sensitisers for Eu3+ emission and absorb light 
with a maximum absorption wavelength at 332 nm. Using this wavelength of excitation light avoids 
the excitation of biological fluorophores, such as the aromatic amino acid residues. The molar 
extinction coefficient of [Eu·L12] at 332 nm is very high (60,000 M-1 cm-1), as a result of incorporating 
three chromophores per complex. The chromophore excited state has an energy that is well suited to 
Eu3+ sensitisation, being close enough in energy to maximise energy transfer, while remaining high 
enough in energy to avoid back energy transfer. This property, along with the shielded nature of the 
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central Eu3+ ion, results in an emission quantum yield of 54 %, which is exceptionally high for a 
solution state Eu3+ complex. The highly shielded nature of the central Eu3+ ion, due to the presence of 
three phenyl groups below the plane of the complex, also gives [Eu·L12] high emission stability in the 
assay medium. Addition of a series of potential quenchers in a million fold excess led to no reduction 
in the Eu3+ emission. Both the solid and solution state structure of [Eu·L12] were elucidated and 
revealed a pseudo-C3 symmetric geometry about the Eu3+ centre. Combined with the presence of three 
polarisable phosphinate donor groups, this led to a highly favourable emission spectrum, with large 
relative integrated emission intensity in the ∆J = 2 region, giving [Eu·L12] excellent spectral overlap 
with the designated acceptor moiety in the HTRF experiment. Finally, the presence of the two PEG 
chains gives [Eu·L12] moderate water solubility and the primary amine allows conjugation in future 
HTRF experiments. 
 
Table 7.1 Comparison of the properties of the new donor complex, [Eu·L12], and the currently used donor, 
[Eu·L1.1]3+. Values for [Eu·L12] measured in H2O : CH3OH (3 : 1). Values for [Eu·L1.1]3+ measured in H2O (0.4 
M KF). 
Properties [Eu·L12] [Eu·L1.1]3+ 
Maximum Absorption Wavelength, λabs  332 nm 303 nm 
Molar Extinction Coefficient, ε 60,000 M-1 cm-1 18,000 M-1 cm-1 
Emission Quantum Yield, Φ 54 % 10 % 
Brightness (ε × Φ)  32.4 mM-1 cm-1 1.8 mM-1 cm-1 
∆J = 2 : ∆J = 1 intensity ratio 7.1 1.4 
∆J = 2 : ∆J = 4 intensity ratio 3.8 1.3 
Aqueous Solubility Moderate High 
Conjugation Point 
✓ ✓ 
Stability in the Assay Medium High High 
 
To assess the potential for [Eu·L12] to act as a FRET donor, its properties can be compared to the 
currently used donor complex (Table 7.1). The higher values for the molar extinction coefficient and 
the emission quantum yield give [Eu·L12] an 18 fold increase in overall brightness (ε × Φ). The 
spectral overlap with the acceptor moiety, which can be quantified by the ∆J = 2 : ∆J = 1 ratio, shows 
a 5 fold increase. Along with these vast improvements upon [Eu·L1.1]3+, [Eu·L12] is stable in the assay 
medium, incorporates a conjugation point and has high enough water solubility for the HTRF 
experiment. Overall, [Eu·L12] is an excellent candidate to act as a FRET donor in the HTRF assays, 
and commercial development of these systems is underway. 
 
The pyridylalkynylphenoxy chromophore is very well suited to sensitisation of Eu3+ emission. As well 
as the HTRF experiment, many other applications of emissive Eu3+ complexes would benefit from the 
high molar extinction coefficients and emissive quantum yields, which result from incorporation of 
this chromophore. Indeed, the responsive system, [Eu·L13]+, which was shown to bind to a number of 
anions, leading to large changes in the Eu3+ emission spectral form, has excellent photophysical 
properties (ε = 44,000 M-1 cm-1 and Φ = 23 %), notwithstanding the presence of an inner sphere water 
molecule. Competitive anion binding studies found [Eu·L13]+ to be selective toward bicarbonate, due 
to the steric demand at the Eu3+ centre. This result demonstrates the ability of complexes 
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incorporating the chromophore to combine very high brightness with responsiveness, opening up the 
possibilities of more sensitive optical probes for fluorescence microscopy. In conclusion, the 
pyridylalkynylphenoxy moiety may define the next generation of chromophores for sensitised 
europium emission. 
 
An interesting result came out of the investigation into the stereochemistry of the C3 symmetric series, 
[Ln·L9]. In solution, the complexes were found to exist as enantiomers of a single diastereomer. The 
steric bulk of the three phenylphosphinate groups led to consistent stereochemistry at each phosphorus 
centre (RRR or SSS). This, in turn, dictated the conformation of both the 1,4,7-triazacyclononane ring 
(δδδ or λλλ) and the Nring-C-C-Npy (∆ or Λ) torsion angles. The resulting enantiomers were resolved by 
chiral-HPLC and the absolute stereochemistry was determined by comparison of the theoretical and 
calculated circular dichroism spectra. Following excitation, intense CPL was measured from the 
enantiomers of [Eu·L9] and [Tb·L9], with gem values up to 0.4. There is a potential application for 
enantiopure highly luminescent lanthanide complexes in cellular microscopy. If a complex can be 
prepared with intense CPL and suitable intracellular photophysical properties, it may be able to report 
changes in the chiral environment within a cell by changes in the CPL emission. Enantiomers of the 
model complex, [Eu·L11], which has the same core structure as [Eu·L9], and incorporates the 
alkynylphenoxy sensitising groups, did not separate under the same chiral-HPLC conditions. If 
resolution can be achieved, then complexes of this type may find use as intracellular chiroptical 
probes. 
 
Whilst not applicable to the HTRF application, complexes incorporating azaxanthone and 
azathiaxanthone chromophores showed some intriguing behaviour in cells. Fluorescence microscopy 
was used to visualise the complexes in a number of cell lines at a various concentrations. Using a 50 
µM complex concentration in the incubation medium, the bis(azaxanthone) complexes, [Ln·L2]+ and 
[(1-AX)-Ln·L2]+, localised in the lysosomes of CHO and NIH-3T3 cell lines. At lower concentrations 
(50 nM), [Tb·L2]+ and [(1-AX)-Tb·L2] were found to localise within cell nuclei. More specifically, the 
complexes associated with chromatin of cells undergoing mitosis. In contrast, the 
bis(azathiaxanthone) complex, [Eu·L2b]+, was found to localise within the nucleoli, which are known 
to be rich in ribosomes. The results suggest the complexes have an affinity for protein, but their 
behaviour is very curious and not easily rationalised. One thing that is clear is that if the mechanisms 
for uptake and trafficking of these complexes can be better understood there is huge potential for the 
use of emissive lanthanide complexes as intracellular probes.     
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7.2 Future Work 
 
The photophysical properties of [Eu·L12] are ideal for the HTRF application. It is hard to envisage 
significant increases in the molar extinction coefficient or emissive quantum yield without moving to 
a completely new chromophore and ligand system. One area in which improvement can be made is 
the aqueous solubility. The rather hydrophobic [Eu·L12] has sufficient water solubility for the HTRF 
experiment but for other applications, such as intracellular fluorescence microscopy, an increase in the 
solubility is required. To increase the water solubility, while retaining the favourable photophysical 
properties of [Eu·L12], there are two sites which could be modified. These are the phenylphosphinate 
groups and the terminal groups, which are PEG or propylamine for [Eu·L12] (Figure 7.1). Initially, the 
phenyl moiety was selected as the phosphinyl precursor was commercially available. Subsequently, it 
was found that the phenyl groups play an important role in shielding the Eu3+ centre from external 
quenchers. Exchange of the phenyl groups for more water soluble groups, which also shield the Eu3+ 
centre, could be a great advantage. One example has already been investigated in the transition from 
[Eu·L9] to [Eu·L10]. In this case, exchange of phenyl for methyl groups led to a large increase in water 
solubility, with only a small decrease in the emission stability. A similar exchange in [Eu·L12] would 
be a good first step towards improving solubility. Other water solubilising groups, which could take 
the place of Ph include CH2CH2CO2-, CH2CH2SO3- and PhCO2-.  
 
 
Figure 7.1 
 
The other site available for modification is the terminal alkynylaryl groups (Figure 7.1 – R2). Two 
PEG chains were incorporated into [Eu·L12] to increase the water solubility. Whilst some 
improvement was seen, in comparison to [Eu·L11], further improvements could be achieved by 
incorporating longer chain or dendritic PEG moieties. Alternatively, other water solubilising groups 
could be investigated, such as SO3-, CO2- or sugar based moieties. One example of an open chain 
sugar in this position has already been synthesised, and was found to increase the water solubility to a 
reasonable extent. To maximise aqueous solubility, modification of both sites on [Eu·L12], although 
synthetically challenging, is probably required. 
 
A second area of future development is to achieve sensitisation of Tb3+ emission with 
pyridylalkynylaryl chromophores. Whilst the chromophore employed in the complexes [Eu·L11] and 
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[Eu·L12] are very capable of sensitising Eu3+ emission, the analogous [Tb·L11] gave very weak 
emission, following excitation at 332 nm. Measurement of the triplet energy of the 
pyridylalkynylanisole moiety (43) indicated that back energy transfer from the Tb3+ long-lived excited 
state was likely to take place, resulting in the observed weak Tb3+ emission. To allow Tb3+ 
sensitisation, a chromophore must be devised, which has a higher triplet energy level. So as to retain 
the high molar extinction coefficient, the pyridylalkynylphenyl moiety should be retained. Variation 
of the terminal group is the most reasonable way to raise the triplet energy. To predict which groups 
will raise the triplet energy is non-trivial. A screening process may be required to investigate the 
effects of polarity and electron donation or withdrawal of the terminal group upon the triplet energy. It 
can be predicted that once a triplet energy level of around 22,400 cm-1 is achieved, Tb3+ sensitisation 
will be possible. 
 
Another area of future development involves the responsive complexes, such as [Eu·L13]+. This highly 
emissive complex was found to give large changes in spectral form upon anion binding, and was 
selective towards bicarbonate. Emissive complexes based upon [Eu·L13]+ which are selective towards 
other biological anions, such as citrate and lactate, are very desirable. It may be that variation of the 
Ph groups of [Eu·L13]+ for less sterically demanding groups would relieve steric demand about the 
Eu3+ centre, and lead to greater selectivity towards larger anions. One application for such a probe is 
in intracellular assays, where fluctuations in the concentration of anions are associated with biological 
processes. Fluorescence microscopy is the technique used to visualise emissive probes from within 
cells, and requires that changes in emission are large and spectrally resolved. One technique employed 
in intracellular anion detection is to combine Eu3+ and Tb3+ complexes of a common ligand. In these 
systems, the emission intensity of the Eu3+ analogue is more responsive to anion binding, leading to a 
ratiometric analysis by comparing the Eu3+ and Tb3+ emission. For this type of ratiometric sensing to 
be applicable for complexes incorporating the pyridylalkynylaryl chromophore, the two previously 
discussed improvements, concerning Tb3+ sensitisation and aqueous solubility, must be made.    
 
The final area in which future work should be concentrated is in the application of circularly polarised 
luminescence. While resolution of [Ln·L9] was achieved, enantiomers of the extended system 
[Eu·L11] were not isolated. For the proposed application of intracellular chiroptical microscopy, which 
may reveal changes in the chiral cellular environment by a variation in CPL from emissive 
complexes, a highly emissive and enantiopure system is required, which can absorb incident light at a 
wavelength greater than 300 nm. The enantiomers of [Eu·L12], or perhaps a more water soluble 
analogue, would be ideal candidates for this technique. If resolution of [Eu·L12] cannot be achieved, 
one possible alternative would be to resolve an analogue of [Eu·L9], say the pyridyl para-bromo 
complex, which could subsequently be functionalised with the alkynylaryl groups. Chiroptical 
microscopy relies not only upon emissive enantiopure complexes but also the equipment to detect 
CPL from within cells. Generally, CPL has fairly low intensity and detection from within cells, where 
quenching processes lead to decreases in emission intensity, is a great challenge, and would require 
very sensitive detectors. Despite this, a lot of information about cellular processes may be obtained if 
such a technique were available.        
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7.3 Final Remarks 
 
Emissive lanthanide complexes are excellent donor moieties for FRET and are routinely exploited in 
the HTRF immunoassay technology. The development of complexes with high molar extinction 
coefficients and emissive quantum yields, such as [Eu·L12], leads to improvements in the efficiency of 
the technique, and ultimately result in a reduction in the cost of each assay.  
 
In the field of fluorescence microscopy, lanthanide complexes are yet to make any commercial impact 
as intracellular emissive species. The advantages of these systems are the long-lived emission, 
allowing time-gated detection, and, in the case of europium complexes, the responsiveness of the 
emission to the coordination environment of the central ion, leading to systems that can probe the 
cellular environment. To compete with the organic dyes and fluorescent proteins commonly used in 
fluorescence microscopy, bright and water soluble lanthanide complexes are required, that are 
resistant to intracellular quenching of emission. The europium complexes described in the latter part 
of this report, which have quantum yields of up to 50 % and are highly resistant to quenching, due to 
the shielded lanthanide centre, may well be an important step towards the development of highly 
emissive lanthanide complexes for fluorescence microscopy. 
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8.  Experimental 
 
8.1 Experimental Procedures 
 
8.1.1 General Procedures 
 
Commercially available reagents were used as received from suppliers. Solvents were laboratory 
grade and dried using an appropriate drying agent when required. Reactions requiring anhydrous 
conditions were carried out under an atmosphere of dry argon using Schlenk-line techniques. Where 
appropriate, solvents were degassed using the freeze-thaw cycle method. 
 
Thin-layer chromatography was carried out on silica plates (Merck 5554) or neutral alumina plates 
(Merck Art 5550) and visualised under UV (254/365 nm) irradiation or by staining with iodine. 
Preparative column chromatography was carried out using silica (Merck Silica Gel 60, 230400 mesh) 
or neutral alumina (Merck Aluminium Oxide 90, activity II-III, 70230 mesh), pre-soaked in ethyl 
acetate.  
 
pH measurements were carried out at 295 K using a Jenway 3320 pH meter with a Sigma-Aldrich 
micro-pH combination electrode. Calibration was performed using commercially available buffer 
solutions at pH = 4.0 ±0.02, pH = 7.00 ±0.02 and pH = 10.00 ±0.02.  
 
NMR spectra (1H, 13C, 31P) were recorded on a Varian VXR-400 spectrometer (1H at 399.97 MHz, 13C 
at 100.57 MHz, 31P at 161.91 MHz), a Varian Inova-500 spectrometer (1H at 499.78 MHz, 13C at 
125.67 MHz) or a Varian VNMRS-700 spectrometer (1H at 699.73 MHz, 13C at 175.95 MHz). Spectra 
were recorded at 295 K in commercially available deuterated solvents and referenced internally to the 
residual solvent proton resonances. Variable temperature NMR was carried out using the Varian 
Inova-500 spectrometer with the assistance of Dr. Alan Kenwright at Durham University. 
 
Both electrospray and high resolution mass spectrometry were performed on a Thermo-Finnigan LTQ 
FT system using methanol as the carrier solvent. 
 
Melting points were recorded using a Reichart-Köfler block and are uncorrected. 
 
8.1.2 HPLC Analysis 
 
Reverse phase HPLC analysis was performed at 298 K on a Perkin Elmer system, comprising a Perkin 
Elmer Series 200 pump, Perkin Elmer Series 200 autosampler, Perkin Elmer Series 200 UV/Vis 
detector and Perkin Elmer Series 200 fluorescence detector. Either a 150 × 4.66 mm 4 micron 
Phenomenex Synergi 4µ Fusion-RP 80i column or an XBridge C18 10 cm 3.5 µm column was used 
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with a flow rate of 1 mL / min and run times varying from 15 – 25 min. A solvent system of H2O (0.1 
% HCOOH) / CH3CN (0.1 % HCOOH) (gradient elution) was used. The UV/Vis and fluorescence 
detectors were set at appropriate wavelengths according to the species being analysed. Methods and 
HPLC traces for each complex can be found in Appendix 1. 
 
Chiral HPLC was performed at 288 K on the same Perkin Elmer system described above using a 
CHIRALPAK-IC 4.6 × 250 mm 5 µm column at a flow rate of 1 mL / min and a solvent system of 
CH3OH / CH3CH2OH / HNEt2 (50 : 50 : 0.1) (isocratic elution). 
 
8.1.3 Optical Techniques 
 
All samples for optical analyses were contained in quartz cuvettes with a path length of 1 cm and a 
polished base. Measurements were recorded at 295 K unless otherwise stated. 
 
UV/Vis absorbance spectra were measured on a Perkin Elmer Lambda 900 UV/Vis/NIR spectrometer 
using FL Winlab software. Samples were measured relative to a reference of pure solvent contained in 
a matched cell. 
 
Emission spectra were measured on a ISA Joblin-Yvon Spex Fluorolog-3 luminescent spectrometer 
using DataMax v2.20 software. Excitation wavelengths were selected according the specific 
measurement. An integration time of 0.5 seconds, increment of 0.5 nm and excitation and emission 
slit widths of 2.5 and 1.5 nm, respectively, were used throughout.   
 
CD spectra were measured by Dr. Lorenzo Di Bari at the University of Pisa. 
 
CPL spectra were recorded on a custom modified Spex Fluoromax-2 spectrometer at the University of 
Glasgow, with the assistance of Dr. Bob Peacock. 
 
Lifetime measurements were carried out using a Perkin Elmer LS55 luminescence spectrometer. 
Lanthanide excited state lifetimes were measured by excitation of the sample by a short pulse of light 
followed by monitoring the integrated intensity of light emitted during a fixed gate time, tg, after a 
delay time of td. Excitation and emission wavelengths were selected based upon the Ln complex. 
Measurements were made for at least 30 delay times over a period of three or more lifetimes. A gate 
time of 0.1 ms was used and the excitation and emission slits were both set to 4 nm. The obtained 
decay curves were fitted to Equation 8.1, using Origin 6.0 software. 
 
 =  + 	
                                                           [8.1] 
 
where: I is the intensity at time t after the excitation pulse; A0 is the intensity after decay is completed; 
A1 is the pre-exponential factor and k is the rate constant for decay of the excited state. The excited 
state lifetime, τ, is the inverse of the rate constant, k. 
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The inner sphere hydration number (q) of Eu and Tb complexes were obtained by measuring the 
excited state lifetime in H2O and D2O, following D2O exchange. The q value was calculated using 
Equation 8.2 and 8.3 (see Beeby et al. for derivation).1 
 
 = 1.2	 −  − 0.25 − 0.075                                       [8.2] 
 
 = 5.0	 −  − 0.06 − 0.010                                       [8.3] 
 
where: qLn is the inner sphere hydration number; k is the inverse of the excited state lifetime, τ, and n 
is the number of proximal amide NH oscillators.  
 
Molar extinction coefficients were measured using a Perkin Elmer Lambda 900 UV/Vis/NIR 
spectrometer. For each sample, a bulk solution was made up by dissolving a known amount of solid 
(typically 5 mg to ± 0.05 mg accuracy) in a known amount of solvent (typically 10 mL to ± 0.1 µL 
accuracy). Five solutions of known concentration were then made up by dilution of the bulk solution, 
with absorbances ranging between 0.05 and 0.5. Molar extinction coefficients were calculated by 
plotting absorbance as a function of concentration according to Equation 8.4. 
 
 = !"#                                                                      [8.4] 
 
where: A is the absorbance at λmax; ε is the molar extinction coefficient; c is the concentration and l is 
the pathlength of the cell. 
 
Photoluminescence quantum yield measurements were carried out using a HORIBA Jobin-Yvon 
Fluorolog 3-22 Tau-3 fluorimeter with a Labsphere Optical Spectralon integrating sphere (diameter 
100 mm, reflectance > 99 % over 400 – 1500 nm range) using a method developed by Porrés et al.2 
Measurements were performed at 295 K using solutions with absorbances of 0.1 at λmax, contained in a 
cylindrical quartz cuvette (8 mm diameter) fitted with a Teflon stopper. Quantum yields were also 
measured by comparison with relevant, known standards (e.g. [Eu·L11] was used as a standard for 
[Eu·L12]). For the standards and each of the unknowns, five solutions with absorbances between 0.05 
and 0.15 were used. The quantum yield was calculated by plotting the integrated emission as a 
function of the absorbance for both the known and unknown species according to the Equation 8.5. 
 
$% = $& ∙ ()(* ∙
*
) ∙
+)
+* ∙
,*
,)                                                          [8.5] 
 
where: r and x refer to the reference standard and the unknown, respectively; A is the absorbance at 
λmax; E is the corrected integrated emission intensity; I is the corrected intensity of excitation light and 
η is the refractive index of the solution. 
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Triplet energy measurements were carried out using an Oxford Instruments optical cryostat with an 
ISA Joblin-Yvon Spex Fluorolog-3 luminescent spectrometer. Samples were dissolved in EPA (Et2O : 
isopentane : EtOH [2 : 5 : 5 v/v]) and cooled to 77 K. Triplet energies were calculated by measuring 
the highest energy phosphorescence emission band, which was attributed to the 0 – 0 transition from 
the triplet excited state to the ground state. 
 
Binding constants of selected anions and HSA with [Eu·L13] were calculated by luminescence 
titrations. Highly concentrated anion solutions were added so as to minimise increase in sample 
volume (typically 1 – 50 µL additions to 2500 µL [Eu·L13] solution). Each Eu emission spectrum was 
corrected for dilution. HSA was added as a solid. Apparent binding constants were calculated 
according to Equation 8.6, using Microsoft Excel non-linear iterative curve fitting software. 
 
-./ =
0123245 12632457 8
9 :-/∙;
1<<45 1<6<457 =-/∙;
1<<45 1<6<457 =

;1<<45 1<6<457 =
                        [8.6] 
 
where: [X] is the total concentration of anion in the solution; [Eu] is the total concentration of the 
complex; K is the binding constant; F is the ratio of selected integrals; F0 is the initial ratio and F1 is 
the final ratio.  
 
8.1.4 Cellular Studies and Microscopy 
 
Four cell lines were selected for cellular studies: CHO (Chinese Hamster Ovary), NIH 3T3 (mouse 
skin fibroblast), HeLa (human endothelial carcinoma cells) and PC3 (human prostate cancer cells). 
Cells were maintained in exponential growth as monolayers in appropriate media, which were 
supplemented with 10% foetal bovine serum (FBS) and 1% penicillin and streptomycin. Cells were 
incubated at 37 °C, 20% average humidity and 5% (v/v) CO2. 
 
Epifluorescence microscopy images were taken on a Zeiss Axiovert 200M epifluorescence 
microscope, equipped with an Axiocam CCD camera. Samples were excited using a 340 - 390 nm 
(90% transmission) bandpass filter. Eu and Tb emission were observed using a 570 nm long-pass 
filter (85% transmission) and a 490 nm long-pass (LP) filter (85% transmission), respectively.  
 
Cytotoxicity studies were carried out using the MTT assay with the NIH-3T3 cell line.3 
Approximately 1 x 104 cells in 100 µL DMEM were seeded into each well of a 96-well plate and 
allowed to attach overnight. Solutions of complexes were added to triplicate wells to give final 
concentrations over a 2-log range. After 24 h incubation, MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (final concentration 1.0 mM) was added to each well and the plate 
incubated for a further 4 h. The culture medium was removed, and DMSO (150 µL) was added. The 
plate was shaken for 20 sec and the absorbance measured immediately at 540 nm in a microplate 
reader against a blank of DMSO. IC50 values were determined as the complex concentration required 
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to reduce the absorbance to 50% of that in the untreated, control wells, and represent the mean value 
for data from at least three independent experiments. 
 
8.1.5 X-ray Studies 
 
X-ray diffraction structures were carried out by Dr. Horst Puschmann and Dr. Dmitry Yufit. Single 
crystal X-ray data for the complexes [Ln·L9] were collected at 120 K on a Bruker SMART-CCD 6000 
diffractometer (ω-scan, 0.3-0.5° / frame) equipped with an Oxford Cryostream open-flow nitrogen 
cryostat. The structures were solved by Patterson method and refined by full-matrix least squares on 
F2 for all data using SHELXTL4 and OLEX25 software. All non-disordered non-hydrogen atoms were 
refined with anisotropic displacement parameters. All hydrogen atoms were placed into calculated 
positions and refined in ‘riding’-mode. All structures contain a number of severely disordered solvent 
molecules. Their contribution to the scattering factors has been taken into account using the MASK 
procedure of OLEX2 software.   
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8.2 Synthetic Procedures 
 
 
3-(Dimethylaminomethylene)-4-oxo-6-methyl-2-pyrone, 16 
To a suspension of 4-hydroxy-6-methyl-2-pyrone (25 g, 0.2 mol) in p-dioxane (100 mL) was added 
N,N-dimethylformamide dimethyl acetal (44 g, 0.37 mol). The resulting solution was stirred at room 
temperature for 1 h to give a deep red solution containing a yellow precipitate. The mixture was left in 
the fridge overnight before the precipitate was collected by filtration to yield the title compound (25 g, 
69 %). A small sample was recrystallized from hot ethanol for characterisation. m.p. 145 - 147 °C 
(Lit.6 152 – 154 °C), δH (CDCl3) 8.22 (1H, s, H3), 5.64 (1H, s, H7), 3.45 (3H, s, H8), 3.36 (3H, s, H9), 
2.12 (3H, s, H1), m/z (HRMS+) 182.0821 [M + H]+ (C9H12NO3 requires 182.0817). 
 
 
4-Hydroxy-6-methylnicotinic acid, 26 
To a solution of 3-(Dimethylaminomethylene)-4-oxo-6-methyl-2-pyrone, 1 (6.5 g, 36 mmol) in 
distilled water (45 mL) was added 35 % ammonia solution (17.8 g, 15.7 mL, 0.37 mol) causing a 
yellow precipitate to form. After stirring at room temperature for 30 min, 40 % dimethylamine 
solution was added (4.05 g, 4.55 mL, 36 mmol). The resulting yellow solution was heated at 50 °C for 
30 mins before being cooled to room temperature. Upon acidification to pH 5 by addition of sulphuric 
acid a yellow precipitate formed. The mixture was stirred in an ice bath for 1 h before the precipitate 
was collected by filtration to yield the title compound (4.0 g, 72 %), m.p. 241 - 243 °C (Lit.6 267 – 
268 °C) , δH (D2O) 8.44 (1H, s, H6), 6.71 (1H, s, H3), 2.37 (3H, s, H1), δC (D2O) 176.5 (C7), 168.9 
(C4), 154.5 (C5), 143.0 (C6), 115.6 (C3), 114.2 (C2), 18.5 (C1), m/z (HRMS-) 152.0352 [M – H]- 
(C7H6NO3 requires 152.0353).  
 
 
4-Chloro-6-methylnicotinic acid, 3 
4-Hydroxy-6-methylnicotinic acid, 2 (6.49 g, 38 mmol) was stirred in neat phosphorus oxychloride 
(50 mL) at 100 °C for 14 h under argon. Excess phosphorus oxychloride was removed by distillation 
to leave a brown residue. Addition of water (50 mL) afforded a yellow solution containing a light 
brown precipitate which was collected by filtration to yield the title compound (3.65 g, 56%), m.p. 
215 - 217 °C, δH (D2O) 8.85 (1H, s, H6), 7.91 (1H, s, H3), 2.63 (3H, s, H1), δC (D2O) 165.3 (C7), 156.2 
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(C4), 152.9 (C5), 142.8 (C6), 130.2 (C3), 129.7 (C2), 18.9 (C1), m/z (HRMS-) 170.0014 [M – H]- 
(C7H635ClNO2 requires 170.0014). 
 
 
4-Phenoxy-6-methylnicotinic acid, 4 
A solution of sodium methoxide was prepared by dissolving sodium metal (1.38 g, 60 mmol) in dry 
methanol (30 mL). To this solution were added phenol (9.60 g, 100 mmol) and 4-chloro-6-
methylnicotinic acid, 3 (3.50 g, 20 mmol). The brown solution was stirred at 65 °C for 1 h under 
argon before the methanol was removed under reduced pressure. The resulting brown residue was 
stirred at 180 °C for 3 h under argon. The residue was allowed to cool to room temperature before 
being dissolved in water (20 mL). Excess phenol was removed by extraction with diethyl ether (3 × 
25 mL). Acidification of the aqueous layer by addition of acetic acid generated a white precipitate 
which was collected by filtration to yield the title compound (1.5 g, 30 %), m.p. 123-126 °C, δH 
(CDCl3) 8.41 (1H, s, H6), 7.37 (2H, t, J 8.0 Hz, H10), 7.22 (1H, t, J 8.0 Hz, H11), 7.04 (2H, d, J 8.0 Hz, 
H9), 6.61 (1H, s, H3), 2.28 (3H, s, H1), δC (CDCl3) 170.2 (C7), 163.7 (C4), 160.3 (C5), 154.4 (C6), 
149.7 ( C8), 130.2 (C3), 125.4 (C2), 123.2 (C9), 120.9 (C10), 110.5 (C11), 20.1 (C1), m/z (HRMS-) 
228.0665 [M – H]- (C13H10NO3 requires 228.0666).  
 
 
2-Methyl-3-azaxanthone, 5 
4-Phenoxy-6-methylnicotinic acid, 4 (820 mg, 3.6 mmol) and polyphosphoric acid (50 g) were heated 
to 120 °C for 14 h under argon. The resulting brown solution was cooled to room temperature and 
poured into ice water (250 mL). The pH of the yellow solution was adjusted to 7 by addition of KOH 
pellets. The aqueous solution was then extracted with CH2Cl2 (3 × 100 mL). The organic layers were 
combined, dried over MgSO4, filtered and the solvent was removed under reduced pressure to yield 
the title compound as a pale brown solid (600 mg, 79 %), m.p. 156 - 157 °C, δH (CDCl3) 9.32 (1H, s, 
H4), 8.24 (1H, d, J 8.4 Hz, H6), 7.69 (1H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.41 (1H, d, J 8.4 Hz, H9), 7.36 
(1H, dd, J 7.0 Hz, 8.4 Hz, H7), 7.13 (1H, s, H1), 2.64 (3H, s, CH3), δC (CDCl3) 176.3 (C5), 164.5 (C2), 
161.6 (C4’), 156.0 (C9’), 150.3 (C4), 135.6 (C8), 126.8 (C6), 124.9 (C7), 123.1 (C6’), 118.3 (C9), 115.8 
(C1’), 111.2 (C1), 25.2 (CH3), m/z (HRMS+) 212.0705 [M + H]+ (C13H10NO2 requires 212.0706). 
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3-(N-oxide)-azaxanthone, 6 
3-Azaxanthone (43 mg, 0.22 mmol) was dissolved in CHCl3 (25 mL) and meta-chloroperoxybenzoic 
acid (37 mg, 0.22 mmol) was added. The solution was stirred at 0 °C for 2 h and then, over a further 
10 h, allowed to warm to room temperature. The solvent was removed under reduced pressure and the 
yellow residue was dissolved in CH2Cl2 (20 mL). The solution was washed with sodium bicarbonate 
solution (3 × 20 mL) and the organic layer was dried over MgSO4, filtered and the solvent was 
removed under reduced pressure to give the title compound as a bright yellow solid (42 mg, 90 %), 
m.p. 225 - 228 °C, δH (CDCl3) 9.03 (1H, s, H4), 8.42 (1H, d, J 7.6 Hz, H2), 8.33 (1H, d, J 8.4 Hz, H6), 
7.84 (1H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.55 (1H, d, J 8.4 Hz, H9), 7.50 (1H, dd, J 7.0 Hz, 8.4 Hz, H7), 
7.47 (1H, d, J 7.6 Hz H1), δC (CDCl3) 172.6 (C5), 154.8 (C4’), 151.3 (C9’), 143.6 (C2), 135.6 (C4), 
135.2 (C8), 125.9 (C6), 124.6 (C7), 120.5 (C6’), 118.8 (C1’), 117.3 (C9), 115.4 (C1), m/z (HRMS+) 
214.0501 [M + H]+ (C12H8O3N1 requires 214.0499).  
 
 
2-Bromomethyl-3-azaxanthone, 7 
To a solution of 2-methyl-3-azaxanthone, 5 (1.48 g, 7.0 mmol) in carbon tetrachloride (50 mL) was 
added N-bromo-succinimde (1.87 g, 10.5 mmol) and dibenzoyl peroxide (40 mg, 0.17 mmol). The 
mixture was stirred and irradiated by a 100 W lamp for 14 h under argon. The reaction was monitored 
by 1H-NMR and stopped after 14 h. The solvent was removed under reduced pressure and the crude 
product was dissolved in CH2Cl2 (30 mL) and washed with dilute K2CO3 solution (30 mL) to remove 
excess succinimide. The organic layer was dried over MgSO4, filtered and the solvent removed under 
reduced pressure. Purification by column chromatography on silica (elution: toluene-CH2Cl2 1 : 1, 
MeOH 0 – 2 % using 0.1 % increments) yielded the title compound as a yellow solid (620 mg, 30 %), 
m.p. 177 - 179 °C, δH (CDCl3) 9.44 (1H, s, H4), 8.31 (1H, d, J 8.4 Hz, H6), 7.77 (1H, dd, J 7.0 Hz, 8.4 
Hz, H8), 7.53 (1H, s, H1), 7.52 (1H, d, J 8.4 Hz, H9), 7.44 (1H, dd, J 7.0 Hz, 8.4 Hz, H7), 4.63 (2H, s, 
CH2Br ), δC (CDCl3) 175.9 (C5), 162.1 (C2), 161.9 (C4’), 156.1 (C9’), 150.9 (C4), 135.9 (C8), 127.0 
(C6), 125.4 (C7), 123.2 (C6’), 118.4 (C9), 117.0 (C1’), 112.1 (C1), 33.0 (CH2Br), m/z (HRMS+) 
291.9785 [M + H]+ (C13H9 81BrNO2 requires 291.9791), Rf = 0.57 (silica, toluene-CH2Cl2 1 : 1 – 
MeOH 5 %). 
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1,4,7-Tris(tert-butoxycarbonyl)-10-[2-methyl-3-azaxanthone]-1,4,7,10-
tetraazacyclododecane, 8 
1,4,7-Tris(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (120 mg, 0.23 mmol), 2-
bromomethyl-3-azaxanthone, 7 (67 mg, 0.23 mmol) and K2CO3 (16 mg, 0.12 mmol) were stirred in 
dry CH3CN (3 mL) at 78 °C for 24 h under argon. The reaction was monitored by TLC to conform 
that all the brominated starting material had been consumed. The solvent was removed under reduced 
pressure and the resultant solid was dissolved in CH2Cl2 (25 mL) and extracted with water (3 × 25 
mL). The organic layer was dried over MgSO4, filtered and the solvent was removed under reduced 
pressure to give a yellow residue. Purification by column chromatography on silica (CH2Cl2 : 0 – 5 % 
MeOH) gave the title compound as a glassy yellow solid (145 mg, 87 %), δH (CDCl3) 9.39 (1H, s, H4), 
8.24 (1H, d, J 8.4 Hz, H6), 7.82 (1H, s, H1), 7.77 (1H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.48 (1H, d, J 8.4 Hz, 
H9), 7.41 (1H, dd, J 7.0 Hz, 8.4 Hz, H7), 4.76 (2H, s, Ha), 3.63 (2H, s, Hb), 3.49 (4H, s, Hf), 3.42 – 
2.86 (16H, m, cyclen Hs), 1.41 (9H, s, He), 1.38 (18H, s, Hi), δC (CDCl3) 176.2 (C5), 170.3 (Cc), 169.6 
(Cg), 161.7 (C2), 159.8 (C4’), 156.1 (C9’), 150.5 (C4), 136.2 (C8), 126.8 (C6), 125.4 (C7), 123.0 (C6’), 
118.6 (C9), 117.2 (C1’), 114.7 (C1), 82.4 (Ch), 82.0 (Cd), 56.7 (Cb), 56.5 (Cf) 53.7 (Ca) 52.0 – 48.0 
(cyclen Cs), 28.4 (Ce), 28.3 (Ci), m/z (HRMS+) 724.4281 [M + H]+ (C39H58N5O8 requires 724.4280); 
Rf = 0.24 (silica, CH2Cl2 : 5 %MeOH).  
 
 
1,7-Bis(tert-butoxycarbonyl)-4,10-bis[2-methyl-3-azaxanthone]-1,4,7,10-
tetraazacyclododecane, 9 
1,7-Bis(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (75 mg, 0.19 mmol), 2-bromomethyl-3-
azaxanthone, 7 (108 mg, 0.37 mmol) and K2CO3 (26 mg, 0.19 mmol) were stirred in dry CH3CN (3 
mL) at 78 °C for 48 h under argon. The reaction was monitored by TLC to conform that all the 
brominated starting material had been consumed. The solvent was removed under reduced pressure 
and the resultant solid was dissolved in CH2Cl2 (25 mL) and extracted with water (3 × 25 mL). The 
organic layer was dried over MgSO4, filtered and the solvent was removed under reduced pressure to 
give a yellow residue. Purification by column chromatography on silica (CH2Cl2 : 0 – 5 % MeOH) 
gave the title compound as a glassy yellow solid (61 mg, 40 %), δH (CDCl3) 9.42 (2H, s, H4), 8.30 
(2H, s, H1), 7.98 (2H, d, J 8.4 Hz, H6), 7.41 (2H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.10 (2H, dd, J 7.0 Hz, 8.4 
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Hz, H7), 6.62 (2H, d, J 8.4 Hz, H9), 3.94 (4H, s, Ha), 3.25 (4H, s, Hb), 3.00 – 2.80 (16H, m, cyclen Hs), 
1.40 (18H, s, He), δC (CDCl3) 176.3 (C5), 171.1 (Cc), 167.6 (C2), 162.0 (C4’), 155.4 (C9’), 150.1 (C4), 
135.2 (C8), 126.4 (C6), 124.6 (C7), 122.6 (C6’), 117.7 (C9), 116.3 (C1’), 111.1 (C1), 81.2 (Cd), 60.5 
(Cb), 56.9 (Ca), 55.0 – 52.0 (cyclen Cs), 28.4 (Ce), m/z (HRMS+) 819.4084 [M + H]+ (C46H55N6O8 
requires 819.4076); Rf = 0.17 (silica, CH2Cl2 : 5 %MeOH).  
 
 
10-(Ethoxycarbonyl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylic acid tri-tert-butyl 
ester, 10 
1,4,7,10-Tetraazacyclododecane-1,4,7-tricarboxylic acid tri-tert-butyl ester (270 mg, 0.572 mmol), 
ethyl bromoacetate (97 mg, 0.572 mml) and K2CO3 (40 mg, 0.3 mmol) were stirred in dry CH3CN (5 
mL) at 78 °C for 36 h under argon. The solvent was removed under reduced pressure and the resultant 
solid was dissolved in CH2Cl2 (25 mL) and extracted with water (3 × 25 mL). The organic layer was 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The residue was 
purified by column chromatography on silica (elution: CH2Cl2, MeOH 0 – 1 % using 0.1 % 
increments) to give the title compound as a yellow oil (244 mg, 77%), δH (CDCl3) 4.14 (2H, q, J 7.2 
Hz, Hf), 3.47 (2H, s, Hd), 3.6 – 2.8 (16H, m, cyclen Hs), 1.45 (27H, s, Ha), 1.25 (3H, t, J 7.2 Hz, Hg), 
δC (CDCl3) 170.6 (Ce), 155.8 (Cc), 79.5 (Cb), 60.3 (Cd), 55.0 (Cf), 53.0 – 47.0 (cyclen Cs), 28.7 (Ca), 
14.3 (Cg), m/z (HRMS+) 559.3698 [M + H]+ (C27H51N4O8 requires 559.3701), Rf = 0.6 (silica, CH2Cl2 
– MeOH 5 %). 
 
 
1-(Ethoxycarbonyl)-1,4,7,10-tetraazacyclododecane, 11 
10-(Ethoxycarbonyl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylic acid tri-tert-butyl ester, 10 
(219 mg, 0.39 mmol) was dissolved in CH2Cl2 (2 mL) and CF3CO2H (2 mL) was added. The mixture 
was stirred at 20 °C for 12 h under argon. The solvent and excess CF3CO2H were removed under 
reduced pressure and the residue was dissolved in dry CH2Cl2 (20 mL). The solution was dried over 
K2CO3 before being filtered and the solvent removed under reduced pressure to yield the title product 
as a yellow oil (98 mg, 98 %), δH (CDCl3) 4.21 (2H, q, J 7.2 Hz, Hf), 3.54 (2H, s, Hd), 3.3 – 2.8 (16H, 
m, cyclen Hs), 1.28 (3H, t, J 7.2 Hz, Hg), δC (CDCl3) 174.4 (Ce), 62.8 (Cd), 55.3 (Cf), 50.0 – 43.0 
(cyclen Cs), 14.4 (Cg), m/z (HRMS+) 259. 2129 [M + H]+ (C12H27N4O2 requires 259.2129). 
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1-(Ethoxycarbonyl)-4,7,10-tris[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, 
12 
1-(Ethoxycarbonyl)-1,4,7,10-tetraazacyclododecane, 11 (16 mg, 0.06 mmol), 2-bromomethyl-3-
azaxanthone, 7 (70 mg, 0.24 mmol) and K2CO3 (25 mg, 0.18 mmol) were dissolved in dry MeCN (3 
mL). The solution was stirred at 78 °C for 48 h under argon. The solvent was removed under reduced 
pressure and the yellow residue was dissolved in CH2Cl2 (20 mL). After washing with water (3 × 20 
mL), the organic layer was dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. Purification by column chromatography on alumina (elution: CH2Cl2, MeOH 0 – 2 % using 
0.1 % increments) gave the title product as a yellow oil (43 mg, 80 %), δH (CDCl3) 9.38 (2H, s, H4), 
9.34 (1H, s, H4*), 8.19 (1H, d, J 8.4 Hz, H6*), 8.13 (2H, d, J 8.4 Hz, H6), 7.75 (2H, dd, J 7.0 Hz, 8.4 
Hz, H8), 7.68 (1H, dd, J 7.0 Hz, 8.4 Hz, H8*), 7.64 (2H, s, H1), 7.58 (1H, s, H1*), 7.52 (2H, d, J 8.4 Hz, 
H9), 7.46 (1H, d, J 8.4 Hz, H9*), 7.35 (2H, dd, J 7.0 Hz, 8.4 Hz, H7), 7.27 (1H, dd, J 7.0 Hz, 8.4 Hz, 
H7*), 4.09 (2H, q, J 7.2 Hz, Hf), 3.91 (4H, s, Ha), 3.76 (2H, s, Ha*), 3.44 (2H, s, Hd), 3.1 – 2.8 (16H, m, 
cyclen Hs), 1.19 (3H, t, J 7.2 Hz, Hg), δC (CDCl3) 176.1 (C5), 171.4 (Ce), 170.6 (C2), 161.8 (C4’), 
156.1 (C9’), 150.3 (C4), 135.6 (C8), 126.8 (C6), 125.0 (C7), 122.8 (C6’), 118.5 (C9), 116.7 (C1’), 112.2 
(C1), 60.7 (Ca), 55.8 (Cd), 55.0 (Cf), 54.0 – 48.0 (cyclen Cs), 14.5 (Cg), m/z (HRMS+) 908.3377 [M + 
Na]+ (C51H47O8N7Na1 requires 908.3378), Rf = 0.40 (alumina, CH2Cl2 – MeOH 5 %). 
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1,4,7,10-Tetra[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, L4 
1,4,7,10-tetraazacyclododecane (18 mg, 0.10 mmol), 2-bromomethyl-3-azaxanthone, 7 (114 mg, 0.40 
mmol) and K2CO3 (46 mg, 0.34 mmol) were dissolved in dry MeCN (4 mL). The solution was stirred 
at 78 °C for 72 h under argon. The solvent was removed under reduced pressure and the yellow 
residue was dissolved in CH2Cl2 (20 mL). After washing with water (3 × 20 mL), the organic layer 
was dried over MgSO4, filtered and the solvent was removed under reduced pressure. Purification by 
column chromatography on alumina (elution: CH2Cl2, MeOH 0 – 1 % using 0.1 % increments) gave 
the title product as a yellow oil (60 mg, 60 %), δH (CDCl3) 9.37 (4H, s, H4), 8.10 (4H, d, J 8.4 Hz, 
H6), 7.76 (4H, s, H1), 7.53 (4H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.25 (4H, dd, J 7.0 Hz, 8.4 Hz, H7), 7.08 
(4H, d, J 8.4 Hz, H9), 3.87 (8H, s, Ha), 3.00 – 2.80 (16H, m, cyclen Hs), m/z (HRMS+) 1009.3678 [M 
+ H]+ (C60H49O8N8 requires 1009.3668), Rf = 0.56 (alumina, CH2Cl2 – MeOH 5 %). 
 
 
Mono-aqua europium(III) complex of 1,4,7-tris(acetic acid)-10-[2-methyl-3-azaxanthone]-
1,4,7,10-tetraazacyclododecane, [Eu·L1(H2O)] 
1,4,7-Tris(tert-butoxycarbonyl)-10-[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, 8 (55 
mg, 0.10 mmol) was dissolved in CH2Cl2 (2 mL) and CF3CO2H (2 mL) was added. The mixture was 
stirred at 22 °C, under argon, for 12 h. Excess CF3CO2H and CH2Cl2 were removed under reduced 
pressure and the yellow residue was dissolved in CH2Cl2, which was again removed under reduced 
pressure to ensure the removal of all CF3CO2H. Deprotection of the OtBu groups was confirmed by 
1H-NMR, before the residue was dissolved in H2O – CH3OH (4 : 1 v/v, 5 mL). Addition of Eu(OAc)3 
(48 mg, 0.12 mmol) was followed by adjustment of the pH to 5.8, by the addition of aq. ammonia 
solution, and the mixture was stirred at 60 °C for 48 h. After allowing the solution to cool to room 
temperature, the pH was increased to 10 by the addition of aq. ammonia solution. The solution was 
stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was removed by syringe filtration. 
Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by lyophilisation of the solvent, 
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gave the title compound as a yellow solid (52 mg, 74 %), m/z (HRMS+) 704.1374 [M + H]+ 
(C27H31O8N5151Eu requires 704.1366), =OH 2τ 0.60 ms, =OD2τ  1.98 ms, =Φ
em
OH2  6.9 %, tR (Method 
A) = 8.6 min. 
 
 
Mono-aqua terbium(III) complex of 1,4,7-tris(acetic acid)-10-[2-methyl-3-azaxanthone]-
1,4,7,10-tetraazacyclododecane, [Tb·L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu·L1] was followed using 1,4,7-
tris(tert-butoxycarbonyl)-10-[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, 8 (55 mg, 
0.10 mmol) and Tb(OAc)3 (43 mg, 0.011 mmol). The title compound was isolated as a yellow solid 
(49 mg, 72 %), m/z (HRMS+) 712.1426 [M + H]+ (C27H31O8N5159Tb requires 712.1421), =OH 2τ 1.64 
ms, =OD2τ  2.86 ms, =Φ
em
OH2  39 %, tR (Method B) = 21.0 min. 
 
 
Mono-aqua europium(III) chloride complex of 1,7-bis(acetic acid)-4,10-bis[2-methyl-3-
azaxanthone]-1,4,7,10-tetraazacyclododecane, [Eu·L2(H2O)]Cl 
1,7-Bis(tert-butoxycarbonyl)-4,10-bis[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, 9 
(22 mg, 0.031 mmol) was dissolved in CH2Cl2 (2 mL) and CF3CO2H (2 mL) was added. The mixture 
was stirred at 22 °C, under argon, for 12 h. Excess CF3CO2H and CH2Cl2 were removed under 
reduced pressure and the yellow residue was redissolved in CH2Cl2. The solvent was again removed 
under reduced pressure to ensure the removal of all CF3CO2H. Deprotection of the OtBu groups was 
confirmed by 1H-NMR before the residue was dissolved in H2O – CH3OH (4 : 1 v/v, 4 mL). Addition 
of Eu(OAc)3 (15 mg, 0.037 mmol) was followed by adjustment of the pH to 5.8, by the addition of aq. 
ammonia solution, and the mixture was stirred at 60 °C for 48 h. After allowing the solution to cool to 
room temperature, the pH was raised to 10 by the addition of aq. ammonia solution. The solution was 
stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was removed by syringe filtration. 
Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by lyophilisation of the solvent, 
gave the product as the acetate salt. The solid was converted to the chloride salt by stirring in H2O for 
1 h with Dowex 1 × 8 200-400 mesh Cl-, which had been washed successively with 1 M HCl and 
water. The Dowex was removed by filtration and the solvent lyophilised to yield the title compound as 
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a yellow solid (18 mg, 66 %), m/z (HRMS+) 855.1798 [M - Cl]+ (C38H36O8N6151Eu requires 855.1788), 
=OH 2τ 0.56 ms, =OD2τ  1.54 ms, =Φ
em
OH2  10 %,  tR (Method A) = 8.9 min. 
 
 
Mono-aqua terbium(III) chloride complex of 1,7-bis(acetic acid)-4,10-bis[2-methyl-3-
azaxanthone]-1,4,7,10-tetraazacyclododecane, [Tb·L2(H2O)]Cl. 
An analogous procedure to that described for the synthesis of [Eu·L2]Cl was followed using 1,7-
bis(tert-butoxycarbonyl)-4,10-bis[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, 9 (22 
mg, 0.031 mmol) and Tb(OAc)3 (15 mg, 0.037 mmol). The title compound was isolated as a yellow 
solid (19 mg, 69 %), m/z (HRMS+) 863.1853 [M]+ (C38H36O8N6159Tb requires 863.1843), =OH 2τ 1.52 
ms, =OD2τ  2.75 ms, =Φ
em
OH2  34 %, tR (MethodA) = 8.9 min. 
 
 
Mono-aqua europium (III) chloride complex of 1-(acetic acid)-4,7,10-tris[2-methyl-3-
azaxanthone]-1,4,7,10-tetraazacyclododecane, [Eu·L3(H2O)]Cl2 
1-(Ethoxycarbonyl)-4,7,10-tris[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, 12 (20 mg,  
0.023 mmol) was dissolved in 2 mM HCl (4 mL) and the solution was stirred at 100 °C for 2 h. 
Removal of the OEt protecting group was confirmed by 1H-NMR. The pH was raised to 5.0 using 
NaOH before EuCl3 (9 mg, 0.028 mmol) was added and the mixture was stirred at 60 °C for 40 h. 
After allowing the solution to cool to room temperature, the pH was raised to 10 by the addition of aq. 
NaOH solution. The solution was stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which 
was removed by syringe filtration. Adjustment of the pH to 5.8 by the addition of HCl, followed by 
lyophilisation of the solvent, gave the title compound as a white solid, (3 mg, 23 %), m/z (HRMS+) 
503.6147 [M]2+ ([C49H42O8N7151Eu]2+ requires 503.6141), =OH 2τ 0.50 ms, =OD2τ  1.61 ms, =Φ
em
OH2  
1.0 %,tR (Method A) = 8.7 min. 
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Europium (III) chloride complex of 1,4,7,10-tetra[2-methyl-3-azaxanthone]-1,4,7,10-
tetraazacyclododecane, [Eu·L4]Cl3 
1,4,7,10-Tetra[2-methyl-3-azaxanthone]-1,4,7,10-tetraazacyclododecane, L4 (12 mg, 0.012 mmol) and 
Eu(OTf)3 (6.5 mg, 0.011 mmol) were dissolved in CH3CN (3 mL) at 78 °C, under argon, for 40 h. The 
solvent was removed under reduced pressure and the yellow residue was redissolved in CH3CN (0.1 
mL). This solution was dropped into Et2O (10 mL) causing immediate precipitation of the product as 
the triflate salt. The pale yellow solid was converted to the chloride salt by stirring in H2O for 1 h with 
Dowex 1 × 8 200-400 mesh Cl-, which had been washed with 1 M HCl and neutralised with water. 
The Dowex resin was removed by filtration and the solvent lyophilised to yield the title compound as 
a yellow solid (2 mg, 15 %), m/z (HRMS+) 588.1404 [M – 3Cl + OH]2+ (C60H49O9N8151Eu requires 
588.1405), =OH 2τ 0.71 ms, =OD2τ  1.20 ms,
 
=ΦemOH2  5.4 %, tR (Method A) = 9.5 min. 
 
 
4-Thiophenoxy-6-methylnicotinic acid, 13 
4-Chloro-6-methylnicotinic acid, 3 (4.6 g, 27 mmol) and thiophenol (3.6 g, 33 mmol) were dissolved 
in dimethylformamide (50 mL). CuBr (250 mg, 1.7 mmol) and K2CO3 (5.4 g, 40 mmol) were added 
and the mixture was stirred at 150 °C for 16 h under argon. After allowing the brown solution to cool 
to 23 °C, H2O (150 mL) was added and excess thiophenol was extracted with Et2O (3 × 50 mL). The 
pH was reduced to 4.6 by the addition of AcOH. Upon stirring at 0 °C a pale brown precipitate 
formed which was collected by filtration to give the title compound (1.8 g, 27 %); m.p. 142 – 144 ºC, 
δH (CDCl3) 8.82 (1H, s, H6), 7.58 (5H, m, H8, 9, 10, 11), 6.52 (1H, s, H3), 2.29 (3H, s, CH3); δC (CDCl3) 
166.8 (C7), 160.0 (C4), 156.9 (C5), 154.7 (C6), 149.6 ( C8), 135.7 (C3), 130.0 (C2), 129.2 (C9), 119.5 
(C10), 109.2 (C11), 22.0 (C1), m/z (HRMS–) 244.0436 [M – H]– (C13H10O2NS requires 244.0438). 
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2-Methyl-3-azathiaxanthone, 14 
4-Thiophenoxy-6-methylnicotinic acid, 13 (1.80 g, 7.35 mmol) and polyphosphoric acid (50 g) were 
heated to 120 °C for 16 h under argon. The resulting brown solution was cooled to room temperature 
and poured into ice (250 g). The pH of the yellow solution was adjusted to 7 by addition of KOH 
pellets. The aqueous solution was then extracted with CHCl3 (3 × 100 mL). The organic layers were 
combined, dried over MgSO4, filtered and the solvent was removed under reduced pressure to give a 
brown solid, which was purified by column chromatography on silica (CH2Cl2 : 0 – 5 % MeOH in 0.5 
% increments) to yield the title compound as a pale yellow solid (1.00 g, 60 %), m.p. 174 - 176 °C, δH 
(CDCl3) 9.54 (1H, s, H4), 8.56 (1H, d, J 8.4 Hz, H6), 7.61 (1H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.52 (1H, d, 
J 8.4 Hz, H9), 7.49 (1H, dd, J 7.0 Hz, 8.4 Hz, H7), 7.25 (1H, s, H1), 2.62 (3H, s, CH3); δC (CDCl3) 
179.2 (C5), 160.3 (C2), 151.8 (C4), 146.8 (C4’), 136.0 (C9’), 132.4 (C8), 130.5 (C6’), 129.7 (C6), 127.2 
(C7), 126.2 (C9), 121.9 (C1’), 118.5 (C1), 24.6 (CH3), m/z (HRMS+) 228.0402 [M + H]+ (C13H10ONS 
requires 228.0405); Rf = 0.46 (silica, CH2Cl2 : 2.5 % MeOH). 
 
 
2-Bromomethyl-3-azathiaxanthone, 15 
To a solution of 2-methyl-3-azathiaxanthone, 14 (500 mg, 2.20 mmol) in carbon tetrachloride (40 mL) 
was added N-bromo-succinimde (376 mg, 2.20 mmol) and dibenzoyl peroxide (20 mg, 0.08 mmol). 
The mixture was stirred and irradiated by a 100 W lamp under argon. The reaction was monitored by 
1H-NMR and stopped after 14 h. The solvent was removed under reduced pressure and the crude 
product was dissolved in CH2Cl2 (30 mL) and washed with dilute K2CO3 solution (30 mL) to remove 
excess succinimide. The organic layer was dried over MgSO4, filtered and the solvent removed under 
reduced pressure. Purification by column chromatography on silica (petroleum ether (60 – 80 °C bp) : 
0 – 10 % EtOAc in 1 % increments) yielded the title compound as a yellow solid (160 mg, 24 %), 
m.p. 189 - 192 °C, δH (CDCl3) 9.59 (1H, s, H4), 8.58 (1H, d, J 8.4 Hz, H6), 7.66 (1H, dd, J 7.0 Hz, 8.4 
Hz, H8), 7.57 (1H, s, H1), 7.55 (1H, d, J 8.4 Hz, H9), 7.54 (1H, dd, J 7.0 Hz, 8.4 Hz, H7), 4.60 (2H, s, 
CH2Br); δC (CDCl3) 178.8 (C5), 157.8 (C2), 152.1 (C4), 147.7 (C4’), 135.7 (C9’), 133.2 (C8), 129.7 (C6), 
128.4 (C6’), 127.4 (C7), 126.3 (C9), 123.1 (C1’), 119.2 (C1), 32.6 (CH2Br), m/z (HRMS+) 305.9513 [M 
+ H]+ (C13H9ONS79Br requires 305.9508); Rf = 0.58 (silica, CH2Cl2 : MeOH 2 %). 
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1,7-Bis(tert-butoxycarbonyl)-4,10-bis[2-methyl-3-azathiaxanthone]-1,4,7,10-
tetraazacyclododecane, 16 
1,7-Bis(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (49 mg, 0.12 mmol), 2-bromomethyl-3-
azathiaxanthone, 15 (106 mg, 0.35 mmol) and K2CO3 (35 mg, 0.34 mmol) were stirred in dry CH3CN 
(4 mL) at 78 °C for 18 h under argon. The reaction was monitored by TLC to conform that all the 
brominated starting material had been consumed. The solvent was removed under reduced pressure 
and the resultant solid was dissolved in CH2Cl2 (25 mL) and extracted with water (3 × 25 mL). The 
organic layer was dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The yellow residue was purified by column chromatography on silica (CH2Cl2 : 5 % MeOH) to give 
the title compound as a glassy yellow solid (70 mg, 68 %); δH (CDCl3) 9.42 (2H, s, H4), 8.55 (2H, d, J 
8.4 Hz, H6), 7.67 (2H, dd, J 7.0 Hz, 8.4 Hz, H8), 7.60 (2H, dd, J 7.0 Hz, 8.4 Hz, H7), 7.51 (2H, d, J 8.4 
Hz, H9), 7.48 (2H, s, H1), 3.51 (4H, br s, Ha), 3.25 (4H, s, Hb), 3.00 – 2.40 (16H, br m, cyclen Hs), 
1.38 (18H, s, He), δC (CDCl3) 178.8 (C5), 172.5 (Cc) 160.1 (C2), 151.8 (C4), 147.4 (C4’), 135.6 (C9’), 
133.2 (C8), 130.2 (C6’), 129.7 (C6), 127.3 (C7), 126.4 (C9), 123.1 (C1’), 119.3 (C1), 82.7 (Cd), 58.6 
(Cb), 57.2 (Ca), 51.0 – 49.0 (cyclen Cs), 28.1 (Ce), m/z (HRMS+) 851.3629 [M + H]+ (C46H55O6N6S2 
requires 851.3624); Rf = 0.58 (silica, CH2Cl2 : MeOH 2 %). 
 
 
Mono-aqua europium(III) chloride complex of 1,7-bis(acetic acid)-4,10-bis[2-methyl-3-
azathiaxanthone]-1,4,7,10-tetraazacyclododecane, [Eu·L2b(H2O)]Cl 
1,7-Bis(tert-butoxycarbonyl)-4,10-bis[2-methyl-3-azathiaxanthone]-1,4,7,10-tetraazacyclododecane, 
16 (41 mg, 0.048 mmol) was dissolved in CH2Cl2 (2 mL) and CF3CO2H (2 mL) was added. The 
mixture was stirred at 22 °C under argon for 16 h. Excess CF3CO2H and CH2Cl2 were removed under 
reduced pressure and the yellow residue was redissolved in CH2Cl2. The solvent was again removed 
under reduced pressure to ensure the removal of all CF3CO2H. Deprotection of the OtBu groups was 
confirmed by 1H-NMR before the residue was dissolved in H2O – CH3OH (4 : 1 v/v, 4 mL). Addition 
of Eu(OAc)3 (23 mg, 0.058 mmol) was followed by adjustment of the pH to 5.8, by the addition of aq. 
ammonia solution, and the mixture was stirred at 60 °C for 18 h. After allowing the solution to cool to 
room temperature, the pH was raised to 10 by the addition of aq. ammonia solution. The solution was 
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stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was removed by syringe filtration. 
Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by lyophilisation of the solvent, 
gave the product as the acetate salt. The solid was converted to the chloride salt by stirring in H2O for 
1 h with Dowex 1 × 8 200-400 mesh Cl-, which had been washed with 1 M HCl and neutralised with 
water. The Dowex resin was removed by filtration and the solvent lyophilised to yield the title 
compound as a yellow solid (20 mg, 47 %), m/z (HRMS+) 887.1329 [M - Cl]+ (C38H36O6N6S2151Eu 
requires 887.1336); =OH 2τ 0.56 ms, =OD2τ  1.57 ms,
 
=ΦemOH2  5.1 %  tR (Method C) = 6.4 min. 
 
 
2-(Diethylphosphoryl)-6-methylpyridine, 18 
To tetrahydrofuran (20 mL) stirred at -78 °C under argon was added 2.5 M n-butyl lithium in hexane 
(2.9 mL, 7.3 mmol) and 2-bromo-6-methylpyridine, 17 (1.75 g, 7.3 mmol). After 1 h, 
chlorodiethylphosphine (0.90 g, 7.3 mmol) was added and the mixture was left to stir overnight at 23 
°C. 31P-NMR was used to confirm coupling of the lithiated pyridine with chlorodiethylphosphine (31P 
resonance at -11.15 ppm). Oxidation to the phosphorus(V) species was achieved by addition of 34 % 
H2O2 in water (0.22 mL, 7.3 mmol). After stirring at 23 °C for 30 min, the solvent was removed by 
reduced pressure to give a yellow residue which was purified by column chromatography on silica 
(CH2Cl2 : 0 – 5 % MeOH in 0.2 % increments) yielding the title product as a colourless oil (1.0 g, 70 
%); δH (CDCl3) 7.77 (1H, dd, 3JH-H 6.0 Hz 3JH-P 6.0 Hz, H5), 7.57 (1H, td, 3JH-H 6.0 Hz 4JH-P 3.6 Hz, 
H4), 7.10 (1H, d, 3JH-H 6 Hz, H3), 2.45 (3H, s, H1), 1.91 (4H, qd, 3JH-H 7.7 Hz, 3JH-P 3.5 Hz, H7), 0.97 
(6H, t, 3JH-H 7.7 Hz, H8); δC (CDCl3) 159.0 (C2), 154.9 (d, 1JC-P 119 Hz, C6), 135.8 (C4), 125.1 (C5), 
124.7 (C3), 24.5 (C1), 20.7 (d, 1JC-P 96 Hz, C7), 5.9 (d, 2JC-P 6 Hz, C8); δP (CDCl3) 49.1; m/z (HRMS+) 
198.1039 [M + H]+ (C10H17ONP requires 198.1042) ; Rf = 0.23 (silica, CH2Cl2 : 5 % MeOH). 
 
 
2-(Bromomethyl)-6-(diethylphosphoryl)pyridine, 19 
To a solution of 2-(diethylphosphoryl)-6-methylpyridine, 18 (210 mg, 1.06 mmol) in carbon 
tetrachloride (20 mL) was added N-bromo-succinimde (192 mg, 1.06 mmol) and dibenzoyl peroxide 
(10 mg, 0.4 mmol). The mixture was stirred and irradiated by a 100 W lamp under an argon 
atmosphere. The reaction was monitored by 1H-NMR and stopped after 16 h. The solvent was 
removed under reduced pressure and the crude product was dissolved in CH2Cl2 (20 mL) and washed 
with dilute K2CO3 solution (20 mL) to remove excess succinimide. The organic layer was dried over 
MgSO4, filtered and the solvent removed under reduced pressure. Purification by column 
chromatography on silica (toluene-CH2Cl2 1 : 1, MeOH 0 – 2 % using 0.1 % increments) yielded the 
title compound as a yellow oil (102 mg, 35 %); δH (CDCl3) 7.96 (1H, dd, 3JH-H 6.0 Hz 3JH-P 6.0 Hz, 
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H5), 7.87 (1H, td, 3JH-H 6.0 Hz 4JH-P 3.6 Hz, H4), 7.55 (1H, d, 3JH-H 6 Hz, H3), 4.56 (2H, s, H1), 2.08 
(4H, qd, 3JH-H 7.7 Hz, 3JH-P 3.5 Hz, H7), 1.15 (6H, t, 3JH-H 7.7 Hz, H8); δC (CDCl3) 157.8 (C2), 154.4 (d, 
1JC-P 120 Hz, C6), 135.3 (C4), 125.0 (C5), 124.5 (C3), 33.4 (C1), 20.7 (d, 1JC-P 96 Hz, C7), 5.9 (d, 2JC-P 6 
Hz, C8); δP (CDCl3) 48.7; m/z (HRMS+) 276.0150 [M + H]+ (C10H16ONP79Br requires 276.0153);Rf = 
0.44 (silica, CH2Cl2 : 5 % MeOH). 
 
 
1,4,7-Tris(tert-butoxycarbonyl)-10-[2-(diethylphosphoryl)-6-methylpyridine]-1,4,7,10-
tetraazacyclododecane, 20 
1,4,7-Tris(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (45 mg, 0.09 mmol), 2-
(bromomethyl)-6-(diethylphosphoryl)pyridine, 19 (24 mg, 0.09 mmol) and K2CO3 (12 mg, 0.09 
mmol) were stirred in dry CH3CN (3 mL) at 78 °C for 24 h under argon. The reaction was monitored 
by TLC to confirm that all the brominated starting material had been consumed. The solvent was 
removed under reduced pressure and the resultant residue was dissolved in CH2Cl2 (20 mL) and 
washed with water (3 × 20 mL). The organic layer was dried over MgSO4, filtered and the solvent 
was removed under reduced pressure. Purification by column chromatography on silica (CH2Cl2 : 0 – 
5 % MeOH in 0.2 % increments) gave the title compound as a glassy colourless solid (33 mg, 52 %); 
δH (CDCl3) 7.88 (1H, m, H5), 7.87 (1H, m, H4), 7.62 (1H, m, H3), 3.20 – 2.85 (8H, br s, H1/a/a’), 2.75 – 
2.10 (16H, br m, cyclen Hs), 2.02 (4H, qd, 3JH-H 7.7 Hz, 3JH-P 3.5 Hz, H7), 1.42 (9H, s, Hd), 1.37 (18H, 
s, Hd’), 1.07 (6H, t, 3JH-H 7.7 Hz, H8); δC (CDCl3) 172.3 (Cb), 172.0 (Cb’), 158.8 (C2), 154.8 (d, 1JC-P 
113 Hz, C6), 137.3 (C4), 126.0 (C5), 125.8 (C3), 82.1 (Cc/c’), 59.5 (Ca), 56.1 (Ca’), 56.0 (C1), 52.0 – 
48.0 (cyclen Cs), 28.1 (Cd), 28.0 (Cd’), 21.0 (d, 1JC-P 69 Hz, C7), 5.5 (d, 2JC-P 6 Hz, C8); δP (CDCl3) 
44.2; m/z (HRMS+) 710.4605 [M + H]+ (C36H65O7N5P requires 710.4616) ; Rf = 0.15 (silica, CH2Cl2 : 
5 % MeOH). 
 
 
Europium(III) complex of 1,4,7-tris(acetic acid)-10-[2-(diethylphosphoryl)-6-
methylpyridine]-1,4,7,10-tetraazacyclododecane, [Eu·L5] 
1,4,7-Tris(tert-butoxycarbonyl)-10-[2-(diethylphosphoryl)-6-methylpyridine]-1,4,7,10-
tetraazacyclododecane, 20 (33 mg, 0.046 mmol) was dissolved in CH2Cl2 (2 mL) and CF3CO2H (1 
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mL) was added. The mixture was stirred at 22 °C, under argon, for 16 h. Excess CF3CO2H and 
CH2Cl2 were removed under reduced pressure and the yellow residue was dissolved in CH2Cl2, which 
was again removed by reduced pressure to ensure the removal of all CF3CO2H. Deprotection of the 
OtBu groups was confirmed by 1H-NMR, before the residue was dissolved in H2O – CH3OH (2 : 1 
v/v, 3 mL). Addition of Eu(OAc)3 (19 mg, 0.046 mmol) was followed by adjustment of the pH to 5.8, 
by the addition of aq. ammonia solution, and the mixture was stirred at 60 °C for 24 h. After allowing 
the solution to cool to room temperature, the pH was raised to 10 by the addition of aq. ammonia 
solution. The solution was stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was 
removed by syringe filtration. Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by 
lyophilisation of the solvent, gave the title compound as a white solid (24 mg, 74 %); m/z (HRMS+) 
690.1711 [M + H]+ (C31H38O7N5P151Eu requires 690.1707); =OH 2τ 1.21 ms, =OD2τ  1.85 ms,
 
=ΦemOH2  7.5 %; tR (Method B) = 10.3 min. 
 
 
Ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate, 21 
2-Bromo-6-methylpyridine, 17 (3.0 g, 17.4 mmol), ethyl phenylphosphinate (3.56 g, 20.9 mmol) and 
triethylamine (10 mL, 71 mmol) were added to dry degassed (freeze-thaw cycle) toluene (30 mL). 
Tetrakis(triphenylphosphine)palladium(0) (320 mg, 0.27 mmol) was added and the mixture was 
degassed three times before being stirred at 125 °C for 16 h under argon. The solution was diluted 
with CH2Cl2 (50 mL), washed with HCl (1M, 2 × 60 mL) and water (3 × 60 mL), dried over K2CO3, 
filtered and the solvent removed under reduced pressure to give a dark residue. Purification by 
column chromatography on silica (CH2Cl2 : 0.5 % MeOH) gave the title compound as a colourless oil 
(3.1 g, 66 %); δH (CDCl3) 8.01 (2H, dd, 3JH-H 8.0 Hz 3JH-P 12.0 Hz, Ho), 7.91 (1H, dd, 3JH-H 7.0 Hz 3JH-
P 14.0 Hz, H5), 7.67 (1H, td, 3JH-H 7.0 Hz 4JH-P 3.0 Hz, H4), 7.54 (1H, t, 3JH-H 8.0 Hz, Hp), 7.48 (2H, td, 
3JH-H 8.0 Hz 4JH-P 4.0 Hz, Hm), 7.23 (1H, d, 3JH-H 7.0 Hz, H3), 4.15 (2H, qd, 3JH-H 7.0 Hz 3JH-P 4.5 Hz, 
H7), 2.60 (3H, s, H1), 1.38 (3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 159.8 (d, 3JC-P 20 Hz, C2), 154.0 (d, 
1JC-P 167 Hz, C6), 135.8 (d, 3JC-P 10 Hz, C4), 132.6 (d, 2JC-P 12 Hz, Co), 132.5 (d, 4JC-P 4 Hz, Cp), 130.6 
(d, 1JC-P 136 Hz, Ci), 128.5 (d, 3JC-P 9 Hz, Cm), 125.8 (d, 4JC-P 4 Hz, C3), 125.6 (d, 2JC-P 22 Hz, C5), 61.9 
(d, 2JC-P 6 Hz, C7), 24.9 (C1), 16.7 (C8); δP (CDCl3) 26.8; m/z (HRMS+) 262.0999 [M + H]+ 
(C14H17O2NP requires 262.0997); Rf = 0.37 (silica, CH2Cl2 : 5 % MeOH). 
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Ethyl [6-(bromomethyl)pyridin-2-yl](phenyl)phosphinate, 22 
To a solution of ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate, 21 (400 mg, 1.53 mmol) in carbon 
tetrachloride (25 mL) was added N-bromo-succinimde (327 mg, 1.84 mmol) and dibenzoyl peroxide 
(20 mg, 0.8 mmol). The mixture was stirred and irradiated by a 100 W lamp under an argon 
atmosphere. The reaction was monitored by 1H-NMR and stopped after 16 h. The solvent was 
removed under reduced pressure and the crude product was dissolved in CH2Cl2 (20 mL) and washed 
with dilute K2CO3 solution (20 mL) to remove excess succinimide. The organic layer was dried over 
MgSO4, filtered and the solvent removed under reduced pressure. Purification by column 
chromatography on silica (CH2Cl2, MeOH 0 – 1 % using 0.05 % increments) yielded the title 
compound as a colourless oil (198 mg, 38 %); δH (CDCl3) 8.01 (1H, dd, 3JH-H 7.0 Hz 3JH-P 14.0 Hz, 
H5), 8.00 (2H, dd, 3JH-H 8.0 Hz 3JH-P 12.0 Hz, Ho), 7.79 (1H, td, 3JH-H 7.0 Hz 4JH-P 3.0 Hz, H4), 7.53 
(1H, t, 3JH-H 8.0 Hz, Hp), 7.52 (1H, d, 3JH-H 7.0 Hz, H3), 7.46 (2H, td, 3JH-H 8.0 Hz 4JH-P 4.0 Hz, Hm), 
4.57 (2H, s, H1), 4.13 (2H, qd, 3JH-H 7.0 Hz 3JH-P 4.5 Hz, H7), 1.37 (3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 
158.0 (d, 3JC-P 20 Hz, C2), 154.7 (d, 1JC-P 167 Hz, C6), 137.3 (d, 3JC-P 10 Hz, C4), 132.7 (d, 2JC-P 12 Hz, 
Co), 132.6 (d, 4JC-P 4 Hz, Cp), 130.2 (d, 1JC-P 136 Hz, Ci), 128.5 (d, 3JC-P 9 Hz, Cm), 127.5 (d, 2JC-P 22 
Hz, C5), 125.8 (d, 4JC-P 4 Hz, C3), 62.1 (d, 2JC-P 6 Hz, C7), 33.6 (C1), 16.7 (C8); δP (CDCl3) 26.0; m/z 
(HRMS+) 340.0122 [M(79Br) + H]+ (C14H16O2NP79Br requires 340.0102), 342.0098 [M(81Br) + H]+ 
(C14H16O2NP81Br requires 342.0088); Rf = 0.57 (silica, CH2Cl2 : 5 % MeOH). 
 
 
1,4,7-Tris(tert-butoxycarbonyl)-10-[ethyl(6-methylpyridin-2-yl)(phenyl)phosphinate]-
1,4,7,10-tetraazacyclododecane, 23 
1,4,7-Tris(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (162 mg, 0.30 mmol), ethyl [6-
(bromomethyl)pyridin-2-yl](phenyl)phosphinate, 22 (107 mg, 0.30 mmol) and K2CO3 (42 mg, 0.30 
mmol) were stirred in dry CH3CN (5 mL) at 80 °C for 16 h under argon. The reaction was monitored 
by TLC to confirm that all the brominated starting material had been consumed. The solvent was 
removed under reduced pressure and the resultant residue was dissolved in CH2Cl2 (30 mL) and 
washed with water (3 × 30 mL). The organic layer was dried over MgSO4, filtered and the solvent 
was removed under reduced pressure. Purification by column chromatography on silica (CH2Cl2 : 0 – 
5 % MeOH in 0.4 % increments) gave the title compound as a glassy yellow solid (175 mg, 75 %); δH 
(CDCl3) 7.88 (1H, dd, 3JH-H 7.0 Hz 3JH-P 14.0 Hz, H5), 7.87 (2H, dd, 3JH-H 8.0 Hz 3JH-P 12.0 Hz, Ho), 
7.78 (1H, td, 3JH-H 7.0 Hz 4JH-P 3.0 Hz, H4), 7.68 (1H, d, 3JH-H 7.0 Hz, H3), 7.54 (1H, t, 3JH-H 8.0 Hz, 
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Hp), 7.43 (2H, td, 3JH-H 8.0 Hz 4JH-P 4.0 Hz, Hm), 4.08 (2H, dqd, 2JH-H -16 Hz 3JH-H 7.0 Hz 3JH-P 4.5 Hz, 
H7), 3.74 (2H, br s, H1), 3.07 (6H, br s, Ha/a’), 2.98 – 2.06 (16H, br m, cyclen Hs), 1.40 (9H, s, Hd), 
1.38 (18H, s, Hd’), 1.35 (3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 172.4 (Cb), 172.1 (Cb’),  159.1 (d, 3JC-P 20 
Hz, C2), 153.5 (d, 1JC-P 167 Hz, C6), 137.8 (d, 3JC-P 10 Hz, C4), 132.9 (d, 4JC-P 4 Hz, Cp), 132.2 (d, 2JC-P 
12 Hz, Co), 130.1 (d, 1JC-P 136 Hz, Ci), 128.8 (d, 3JC-P 9 Hz, Cm), 126.8 (d, 4JC-P 4 Hz, C3), 126.5 (d, 
2JC-P 22 Hz, C5), 82.3 (Cc/c’), 62.1 (d, 2JC-P 6 Hz, C7), 59.3 (Ca), 56.4 (Ca’), 56.0 (C1), 51.2 – 49.3 
(cyclen Cs), 28.2 (Cd), 28.1 (Cd’), 16.6 (C8); δP (CDCl3) 26.8; m/z (HRMS+) 774.4588 [M + H]+ 
(C40H65O8N5P requires 774.4571); Rf = 0.20 (silica, CH2Cl2 : 5 % MeOH). 
 
 
Europium(III) complex of 1,4,7-tris(acetic acid)-10-[ ethyl (6-methylpyridin-2-
yl)(phenyl)phosphinate]-1,4,7,10-tetraazacyclododecane, Na[Eu·L6] 
1,4,7-Tris(tert-butoxycarbonyl)-10-[ethyl(6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7,10-
tetraazacyclododecane, 23 (55 mg, 0.070 mmol) was dissolved in HCl (6M, 10 mL) and the solution 
was stirred at 100 °C for 16 h. The solvent was lyophilised to give a yellow solid. Hydrolysis of the 
OtBu and OEt groups was confirmed by 1H- and 31P-NMR (δP (D2O) 13.0). The solid was dissolved in 
H2O and the pH of the solution adjusted to 5.8 using aq. ammonia solution. Eu(OAc)3 (29 mg, 0.072 
mmol) was added and the solution was stirred at 50 °C for 16 h. After allowing the solution to cool to 
room temperature, the pH was raised to 10 by the addition of aq. ammonia solution. The solution was 
stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was removed by syringe filtration. 
Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by lyophilisation of the solvent, 
gave the title compound as a white solid (40 mg, 80 %); m/z (HRMS-) 724.1166 [M]– 
(C26H32O8N5P151Eu requires 724.1187); =OH 2τ 1.27 ms, =OD2τ  1.92 ms,
 
=ΦemOH2  16 %; tR (Method 
B) = 12.8 min. 
 
 
Ethyl 6-(bromomethyl)pyridine-2-carboxylate, 25 
To a solution of ethyl 6-methylpridine-2-carboxylate, 24 (2.0 g, 12.1 mmol) in carbon tetrachloride 
(40 mL) was added N-bromo-succinimde (2.2 g, 12.1 mmol) and dibenzoyl peroxide (20 mg, 0.8 
mmol). The mixture was stirred and irradiated by a 100 W lamp under an argon atmosphere. The 
reaction was monitored by 1H-NMR and stopped after 16 h. The solvent was removed under reduced 
pressure and the crude product was dissolved in CH2Cl2 (40 mL) and washed with K2CO3 solution 
Experimental                                                                                                                            Chapter 8 
 
164 
 
(1.0 M, 40 mL) to remove excess succinimide. The organic layer was dried over MgSO4, filtered and 
the solvent removed under reduced pressure. Purification by column chromatography on silica 
(CH2Cl2 isocratic elution) yielded the title compound as a colourless oil (1.03 g, 35 %); δH (CDCl3) 
7.97 (1H, d, 8.0 Hz, H5), 7.79 (1H, t, 8.0 Hz, H4), 7.61 (1H, d, 8.0 Hz, H3), 4.58 (2H, s, H1), 4.43 (2H, 
q, 6.8 Hz, H8), 1.37 (3H, t, 6.8 Hz, H9); δC (CDCl3) 164.8 (C7), 157.3 (C2), 147.8 (C6), 138.0 (C4), 
126.9 (C3), 124.3 (C5), 62.1 (C8), 33.2 (C1), 14.3 (C9); m/z (HRMS+) 243.9977 [M(79Br) + H]+ 
(C9H11O2N79Br requires 243.9973), 245.9957 [M(81Br) + H]+ (C9H11O2N81Br requires 245.9953); Rf = 
0.51 (silica, CH2Cl2 : 2 % MeOH). 
 
 
1,4,7-Tris(tert-butoxycarbonyl)-10-[ethyl 6-(bromomethyl)pyridine-2-carboxylate]-
1,4,7,10-tetraazacyclododecane, 26 
1,4,7-Tris(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (500 mg, 0.97 mmol), ethyl 6-
(bromomethyl)pyridine-2-carboxylate, 25 (237 mg, 0.97 mmol) and K2CO3 (130 mg, 0.97 mmol) 
were stirred in dry CH3CN (10 mL) at 80 °C for 20 h under argon. The reaction was monitored by 
TLC to confirm that all the brominated starting material had been consumed. The solvent was 
removed under reduced pressure and the resultant residue was dissolved in CH2Cl2 (50 mL) and 
washed with water (3 × 50 mL). The organic layer was dried over MgSO4, filtered and the solvent 
was removed under reduced pressure. Purification by column chromatography on silica (CH2Cl2 : 0 – 
5 % MeOH in 0.5 % increments) gave the title compound as a glassy yellow solid (526 mg, 57 %); δH 
(CDCl3) 7.98 (1H, d, 8.0 Hz, H5), 7.91 (1H, t, 8.0 Hz, H4), 7.55 (1H, d, 8.0 Hz, H3), 4.33 (2H, q, 6.8 
Hz, H8), 3.60 – 3.20 (8H, br s, H1/a/a’), 3.20 – 2.20 (16H, br m, cyclen Hs), 1.46 (9H, s, Hd), 1.44 (18H, 
s, Hd’), 1.36 (3H, t, 6.8 Hz, H9); δC (CDCl3) 172.0 (Cb/b’), 164.7 (C7), 159.2 (C2), 146.6 (C6), 138.3 
(C4), 127.1 (C3), 123.4 (C5), 82.0 (Cc/c’), 61.7 (C8), 59.0 (Ca), 56.1 (Ca’), 55.7 (C1), 52.0 – 49.5 (cyclen 
Cs), 28.1 (Cd), 28.0 (Cd’), 14.3 (C9); m/z (HRMS+) 678.4459 [M + H]+ (C35H60O8N5 requires 
678.4442); Rf = 0.48 (silica, CH2Cl2 : 15 % MeOH). 
 
Europium(III) complex of 1,4,7-tris(acetic acid)-10-[ethyl 6-(bromomethyl)pyridine-2-
carboxylate]-1,4,7,10-tetraazacyclododecane, Na[Eu·L7] 
1,4,7-Tris(tert-butoxycarbonyl)-10-[ethyl 6-(bromomethyl)pyridine-2-carboxylate]-1,4,7,10-
tetraazacyclododecane (100 mg, 0.15 mmol) was dissolved in CH2Cl2 (2 mL) and CF3CO2H (2 mL) 
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was added. The mixture was stirred at 22 °C, under argon, for 16 h. Excess CF3CO2H and CH2Cl2 
were removed under reduced pressure and the yellow residue was dissolved in CH2Cl2, which was 
again removed by reduced pressure to ensure the removal of all CF3CO2H. Deprotection of the OtBu 
groups was confirmed by 1H-NMR. The residue was dissolved in aq. NaOD solution (2 mL, pH 11) 
and the mixture stirred for 30 min at 22 °C. 1H-NMR was used to confirm that the hydrolysis of the 
ethyl ester had gone to completion. Adjustment of the pH to 5.8 by the addition of HCl was followed 
by addition of EuCl3 (52 mg, 0.165 mmol) and the solution was stirred at 60 °C for 40 h. After 
allowing the solution to cool to room temperature, the pH was raised to 10 by the addition of aq. 
NaOH solution (1.0 M). The solution was stirred for 1 h causing excess Eu3+ to precipitate as 
Eu(OH)3, which was removed by syringe filtration. Adjustment of the pH to 5.8 by the addition of 
HCl, followed by lyophilisation of the solvent, gave the title compound as a white solid (70 mg, 74 
%); m/z (HRMS–) 628.1079 [M]– (C21H27O8N5151Eu requires 628.1058); =OH 2τ 1.14 ms, =OD2τ  1.85 
ms,
 
=ΦemOH2  12 %, tR (Method B) = 4.2 min. 
 
 
1,4,7-Tri-tert-butyl-10-[ethyl-(6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7,10-
tetraazacyclododecane-1,4,7-tricarboxylate, 27 
1,4,7-Tris(carboxylic acid tert-butyl ester)-1,4,7,10-tetraazacyclododecane (169 mg, 0.36 mmol), 
ethyl [6-(bromomethyl)pyridin-2-yl](phenyl)phosphinate 22 (123 mg, 0.36 mmol) and K2CO3 (49 mg, 
0.36 mmol) were stirred in dry CH3CN (6 mL) at 80 °C for 16 h under argon. The reaction was 
monitored by TLC to confirm that all the brominated starting material had been consumed. The 
solvent was removed under reduced pressure and the resultant residue was dissolved in CH2Cl2 (40 
mL) and washed with water (3 × 40 mL). The organic layer was dried over MgSO4, filtered and the 
solvent was removed under reduced pressure. Purification by column chromatography on silica 
(CH2Cl2 : 0 – 3 % MeOH in 0.1 % increments) gave the title compound as a white foam solid (156 
mg, 67 %); δH (CDCl3) 7.97 (1H, dd, 3JH-H 7.0 Hz 3JH-P 14.0 Hz, H5), 7.94 (2H, dd, 3JH-H 8.0 Hz 3JH-P 
12.0 Hz, Ho), 7.71 (1H, td, 3JH-H 7.0 Hz 4JH-P 3.0 Hz, H4), 7.51 (1H, t, 3JH-H 8.0 Hz, Hp), 7.44 (2H, td, 
3JH-H 8.0 Hz 4JH-P 4.0 Hz, Hm), 7.35 (1H, d, 3JH-H 7.0 Hz, H3), 4.10 (2H, qd, 3JH-H 7.0 Hz 3JH-P 4.5 Hz, 
H7), 3.92 (2H, br s, H1), 3.60 – 2.40 (16H, br m, cyclen Hs), 1.46 (9H, s, Hc), 1.41 (18H, s, Hc’), 1.34 
(3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 172.4 (Ca), 172.1 (Ca’),  159.3 (d, 3JC-P 20 Hz, C2), 155.4 (d, 1JC-P 
167 Hz, C6), 136.3 (d, 3JC-P 10 Hz, C4), 132.7 (d, 4JC-P 4 Hz, Cp), 132.6 (d, 2JC-P 12 Hz, Co), 130.3 (d, 
1JC-P 136 Hz, Ci), 128.5 (d, 3JC-P 9 Hz, Cm), 128.4 (d, 4JC-P 4 Hz, C3), 126.6 (d, 2JC-P 22 Hz, C5), 79.6 
(Cb/b’), 61.8 (d, 2JC-P 6 Hz, C7), 56.2 (C1), 52.1 – 46.3 (cyclen Cs), 28.7 (Cc), 28.5 (Cc’), 16.8 (C8); δP 
(CDCl3) 26.0; m/z (HRMS+) 732.4102 [M + H]+ (C37H59O8N5P requires 732.4101); Rf = 0.40 (silica, 
CH2Cl2 : 5 % MeOH). 
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1-[Ethyl-(6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7,10-tetraazacyclododecane, 28 
1,4,7-Tri-tert-butyl-10-[ethyl(6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7,10-
tetraazacyclododecane-1,4,7-tricarboxylate, 27 (91 mg, 0.14 mmol) was dissolved in CH2Cl2 (2 mL). 
CF3CO2H (2 mL) was added and the solution was stirred at 23 °C for 16 h under argon. The solvent 
and excess CF3CO2H were removed under reduced pressure and the yellow residue was redissolved in 
CH2Cl2 (2 mL). The solvent was again removed under reduced pressure. This process was repeated 3 
times to ensure the removal of all CF3CO2H. No further purification was required and the title product 
was isolated as a yellow glass (59 mg, 98 %); δH (CDCl3) 7.77 (1H, td, 3JH-H 7.0 Hz 4JH-P 3.0 Hz, H4), 
7.67 (1H, dd, 3JH-H 7.0 Hz 3JH-P 14.0 Hz, H5), 7.65 (2H, dd, 3JH-H 8.0 Hz 3JH-P 12.0 Hz, Ho), 7.56 (1H, t, 
3JH-H 8.0 Hz, Hp), 7.47 (2H, td, 3JH-H 8.0 Hz 4JH-P 4.0 Hz, Hm), 7.31 (1H, d, 3JH-H 7.0 Hz, H3), 4.13 (2H, 
qd, 3JH-H 7.0 Hz 3JH-P 4.5 Hz, H7), 3.94 (2H, d, 2JH-H 36 Hz, H1), 3.60 – 2.80 (16H, br m, cyclen Hs), 
1.36 (3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 158.7 (d, 3JC-P 20 Hz, C2), 153.4 (d, 1JC-P 167 Hz, C6), 137.9 
(d, 3JC-P 10 Hz, C4), 133.5 (d, 4JC-P 4 Hz, Cp), 131.5 (d, 2JC-P 12 Hz, Co), 129.3 (d, 3JC-P 9 Hz, Cm), 129.1 
(d, 1JC-P 136 Hz, Ci), 127.1 (d, 2JC-P 22 Hz, C5), 126.3 (d, 4JC-P 4 Hz, C3), 62.9 (d, 2JC-P 6 Hz, C7), 57.0 
(C1), 51.0 – 49.0 (cyclen Cs), 16.4 (C8); δP (CDCl3) 28.9; m/z (HRMS+) 432.2544 [M + H]+ 
(C22H35O2N5P requires 432.2528). 
 
 
Ethyl-phenyl((6-[(4,7,10-tri([ethoxy(methyl)phosphoryl]methyl)-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-2-yl))phosphinate, 29 
1-[Ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7,10-tetraazacyclododecane, 28 (40 mg, 
0.093 mmol) was dissolved in tetrahydrofuran (20 mL) in a flask fitted with a drying tube containing 
molecular sieves. The solution was heated under reflux for 2 h under argon until a steady flow of 
solvent through the molecular sieves was established. Paraformaldehyde (12 mg, 0.40 mmol) and 
diethyl methylphosphonite (57 mg, 0.4 mmol) were added and the mixture was stirred at reflux under 
argon for a further 18 h. The solution was allowed to cool and excess paraformaldehyde was removed 
by filtration. The solvent was removed under reduced pressure to give a brown residue which was 
purified by column chromatography on alumina (CH2Cl2 : 0 – 3 % MeOH in 0.1 % increments) to 
give the title compound as a yellow oil (40 mg, 55 %); δH (CDCl3) 7.96 (1H, dd, 3JH-H 7.0 Hz 3JH-P 
14.0 Hz, H5), 7.95 (2H, dd, 3JH-H 8.0 Hz 3JH-P 12.0 Hz, Ho), 7.73 (1H, td, 3JH-H 7.0 Hz 4JH-P 3.0 Hz, H4), 
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7.60 (1H, d, 3JH-H 7.0 Hz, H3), 7.51 (1H, t, 3JH-H 8.0 Hz, Hp), 7.44 (2H, td, 3JH-H 8.0 Hz 4JH-P 4.0 Hz, 
Hm), 4.11 (2H, qd, 3JH-H 7.0 Hz 3JH-P 4.5 Hz, H7), 4.01 (6H, qd, 3JH-H 7.0 Hz 3JH-P 5.6 Hz, Hc), 3.12 – 
2.86 (8H, br s, H1/a), 2.84 – 2.42 (16H, br m, cyclen Hs), 1.49 (9H, d, 2JH-P 36 Hz, Hb), 1.34 (3H, t, 3JH-
H 7.0 Hz, H8), 1.26 (9H, t, 7.0 Hz, Hd); δC (CDCl3) 155.5 (d, 3JC-P 20 Hz, C2), 150.5 (d, 1JC-P 167 Hz, 
C6), 136.3 (d, 3JC-P 10 Hz, C4), 132.7 (d, 4JC-P 4 Hz, Cp), 132.5 (d, 2JC-P 12 Hz, Co), 130.5 (d, 1JC-P 136 
Hz, Ci), 128.5 (d, 3JC-P 9 Hz, Cm), 126.6 (d, 2JC-P 22 Hz, C5), 125.4 (d, 4JC-P 4 Hz, C3), 61.6 (d, 2JC-P 6 
Hz, C7), 60.2 (d, 2JC-P 6 Hz, Cc), 55.1 (C1), 55.0 – 52.0 (cyclen Cs), 16.7 (Cd), 16.5 (C8), 13.6 (d, 1JC-P 
94 Hz); δP (CDCl3) 53.7 53.5 53.3 (P-Me), 26.8 (P-Ph); m/z (HRMS+) 792.3532 [M + H]+ 
(C34H62O8N5P4 requires 792.3549); Rf = 0.33 (alumina, CH2Cl2 : 5 % MeOH). 
 
 
Europium(III) complex of ethyl phenyl((6-[(4,7,10-tri([ethoxy(methyl)phosphoryl]-methyl)-
1,4,7,10-tetraazacyclododecan-1-yl)methyl]pyridin-2-yl))phosphinate, Na[Eu·L8] 
Ethyl-phenyl((6-[(4,7,10-tri([ethoxy(methyl)phosphoryl]methyl)-1,4,7,10-tetraazacyclododecan-1-
yl)methyl]pyridin-2-yl))phosphinate, 29 (18 mg, 0.023 mmol) was dissolved in HCl (6M, 5 mL) and 
the solution was stirred at 100 °C for 16 h. The solvent was lyophilised to give a yellow solid. 
Hydrolysis of the OEt groups was confirmed by 1H- and 31P-NMR. The solid was dissolved in H2O 
and the pH of the solution adjusted to 5.8 using aq. ammonia solution. Eu(OAc)3 (9.2 mg, 0.025 
mmol) was added and the solution was stirred at 50 °C for 16 h. After allowing the solution to cool to 
room temperature, the pH was raised to 10 by the addition of aq. ammonia solution. The solution was 
stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was removed by syringe filtration. 
Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by lyophilisation of the solvent, 
gave the title compound as a white solid (16 mg, 88 %); m/z (HRMS-) 826.1129 [M]– 
(C26H41O8N5P4151Eu requires 826.1104); =OH 2τ 0.95 ms, =OD2τ  1.25 ms,
 
=ΦemOH2  18 %; tR (Method 
C) = 11.5 min. 
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1,4,7-Tri[ethyl-(6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 
1,4,7-Triazacyclononane (14 mg, 0.11 mmol), ethyl [6-(bromomethyl)pyridin-2-
yl](phenyl)phosphinate, 22 (130 mg, 0.38 mmol) and K2CO3 (51 mg, 0.38 mmol) were stirred in dry 
CH3CN (5 mL) at 80 °C for 20 h under argon. The reaction was monitored by TLC to confirm that all 
the brominated starting material had been consumed. The solvent was removed under reduced 
pressure and the resultant residue was dissolved in CH2Cl2 (30 mL) and washed with water (3 × 30 
mL). The organic layer was dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. Purification by column chromatography on alumina (CH2Cl2 : 0 – 2 % MeOH in 0.05 % 
increments) gave the title compound as a glassy yellow solid (60 mg, 62 %); δH (CDCl3) 7.96 (3H, dd, 
3JH-H 7.0 Hz 3JH-P 14.0 Hz, H5), 7.95 (6H, dd, 3JH-H 8.0 Hz 3JH-P 12.0 Hz, Ho), 7.74 (3H, td, 3JH-H 7.0 Hz 
4JH-P 3.0 Hz, H4), 7.54 (3H, d, 3JH-H 7.0 Hz, H3), 7.47 (3H, t, 3JH-H 8.0 Hz, Hp), 7.39 (6H, td, 3JH-H 8.0 
Hz 4JH-P 4.0 Hz, Hm), 4.11 (6H, qd, 3JH-H 7.0 Hz 3JH-P 4.5 Hz, H7), 3.83 (6H, br s, H1), 2.74 (12H, br s, 
ring Hs), 1.34 (9H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 161.7 (d, 3JC-P 20 Hz, C2), 153.9 (d, 1JC-P 167 Hz, 
C6), 136.4 (d, 3JC-P 10 Hz, C4), 132.6 (d, 4JC-P 4 Hz, Cp), 132.5 (d, 2JC-P 12 Hz, Co), 130.5 (d, 1JC-P 136 
Hz, Ci), 128.4 (d, 3JC-P 9 Hz, Cm), 126.6 (d, 2JC-P 22 Hz, C5), 125.6 (d, 4JC-P 4 Hz, C3), 64.1 (C1), 61.8 
(d, 2JC-P 6 Hz, C7), 55.7 (ring Cs), 16.7 (C8); δP (CDCl3) 26.7; m/z (HRMS+) 907.3661 [M + H]+ 
(C48H58O6N6P3 requires 907.3631); Rf = 0.56 (alumina, CH2Cl2 : 5 % MeOH). 
 
 
Europium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Eu·L9] 
1,4,7-Tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (38 mg, 
0.042 mmol) was dissolved in HCl (6M, 8 mL) and the solution was stirred at 100 °C for 16 h. The 
solvent was lyophilised to give a yellow solid, 3. Hydrolysis of the OEt groups was confirmed by 1H- 
and 31P-NMR (δP (CDCl3) 16.0). The solid was dissolved in H2O – CH3OH (1 : 1 v/v, 6 mL) and the 
pH of the solution adjusted to 5.8 using aq. NaOH solution. Eu(OAc)3 (18 mg, 0.046 mmol) was 
added and the solution was stirred at 50 °C for 18 h. After allowing the solution to cool to room 
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temperature, the pH was raised to 10 by the addition of aq. ammonia solution. The solution was 
stirred for 1 h causing excess Eu3+ to precipitate as Eu(OH)3, which was removed by syringe filtration. 
Adjustment of the pH to 5.8 by the addition of CH3CO2H, followed by lyophilisation of the solvent, 
gave a solid, which was purified by column chromatography (silica, CH2Cl2: 20 % CH3OH: 1 % NH3) 
to give the title compound as a white solid (32 mg, 82 %); m/z (HRMS+) 971.1675 [M + H]+ 
(C42H43O6N6P3151Eu requires 971.1656); δP (CD3OD) +16.6; =OH 2τ 1.36 ms, =OD2τ  1.54 ms,
 
=ΦemOH2  9.0 %, tR (Method C) = 6.8 min. Single crystals of [Eu·L
9] suitable for X-ray diffraction 
studies were grown by dissolving 10 mg of complex in CH3OH (1 mL). Addition of H2O (0.5 mL) led 
to crystal formation over 16 h. CCDC Ref. 836099. 
 
Cerium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Ce·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Ce(OAc)3 (7.0 mg, 0.018 mmol) to give the title compound  as a white solid (12.2 mg, 77 
%); m/z (ESI-MS+) 960.3 [M (140Ce) + H]+; δP (CD3OD) +27.8; tR (Method C) = 6.8 min. 
 
Praseodymium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-
1,4,7-triazacyclononane, [Pr·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Pr(OAc)3 (7.0 mg, 0.018 mmol) to give the title compound  as a white solid (13.3 mg, 84 
%); m/z (ESI-MS+) 961.3 [M (141Pr) + H]+; δP (CD3OD) +31.3; tR (Method C) = 6.8 min. 
 
Neodymium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-
1,4,7-triazacyclononane, [Nd·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Nd(OAc)3 (7.1 mg, 0.018 mmol) to give the title compound  as a white solid (12.7 mg, 80 
%); m/z (ESI-MS+) 964.2 [M (144Nd) + H]+; δP (CD3OD) +21.0; tR (Method C) = 6.8 min, CCDC Ref. 
836097. 
 
Samarium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Sm·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Sm(OAc)3 (7.2 mg, 0.018 mmol) to give the title compound  as a white solid (12.5 mg, 78 
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%); m/z (ESI-MS+) 972.2 [M (152Sm) + H]+; δP (CD3OD) +31.4; tR (Method C) = 6.8 min, CCDC Ref. 
836098. 
 
Gadolinium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-
1,4,7-triazacyclononane, [Gd·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Gd(OAc)3 (7.3 mg, 0.018 mmol) to give the title compound  as a white solid (13.0 mg, 81 
%); m/z (ESI-MS+) 976.2 [M (156Gd) + H]+; tR (Method C) = 6.8 min. 
 
Terbium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Tb·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Tb(OAc)3 (7.3 mg, 0.018 mmol) to give the title compound  as a white solid (12.6 mg, 78 
%); m/z (ESI-MS+) 979.2 [M (159Tb) + H]+;  δP (CD3OD) -35.7; =OH 2τ 2.13 ms, =OD2τ  2.64 ms, 
=ΦemOH2  60 %, tR (Method C) = 6.8 min. 
 
Dysprosium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-
1,4,7-triazacyclononane, [Dy·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Dy(OAc)3 (7.4 mg, 0.018 mmol) to give the title compound  as a white solid (13.0 mg, 80 
%); m/z (ESI-MS+) 984.2 [M (164Dy) + H]+; δP (CD3OD) -13.9; tR (Method C) = 6.8 min. 
 
Holmium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Ho·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Ho(OAc)3 (7.4 mg, 0.018 mmol) to give the title compound  as a white solid (12.7 mg, 78 
%); m/z (ESI-MS+) 985.3 [M (165Ho) + H]+; δP (CD3OD) -24.6; tR (Method C) = 6.8 min, CCDC Ref. 
836100. 
 
Erbium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Er·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
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mmol) and Er(OAc)3 (7.5 mg, 0.018 mmol) to give the title compound  as a white solid (14.3 mg, 88 
%); m/z (ESI-MS+) 988.2 [M (168Er) + H]+; δP (CD3OD) -10.5; tR (Method C) = 6.8 min. 
 
Thulium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Tm·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Tm(OAc)3 (7.5 mg, 0.018 mmol) to give the title compound  as a white solid (12.9 mg, 79 
%); m/z (ESI-MS+) 989.3 [M (169Tm) + H]+; δP (CD3OD) +8.4; tR (Method C) = 6.8 min, CCDC Ref. 
836101. 
 
Ytterbium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Yb·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Yb(OAc)3 (7.6 mg, 0.018 mmol) to give the title compound  as a white solid (13.6 mg, 83 
%); m/z (ESI-MS+) 994.2 [M (174Yb) + H]+; δP (CD3OD) +17.7; tR (Method C) = 6.8 min. 
 
Yttrium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-
triazacyclononane, [Y·L9] 
An analogous procedure to that described for the synthesis of [Eu·L9] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(phenyl)phosphinate]-1,4,7-triazacyclononane, 30 (15 mg, 0.017 
mmol) and Y(OAc)3 (6.4 mg, 0.018 mmol) to give the title compound  as a white solid (13.3 mg, 86 
%); m/z (ESI-MS+) 908.2 [M (89Y) + H]+; δP (CD3OD) +23.9; tR (Method C) = 6.8 min, CCDC Ref. 
836102. 
 
 
Ethyl methylphosphinate, 31 
Neat diethyl methylphosphonite (2 g, 14.7 mmol) was stirred at 0°C and H2O (264 µL, 14.7 mmol) 
was added. The mixture was allowed to reach 22 °C over 1 h and stirred for a further 16 h. 1H- and 
31P-NMR was used to confirm formation of the title compound, which was used in situ without further 
purification. The reaction mixture also contains one equivalent of ethanol as a by-product (100 % 
conversion by 1H-NMR); δH (CDCl3) 7.22 (1H, dq, 1JH-P 536 2JH-H 2.1 Hz, H1), 4.11 (2H, dqd, 2JH-H 36 
Hz 3JH-H 7.0 Hz 3JH-P 4.0 Hz, H2), 1.54 (3H, dd, 2JH-P 15.1 Hz 3JH-H 2.1 Hz, H4), 1.23 (3H, 3JH-H 7.0 Hz, 
H3); δP (CDCl3) +34.5; δC (CDCl3) 62.3 (d, 2JC-P 7 Hz, C2), 16.1 (C3), 14.9 (d, 1JC-P 95 Hz, C4); m/z 
(HRMS+) 109.0414 [M + H]+ (C3H10O2P requires 109.0418). 
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Ethyl (6-methylpyridin-2-yl)(methyl)phosphinate, 32 
To neat ethyl methylphospinate, 31 (1.59 g, 14.7 mmol), containing one equivalent of ethanol, dry 
degassed (freeze-thaw cycle) toluene (20 mL), 2-bromo-6-methylpyridine, 17 (2.1 g, 12.3 mmol) and 
triethylamine (6 mL, 43 mmol) were added. Argon was bubbled through the solution for 1 h and 
tetrakis(triphenylphosphine)palladium(0) (320 mg, 0.27 mmol) was added and the mixture was stirred 
at 125 °C for 16 h under argon. The resulting solution was decanted from the white ammonium salt 
precipitate and the solvent removed under reduced pressure. Purification of the yellow oil by column 
chromatography on silica (silica, CH2Cl2 : CH3OH 0 – 1.6 % in 0.1 % increments) gave the title 
compound as a colourless oil (700 mg, 29 %); δH (CDCl3) 7.75 (1H, dd, 3JH-H 7.0 Hz 3JH-P 10 Hz, H5), 
7.59 (1H, td, 3JH-H 7.0 Hz 4JH-P 4.8 Hz, H4), 7.16 (1H, d, 3JH-H 7.0 Hz, H3), 3.86 (2H, dqd, 2JH-H 80 Hz 
3JH-H 7.0 Hz 3JH-P 4.5 Hz, H7), 2.50 (3H, s, H1), 1.66 (3H, d, 2JH-P 15 Hz, H9), 1.61 (3H, t, 3JH-H 7.0 Hz, 
H8); δC (CDCl3) 159.4 (d, 3JC-P 20 Hz, C2), 153.7 (d, 1JC-P 158 Hz, C6), 136.0 (d, 3JC-P 10 Hz, C4), 125.6 
(d, 2JC-P 3 Hz, C3), 124.6 (d, 4JC-P 22 Hz, C5), 60.8 (d, 2JC-P 6 Hz, C7), 24.5 (C1), 16.3 (C8) 13.3 (d, 1JC-P 
103 Hz, H9); δP (CDCl3) +41.2; m/z (HRMS+) 200.0858 [M + H]+ (C9H14O2NP requires 200.0862); Rf 
= 0.25 (silica, CH2Cl2 : 5 % MeOH). 
 
 
Ethyl methyl(6-methyl-1-oxo-pyridin-2-yl)phosphinate, 33 
To a stirred solution of ethyl (6-methylpyridin-2-yl)(methyl)phosphinate, 32 (600 mg, 3.0 mmol) in 
CHCl3 (15 mL) MCPBA (1.04 g, 6.0 mmol) was added. The resulting solution was stirred at 65 °C for 
16 h under argon. The reaction was monitored by TLC (silica; CH2Cl2 : 5 % CH3OH, Rf(product) = 
0.19, Rf(reactant) = 0.25). The solvent was removed under reduced pressure to give a yellow oil. 
CH2Cl2 (10 mL) was added and the solution decanted from the white benzoic acid precipitate. CH2Cl2 
was removed under reduced pressure and the resultant yellow oil was purified by column 
chromatography (silica, CH2Cl2 : CH3OH 0 – 3.2 % in 0.2 % increments) to give the title compound 
as a yellow oil (360 mg, 56 %); δH (CDCl3) 7.90 (1H, dd, 3JH-H 7.0 Hz 3JH-P 10 Hz, H5), 7.40 (1H, d, 
3JH-H 7.0 Hz, H3), 7.26 (1H, td, 3JH-H 7.0 Hz 4JH-P 4.8 Hz, H4), 4.03 (2H, dqd, 2JH-H 80 Hz 3JH-H 7.0 Hz 
3JH-P 4.5 Hz, H7), 2.50 (3H, s, H1), 1.96 (3H, d, 2JH-P 15 Hz, H9), 1.28 0(3H, t, 3JH-H 7.0 Hz, H8); δC 
(CDCl3) 149.7 (d, 3JC-P 20 Hz, C2), 142.6 (d, 1JC-P 158 Hz, C6), 130.4 (d, 2JC-P 3 Hz, C3), 124.5 (d, 4JC-P 
22 Hz, C5), 124.5 (d, 3JC-P 10 Hz, C4), 61.7 (d, 2JC-P 6 Hz, C7), 17.5 (C1), 16.3 (C8) 11.7 (d, 1JC-P 103 
Hz, H9); δP (CDCl3) +34.3; m/z (HRMS+) 238.0607 [M + Na]+ (C9H14O3NPNa requires 238.0609); Rf 
= 0.19 (silica, CH2Cl2 : 5 % MeOH). 
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Ethyl [6-(hydroxymethyl)pyridine-2-yl](methyl)phosphinate, 34 
Ethyl methyl(6-methyl-1-oxo-pyridin-2-yl)phosphinate, 33 (360 mg, 1.67 mmol) was dissolved in 
CHCl3 (10 mL) and (CF3CO)2O (8 mL, 56 mmol) was added. The mixture was stirred at 60 °C and 
the formation of the trifluoroacetate analogue of the title compound was monitored by LC-MS. After 
3 h the solution was cooled to 22 °C and the solvent removed under reduced pressure. The residue 
was dissolved in CH3CH2OH (10 mL) and the solution stirred at 60 °C for 3 h. The solvent was 
removed under reduced pressure to give the crude alcohol which was purified by column 
chromatography (silica, CH2Cl2 : CH3OH 0 – 2.5 % in 0.25 % increments) to give the title compound 
(220 mg, 60 %); δH (CDCl3) 7.91 (1H, dd, 3JH-H 7.0 Hz 3JH-P 10 Hz, H5), 7.80 (1H, td, 3JH-H 7.0 Hz 4JH-
P 4.8 Hz, H4), 7.43 (1H, d, 3JH-H 7.0 Hz, H3), 4.80 (2H, s, H1), 3.93 (2H, dqd, 2JH-H 80 Hz 3JH-H 7.0 Hz 
3JH-P 4.5 Hz, H7), 1.75 (3H, d, 2JH-P 15 Hz, H9), 1.24 (3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 160.4 (d, 3JC-
P 20 Hz, C2), 153.1 (d, 1JC-P 156 Hz, C6), 136.8 (d, 3JC-P 10 Hz, C4), 126.3 (d, 4JC-P 22 Hz, C5), 123.0 
(d, 2JC-P 4 Hz, C3), 64.1 (C1), 61.1 (d, 2JC-P 6 Hz, C7), 16.4 (C8) 13.4 (d, 1JC-P 103 Hz, H9); δP (CDCl3) 
+40.0; m/z (HRMS+) 216.0808 [M + H]+ (C9H14O3NP requires 216.0801); Rf = 0.20 (silica, CH2Cl2 : 7 
% MeOH). 
 
 
(6-[Ethoxy(methyl)phosphoryl]pyridine-2-yl)methyl methanesulphonate, 35 
Ethyl [6-(hydroxymethyl)pyridine-2-yl](methyl)phosphinate, 34 (110 mg, 0.51 mmol) was dissolved 
in anhydrous THF (3 mL) and NEt3 (213 µL, 1.5 mmol) was added. The mixture was stirred at 5 °C 
and methanesulfonyl chloride (59 µL, 0.77 mmol) was added. The reaction was monitored by TLC 
(silica; CH2Cl2 : 7 % CH3OH, Rf(product) = 0.45, Rf(reactant) = 0.20) and stopped after 15 min. The 
solvent was removed under reduced pressure and the residue dissolved in CH2Cl2 (15 mL) and washed 
with NaCl solution (saturated, 10 mL). The aqueous layer was re-extracted with CH2Cl2 (3 × 10 mL) 
and the organic layers combined, dried over MgSO4 and the solvent removed under reduced pressure 
to leave the title compound, which was used directly in the next step without further purification (100 
mg, 67 %); δH (CDCl3) 8.07 (1H, dd, 3JH-H 7.0 Hz 3JH-P 10 Hz, H5), 7.92 (1H, td, 3JH-H 7.0 Hz 4JH-P 4.8 
Hz, H4), 7.64 (1H, d, 3JH-H 7.0 Hz, H3), 5.41 (2H, s, H1), 4.03 (2H, dqd, 2JH-H 80 Hz 3JH-H 7.0 Hz 3JH-P 
4.5 Hz, H7), 3.15 (3H, s, H10), 1.80 (3H, d, 2JH-P 15 Hz, H9), 1.29 (3H, t, 3JH-H 7.0 Hz, H8); δP (CDCl3) 
+39.4; m/z (HRMS+) 294.2083 [M + H]+ (C10H10O5NP requires 294.2078); Rf = 0.45 (silica, CH2Cl2 : 
7 % MeOH). 
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1,4,7-Tri[ethyl-(6-methylpyridin-2-yl)(methyl)phosphinate]-1,4,7-triazacyclononane, 36 
1,4,7-Triazacyclononane (15.2 mg, 0.12 mmol), (6-[ethoxy(methyl)phosphoryl]pyridine-2-yl)methyl 
methanesulphonate, 35 (100 mg, 0.34 mmol) and K2CO3 (47 mg, 0.34 mmol) were stirred in dry 
CH3CN (4 mL) at 60 °C for 3 h under argon. The reaction was monitored by TLC to confirm that all 
the mesylated starting material had been consumed. The solution was decanted from excess potassium 
salts and the solvent removed under reduced pressure. Purification by column chromatography on 
silica (CH2Cl2 : 0 – 20 % MeOH in 1 % increments) gave the title compound as a colourless oil (40 
mg, 47 %); δH (CDCl3) 7.89 (3H, dd, 3JH-H 7.0 Hz 3JH-P 10 Hz, H5), 7.75 (3H, td, 3JH-H 7.0 Hz 4JH-P 4.8 
Hz, H4), 7.60 (3H, d, 3JH-H 7.0 Hz, H3), 3.95 (6H, dqd, 2JH-H 80 Hz 3JH-H 7.0 Hz 3JH-P 4.5 Hz, H7), 3.90 
(6H, br s, H1), 2.89 (12H, br s, ring Hs), 1.72 (9H, d, 2JH-P 15 Hz, H9), 1.22 (9H, t, 3JH-H 7.0 Hz, H8); 
δC (CDCl3) 157.1 (d, 3JC-P 20 Hz, C2), 154.6 (d, 1JC-P 156 Hz, C6), 137.1 (d, 3JC-P 10 Hz, C4), 126.7 (d, 
4JC-P 20 Hz, C5), 126.2 (d, 2JC-P 4 Hz, C3), 64.1 (C1), 60.9 (d, 2JC-P 6 Hz, C7), 52.7 (ring Cs), 16.5 (C8) 
13.5 (d, 1JC-P 102 Hz, H9); δP (CDCl3) +41.2; m/z (HRMS+) 721.4368 [M + H]+ (C33H51O6N6P3 
requires 721.4361); Rf = 0.05 (silica, CH2Cl2 : 10 % MeOH). 
 
 
Europium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(methyl)phosphinate]-1,4,7-
triazacyclononane, [Eu·L10] 
1,4,7-Tri[ethyl (6-methylpyridin-2-yl)(methyl)phosphinate]-1,4,7-triazacyclononane, 36 (10 mg, 
0.014 mmol) was dissolved in HCl (6M, 3 mL) and the solution was stirred at 100 °C for 16 h. The 
solvent was lyophilised to give a white solid. Hydrolysis of the OEt groups was confirmed by 1H- and 
31P-NMR (δP (CDCl3) +34.5). The solid was dissolved in H2O – CH3OH (1 : 1 v/v, 2 mL) and the pH 
of the solution adjusted to 5.8 using aq. NaOH solution. Eu(OAc)3 (6.7 mg, 0.015 mmol) was added 
and the solution was stirred at 50 °C for 18 h. After allowing the solution to cool to room temperature, 
the pH was raised to 10 by the addition of aq. NaOH solution. The solution was stirred for 1 h causing 
excess Eu3+ to precipitate as Eu(OH)3, which was removed by centrifugation. Adjustment of the pH to 
5.8 by the addition of HCl, followed by lyophilisation of the solvent, gave the title compound as a 
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white solid containing < 2 % NaCl from pH adjustments (8.8 mg, 80 %); m/z (HRMS+) 785.1127 [M 
+ H]+ (C27H36O6N6P3151Eu requires 785.1121); δP (CD3OD) +40.1; =OH 2τ 1.54 ms, =OD2τ  1.65 ms,
 
=ΦemOH2  7.1 %. 
 
Terbium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(methyl)phosphinate]-1,4,7-
triazacyclononane, [Tb·L10] 
An analogous procedure to that described for the synthesis of [Eu·L10] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(methyl)phosphinate]-1,4,7-triazacyclononane, 36 (10 mg, 0.014 
mmol) and Tb(OAc)3 (6.2 mg, 0.015 mmol) to give the title compound  as a white solid (8.9 mg, 80 
%); m/z (ESI-MS+) 793.1 [M (159Tb) + H]+; δP (CD3OD) +5.1; =OH 2τ 2.59 ms, =OD2τ  2.98 ms,
 
=ΦemOH2  61 %. 
 
 
Gadolinium(III) complex of 1,4,7-tri[ethyl (6-methylpyridin-2-yl)(methyl)phosphinate]-
1,4,7-triazacyclononane, [Gd·L10] 
An analogous procedure to that described for the synthesis of [Eu·L10] was followed using 1,4,7-
tri[ethyl (6-methylpyridin-2-yl)(methyl)phosphinate]-1,4,7-triazacyclononane, 36 (10 mg, 0.014 
mmol) and Gd(OAc)3 (6.1 mg, 0.015 mmol) to give the title compound  as a white solid (8.6 mg, 78 
%); m/z (ESI-MS+) 790.1 [M (156Gd) + H]+. 
 
 
2-Bromo-6-methylpyridine-1-oxide, 37  
2-Bromo-6-methylpyridine, 17 (20 g, 0.116 mol) was dissolved in CHCl3 (300 mL). MCPBA (40.1 g, 
0.232 mol) was added and the solution was stirred at 65 °C under argon for 18 h. The volume of the 
solution was reduced to 150 mL by removal of the solvent under reduced pressure. The solution was 
left to stand in the fridge overnight causing precipitation of 3-chlorobenzoic acid, which was removed 
by filtration. From the remaining filtrate, the solvent was removed under reduced pressure to give a 
yellow oil, which was dissolved in aq. NaOH solution (1M, 100 mL) and extracted with CH2Cl2 (3 × 
100 mL). The organic extracts were combined, dried over MgSO4, filtered and the solvent removed 
under reduced pressure to give the title compound as a yellow oil, which cyrstallised upon standing 
(15 g, 67 %); m.p. 58 – 61 °C; δH (CDCl3) 7.55 (1H, dd, J 7.9 Hz, 1.6 Hz, H5), 7.23 (1H, dd, J 7.9 Hz, 
1.6 Hz, H3), 7.01 (1H, t, J 7.9 Hz, H4), 2.57 (3H, s, H1); δC (CDCl3) 151.2 (C2), 133.5 (C6), 128.7 (C5), 
125.3 (C3), 125.2 (C4), 19.3 (C1); m/z (HRMS+) 187.9698 [M + H]+ (C6H7NO79Br requires 187.9711); 
Rf = 0.16 (silica, CH2Cl2 : 2 % MeOH). 
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2-Bromo-6-methyl-4-nitropyridine-1-oxide, 38 
2-Bromo-6-methylpyridine-1-oxide, 37 (15 g, 80 mmol) was dissolved in concentrated H2SO4 (98 %, 
23 mL, 0.40 mol). The solution was stirred at 0 °C and HNO3 (70 %, 26 mL, 0.38 mol) was added 
dropwise. The mixture was heated to 100 °C for 16 h. The yellow solution was dropped onto stirred 
ice (150 g) causing a pale yellow solid to precipitate. After 1 h the precipitate was filtered and dried 
under high vacuum to yield the title compound (12 g, 65 %); m.p. 138 – 139 °C; δH (CDCl3) 8.40 (1H, 
d, 2.8 Hz, H5), 8.09 (1H, d, 2.8 Hz, H3), 2.62 (3H, s, H1); δC (CDCl3) 151.8 (C2), 140.7 (C4), 134.0 
(C6), 122.8 (C5), 118.9 (C3), 19.6 (C1); m/z (HRMS+) 232.9564 [M + H]+ (C6H6N2O379Br requires 
232.9556); Rf = 0.53 (silica, CH2Cl2 : 2 % MeOH). 
 
 
2-Bromo-6-methyl-4-nitropyridine, 39 
2-Bromo-6-methyl-4-nitropyridine-1-oxide, 38 (5g, 22 mmol) was dissolved in CHCl3 (200 mL) and 
PBr3 (6.26 mL, 66 mmol) was added dropwise. The mixture was stirred at 60 °C under argon for 16 h. 
The solvent was removed under reduced pressure to give a yellow oil. NaOH solution (2 M, 50 mL) 
was added cautiously and the solution was extracted with CH2Cl2 (3 × 100 mL). The organic extracts 
were combined, dried over MgSO4 and the solvent removed under reduced pressure to give a yellow 
oil, which was purified by column chromatography on silica (CH2Cl2) to yield the title compound as a 
pale yellow oil (3.0 g, 74 %); δH (CDCl3) 8.02 (1H, d, 2.8 Hz, H5), 7.83 (1H, d, 2.8 Hz, H3), 2.70 (3H, 
s, H1); δC (CDCl3) 162.9 (C2), 154.9 (C4), 142.4 (C6), 118.4 (C5), 115.0 (C3), 24.6 (C1); m/z (HRMS+) 
216.9621 [M + H]+ (C6H6N2O279Br requires 216.9613); Rf = 0.75 (silica, CH2Cl2 : 2 % MeOH). 
 
 
Ethyl (6-methyl-4-nitropyridin-2-yl)(phenyl)phosphinate, 40 
2-Bromo-6-methyl-4-nitropyridine, 39 (1.01 g, 4.68 mmol), ethyl phenylphosphinate (0.95 g, 5.60 
mmol) and triethylamine (2.6 mL, 19.0 mmol) were added to dry degassed (3 × freeze-thaw cycle) 
toluene (10 mL). Tetrakis(triphenylphosphine)palladium(0) (83 mg, 0.07 mmol) was added and the 
mixture was degassed three times before being stirred at 125 °C for 16 h under argon. The solution 
was diluted with CH2Cl2 (20 mL), washed with HCl (1M, 2 × 15 mL) and water (3 × 15 mL), dried 
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over K2CO3, filtered and the solvent removed under reduced pressure to give a dark residue. 
Purification by column chromatography on silica (CH2Cl2 : 0.5 % MeOH) gave the title compound as 
a yellow oil (645 mg, 45 %); δH (CDCl3) 8.55 (1H, dd, 3JH-P 5.6 Hz, 4JH-H 1.4 Hz, H5), 7.97 (2H, ddd, 
3JH-P 11.2 Hz, 3JH-H 7.7 Hz, 4JH-H 1.4 Hz, Ho), 7.90 (1H, d, 4JH-H 1.4 Hz, H3), 7.55 (1H, td, 3JH-H 7.7 Hz, 
4JH-H 1.4 Hz, Hp), 7.46 (2H, td, 3JH-H 7.7 Hz 4JH-P 3.5 Hz, Hm), 4.15 (2H, qd, 3JH-H 7.0 Hz, 3JH-P 4.2 Hz, 
H7), 2.72 (3H, s, H1), 1.38 (3H, t, 3JH-H 7.0 Hz, H8); δC (CDCl3) 163.0 (d, 3JC-P 21 Hz, C2), 158.1 (d, 
1JC-P 167 Hz, C6), 154.0 (d, 3JC-P 13 Hz, C4), 132.9 (d, 4JC-P 3 Hz, Cp), 132.5 (d, 2JC-P 10 Hz, Co), 129.1 
(d, 1JC-P 140 Hz, Ci), 128.5 (d, 3JC-P 13 Hz, Cm), 117.6 (d, 2JC-P 24 Hz, C5), 117.5 (d, 4JC-P 3 Hz, C3), 
62.2 (d, 2JC-P 6 Hz, C7), 24.9 (C1), 16.4 (C8); δP (CDCl3) 23.7; m/z (HRMS+) 307.0851 [M + H]+ 
(C14H16N2O4P requires 307.0848); Rf = 0.47 (silica, CH2Cl2 : 5 % MeOH). 
 
 
(4-Bromo-6-methylnitropyridin-2-yl)(phenyl)phosphinic acid, 41 
Ethyl (6-methyl-4-nitropyridin-2-yl)(phenyl)phosphinate, 40 (2.00 g, 6.54 mmol) was dissolved in 
CH3COBr (15 mL, 0.2 mol) and the mixture stirred at 70 °C for 16 h under argon. A pale brown 
precipitate formed. Both precipitate and solution were dropped cautiously into CH3OH (100 mL) 
stirred at 0 °C. The solvent was removed under reduced pressure to yield the title compound as a pale 
brown solid (1.81 g, 90 %); δH (CD3OD) 8.33 (1H, dd, 3JH-P 7.2 Hz, 4JH-H 2.0 Hz, H5), 8.23 (1H, d, 4JH-
H 2.0 Hz, H3), 7.95 (2H, ddd, 3JH-P 13.2 Hz, 3JH-H 7.6 Hz, 4JH-H 1.6 Hz, Ho), 7.63 (1H, td, 3JH-H 7.6 Hz, 
4JH-H 1.6 Hz, Hp), 7.55 (2H, td, 3JH-H 7.6 Hz 4JH-P 3.6 Hz, Hm), 2.77 (3H, s, H1); δC (CD3OD) 159.4 (d, 
3JC-P 20 Hz, C2), 151.7 (d, 1JC-P 160 Hz, C6), 145.1 (d, 3JC-P 10 Hz, C4), 134.8 (d, 4JC-P 3 Hz, Cp), 133.3 
(d, 2JC-P 10 Hz, Co), 131.0 (d, 2JC-P 24 Hz, C5), 130.6 (d, 4JC-P 3 Hz, C3), 130.2 (d, 1JC-P 140 Hz, Ci), 
129.6 (d, 3JC-P 12 Hz, Cm), 20.4 (C1); δP (CD3OD) 14.3; m/z (HRMS-) 309.9648 [M – H]- 
(C12H10NO279BrP requires 309.9633); Rf = 0.01 (silica, CH2Cl2 : 5 % MeOH). 
 
 
Ethyl (4-bromo-6-methylnitropyridin-2-yl)(phenyl)phosphinate, 42 
(4-Bromo-6-methylnitropyridin-2-yl)(phenyl)phosphinic acid, 41 (1.80 g, 5.80 mmol) was added to 
HC(OCH2CH3)3 (50 mL) and the mixture stirred at 140 °C for 72 h under argon. The solvent was 
removed under reduced pressure and the resulting residue was purified by column chromatography on 
silica (CH2Cl2 : 0.5 % MeOH) to yield the title compound as a yellow oil (1.08 g, 55 %); δH (CDCl3) 
8.04 (1H, dd, 3JH-P 6.3 Hz, 4JH-H 1.4 Hz, H5), 7.95 (2H, ddd, 3JH-P 11.2 Hz, 3JH-H 7.0 Hz, 4JH-H 1.4 Hz, 
Ho), 7.51 (1H, td, 3JH-H 7.0 Hz, 4JH-H 1.4 Hz, Hp), 7.43 (2H, td, 3JH-H, 7.0 Hz 4JH-P 3.5 Hz, Hm), 7.37 
(1H, d, 4JH-H 1.4 Hz, H3), 4.11 (2H, qd, 3JH-H 7.0 Hz, 3JH-P 4.2 Hz, H7), 2.52 (3H, s, H1), 1.34 (3H, t, 
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3JH-H 7.0 Hz, H8); δC (CDCl3) 161.2 (d, 3JC-P 22 Hz, C2), 155.7 (d, 1JC-P 165 Hz, C6), 133.5 (d, 3JC-P 15 
Hz, C4), 132.7 (d, 4JC-P 3 Hz, Cp), 132.6 (d, 2JC-P 10 Hz, Co), 130.0 (d, 1JC-P 139 Hz, Ci), 128.5 (d, 4JC-P 
3 Hz, C3), 128.4 (d, 2JC-P 23 Hz, C5), 128.3 (d, 3JC-P 13 Hz, Cm), 62.1 (d, 2JC-P 6 Hz, C7), 24.5 (C1), 16.7 
(C8); δP (CDCl3) 25.5; m/z (HRMS+) 340.0102 [M + H]+ (C14H16NO279BrP requires 340.0102); Rf = 
0.56 (silica, CH2Cl2 : 5 % MeOH). 
 
 
Ethyl (4-[2-(4-methoxyphenyl)ethynyl]-6-methylpyridin-2-yl)(phenyl)phosphinate, 43 
Ethyl (4-bromo-6-methylnitropyridin-2-yl)(phenyl)phosphinate, 42 (32 mg, 0.094 mmol) was 
dissolved in dry THF (1 mL) and the solution was degassed (freeze-thaw cycle) three times. 4-
Ethynylanisole (19 mg, 0.14 mmol) and NEt3 (0.5 mL) were added and the solution was degassed 
once. Tetrakis(triphenylphosphine)palladium(0) (10 mg, 8.7 µmol) and CuI (3.6 mg, 0.019 mmol) 
were added and the solution was degassed a further three times. The solution was stirred at 65 °C 
under argon. The reaction was monitored by TLC (silica; CH2Cl2 : 2.5 % CH3OH, Rf(product) = 0.21, 
Rf(reactant) = 0.26) and stopped after 3 h. The solvent was removed under reduced pressure and the 
crude material purified by column chromatography (silica, CH2Cl2 : CH3OH 0 – 1.6 % in 0.1 % 
increments) to give a yellow oil (20 mg, 55 %); δH (CDCl3) 8.01 (1H, dd, 3JH-P 6.0 Hz, 4JH-H 1.6 Hz, 
H5), 7.98 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.53 (1H, t, 3JH-H 8.4 Hz, Hp), 7.47 (2H, d, 3JH-H 8.8 
Hz, H12), 7.45 (2H, td, 3JH-H 8.4 Hz 4JH-P 4.2 Hz, Hm), 7.28 (1H, d, 4JH-H 1.6 Hz, H3), 6.89 (2H, d, 3JH-H 
8.8 Hz, H13), 4.13 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, H7), 3.84 (3H, s, H15), 2.57 (3H, s, H1), 1.38 (3H, 
t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 160.4 (s, C14), 159.7 (d, 3JC-P 20 Hz, C2), 153.8 (d, 1JC-P 165 Hz, C6), 
134.7 (d, 2JC-P 12 Hz, C4), 133.4 (s, C12), 132.4 (d, 4JC-P 5 Hz, Cp), 132.2 (d, 2JC-P 10 Hz, Co), 130.2 (d, 
1JC-P 139 Hz, Ci), 128.2 (d, 3JC-P 22 Hz, C5), 128.1 (d, 3JC-P 12 Hz, Cm), 126.8 (d, 4JC-P 3 Hz, C3), 114.1 
(s, C13), 114.0 (s, C11), 94.9 (s, C10), 85.3 (d, 4JC-P 2 Hz, C9), 61.7 (d, 2JC-P 6 Hz, C7), 55.2 (s, C15), 27.9 
(s, C1), 16.6 (s, C8); δP (CDCl3) +26.6; m/z (HRMS+) 414.1247 [M + Na]+ (C23H22O3NPNa requires 
414.1235); Rf = 0.21 (silica, CH2Cl2 : 2.5 % MeOH). 
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Ethyl (4-bromo-6-methyl-1-oxo-1-pyridin-2-yl)(phenyl)phosphinate, 44 
To a stirred solution of ethyl (4-bromo-6-methylnitropyridin-2-yl)(phenyl)phosphinate 42 (1.25 g, 
3.68 mmol) in CHCl3 (20 mL) was added MCPBA (1.27 g, 7.35 mmol). The resulting solution was 
stirred at 65 °C overnight (16 h) under argon. The reaction was monitored by TLC (silica; CH2Cl2 : 5 
% CH3OH, Rf(product) = 0.28, Rf(reactant) = 0.56). The solvent was removed under reduced pressure 
to give a yellow oil. This oil was dissolved in CH2Cl2 and washed with NaHCO3 solution (0.5 M, 50 
mL). The layers were separated and the aqueous layer extracted with CH2Cl2 (3 × 30 mL). All organic 
layers were combined, dried over MgSO4, filtered and the solvent removed under reduced pressure. 
The resultant yellow oil was purified by column chromatography (silica, CH2Cl2 : CH3OH 0 – 2 % in 
0.1 % increments) to give a yellow oil (1.11 g, 75 %); δH (CDCl3) 8.05 (1H, dd, 3JH-P 7.7 Hz, 4JH-H 2.1 
Hz, H5), 7.98 (2H, dd, 3JH-H 7.7 Hz 3JH-P 13.3 Hz, Ho), 7.50 (1H, t, 3JH-H 7.7 Hz, Hp), 7.44 (1H, d, 4JH-H 
2.1 Hz, H3), 7.41 (2H, td, 3JH-H 7.7 Hz 4JH-P 4.2 Hz, Hm), 4.13 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.9 Hz, H7), 
2.32 (3H, s, H1), 1.34 (3H, t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 151.0 (d, 3JC-P 4 Hz, C2), 144.2 (d, 1JC-P 149 
Hz, C6), 133.2 (d, 2JC-P 11 Hz, Co), 133.1 (d, 4JC-P 4 Hz, Cp), 133.0 (d, 3JC-P 11 Hz, C5), 132.2 (d, 4JC-P 4 
Hz, C3), 129.0 (d, 1JC-P 152 Hz, Ci), 128.4 (d, 3JC-P 14 Hz, Cm), 117.4 (d, 2JC-P 12 Hz, C4), 62.3 (d, 2JC-P 
6 Hz, C7), 17.5 (C1), 16.7 (C8); δP (CDCl3) +21.2; m/z (HRMS+) 356.0061 [M + H]+ (C14H16O379BrNP 
requires 356.0051); Rf = 0.28 (silica, CH2Cl2 : 5 % MeOH). 
 
 
(4-Bromo-6-[ethoxy(phenyl)phosphoryl]pyridine-2-yl)methyl acetate, 45 
Ethyl (4-bromo-6-methyl-1-oxo-1-pyridin-2-yl)(phenyl)phosphinate, 44 (1.8 g, 5.1 mmol) was 
dissolved in acetic anhydride (35 mL) and the solution was heated to 120 °C for 3 h with stirring. 
Reaction progress was monitored by 31P-NMR and TLC (silica, CH2Cl2 : 5 % CH3OH, Rf(product) = 
0.46, Rf(reactant) = 0.28). The solvent was removed under reduced pressure and the residue purified 
by column chromatography (silica, CH2Cl2 : CH3OH 0 – 1 % in 0.1 % increments) to give a yellow 
oil (0.66 g, 33 %); δH (CDCl3) 8.16 (1H, dd, 3JH-P 7.7 Hz, 4JH-H 2.1 Hz, H5), 7.93 (2H, dd, 3JH-H 7.7 Hz 
3JH-P 13.3 Hz, Ho), 7.55 (1H, d, 4JH-H 2.1 Hz, H3), 7.51 (1H, t, 3JH-H 7.7 Hz, Hp), 7.43 (2H, td, 3JH-H 7.7 
Hz 4JH-P 4.2 Hz, Hm), 5.18 (2H, s, H1), 4.09 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.9 Hz, H7), 2.12 (3H, s, HOAc), 
1.33 (3H, t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 170.5 (s, CC=O(OAc)), 158.6 (d, 3JC-P 4 Hz, C2), 156.0 (d, 1JC-P 
149 Hz, C6), 134.3 (d, 2JC-P 25 Hz, C4), 132.9 (d, 4JC-P 5 Hz, Cp), 132.7 (d, 2JC-P 10 Hz, Co), 130.5 (d, 
3JC-P 23 Hz, C5), 129.5 (d, 1JC-P 139 Hz, Ci), 128.6 (d, 3JC-P 13 Hz, Cm), 126.6 (d, 4JC-P 3 Hz, C3), 66.0 
(s, C1), 62.2 (d, 2JC-P 6 Hz, C7), 21.0 (s, CMe(OAc)), 16.7 (C8); δP (CDCl3) +25.0; m/z (HRMS+) 398.0157 
[M + H]+ (C16H18O479BrNP requires 398.0151); Rf = 0.46 (silica, CH2Cl2 : 5 % MeOH). 
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(6-[ethoxy(phenyl)phosphoryl]-4-[2-(4-methoxyphenyl)ethynyl]pyridine-2-yl)methyl 
acetate, 46 
(4-Bromo-6-[ethoxy(phenyl)phosphoryl]pyridine-2-yl)methyl acetate, 45 (500 mg, 1.26 mmol) was 
dissolved in dry THF (10 mL) and the solution was degassed (freeze-thaw cycle) three times. 4-
Ethynylanisole (249 mg, 1.89 mmol) and NEt3 (5 mL) were added and the solution was degassed 
once. Tetrakis(triphenylphosphine)palladium(0) (145 mg, 0.126 mmol) and CuI (42 mg, 0.252 mmol) 
were added and the solution was degassed a further three times. The solution was stirred at 60 °C 
under argon. The reaction was monitored by TLC (silica; CH2Cl2 : 5 % CH3OH, Rf(product) = 0.57, 
Rf(reactant) = 0.46) and stopped after 4 h. The solvent was removed under reduced pressure. The 
crude residue was dissolved in CH2Cl2 (50 mL) and washed with NH4Cl (sat. aq. solution, 3 × 40 mL) 
and NaCl (sat. aq. solution, 1 × 40 mL). The organic layer was dried over MgSO4, filtered and the 
solvent was removed to give a yellow oil, which was purified by column chromatography (silica, 
CH2Cl2 : CH3OH 0 – 2.0 % in 0.1 % increments) to give the title compound as a yellow oil (400 mg, 
81 %); δH (CDCl3) 8.09 (1H, dd, 3JH-P 6.0 Hz, 4JH-H 1.6 Hz, H5), 7.98 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 
Hz, Ho), 7.54 (1H, t, 3JH-H 8.4 Hz, Hp), 7.49 (2H, d, 3JH-H 8.8 Hz, H12), 7.47 (2H, td, 3JH-H 8.4 Hz 4JH-P 
4.2 Hz, Hm), 7.26 (1H, d, 4JH-H 1.6 Hz, H3), 6.90 (2H, d, 3JH-H 8.8 Hz, H13), 5.24 (2H, s, H1), 4.13 (2H, 
qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, H7), 3.84 (3H, s, H15), 2.16 (3H, s, HOAc), 1.38 (3H, t, 3JH-H 5.6 Hz, H8); 
δC (CDCl3) 170.5 (s, CC=O(OAc)), 160.6 (s, C14), 157.1 (d, 3JC-P 20 Hz, C2), 154.4 (d, 1JC-P 165 Hz, C6), 
133.7 (s, C12), 133.2 (d, 2JC-P 12 Hz, C4), 132.5 (d, 4JC-P 5 Hz, Cp), 132.4 (d, 2JC-P 10 Hz, Co), 130.3 (d, 
1JC-P 139 Hz, Ci), 129.1 (d, 3JC-P 22 Hz, C5), 128.8 (d, 3JC-P 12 Hz, Cm), 124.4 (d, 4JC-P 3 Hz, C3), 114.3 
(s, C13), 113.7 (s, C11), 96.0 (s, C10), 85.3 (d, 4JC-P 2 Hz, C9), 66.3 (s, C1), 61.9 (d, 2JC-P 6 Hz, C7), 55.4 
(C15), 20.9 (s, CMe(OAc)), 16.5 (C8); δP (CDCl3) +26.1; m/z (HRMS+) 472.1303 [M + Na]+ 
(C25H24O5NPNa requires 472.1290); Rf = 0.57 (silica, CH2Cl2 : 5 % MeOH). 
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Ethyl (6-(hydroxymethyl)-4-[2-(4-methoxyphenyl)ethynyl]pyridin-2-
yl)(phenyl)phosphinate, 47 
(6-[Ethoxy(phenyl)phosphoryl]-4-[2-(4-methoxyphenyl)ethynyl]pyridine-2-yl)methyl acetate, 46 (350 
mg, 0.78 mmol) was dissolved in anhydrous CH3CH2OH (12 mL). A catalytic amount of sodium 
metal (~5 mg) was added and the solution was stirred at 40 °C under argon. The reaction was 
monitored by TLC (silica; CH2Cl2 : 5 % CH3OH, Rf(product) = 0.28, Rf(reactant) = 0.57) and stopped 
after 40 min. To the crude reaction mixture CH2Cl2 (100 mL) was added and sodium salts were 
removed by washing with H2O (1 × 25 mL). The aqueous layer was re-extracted with CH2Cl2 (3 × 20 
mL). The organic layers were combined, dried over MgSO4, filtered and the solvent was removed 
under reduced pressure. The crude residue was purified by column chromatography (silica, CH2Cl2 : 
CH3OH 0 – 3.0 % in 0.2 % increments) to give a colourless oil (200 mg, 82 %); δH (CDCl3) 8.01 (1H, 
dd, 3JH-P 6.0 Hz, 4JH-H 1.6 Hz, H5), 7.93 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.51 (1H, t, 3JH-H 8.4 
Hz, Hp), 7.45 (1H, d, 4JH-H 1.6 Hz, H3), 7.44 (2H, d, 3JH-H 8.8 Hz, H12), 7.43 (2H, td, 3JH-H 8.4 Hz 4JH-P 
4.2 Hz, Hm), 6.87 (2H, d, 3JH-H 8.8 Hz, H13), 4.75 (2H, s, H1), 4.12 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, 
H7), 3.80 (3H, s, H15), 1.35 (3H, t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 161.4 (d, 3JC-P 20 Hz, C2), 160.8 (s, 
C14), 153.4 (d, 1JC-P 165 Hz, C6), 133.9 (s, C12), 133.2 (d, 2JC-P 12 Hz, C4), 132.8 (d, 4JC-P 5 Hz, Cp), 
132.4 (d, 2JC-P 10 Hz, Co), 129.8 (d, 1JC-P 140 Hz, Ci), 128.7 (d, 3JC-P 12 Hz, Cm), 128.4 (d, 3JC-P 22 Hz, 
C5), 124.1 (d, 4JC-P 3 Hz, C3), 114.5 (s, C13), 114.0 (s, C11), 96.1 (s, C10), 85.6 (d, 4JC-P 2 Hz, C9), 64.3 
(s, C1), 62.0 (d, 2JC-P 6 Hz, C7), 55.6 (C15), 16.7 (C8); δP (CDCl3) +25.6; m/z (HRMS+) 408.1382 [M + 
H]+ (C23H23O4NP requires 408.1365); Rf = 0.28 (silica, CH2Cl2 : 5 % MeOH). 
 
 
Ethyl-[6-(bromomethyl)-4-[2-(4-methoxyphenyl)ethynyl]pyridin-2-yl](phenyl)phosphinate, 
48 
Ethyl-(6-(hydroxymethyl)-4-[2-(4-methoxyphenyl)ethynyl]pyridin-2-yl)(phenyl)phosphinate, 47 (143 
mg, 0.35 mmol) was dissolved in dry CH2Cl2 (4 mL) and the solution was stirred at 0 °C under argon. 
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PBr3 (50 µL, 0.53 mmol) was added and the solution was stirred for a further 1 h at 0 °C. The reaction 
mixture was allowed to warm to room temperature and monitored by TLC (silica; CH2Cl2 : 5 % 
CH3OH, Rf(product) = 0.69, Rf(reactant) = 0.28). After 1 h at 20 °C CH2Cl2 (50 mL) was added and 
the solution was washed with aq. NaHCO3 solution (1M, 25 mL). The aqueous layer was re-extracted 
with CH2Cl2 (3 × 20 mL). The organic layers were combined, dried over MgSO4 and the solvent was 
removed under reduced pressure. The crude residue was purified by column chromatography (silica, 
CH2Cl2 : CH3OH 0 – 0.5 % in 0.1 % increments) to give a pale yellow oil (110 mg, 66 %); δH (CDCl3) 
8.05 (1H, dd, 3JH-P 6.0 Hz, 4JH-H 1.6 Hz, H5), 8.00 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.56 (1H, d, 
4JH-H 1.6 Hz, H3), 7.50 (1H, t, 3JH-H 8.4 Hz, Hp), 7.47 (2H, d, 3JH-H 8.8 Hz, H12), 7.46 (2H, td, 3JH-H 8.4 
Hz 4JH-P 4.2 Hz, Hm), 6.87 (2H, d, 3JH-H 8.8 Hz, H13), 4.52 (2H, s, H1), 4.13 (2H, qd, 3JH-H 5.6 Hz 3JH-P 
4.8 Hz, H7), 3.80 (3H, s, H15), 1.36 (3H, t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 160.9 (s, C14), 158.1 (d, 3JC-P 
20 Hz, C2), 154.8 (d, 1JC-P 165 Hz, C6), 133.9 (s, C12), 133.6 (d, 2JC-P 12 Hz, C4), 132.7 (d, 4JC-P 5 Hz, 
Cp), 132.5 (d, 2JC-P 10 Hz, Co), 130.3 (d, 1JC-P 140 Hz, Ci), 128.8 (d, 3JC-P 12 Hz, Cm), 128.7 (d, 3JC-P 22 
Hz, C5), 126.8 (d, 4JC-P 3 Hz, C3), 114.5 (s, C13), 113.9 (s, C11), 96.5 (s, C10), 85.1 (d, 4JC-P 2 Hz, C9), 
62.2 (d, 2JC-P 6 Hz, C7), 55.6 (C15), 33.3 (s, C1), 16.7 (C8); δP (CDCl3) +25.8; m/z (HRMS+) 492.0341 
[M + Na]+ (C23H21O3NP79BrNa requires 492.0340); Rf = 0.69 (silica, CH2Cl2 : 5 % MeOH). 
 
 
Tri-ethyl phenylphosphinate ester of L11, 49 
1,4,7-Triazacyclononane (10 mg, 0.078 mmol) and ethyl-[6-(bromomethyl)-4-[2-(4-
methoxyphenyl)ethynyl]pyridin-2-yl](phenyl)phosphinate, 48 (110 mg, 0.234 mmol) were dissolved 
in anhydrous CH3CN (5 mL) and K2CO3 (32 mg, 0.234 mmol) was added. The mixture was stirred 
under argon at 78 °C and monitored by TLC (silica; CH2Cl2 : 10 % CH3OH, Rf(product) = 0.06, 
Rf(reactant 48) = 0.85). After 16 h the reaction was cooled and the solution decanted from excess 
potassium salts. The solvent was removed under reduced pressure and the crude material purified by 
column chromatography (silica, CH2Cl2 : CH3OH 0 – 30 % in 1 % increments) to give the title 
product as a yellow oil (23 mg, 23 %): δH (CDCl3) 8.03 (3H, dd, 3JH-P 6.0 Hz, H5), 7.94 (6H, dd, 3JH-P 
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12.4 Hz, 3JH-H 6.8 Hz, Ho), 7.58 (3H, s, H3), 7.45 (6H, d, 3JH-H 8.8 Hz, H12), 7.42 (3H, t, 3JH-H 6.8 Hz, 
Hp), 7.37 (6H, td, 3JH-H, 6.8 Hz 4JH-P 3.6 Hz, Hm), 6.87 (6H, d, 3JH-H 8.8 Hz, H13), 4.10 (6H, qd, 3JH-H 
7.2 Hz, 3JH-P 4.2 Hz, H7), 3.83 (6H, s, H1), 3.82 (9H, s, H15), 2.74 (12H, br s, ring Hs), 1.33 (9H, t, 3JH-
H 7.2 Hz, H8); δP (CDCl3) +26.6; m/z (HRMS+) 1297.486 [M + H]+ (C75H76O9N6P3 requires 1297.488); 
Rf = 0.06 (silica, CH2Cl2 : 10 % MeOH). 
 
[Eu·L11] 
The tri-ethyl phenylphosphinate ester of L11, 49 (10 mg, 7.7 µmol) was dissolved in CD3OD (3 mL) 
and NaOD (0.1 M in D2O, 1 mL) was added. The solution was stirred at 60 °C and monitored by 1H-
NMR (loss of CH3CH2 peaks at 4.10 and 1.33 ppm) and 31P-NMR (reactant 26.6 ppm, product 17.5 
ppm) and stopped after 16 h. The pH of the solution was adjusted to 7 by addition of HCl (1M). 
Eu(OAc)3 (3.4 mg, 8.5 µmol) in a H2O : CH3OH solution (0.5 mL, 1:1 v/v) was added and the 
solution was stirred at 50 °C for 24 h. The solvent was removed under reduced pressure and the crude 
material purified by column chromatography (silica, CH2Cl2 : 5 % CH3OH) to give the title product as 
a white solid (2.5 mg, 24 %); m/z (HRMS+) 1361.283 [M(151Eu) + H]+ (C69H61O9N6P3151Eu requires 
1361.291), 1363.299 [M(153Eu) + H]+ (C69H61O9N6P3153Eu requires 1363.293); δP (CD3OD) +17.5; Rf 
= 0.25 (silica, CH2Cl2 : 10 % MeOH). =MeOHτ 1.30 ms,  =ΦemMeOH  52 ± 10 %; εMeOH (332 nm) = 58, 
000 M-1 cm-1; tR  (Method D) = 11.5 min. Single crystals of [Eu·L11] suitable for X-ray diffraction 
studies were grown by dissolving 2 mg of complex in CH3OH (0.33 mL). Addition of H2O (0.17 mL) 
led to crystal formation over 16 h. 
 
[Tb·L11] 
An analogous procedure to that described for the synthesis of [Eu·L11] was followed using the tri-
ethyl phenylphosphinate ester of L11, 49 (10 mg, 7.7 µmol) and Tb(OAc)3 (3.1 mg, 7.7 µmol) to give 
the title compound  as a white solid (2.9 mg, 29 %); m/z (HRMS+) 1369.301 [M(159Tb) + H]+ 
(C69H61O9N6P3159Tb requires 1369.296); Rf = 0.25 (silica, CH2Cl2 : 10 % MeOH), tR  (Method D) = 
11.5 min. 
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(6-[Ethoxy(phenyl)phosphoryl]-4-[2-(4-(2-[2-(2-
methoxyethoxy)ethoxy]ethoxy)phenyl)ethynyl]pyridin-2-yl)methyl acetate, 50 
(4-Bromo-6-[ethoxy(phenyl)phosphoryl]pyridine-2-yl)methyl acetate, 45 (540 mg, 1.36 mmol) was 
dissolved in dry THF (8 mL) and the solution was degassed (freeze-thaw cycle) three times. [2-(4-(2-
[2-(2-methoxyethoxy)ethoxy]ethoxy)phenyl)ethynyl]trimethylsilane* (456 mg, 1.36 mmol) and NEt3 
(4 mL) were added and the solution was degassed once. Tetrakis(triphenylphosphine)palladium(0) 
(156 mg, 0.136 mmol) and CuI (26 mg, 0.136 mmol) were added and the solution was degassed a 
further three times. The solution was stirred under argon and tetrabutylammonium fluoride solution (1 
M in THF, 1.9 mL, 2.04  mmol) was added. A colour change from yellow to a dark blue was observed 
and the mixture was stirred at 65 °C under argon. The reaction was monitored by TLC (silica; CH2Cl2 
: 5 % CH3OH, Rf(product) = 0.31, Rf(reactant) = 0.46) and stopped after 3 h. The solvent was removed 
under reduced pressure and the crude material purified by column chromatography (silica, CH2Cl2 : 
CH3OH 0 – 1.5 % in 0.1 % increments) to give a yellow oil (575 mg, 73 %); δH (CDCl3) 8.05 (1H, dd, 
3JH-P 6.0 Hz, 4JH-H 1.6 Hz, H5), 7.96 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.50 (1H, t, 3JH-H 8.4 Hz, 
Hp), 7.44 (2H, d, 3JH-H 8.8 Hz, H12), 7.43 (2H, td, 3JH-H 8.4 Hz 4JH-P 4.2 Hz, Hm), 7.42 (1H, d, 4JH-H 1.6 
Hz, H3), 6.88 (2H, d, 3JH-H 8.8 Hz, H13), 5.21 (2H, s, H1), 4.12 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, H7), 
4.11 (2H, t, 3JH-H 4.8 Hz, H15), 3.83 (2H, t, 3JH-H 4.8 Hz, H16), 3.71 (2H, t, 3JH-H 4.8 Hz, H17), 3.65 (2H, 
t, 3JH-H 4.8 Hz, H18), 3.63 (2H, t, 3JH-H 4.8 Hz, H19), 3.61 (2H, t, 3JH-H 4.8 Hz, H20), 3.34 (3H, s, H21), 
2.13 (3H, s, HOAc), 1.34 (3H, t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 170.6 (s, CC=O(OAc)), 160.1 (s, C14), 157.3 
(d, 3JC-P 20 Hz, C2), 154.7 (d, 1JC-P 165 Hz, C6), 133.8 (s, C12), 133.2 (d, 2JC-P 12 Hz, C4), 132.7 (d, 4JC-P 
5 Hz, Cp), 132.6 (d, 2JC-P 10 Hz, Co), 130.1 (d, 1JC-P 139 Hz, Ci), 128.8 (d, 3JC-P 22 Hz, C5), 128.6 (d, 
3JC-P 12 Hz, Cm), 124.6 (d, 4JC-P 3 Hz, C3), 115.1 (s, C13), 114.1 (s, C11), 96.2 (s, C10), 85.5 (d, 4JC-P 2 
Hz, C9), 72.2 (s, C20), 71.1 (s, C17), 70.9 (s, C18), 70.8 (s, C19), 69.8 (s, C16), 67.8 (C15), 66.5 (s, C1), 
62.1 (d, 2JC-P 6 Hz, C7), 59.3 (s, C21), 21.1 (s, CMe(OAc)), 16.7 (C8); δP (CDCl3) +26.0; m/z (HRMS+) 
582.2260 [M + H]+ (C31H37O8NP requires 582.2257); Rf = 0.31 (silica, CH2Cl2 : 5 % MeOH). 
 
*[2-(4-(2-[2-(2-methoxyethoxy)ethoxy]ethoxy)phenyl)ethynyl]trimethylsilane: 
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(4-(2-[4-(-([(Tert-butoxy)carbonyl]amino)propoxy)phenyl]ethynyl)-6-
[ethoxy(phenyl)phosphoryl]pyridin-2-yl)methyl acetate, 51 
(4-Bromo-6-[ethoxy(phenyl)phosphoryl]pyridine-2-yl)methyl acetate, 45 (170 mg, 0.43 mmol) was 
dissolved in dry THF (3 mL) and the solution was degassed (freeze-thaw cycle) three times. Tert-
butyl N-(3-(4-[2-trimethylsilyl)ethynyl]phenoxy)propyl)carbamate* (148 mg, 0.43 mmol) and NEt3 
(1.5 mL) were added and the solution was degassed once. Tetrakis(triphenylphosphine)palladium(0) 
(49 mg, 0.043 mmol) and CuI (8 mg, 0.043 mmol) were added and the solution was degassed a 
further three times. The solution was stirred under argon and tetrabutylammonium fluoride solution (1 
M in THF, 0.6 mL, 0.64 mmol) was added. A colour change from yellow to a dark blue was observed 
and the mixture was stirred at 65 °C under argon. The reaction was followed using TLC (silica; 
CH2Cl2 : 5 % CH3OH, Rf(product) = 0.42, Rf(reactant) = 0.46) and stopped after 3 h. The solvent was 
removed under reduced pressure and the crude material purified by column chromatography (silica, 
CH2Cl2 : CH3OH 0 – 1.5 % in 0.1 % increments) to give a yellow oil (174 mg, 69 %); δH (CDCl3) 
8.09 (1H, dd, 3JH-P 6.0 Hz, 4JH-H 2.0 Hz, H5), 7.99 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.54 (1H, t, 
3JH-H 8.4 Hz, Hp), 7.47 (2H, d, 3JH-H 8.4 Hz, H12), 7.45 (2H, td, 3JH-H 8.4 Hz 4JH-P 4.2 Hz, Hm), 7.45 
(1H, d, 4JH-H 2.0 Hz, H3), 6.88 (2H, d, 3JH-H 8.4 Hz, H13), 5.24 (2H, s, H1), 4.75 (1H, br s, H18), 4.14 
(2H, qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, H7), 4.05 (2H, t, 3JH-H 6 Hz, H15), 3.33 (2H, m, H17),  2.17 (3H, s, 
HOAc), 1.92 (2H, q, 3JH-H 6 Hz, H16), 1.44 (9H, s, H21), 1.38 (3H, t, 3JH-H 5.6 Hz, H8); δC (CDCl3) 170.7 
(s, CC=O(OAc)), 160.0 (s, C14), 157.3 (d, 3JC-P 20.3 Hz, C2), 156.2 (s, C19), 154.6 (d, 1JC-P 167 Hz, C6), 
133.9 (s, C12), 133.2 (d, 2JC-P 12 Hz, C4), 132.7 (d, 4JC-P 5 Hz, Cp), 132.6 (d, 2JC-P 10 Hz, Co), 130.1 (d, 
1JC-P 138 Hz, Ci), 129.1 (d, 3JC-P 23 Hz, C5), 128.6 (d, 3JC-P 13 Hz, Cm), 124.6 (d, 4JC-P 3 Hz, C3), 114.9 
(s, C13), 114.1 (s, C11), 96.2 (s, C10), 85.5 (d, 4JC-P 2 Hz, C9), 79.5 (s, C20),  66.5 (s, C1), 66.1 (s, C15), 
62.1 (d, 2JC-P 6 Hz, C7), 38.1 (s, C17), 29.7 (s, C16), 28.6 (s, C21), 21.1 (s, CMe(OAc)), 16.7 (C8); δP 
(CDCl3) +26.1; m/z (HRMS+) 593.2435 [M + H]+ (C32H38O7N2P requires 593.2417); Rf = 0.42 (silica, 
CH2Cl2 : 5 % MeOH). 
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* Tert-butyl N-(3-(4-[2-trimethylsilyl)ethynyl]phenoxy)propyl)carbamate: 
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Ethyl-[6-(hydroxymethyl)-4-[2-(4-(2-[2-(2-methoxyethoxy)-
ethoxy]ethoxy)phenyl)ethynyl]pyridin-2-yl](phenyl)phosphinate, 52 
(6-[Ethoxy(phenyl)phosphoryl]-4-[2-(4-(2-[2-(2-
methoxyethoxy)ethoxy]ethoxy)phenyl)ethynyl]pyridin-2-yl)methyl acetate, 50 (50 mg, 0.086 mmol) 
was dissolved in anhydrous CH3CH2OH (200 proof, 2.5 mL). A catalytic amount of sodium metal (~2 
mg) was added and the solution was stirred at 40 °C under argon. The reaction was monitored by TLC 
(silica; CH2Cl2 : 5 % CH3OH, Rf(product) = 0.19, Rf(reactant) = 0.31) and stopped after 40 min. To 
the crude reaction mixture CH2Cl2 (25 mL) was added and sodium salts were removed by filtration 
through a short silica plug. The silica was rinsed with CH2Cl2 : 10 % CH3CH2OH (300 mL) to ensure 
all material was desorbed from the silica. The solvent was removed under reduced pressure and the 
crude material was purified by column chromatography (silica, CH2Cl2 : CH3OH 0 – 2.4 % in 0.2 % 
increments) to give a colourless oil (40 mg, 87 %); δH (CDCl3) 8.06 (1H, dd, 3JH-P 6.0 Hz, 4JH-H 1.6 
Hz, H5), 7.95 (2H, dd, 3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.53 (1H, t, 3JH-H 8.4 Hz, Hp), 7.44 (2H, d, 3JH-H 
8.8 Hz, H12), 7.43 (2H, td, 3JH-H 8.4 Hz 4JH-P 4.2 Hz, Hm), 7.39 (1H, d, 4JH-H 1.6 Hz, H3), 6.90 (2H, d, 
3JH-H 8.8 Hz, H13), 4.75 (2H, s, H1), 4.14 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, H7), 4.11 (2H, t, 3JH-H 4.8 
Hz, H15), 3.86 (2H, t, 3JH-H 4.8 Hz, H16), 3.73 (2H, t, 3JH-H 4.8 Hz, H17), 3.68 (2H, t, 3JH-H 4.8 Hz, H18), 
3.66 (2H, t, 3JH-H 4.8 Hz, H19), 3.63 (2H, t, 3JH-H 4.8 Hz, H20), 3.37 (3H, s, H21), 1.37 (3H, t, 3JH-H 5.6 
Hz, H8); δC (CDCl3) 160.4 (d, 3JC-P 19 Hz, C2), 159.9 (s, C14), 154.0 (d, 1JC-P 165 Hz, C6), 133.6 (s, 
C12), 133.0 (d, 2JC-P 12 Hz, C4), 132.6 (d, 4JC-P 5 Hz, Cp), 132.3 (d, 2JC-P 10 Hz, Co), 129.7 (d, 1JC-P 128 
Hz, Ci), 128.6 (d, 3JC-P 22 Hz, C5), 128.4 (d, 3JC-P 12 Hz, Cm), 123.8 (d, 4JC-P 3 Hz, C3), 114.9 (s, C13), 
113.8 (s, C11), 96.0 (s, C10), 85.3 (d, 4JC-P 2 Hz, C9), 71.9 (s, C20), 70.9 (s, C17), 70.7 (s, C18), 70.6 (s, 
C19), 69.6 (s, C16), 67.5 (C15), 63.9 (s, C1), 61.8 (d, 2JC-P 6 Hz, C7), 59.1 (s, C21), 16.5 (C8); δP (CDCl3) 
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+26.6; m/z (HRMS+) 540.2142 [M + H]+ (C29H35O7NP requires 540.2151); Rf = 0.19 (silica, CH2Cl2 : 
5 % MeOH). 
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Tert-butyl N-(3-[4-(2-(2-[ethoxy(phenyl)phosphoryl]-6-(hydroxymethyl)pyridin-2-
yl)ethynyl)phenoxy]propyl)carbamate, 53 
(4-(2-[4-(-([(Tert-butoxy)carbonyl]amino)propoxy)phenyl]ethynyl)-6-
[ethoxy(phenyl)phosphoryl]pyridin-2-yl)methyl acetate, 51 (32 mg, 0.054 mmol) was dissolved in 
anhydrous CH3CH2OH (200 proof, 2.5 mL). A catalytic amount of sodium metal (~2 mg) was added 
and the solution was stirred at 40 °C under argon. The reaction was monitored by TLC (silica; CH2Cl2 
: 5 % CH3OH, Rf(product) = 0.25, Rf(reactant) = 0.42) and stopped after 40 min. To the crude reaction 
mixture CH2Cl2 (25 mL) was added and sodium salts were removed by filtration through a short silica 
plug. The silica was rinsed with CH2Cl2 : 10 % CH3CH2OH (300 mL) to ensure all material was 
desorbed from the silica. The solvent was removed under reduced pressure and the crude material was 
purified by column chromatography (silica, CH2Cl2 : CH3OH 0 – 2 % in 0.2 % increments) to give a 
colourless oil (24 mg, 80 %); δH (CDCl3) 8.01 (1H, dd, 3JH-P 6.4 Hz, 4JH-H 2.0 Hz, H5), 7.89 (2H, dd, 
3JH-H 8.4 Hz 3JH-P 12.4 Hz, Ho), 7.48 (1H, t, 3JH-H 8.4 Hz, Hp), 7.40 (2H, d, 3JH-H 8.8 Hz, H12), 7.39 (2H, 
td, 3JH-H 8.4 Hz 4JH-P 4.2 Hz, Hm), 7.33 (1H, d, 4JH-H 2.0 Hz, H3), 6.81 (2H, d, 3JH-H 8.8 Hz, H13), 4.73 
(1H, br s, H18), 4.69 (2H, s, H1), 4.08 (2H, qd, 3JH-H 5.6 Hz 3JH-P 4.8 Hz, H7), 3.97 (2H, t, 3JH-H 6 Hz, 
H15), 3.26 (2H, m, H17), 1.92 (2H, q, 3JH-H 6 Hz, H16), 1.37 (9H, s, H21), 1.31 (3H, t, 3JH-H 5.6 Hz, H8); 
δC (CDCl3) 160.3 (d, 3JC-P 18 Hz, C2), 159.8 (s, C14), 156.0 (s, C19), 153.2 (d, 1JC-P 164 Hz, C6), 133.7 
(s, C12), 133.0 (d, 2JC-P 11 Hz, C4), 132.6 (d, 4JC-P 5 Hz, Cp), 132.3 (d, 2JC-P 10 Hz, Co), 129.6 (d, 1JC-P 
138 Hz, Ci), 128.6 (d, 3JC-P 18 Hz, C5), 128.5 (d, 3JC-P 9 Hz, Cm), 123.8 (d, 4JC-P 3 Hz, C3), 114.7 (s, 
C13), 113.8 (s, C11), 96.0 (s, C10), 85.3 (d, 4JC-P 2 Hz, C9), 79.3 (s, C20),  65.9 (s, C15), 63.8 (s, C1), 61.9 
(d, 2JC-P 6 Hz, C7), 37.9 (s, C17), 29.5 (s, C16), 28.4 (s, C21), 16.6 (C8); δP (CDCl3) +25.6; m/z (HRMS+) 
551.2290 [M + H]+ (C30H36O6N2P requires 551.2311); Rf = 0.25 (silica, CH2Cl2 : 5 % MeOH). 
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Ethyl-[6-(bromomethyl)-4-[2-(4-(2-[2-(2-
methoxyethoxy)ethoxy]ethoxy)phenyl)ethynyl]pyridin-2-yl](phenyl)phosphinate, 54 
Ethyl-[6-(hydroxymethyl)-4-[2-(4-(2-[2-(2-methoxyethoxy)-ethoxy]ethoxy)phenyl)ethynyl]pyridin-2-
yl](phenyl)phosphinate, 52 (116 mg, 0.22 mmol) was dissolved in dry CH2Cl2 (5 mL) and the solution 
was stirred at 0 °C under argon. PBr3 (30 µL, 0.33 mmol) was added and the solution was stirred for a 
further 1 h at 0 °C. The reaction mixture was allowed to warm to room temperature and monitored by 
TLC (silica; CH2Cl2 : 5 % CH3OH, Rf(product) = 0.50, Rf(reactant) = 0.19). After 1 h at 20 °C the 
crude reaction mixture was immediately purified by column chromatography (silica, CH2Cl2 : 1 % 
CH3OH) to give the title product as a yellow oil (95 mg, 73 %); δH (CDCl3) 8.00 (1H, dd, 3JH-P 6.0 Hz, 
4JH-H 1.2 Hz, H5), 7.94 (2H, dd, 3JH-H 8.8 Hz 3JH-P 12.4 Hz, Ho), 7.51 (1H, d, 4JH-H 1.2 Hz, H3), 7.48 
(1H, t, 3JH-H 8.8 Hz, Hp), 7.41 (2H, d, 3JH-H 8.8 Hz, H12), 7.40 (2H, td, 3JH-H 8.8 Hz 4JH-P 4.2 Hz, Hm), 
6.85 (2H, d, 3JH-H 8.8 Hz, H13), 4.48 (2H, s, H1), 4.09 (2H, qd, 3JH-H 7.2 Hz 3JH-P 4.8 Hz, H7), 4.08 (2H, 
t, 3JH-H 4.8 Hz, H15), 3.81 (2H, t, 3JH-H 4.8 Hz, H16), 3.67 (2H, t, 3JH-H 4.8 Hz, H17), 3.63 (2H, t, 3JH-H 
4.8 Hz, H18), 3.59 (2H, t, 3JH-H 4.8 Hz, H19), 3.49 (2H, t, 3JH-H 4.8 Hz, H20), 3.31 (3H, s, H21), 1.32 (3H, 
t, 3JH-H 7.2 Hz, H8); δC (CDCl3) 160.1 (d, 3JC-P 19 Hz, C2), 159.9 (s, C14), 154.3 (d, 1JC-P 165 Hz, C6), 
133.6 (s, C12), 133.3 (d, 2JC-P 12 Hz, C4), 132.4 (d, 4JC-P 5 Hz, Cp), 132.3 (d, 2JC-P 10 Hz, Co), 129.7 (d, 
1JC-P 128 Hz, Ci), 128.6 (d, 3JC-P 22 Hz, C5), 128.4 (d, 3JC-P 13 Hz, Cm), 126.7 (d, 4JC-P 3 Hz, C3), 114.9 
(s, C13), 113.8 (s, C11), 96.3 (s, C10), 84.9 (d, 4JC-P 2 Hz, C9), 71.9 (s, C20), 70.9 (s, C17), 70.7 (s, C18), 
70.6 (s, C19), 69.6 (s, C16), 67.5 (C15), 61.0 (d, 2JC-P 5 Hz, C7), 59.1 (s, C21), 33.1 (s, C1), 16.6 (C8); δP 
(CDCl3) +24.8; m/z (HRMS+) 602.1302 [M (79Br) + H]+ (C29H34O6NP79Br  requires 602.1302), Rf = 
0.50 (silica, CH2Cl2 : 5 % MeOH). 
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Tert-butyl N-[3(4-(2-[2-(bromomethyl)-6-[ethoxy(phenyl)phosphoryl]pyridin-4-
yl]ethynyl)phenoxy)propyl]carbamate, 55 
Tert-butyl N-(3-[4-(2-(2-[ethoxy(phenyl)phosphoryl]-6-(hydroxymethyl)pyridin-2-
yl)ethynyl)phenoxy]propyl)carbamate, 53 (25 mg, 0.045 mmol) was dissolved in dry CH2Cl2 (3 mL) 
and the solution was stirred at 0 °C under argon. PBr3 (4.3 µL, 0.045 mmol) was added and the 
solution stirred for a further 45 min at 0 °C. The reaction mixture was allowed to warm to room 
temperature and monitored by TLC (silica; CH2Cl2 : 5 % CH3OH, Rf(product) = 0.45, Rf(reactant) = 
0.25). After 30 min at 23 °C a precipitate formed. The precipitate was found to be the ammonium 
bromide salt of 55 resulting from loss of the BOC protecting group. This material was converted into 
55 according to the procedure described below.* The supernatant, which contained some of the 
desired compound, was decanted and purified immediately by column chromatography (silica, 
CH2Cl2 : 0.8 % MeOH) to give the title compound as a colourless oil (8 mg). 
 
*To the precipitate which formed was added dry CH2Cl2 (3 mL) and di-tert-butyl dicarbonate (19 mg, 
0.087 mmol). N,N-Diisopropylethylamine (30 µL, 0.17 mmol) was added causing the ammonium 
bromide salt of 55 to dissolve. The mixture was stirred under argon at 0 °C for 30 min followed by 30 
min at 23 °C. At this point the reaction mixture was immediately purified by column chromatography 
(silica, CH2Cl2 : 0.8 % MeOH) to give the title compound as a colourless oil (5 mg,). 
 
Total title compound (13 mg, 47 %); δH (CDCl3) 8.07 (1H, dd, 3JH-P 6.0 Hz, 4JH-H 1.2 Hz, H5), 8.01 
(2H, dd, 3JH-H 8.4 Hz 3JH-P 12 Hz, Ho), 7.58 (1H, d, 4JH-H 1.2 Hz, H3), 7.55 (1H, t, 3JH-H 8.4 Hz, Hp), 
7.47 (2H, td, 3JH-H 8.4 Hz 4JH-P 4.2 Hz, Hm), 7.46 (2H, d, 3JH-H 8.8 Hz, H12), 6.89 (2H, d, 3JH-H 8.8 Hz, 
H13), 4.72 (1H, br s, H18), 4.55 (2H, s, H1), 4.15 (2H, qd, 3JH-H 6.0 Hz 3JH-P 4.8 Hz, H7), 4.05 (2H, t, 
3JH-H 6 Hz, H15), 3.33 (2H, m, H17), 2.00 (2H, q, 3JH-H 6 Hz, H16), 1.44 (9H, s, H21), 1.38 (3H, t, 3JH-H 
6.0 Hz, H8); δP (CDCl3) +25.8; m/z (HRMS+) 613.1462 [M (79Br) + H]+ (C30H34O5N2P79Br requires 
613.1462); Rf = 0.45 (silica, CH2Cl2 : 5 % MeOH). 
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Tert-butoxycarbonyl-protected di-ethyl phenylphosphinate ester of  L13, 57 
Tert-butyl-1,4,7-triazacyclononane-1-carboxylate* (22 mg, 0.096 mmol) and ethyl-[6-(bromomethyl)-
4-[2-(4-(2-[2-(2-methoxyethoxy)ethoxy]ethoxy)phenyl)ethynyl]pyridin-2-yl](phenyl)phosphinate, 54 
(95 mg, 0.16 mmol) were dissolved in CH3CN (5 mL) and K2CO3 (27 mg, 0.19 mmol) was added. 
The mixture was stirred under argon at 50 °C and monitored by TLC (silica; CH2Cl2 : 10 % CH3OH, 
Rf(product) = 0.41, Rf(reactant 54) = 0.81). After 1 h all of the starting material had been consumed 
and the reaction was cooled and the solution decanted from excess potassium salts. The solvent was 
removed under reduced pressure and the crude material purified by column chromatography (silica, 
CH2Cl2 : CH3OH 0 – 5 % in 0.5 % increments) to give the title product as a yellow oil (58 mg, 59 %): 
δH (CDCl3) 8.01 (2H, m, H5), 7.95 (4H, m, Ho), 7.56 (2H, br s, H3), 7.45 (2H, m, Hp), 7.41 (4H, d, 3JH-
H 8.8 Hz, H12), 7.40 (4H, m, Hm), 6.87 (4H, d, 3JH-H 8.8 Hz, H13), 4.13 (4H, t, 3JH-H 4.8 Hz, H15), 4.10 
(4H, m, H7), 3.85 (4H, s, H1), 3.84 (4H, t, 3JH-H 4.8 Hz, H16), 3.72 (4H, t, 3JH-H 4.8 Hz, H17), 3.66 (4H, 
t, 3JH-H 4.8 Hz, H18), 3.63 (4H, t, 3JH-H 4.8 Hz, H19), 3.53 (4H, t, 3JH-H 4.8 Hz, H20), 3.35 (6H, s, H21), 
3.24 (4H, br m, ring Hs), 2.97 (4H, br m, ring Hs), 2.53 (4H, br m, ring Hs), 1.45 (9H, s, H24), 1.33 
(6H, m, H8); δC (CDCl3) 161.6, 161.4 (d, 3JC-P 19 Hz, C2), 159.7, 159.6 (s, C22), 155.5 (s, C14), 153.8, 
153.7 (d, 1JC-P 165 Hz, C6), 133.6, 133.5 (s, C12), 133.3 (br m, C4), 132.4 (br m, Cp), 132.3 (br m, Co), 
130.1 (d, 1JC-P 145 Hz, Ci), 128.1 (br m, C5), 128.0 (br m, Cm), 126.2, 125.9 (d, 4JC-P 3 Hz, C3), 114.9, 
114.7 (s, C13), 114.1, 114.0 (s, C11), 95.4, 95.1 (s, C10), 85.7, 85.5 (br m, C9), 71.9 (s, C20), 70.8 (s, 
C17), 70.6 (s, C18), 70.5 (s, C19), 69.6 (s, C16), 67.5 (C15), 63.0 – 49.1 (br m, ring Cs), 61.6 (br m, C7), 
59.0 (s, C21), 53.4 (br m, C1), 28.7, 28.6 (s, C24), 16.5 (C8); δP (CDCl3) +26.6, +26.5; m/z (HRMS+) 
1272.584 [M + H]+ (C69H88O14N5P2  requires 1272.580), Rf = 0.41 (silica, CH2Cl2 : 10 % MeOH). 
 
* Tert-butyl-1,4,7-triazacyclononane-1-carboxylate: 
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Tri-ethyl phenylphosphinate ester of L12, 58 
The tert-butoxycarbonyl-protected di-ethyl phenylphosphinate ester of  L13, 57 (47 mg, 0.037 mmol) 
was dissolved in anhydrous CH2Cl2 (1 mL) and trifluoroacetic acid (0.5 mL) was added. The solution 
was stirred under argon at 23 °C for 30 min. TLC (silica; CH2Cl2 : 10 % CH3OH, Rf(product) = 0.10, 
Rf(reactant) = 0.41) and HRMS+ (1172.528 [M + H]+ C64H80O12N5P2 requires 1172.527) were used to 
confirm protecting group removal had gone to completion. The solvent was removed under reduced 
pressure and the residue re-dissolved in CH2Cl2 (1 mL), which was again removed under reduced 
pressure. This process was repeated 5 times to ensure removal of excess trifluoroacetic acid. The 
residue was dissolved in CH3CN (4 mL) and tert-butyl N-[3(4-(2-[2-(bromomethyl)-6-
[ethoxy(phenyl)phosphoryl]pyridin-4-yl]ethynyl)phenoxy)propyl]carbamate, 55 (18 mg, 0.029 mmol) 
and K2CO3 (15 mg, 0.11 mmol) were added. The solution was stirred at 50 °C and the reaction 
monitored by LC-MS and TLC (silica; CH2Cl2 : 10 % CH3OH, Rf(product) = 0.20, Rf(reactant 55) = 
0.73). After 30 min all of the starting bromide 55 had been consumed and the reaction was cooled and 
the solvent removed under reduced pressure. The crude residue was purified by column 
chromatography (silica, CH2Cl2 : CH3OH 0 – 10 % in 0.5 % increments) to give the title product as a 
yellow oil (25 mg, 50 %); δH (CDCl3) 8.07 (3H, d, 3JH-P 6.0 Hz, H5), 7.85 (6H, dd, 3JH-H 8.4 Hz 3JH-P 
12 Hz, Ho), 7.48 (3H, m, H3), 7.47 (3H, m, Hp), 7.46 (6H, d, 3JH-H 8.8 Hz, H12), 7.39 (6H, m, Hm), 6.90 
(6H, d, 3JH-H 8.8 Hz, H13), 4.76 (1H, br s, H18’), 4.14 (6H, m, H7), 4.11 (4H, t, 3JH-H 4.8 Hz, H15), 4.04 
(2H, t, 3JH-H 6 Hz, H15’), 3.94 (6H, br s, H1), 3.87 (4H, t, 3JH-H 4.8 Hz, H16), 3.73 (4H, t, 3JH-H 4.8 Hz, 
H17), 3.68 (4H, t, 3JH-H 4.8 Hz, H18), 3.65 (4H, t, 3JH-H 4.8 Hz, H19), 3.54 (4H, t, 3JH-H 4.8 Hz, H20), 3.37 
(6H, s, H21), 3.34 (2H, m, H17’), 2.81 (12H, br m, ring Hs), 1.99 (2H, q, 3JH-H 6 Hz, H16’), 1.43 (9H, s, 
H21’), 1.34 (9H, t, 3JH-H 7.2 Hz, H8); δC (CDCl3) 160.8 (d, 3JC-P 19 Hz, C2), 160.2 (s, C19’), 156.2 (s, 
C14), 154.6 (d, 1JC-P 165 Hz, C6), 134.0 (s, C12), 133.9 (br m, C4), 132.9 (br m, Cp), 132.5 (d, 2JC-P 10 
Hz, Co), 130.2 (d, 1JC-P 138 Hz, Ci), 128.8 (br m, C5), 128.7 (br m, Cm), 127.5 (br m, C3), 115.1 (s, 
C13), 113.9 (s, C11), 97.0 (s, C10), 85.3 (s, C9), 79.6 (s, C20’), 72.1 (s, C20), 71.1 (s, C17), 70.9 (s, C18), 
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70.8 (s, C19), 69.8 (s, C16), 67.8 (C15), 65.9 (s, C15’), 62.0 (d, 2JC-P 6 Hz, C7), 59.3 (s, C21), 52.3 (s, C1), 
53.0 – 46.0 (br m, ring Cs), 37.9 (s, C17’), 29.7 (s, C16’), 28.6 (s, C21’), 16.8 (C8); δP (CDCl3) +26.4; m/z 
(HRMS+) 1704.741 [M + H]+ (C94H113O17N7P3  requires 1704.740), Rf = 0.20 (silica, CH2Cl2 : 10 % 
MeOH). 
 
 
[Eu·L12] 
The tri-ethyl phenylphosphinate ester of L12, 58 (25 mg, 0.015 mmol) was dissolved in anhydrous 
CH2Cl2 (1 mL) and trifluoroacetic acid (0.5 mL) was added. The solution immediately underwent a 
change from colourless to yellow and was stirred under argon at 23 °C for 30 min. TLC was used to 
confirm that all starting material had been consumed. The solvent was removed under reduced 
pressure and the residue re-dissolved in CH2Cl2 (1 mL), which was again removed under reduced 
pressure. This process was repeated 5 times to ensure removal of excess trifluoroacetic acid. 1H-NMR 
(loss of CH3 peak at 1.43 ppm) and ESI-MS+ (802.8 [M + 2H]2+, 803.8 [M(13C) + 2H]2+) was used to 
confirm removal of the tert-butoxycarbonyl group. The residue was dissolved in CD3OD (2.5 mL) 
and D2O (1.5 mL) was added. The solution was heated to 60 °C and NaOD solution was added (0.5 
M, 0.5 mL). The reaction was monitored by 1H-NMR (loss of CH3CH2 peaks at 4.14 and 1.34 ppm) 
and 31P-NMR (reactant 26.6 ppm, product 17.3 ppm) and stopped after 24 h. The pH of the solution 
was reduced to 7 by addition of HCl (1M). CH3OH (1 mL) was added to ensure all material was in 
solution. Eu(OAc)3 (7 mg, 0.016 mmol) in a H2O : CH3OH solution (0.5 mL, 1:1 v/v) was added and 
the solution was stirred at 50 °C for 14 h. The solvent was removed under reduced pressure and the 
crude material purified by column chromatography (silica, CH2Cl2 : 10 % CH3OH : aq. NH3 solution 
0 – 1 % in 0.1 % increments) to give the title product as a white solid (9.1 mg, 34 %); m/z (HRMS+) 
1668.498 [M – CF3CO2]+ (C83H90O15N7P3151Eu requires 1668.490); δP (CD3OD) +17.5; Rf = 0.12 
(silica, CH2Cl2 : 10 % MeOH : NH3 1 %). =MeOHτ 1.25 ms, =OH 2τ 0.96 ms, =OD2τ 1.28 ms, 
=ΦemMeOH  55 ± 10 %; εMeOH (332 nm) = 60, 000 M-1 cm-1; tR  (Method D) = 11.5 min. 
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[Eu·L13(H2O)]Cl 
The tert-butoxycarbonyl-protected di-ethyl phenylphosphinate ester of L13, 57 (20 mg, 0.016 mmol) 
was dissolved in anhydrous CH2Cl2 (1 mL) and trifluoroacetic acid (0.5 mL) was added. The solution 
was stirred under argon at 23 °C for 30 min. TLC (silica; CH2Cl2 : 10 % CH3OH, Rf(product) = 0.10, 
Rf(reactant) = 0.41) and HRMS+ (1172.528 [M + H]+ C64H80O12N5P2 requires 1172.527) were used to 
confirm removal of the tert-butoxycarbonyl group. The solvent was removed under reduced pressure 
and the residue re-dissolved in CH2Cl2 (1 mL), which was again removed under reduced pressure. 
This process was repeated 5 times to ensure removal of excess trifluoroacetic acid. The residue was 
dissolved in CD3OD (2 mL) and D2O (1 mL) was added. The solution was heated to 60 °C and NaOD 
solution was added (0.5 M, 0.5 mL). The reaction was monitored by 1H-NMR (loss of CH3CH2 peaks 
at 4.13 and 1.34 ppm) and 31P-NMR (reactant 26.6 ppm, product 16.6 ppm) and stopped after 18 h. 
The pH of the solution was adjusted to 7 by addition of HCl (1M). CH3OH (1 mL) was added to 
ensure all material was in solution. Eu(OAc)3 (7 mg, 0.016 mmol) in a H2O : CH3OH solution (0.5 
mL, 1:1 v/v) was added and the solution was stirred at 50 °C for 16 h. The solvent was removed under 
reduced pressure and the crude material purified by preparative-HPLC to give the title product as a 
white solid (7.8 mg, 38 %); m/z (ESI-MS+) 1266.391 [M]+ (C60H69O12N5P2153Eu requires 1266.363); δP 
(CD3OD) +25.8, +13.6; =OH 2τ 0.33 ms, =OD2τ 0.50 ms, =Φ
em
MeOH  18 ± 10 %; εMeOH (332 nm) = 44, 
000 M-1 cm-1; tR  (Method D) = 9.5 min. 
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Appendix 1.  
HPLC Methods and Traces 
 
Reverse phase HPLC analysis was performed at 298 K on a Perkin Elmer system, comprising a Perkin 
Elmer Series 200 pump, Perkin Elmer Series 200 autosampler, Perkin Elmer Series 200 UV/Vis 
detector and Perkin Elmer Series 200 fluorescence detector. 
 
Column 1: Phenomenex Synergi 4u Fusion-RP 80i 150 × 4.66 mm 4 µm particle size. 
Column 2: XBridge C18 100 × 5.00 mm 3.5 µm particle size. 
 
Method A: 
Time (min) H2O + 0.1 % HCO2H CH3CN + 0.1 % HCO2H 
0 95 5 
2 95 5 
15 0 100 
17 0 100 
22 95 5 
 
Method B: 
Time (min) H2O + 0.1 % HCO2H CH3CN + 0.1 % HCO2H 
0 95 5 
2 95 5 
20 0 100 
23 0 100 
28 95 5 
 
Method C: 
Time (min) H2O + 0.1 % HCO2H CH3CN + 0.1 % HCO2H 
0 95 5 
1 95 5 
8 0 100 
11 0 100 
13 95 5 
 
Method D: 
Time (min) H2O + 0.1 % HCO2H CH3CN + 0.1 % HCO2H 
0 95 5 
2 95 5 
13 0 100 
15 0 100 
17 95 5 
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a) HPLC analysis of [EuL1], Method A, Column 1 λabs = 328. 
 
 
 
 
b) HPLC analysis of [TbL1], Method A, Column 2, λabs = 328. 
 
 
 
 
c) HPLC analysis of [EuL2]Cl, Method A, Column 1, λabs = 328. 
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d) HPLC analysis of [TbL2]Cl, Method A, Column 1, λabs = 328. 
 
 
 
 
e) HPLC analysis of [EuL2b]Cl, Method C, Column 2, λabs = 368. 
 
 
 
f) HPLC analysis of [EuL3]Cl2, Method A, Column 1, λabs = 328. 
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g) HPLC analysis of [EuL4]Cl3, Method A, Column 1, λabs = 328. 
 
 
 
h) HPLC analysis of [EuL5], Method B, Column 1, λabs = 275. 
 
 
 
i) HPLC analysis of Na[EuL6], Method B, Column 1, λabs = 275. 
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j) HPLC analysis of Na[EuL7], Method B, Column 1, λabs = 275. 
 
 
 
 
k) HPLC analysis of Na[EuL8], Method B, Column 1, λabs = 275. 
 
 
 
 
l) HPLC analysis of [EuL9], Method C, Column 2, λabs = 275. 
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      m)  HPLC analysis of [EuL11], Method D, Column 1, λabs = 332. 
 
 
 
 
n) HPLC analysis of [EuL12], Method D, Column 1, λabs = 332. 
 
 
 
 
o) HPLC analysis of [EuL13]Cl, Method D, Column 1, λabs = 332. 
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Appendix 2.  
Stability Assays for Each Complex 
 
 
a) Changes in Eu3+ emission intensity after 15 min (blue) or 18h (red) in the presence of the 
stated additives (10nM complex, 20mM additive,  λex = 335 nm, λex = 620 nm). 
 
              
 
 
b) Changes in Eu3+ emission intensity after 15 min or 18 h in the presence of the stated additives 
(10nM complex, 20mM additive,  λex = 335 nm, λex = 620 nm). 
 
 
 
H2O
20 mM CaCl2
20 mM MgCl2
20 mM MnCl2
20 mM EDTA
50% SVNN
50% RPMI+
[Eu·L5] [Eu·L6]- [Eu·L7]- 
15 min            18 h 15 min            18 h 15 min            18 h 
[Eu·L8]- 
15 min               18 h 15 min                        18 h 
[Eu·L9] 
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c) Stability assay for [Eu·L10] (blue), [Eu·L10] in 0.4 M KF (red) and [Eu·L1.1]3+ (green) after 10 
min (upper) and 18 h (lower) (10nM complex, 20mM additive,  λex = 335 nm, λex = 620 nm). 
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d) Changes in Eu3+ emission intensity after 15 min or 18 h in the presence of the stated additives 
(10nM complex, 20mM additive,  λex = 335 nm, λex = 620 nm).  
 
 
e) Changes in Eu3+ emission intensity after 15 min (left) or 18 h (right) in the presence of the 
stated additives (10nM complex, 20mM additive,  λex = 335 nm, λex = 620 nm). 
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Appendix 3.  
 
List of Complexes 
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